Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
115 "GR"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Complications
Article image
Time-Window Stratified Machine-Learning Risk Prediction Model for Diabetic Retinopathy and Cross-Cohort Study
Jingwen Hui, Zheya Han, Yuxi Bai, Yawen Gong, Quanhong Han, Xuehao Cui
Received November 1, 2025  Accepted December 18, 2025  Published online April 15, 2026  
DOI: https://doi.org/10.4093/dmj.2025.1098    [Epub ahead of print]
  • 5 View
  • 1 Download
AbstractAbstract PDF
Background
Diabetic retinopathy (DR) remains a significant cause of vision loss worldwide. Existing risk models rarely account for when DR develops relative to the onset of diabetes, even though early- and late-onset disease may have different clinical implications. We hypothesized that DR occurring within 6 years of diabetes diagnosis (short-term) represents an early-onset phenotype driven mainly by metabolic dysregulation and microvascular injury, whereas DR developing after 6 years (long-term) reflects late-onset disease shaped by cumulative metabolic burden and aging. This study aimed to develop and validate a time-window- stratified DR risk prediction model.
Methods
Data from two large cohorts (UK Biobank and Tianjin Eye Hospital) were analyzed, including 1,943 patients with diabetes but without DR at baseline. Separate Cox models were built for short-term (≤6 years) and long-term (>6 years) DR incidence. Feature selection used least absolute shrinkage and selection operator (LASSO) and Boruta algorithms, and model performance was assessed by area under the curve (AUC), calibration, and decision curve analyses. Machine-learning models were further developed on pooled data for multiclass classification (no DR, short-term DR, long-term DR) and interpretability using SHapley Additive exPlanations (SHAP) analysis.
Results
Both models identified glycosylated hemoglobin and retinal neurostructural measures (retinal nerve fiber layer thickness and retinal ganglion cell layer thickness) as consistent predictors, indicating that neuroretinal degeneration precedes clinical DR. The short-term model emphasized renal and lipid metabolism markers, whereas the long-term model highlighted age and uric acid. Internal validation and cross-cohort replication showed stable discrimination (AUC 0.79–0.84). The pooled XGBoost model improved accuracy (overall approximately 80%) with transparent interpretability.
Conclusion
Time-window-based modeling revealed distinct early- and late-onset DR risk profiles, thereby enhancing prediction precision. Integrating optical coherence tomography imaging with routine clinical variables offers a practical, interpretable framework for individualized risk assessment and early intervention in DR.
Lifestyle and Behavioral Interventions
Article image
Influence of Fibroblast Growth Factor 21 on Delayed Glycemic Improvement Following Acute Exercise in Type 2 Diabetes Mellitus
Ying Zhang, Dan Liu, Yurun Lu, Piao Kang, Xinyu Liu, Qinyi Wang, Anran Chen, Di Cheng, Liang Wu, Qi Li, Xiaolin Wang, Yanli Li, Yaorui Ye, Jingyi Yang, Jiacheng Ni, Qichen Fang, Zhe Huang, Aimin Xu, Weiping Jia, Yong Wang, Guowang Xu, Huating Li
Received December 12, 2024  Accepted October 14, 2025  Published online March 25, 2026  
DOI: https://doi.org/10.4093/dmj.2024.0814    [Epub ahead of print]
  • 514 View
  • 18 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Exercise positively influences glycemic control. Some individuals experience greater glycemic stability on the day after exercise, even without additional physical activity. However, the mechanisms underlying this delayed glycemic improvement remain unclear.
Methods
Seventy-one patients with type 2 diabetes mellitus were assigned to either a 60-minute exercise or resting group. Serum fibroblast growth factor 21 (FGF21) levels and untargeted metabolomic profiling were assessed at multiple time points before and after exercise. Interstitial glucose levels were monitored using continuous glucose monitoring system. FGF21 knockout mice and wildtype littermates on a high-fat diet, underwent a 3-week exercise intervention, and supplemented with recombinant mouse FGF21.
Results
Individuals exhibiting delayed glycemic improvement (responders) displayed a significantly stronger FGF21 response compared to non-responders. Baseline metabolites, including p-cresol sulfate and dimethylglycine, differed between responders and non-responders and were associated with the FGF21 response. Longitudinal time-series analyses revealed post-exercise differences in acylcarnitines, fatty acids, and complex lipids between responders and non-responders. Dynamic correlation and mediation analyses supported that FGF21 modulates delayed glycemic improvement via regulation of lipid metabolism. In vivo FGF21 knockout and rescue experiments demonstrated that FGF21 is necessary for these metabolic shifts and for the associated improvements in glucose tolerance and insulin sensitivity.
Conclusion
This study finds that the baseline metabolome is associated with the magnitude of the post-exercise FGF21 response, which influences delayed glycemic improvements through regulation of lipid metabolism pathways.
Lifestyle and Behavioral Interventions
Article image
Association between Changes in Physical Activity and Incident Depression among Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Sangwoo Park, Back Kim, Hye Jun Kim, Sun Jae Park, Jihun Song, Jina Chung, Seogsong Jeong, Sang Min Park, Dae Ho Lee, Soo Jung Choi
Received August 17, 2025  Accepted December 18, 2025  Published online February 23, 2026  
DOI: https://doi.org/10.4093/dmj.2025.0766    [Epub ahead of print]
  • 768 View
  • 28 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study aims to investigate the relationship between changes in physical activity patterns following a new diagnosis of type 2 diabetes mellitus (T2DM) and the risk of developing depression.
Methods
This study utilized comprehensive diabetes data from the National Health Insurance Service of South Korea. From this dataset, we included 254,619 individuals newly diagnosed with T2DM between 2009 and 2015 who had health examination data within 2 years before and after their diagnosis date and no prior history of depression. Physical activity levels were quantified using the metabolic equivalent of task (MET) method.
Results
Compared to individuals with 0 MET-min/wk of physical activity prior to a new T2DM diagnosis, those who increased their activity levels to 500–999 MET-min/wk after diagnosis showed a 23% reduction in the risk of depression, while an increase to ≥1,000 MET-min/wk was associated with a 25% reduction in depression risk. Conversely, individuals with 1–499 MET-min/wk before diagnosis who became inactive after diagnosis experienced a 25% increased risk of depression. A similar trend of increased depression risk was observed in those who reduced their physical activity from 500–999 or ≥1,000 MET-min/wk.
Conclusion
Changes in physical activity levels before and after a new diagnosis of T2DM significantly influence the risk of developing depression, with increased activity reducing the risk and decreased activity elevating the risk. This finding underscores the importance of encouraging physical activity to support mental health in patients with newly diagnosed T2DM.
Cardiovascular Risk/Epidemiology
Article image
Prognostic Impact of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Coronary Ischemia: A Retrospective Cohort Study
Haochen Xuan, Yik-Ming Hung, Ran Guo, Qingwen Ren, Jiayi Huang, Jingnan Zhang, Wenli Gu, Ho-Leung Chan, Gaozhen Cao, Run Wang, Calvin Ka-Lam Leung, Tongda Xu, Kai-Hang Yiu
Received March 11, 2025  Accepted July 22, 2025  Published online October 24, 2025  
DOI: https://doi.org/10.4093/dmj.2025.0200    [Epub ahead of print]
  • 6,516 View
  • 65 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Patients with type 2 diabetes mellitus (T2DM) and coronary ischemia face an exceptionally elevated risk, and the achievement of complete revascularization (CR) within this population could be challenging.
Methods
Patients with T2DM and coronary ischemia based on coronary angiography and retrospective angiographic fractional flow reserve analysis between 2014 and 2016 were included. The impact of the extent of revascularization on the improvement of endpoint events by sodium-glucose cotransporter 2 (SGLT2) inhibitors was analyzed. The primary study endpoint was major adverse cardiac events (MACE), while all-cause mortality served as secondary endpoints. Kaplan-Meier analysis and Cox proportional hazards regression model were adopted to assess the association between SGLT2 inhibitors and endpoint incidence.
Results
A total of 671 patients were identified. Among them, 206 (30.7%) were prescribed with SGLT2 inhibitors, while 484 (72.1%) achieved CR after the operation. During a mean 36-month follow-up, 100 MACE and 89 all-cause mortality were recorded. SGLT2 inhibitor users demonstrated lower rates of MACE (8.3% vs. 17.8%, P=0.002) and all-cause mortality (6.3% vs. 16.3%, P<0.001) compared to non-users. After adjusting for confounding factors in multivariable Cox analysis, the association between SGLT2 inhibitors and reduced MACE incidence remained consistent both in the CR and incomplete revascularization subgroups (hazard ratio [HR], 0.498; 95% confidence interval [CI], 0.246 to 0.938; P=0.040; and HR, 0.341; 95% CI, 0.123 to 0.805; P=0.023, respectively).
Conclusion
SGLT2 inhibitors were found to be associated with a reduced risk of 3-year MACE and all-cause mortality in patients with T2DM and coronary ischemia, regardless of extent of revascularization.
Complications
Article image
Targeting SLC25A33 Suppresses Vascular Smooth Muscle Cell Proliferation and Migration by Reducing Cytosolic mtDNA Levels: Implications for Occlusive Vascular Diseases
Daehoon Kim, Jieun Shin, Yeon-Kyung Choi, You Mie Lee, Keun-Gyu Park, Hyang Sook Kim, Jun-Kyu Byun
Diabetes Metab J. 2026;50(1):139-152.   Published online July 30, 2025
DOI: https://doi.org/10.4093/dmj.2024.0632
  • 2,640 View
  • 85 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Vascular smooth muscle cells (VSMCs) play a crucial role in the development of occlusive vascular diseases through abnormal proliferation and migration. This pathological behavior is closely associated with mitochondrial reactive oxygen species (ROS)-mediated mitochondrial DNA (mtDNA) damage. The mitochondrial carrier protein solute carrier family 25 member 33 (SLC25A33), essential for nucleoside transport, is integral to mtDNA production. This study aimed to investigate the effects of SLC25A33 inhibition on the proliferation and migration of VSMCs, as well as its impact on neointima formation.
Methods
VSMCs were isolated from the thoracic aorta of 4-week-old Sprague-Dawley rats. The effects of small interfering RNAinduced silencing of SLC25A33 mRNA on platelet-derived growth factor (PDGF)-induced proliferation and migration of VSMCs were analyzed. The in vivo effects of targeting the SLC25A33 gene on neointima formation were evaluated using a murine carotid artery ligation model by perivascularly applying Lenti-shSLC25A33 with Pluronic F-127 gel.
Results
First, we observed an upregulation of the SLC25A33 protein in the carotid artery ligation-induced neointima in mice. Silencing of SLC25A33 suppressed the PDGF-stimulated proliferation and migration of VSMCs and cell cycle progression. Knockdown of SLC25A33 inhibited PDGF-induced production of mtDNA and ROS, consequently inactivating the cyclic GMP-AMP synthesis (cGAS)-stimulator of interferon genes (STING)-TANK-binding kinase 1 (TBK1)-nuclear factor kappa B (NF-κB) pathway. Furthermore, the downregulation of SLC25A33 reduced carotid artery ligation-induced neointima in mice.
Conclusion
This study suggests that targeting SLC25A33 in VSMCs could be a novel therapeutic strategy to prevent occlusive vascular diseases.
Review
Basic and Translational Research
Article image
Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases
Yeon Jin Roh, Hyeonki Kim, Dong Wook Choi
Diabetes Metab J. 2025;49(3):368-385.   Published online May 1, 2025
DOI: https://doi.org/10.4093/dmj.2025.0195
  • 6,428 View
  • 174 Download
  • 4 Web of Science
  • 8 Crossref
AbstractAbstract PDFPubReader   ePub   
The liver plays a fundamental role in metabolic homeostasis, integrating systemic fuel utilization with the progression of various metabolic diseases. Hepatic stellate cells (HSCs) are a key nonparenchymal cell type in the liver, which is essential for maintaining hepatic architecture in their quiescent state. However, upon chronic liver injury or metabolic stress, HSCs become activated, leading to excessive extracellular matrix deposition and pro-fibrotic signaling, ultimately positioning them as key players in liver pathology. Emerging evidence highlights the critical roles of metabolic reprogramming and epigenetic regulation in HSCs activation. HSCs activation is driven by both intrinsic fuel metabolism reprogramming and extrinsic metabolic cues from the microenvironment, while the metabolic intermediates actively reshape the epigenetic landscape, reinforcing fibrogenic transcriptional programs. In this review, we summarize recent advances in understanding how metabolic and epigenetic alterations drive HSCs activation, thereby shaping transcriptional programs that sustain fibrosis, and discuss potential therapeutic strategies to target these interconnected pathways in human metabolic diseases.

Citations

Citations to this article as recorded by  
  • Breaking Glycolysis Barriers to Immunotherapy with Nanomedicines
    Miya Zhang, Yanhong Ren, Jiaping Li, Jiaji Yu, Qianqi Li, Heng Zhao, Zheng Wang, Xiaoyuan Chen, Junjie Cheng
    ACS Nano Medicine.2026; 1(1): 149.     CrossRef
  • Burden of MASLD and liver fibrosis: evidence from Phenome India cohort
    Meghana Arvind, Anshul Verma, Sreeshma Raj K, Satyartha Prakash, Vignesh S. Kumar, Mohammad Azhar Uddin, Ayushi Narayan, Mamta Rathore, Nancy Rawat, Ankita Sahu, Yogesh Kumar, Pulkit Hasmukhbhai Leuva, Monika Sharma, Rajesh S, Dwaipayan Saha, Ankita Mridh
    The Lancet Regional Health - Southeast Asia.2026; 45: 100723.     CrossRef
  • Beyond Organ-Specific Therapies: A Unified Approach to Multi-Organ Fibrosis
    Ziyan Pan, Shadi Zerehpoosh, Shu-Chi Wang, Necati Örmeci, Won Kim, Mohammed Eslam
    Drug Design, Development and Therapy.2026; Volume 20: 1.     CrossRef
  • α-Hederin Alleviates Endoplasmic Reticulum Stress by Upregulating TRIM38 Expression, Thereby Inhibiting Hepatic Stellate Cell Activation and Liver Fibrosis
    Wei Xu, Yang Yang, Fuqiang Li, Can Li, Gaojun Tang, Baofang Zhang, Mingliang Cheng
    Biomedicines.2026; 14(4): 829.     CrossRef
  • Unveiling the cellular and molecular mechanisms of traditional Chinese medicine in hepatic fibrosis
    Xiang Li, Xuemeng Yang, Yanyu Xu, Qianqian Zhao, Yang Xu, Jiahao Geng, Donghao Yin, Jiabo Wang, Xinhua Song
    Journal of Ethnopharmacology.2026; 365: 121571.     CrossRef
  • Loss of immunometabolic adaptability in MASH: gut-derived signals drive macrophage reprogramming and fibrosis
    Yan Li, Yuyuan Hu, Yuan He, Yuhang Yang, Dingwen Xue, Erkui Xue, Jinghan Jia, Wei Zhang, Jinxi Wang
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Hepatic stellate cell-specific miR-214 expression alleviates liver fibrosis without boosting steatosis and inflammation
    Fangqing Zhao, Xuan Niu, Ge Song, Lijie Wang, Yisheng Fu, Shuwen Li, Xinxin Gu, Qingkun Wang, Jiao Luo
    Journal of Translational Medicine.2025;[Epub]     CrossRef
  • PPARs in molecular pathogenesis and drug treatment of type 2 diabetes-related MASLD
    Amedeo Lonardo, Ralf Weiskirchen
    Exploration of Digestive Diseases.2025;[Epub]     CrossRef
Original Articles
Others
Article image
Fibroblast Growth Factor 21 Levels Are Associated With Perception and Neural Responses to Sweetness in Type 2 Diabetes Mellitus
Piao Kang, Ying Zhang, Dian Zeng, Dan Liu, Rui Han, Yuwei Lu, Di Cheng, Qinyi Wang, Silin Liu, Liang Wu, Qian Wu, Shujie Yu, Anran Chen, Jingyi Guo, Wenli Ge, Jiacheng Ni, Jingyi Yang, Xiaomeng Wu, Lifei Ma, Weiping Jia, Qichen Fang, Yuehua Li, Huating Li
Diabetes Metab J. 2025;49(4):893-905.   Published online March 26, 2025
DOI: https://doi.org/10.4093/dmj.2024.0390
  • 4,526 View
  • 125 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The relationship between fibroblast growth factor 21 (FGF21) and sweet taste perception and preference in type 2 diabetes mellitus (T2DM) remains unclear. This study aims to investigate this relationship and examine the neural responses of T2DM patients to high-calorie sweet (HCS) food pictures, further exploring its correlation with FGF21 levels.
Methods
We assessed sweet taste perception and preference in 40 T2DM patients and 41 controls using classical scales. Subsequently, the neural responses of 11 T2DM patients and 11 controls to HCS pictures were examined using functional magnetic resonance imaging. FGF21 levels were measured using chemiluminescent immunoassay, and the correlations with taste perception and neural responses were analyzed.
Results
Increased FGF21 levels were associated with decreased sweet perception and increased sweet taste preference in T2DM patients. Compared to control, T2DM patients exhibited greater neural activations in the orbitofrontal cortex, anterior cingulate cortex (ACC), thalamus, and hippocampus (HCS vs. non-food) as well as the putamen (HCS vs. low-calorie food). Notable differences were observed in the parahippocampal gyrus, insula, ACC, and hippocampus in T2DM patients (HCS vs. high-calorie non-sweet). Additionally, FGF21 accounted for 30.39% and 32.4% of the associations between T2DM and ACC, and parahippocampal gyrus, respectively.
Conclusion
FGF21 levels were independently associated with changes in sweet taste perception and preference in T2DM patients and were significantly associated with activation in reward-related brain regions. This study reveals the potential role of FGF21 in regulating responses to sweet foods in T2DM and provides insight to develop new therapeutic strategies for diabetes.

Citations

Citations to this article as recorded by  
  • Exploring Biomarkers in Type 2 Diabetes Mellitus versus Normoglycemia Identified through High-Throughput Proteomics: A Systematic Review and Meta-Analysis
    Julia García-Currás, Raquel Pérez-Lois, Guillermo L. Taboada, María P. Pata
    Journal of Proteome Research.2026; 25(1): 4.     CrossRef
  • Efimosfermin for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Mechanism of Action, Clinical Development and Emerging Therapeutic Potential
    Mariam Alamgir, Aalam Sohal, Kris Kowdley
    Drug Design, Development and Therapy.2026; Volume 20: 1.     CrossRef
Complications
Article image
Global, Regional, and National Temporal Trends in Incidence for Type 2 Diabetes Mellitus Related Chronic Kidney Disease from 1992 to 2021
Yu Cao, Huiting Chen, Hui Liu, Hao Wu, Wei Gao
Diabetes Metab J. 2025;49(4):848-861.   Published online March 11, 2025
DOI: https://doi.org/10.4093/dmj.2024.0593
  • 7,936 View
  • 226 Download
  • 3 Web of Science
  • 7 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Type 2 diabetes mellitus (T2DM) is a major cause of declining renal function.
Methods
Temporal trends in T2DM-related chronic kidney disease (CKD-T2DM) incidence across 204 countries and territories from 1992 to 2021 were analyzed using data from the Global Burden of Disease 2021. The impact of macro-factors (demographic change, age, period, and birth cohort) on CKD-T2DM incidence trends was assessed using decomposition analyses and age-period- cohort modeling, highlighting opportunities to improve incidence and reduce regional disparities.
Results
In 2021, global CKD-T2DM incidence cases reached 2.01 million, a 150.92% increase since 1992, with population growth and aging contributing to 80% of this rise. The age-standardized incidence rate (ASIR) ranged from 15.09 per 100,000 in low sociodemographic index (SDI) regions to 23.07 in high SDI regions. China, India, the United States, and Japan have the most incidence cases, accounted for 69% of incidence cases globally. With 175 countries showing an increasing ASIR trend. Unfavorable trend in ASIR increase were generally found in most high-middle and middle SDI countries, such as China and Mexico (net drift=0.15% and 1.17%, per year). Age-period-cohort analyses indicated a high incidence risk near age 80, with worsening risks for recent periods and birth cohorts, except in high SDI areas.
Conclusion
The CKD-T2DM incidence burden continues to rise globally, with significant variations between countries, posing major global health implications. CKD-T2DM is largely preventable and treatable, warranting greater attention in global health policy, particularly for older populations and in low and middle SDI regions.

Citations

Citations to this article as recorded by  
  • Expert perspectives on incorporating glucagon-like peptide-1 receptor agonist in diabetes and chronic kidney disease: challenges and opportunities
    Jean-Michel Halimi, Laurent Fauchier, Alexandre Karras, Chloé Amouyal, Dominique Eladari, Patrick Rossignol, Gabriel Choukroun, Philippe Zaoui, Nicolas Girerd, Samy Hadjadj
    European Journal of Preventive Cardiology.2026; 33(1): 8.     CrossRef
  • Efficacy and safety of novel antidiabetic drugs in patients with type 2 diabetes and chronic kidney disease: a network meta-analysis
    Xiaojian Zhu, Xingjia Wang, Peiru Zhang, Zhuoshi Yang, Na Zhao, Jiameng Li, Yunze Shi, Yichen Zhao, Jian Ma
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • 2026 Latin American consensus for the management of patients with hypertension and cardio-renal and metabolic disturbances: endorsed by the Latin American Society of Hypertension, the Iberoamerican Hypertension League, and the World Hypertension League
    Antonio Coca, Ramiro Sánchez, Dora I. Molina de Salazar, Ernesto Peñaherrera, Luis Alcocer, Eduardo Barbosa, Guido Grassi, Patricio Lopez-Jaramillo, Empar Lurbe, José Parra-Carrillo, Agustín J. Ramirez, Josep Redón, Weimar Sebba-Barroso, Andrés Acosta, Da
    Journal of Hypertension.2026;[Epub]     CrossRef
  • Frailty and incident diabetes among middle-aged and older adults: Evidence from a large prospective cohort in China
    Yingzhen Gu, Xiaorong Han, Jinxing Liu, Yifan Li, Wei Zhang, Naqiang Lv, Aimin Dang
    Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(10): 104114.     CrossRef
  • Addressing Inequities in Early‐Onset Diabetic Kidney Failure in Australia: A Response to Ellis et al.
    Gokhan Koker
    Nephrology.2025;[Epub]     CrossRef
  • An Overview of Sex-Based Differences in the Onset and Progression of DKD in the Well-Known Model, ZSF1 Rats
    Arunita Chatterjee, Sharma S. Prabhakar
    Life.2025; 15(10): 1627.     CrossRef
  • Electroacupuncture ameliorates glycolipid metabolism disorder in skeletal muscle of type 2 diabetic rats via modulation of the AMPK/PGC-1α/TFAM signaling pathway
    Fang Luo, Junjie Feng, Jumahan Nverjiang, Jiangnan Ye, Chang Liu, Hanhan Chen, Zhuoxuan Li, Qunwen Lu, Wei Zhang, Furong Zhang, Jun Zhu, Chengguo Su
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
Basic and Translational Research
Article image
Macrophage-Specific Progranulin Deficiency Prevents Diet-Induced Obesity through the Inhibition of Hypothalamic and Adipose Tissue Inflammation
Chan Hee Lee, Chae Beom Park, Hyun-Kyong Kim, Won Hee Jang, Se Hee Min, Jae Bum Kim, Min-Seon Kim
Diabetes Metab J. 2025;49(4):784-797.   Published online March 11, 2025
DOI: https://doi.org/10.4093/dmj.2024.0486
  • 5,607 View
  • 214 Download
  • 6 Web of Science
  • 6 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Chronic low-grade inflammation in multiple metabolic organs contributes to the development of insulin resistance induced by obesity. Progranulin (PGRN) is an evolutionarily-conserved secretory protein implicated in immune modulation. The generalized deletion of the PGRN-encoded Grn gene improves insulin resistance and glucose intolerance in obese mice fed a high-fat diet (HFD). However, it remains unclear which cells or organs are responsible for the beneficial metabolic effect of Grn depletion.
Methods
Considering the critical role of macrophages in HFD-induced obesity and inflammation, we generated mice with a macrophage-specific Grn depletion (Grn-MΦKO mice) by mating lysozyme M (LysM)-Cre and Grn-floxed mice. Body weight, food intake, energy expenditure, and glucose and insulin tolerance were compared between Grn-MΦKO mice and their wildtype (WT) controls under normal chow diet (NCD)- or HFD-fed conditions. We also examined macrophage activation and inflammation- related gene expression in the visceral adipose tissue and hypothalamus along with insulin and leptin signaling.
Results
Grn-MΦKO mice showed no alteration in metabolic phenotypes under NCD-fed conditions. However, upon HFD feeding, these mice exhibited less weight gain and improved glucose and insulin tolerance compared to WT mice. Moreover, HFD-induced macrophage activation and proinflammatory cytokine expression were significantly reduced in both the adipose tissue and hypothalamus of Grn-MΦKO mice, while HFD-induced impairments in leptin and insulin signaling showed improvement.
Conclusion
Macrophage-derived PGRN and possibly other Grn products play a critical role in the development of HFD-induced obesity, tissue inflammation, and impaired hormonal signaling in both central and peripheral metabolic organs.

Citations

Citations to this article as recorded by  
  • Tissue-specific immune and MAPK signatures in models of reduced Progranulin and Western diet
    Andrea R. Merchak, Maria Elizabeth de Sousa Rodrigues, Cassandra Cole, Noelle Neighbarger, Nilay Bhavsar, Rebecca L. Wallings, Valerie Joers, Jianjun Chang, Sean D. Kelly, Timothy R. Sampson, Malú Gámez Tansey
    Neurobiology of Disease.2026; 220: 107287.     CrossRef
  • The immunometabolic network in obesity-associated insulin resistance: a systemic multi-organ and multi-cellular perspective
    Yi Zhang, Haixin Ding, Xue Zhao, Yutong Li, Pengling Ge
    International Immunopharmacology.2026; 177: 116528.     CrossRef
  • Role of Macrophage-Derived Progranulin in Energy and Glucose Metabolism
    Do Kyeong Song
    Diabetes & Metabolism Journal.2025; 49(4): 580.     CrossRef
  • The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
    Milton Packer
    JACC.2025; 86(16): 1269.     CrossRef
  • Serum Granulin Concentrations Are Elevated in Prediabetes and Newly Diagnosed Diabetes: A Cross-Sectional Study
    Yu-Hsuan Chou, Yuan Kao, Ka Chon Chan, Hsuan-Wen Chou, Yu-Cheng Liang, Hung-Tsung Wu, Horng-Yih Ou
    Journal of Clinical Medicine.2025; 14(18): 6566.     CrossRef
  • TNFR2 signaling in musculoskeletal diseases: Implications for rheumatoid arthritis and osteoarthritis
    Emily Qian, Ryan S MacLeod, Chuan-Ju Liu
    Journal of Leukocyte Biology.2025;[Epub]     CrossRef
Metabolic Risk/Epidemiology
Article image
An Analysis of Age-Related Body Composition Changes and Metabolic Patterns in Korean Adults Using FDG-PET/CT Health Screening Data
Chang-Myung Oh, Ji-In Bang, Sang Yoon Lee, Jae Kyung Lee, Jee Won Chai, So Won Oh
Diabetes Metab J. 2025;49(1):92-104.   Published online September 2, 2024
DOI: https://doi.org/10.4093/dmj.2024.0057
  • 6,132 View
  • 214 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
F-18-fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT) can be used to measure bone mineral density (BMD), cross-sectional muscle area (CSMA), Hounsfield units (HU) of liver and muscle, subcutaneous adipose tissue (SAT), abdominal visceral adipose tissue (VAT), and glucose metabolism. The present study aimed to identify age-related changes in body composition and glucose metabolism in Korean using opportunistic FDG-PET/CT imaging.
Methods
We analyzed FDG-PET/CT, clinical history, and laboratory data abstracted from the medical records of patients who underwent health screening at a single institute between 2017 and 2022.
Results
In total, 278 patients were included in the analysis (male:female=140:138). Age and body mass index were positively correlated in female, but negatively correlated in male. BMD decreased with age more in female, and CSMA decreased with age more in male. Muscle HU decreased with age for both sexes. In female, SAT and VAT increased with age; and in male, SAT decreased slightly while VAT remained stable. Muscle glucose metabolism showed no association with age in male but increased with age in female. CSMA correlated positively with BMD overall; and positively correlated with VAT and SAT in male only. In female only, both SAT and VAT showed negative correlations with glucose metabolism and correlated positively with muscle glucose metabolism. Liver HU values were inversely correlated with VAT, especially in female; and positively correlated with muscle glucose metabolism in female only.
Conclusion
FDG-PET/CT demonstrated distinct patterns of age-related changes in body composition and glucose metabolism, with significant differences between sexes.

Citations

Citations to this article as recorded by  
  • Development of a deep learning model for predicting skeletal muscle density from ultrasound data: a proof-of-concept study
    Federico Pistoia, Marta Macciò, Riccardo Picasso, Federico Zaottini, Giovanni Marcenaro, Simone Rinaldi, Deborah Bianco, Gabriele Rossi, Luca Tovt, Michelle Pansecchi, Sara Sanguinetti, Mehrnaz Hamedani, Angelo Schenone, Carlo Martinoli
    La radiologia medica.2025; 130(9): 1386.     CrossRef
  • Emerging Radioligands as Tools to Track Multi-Organ Senescence
    Anna Gagliardi, Silvia Migliari, Alessandra Guercio, Giorgio Baldari, Tiziano Graziani, Veronica Cervati, Livia Ruffini, Maura Scarlattei
    Diagnostics.2025; 15(19): 2518.     CrossRef
Complications
Article image
Glycemic Control and Retinal Microvascular Changes in Type 2 Diabetes Mellitus Patients without Clinical Retinopathy
Kangmin Lee, Ga Hye Lee, Seung Eun Lee, Jee Myung Yang, Kunho Bae
Diabetes Metab J. 2024;48(5):983-992.   Published online March 13, 2024
DOI: https://doi.org/10.4093/dmj.2023.0149
  • 7,249 View
  • 258 Download
  • 7 Web of Science
  • 6 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
To investigate the association of glycemic control and retinal microvascular changes in patients with type 2 diabetes mellitus (T2DM) without diabetic retinopathy (DR).
Methods
This retrospective, observational, cohort study included patients with T2DM without DR. The patients were categorized into intensive control (IC; mean glycosylated hemoglobin [HbA1c] ≤7.0%) and moderate control (MC; mean HbA1c >7.0%) groups. Optical coherence tomography (OCT) and swept-source OCT angiography (OCTA) image parameters were compared between three groups, including healthy controls.
Results
In total, 259 eyes of 259 participants (88 IC, 81 MC, and 90 controls) were included. The foveal avascular zone area was significantly larger in the MC group than IC and control groups (all P<0.05). The IC group had lower vessel density in the superficial retinal layer and deep retinal layer than the controls (all P<0.05). The choriocapillaris (CC) flow deficit (FD) was significantly greater in the MC group than in the IC and control groups (18.2%, 16.7%, and 14.2%, respectively; all P<0.01). In multivariate regression analysis, CC-FD was associated with the mean HbA1c level (P=0.008). There were no significant differences in OCT parameters among the groups.
Conclusion
OCTA revealed that early CC impairment is associated with HbA1c levels; the CC changes precede clinically apparent DR. The OCTA parameters differed among the groups according to the degree of glycemic control. Our results suggest that microvascular changes precede DR and are closely related to glycemic control.

Citations

Citations to this article as recorded by  
  • Quantitative evaluation of the topographical maps of three-dimensional choroidal vascularity index in gestational diabetes mellitus: a cross-sectional observational study
    Ligang Jiang, Yimei Ji, Xin Jiang, Yune Zhao
    BMC Pregnancy and Childbirth.2026;[Epub]     CrossRef
  • Flow and ischemic changes in retina and choroid across diabetic retinopathy spectrum: a SS-OCTA study
    Qianhui Yang, Kelvin Y. C. Teo, Yueheng Hong, Bingyao Tan, Leopold Schmetterer, Chui Ming Gemmy Cheung, Tien Yin Wong, Gavin Tan Siew Wei
    Eye.2025; 39(8): 1631.     CrossRef
  • Postprandial C-Peptide to Glucose Ratio as a Promising Systemic Marker of Diabetic Retinopathy in Type 2 Diabetes
    Zhaoxia Zheng, Nianen Liu, Yue Zhang, Xiaoya Gu, Hui Li, Xiaobing Yu
    Translational Vision Science & Technology.2025; 14(7): 27.     CrossRef
  • The Correlation Between Macular Vessel Density and Its Clinical Parameters in Diabetes Mellitus Type 2
    Nadia Dewi, Muhammad Arfan, Herisa Rahmasari, Mutiara Putri, Rulli Rosandi
    Clinical Ophthalmology.2025; Volume 19: 3113.     CrossRef
  • Comment on: “Risk factors and incidence of macular edema in eyes with retinal vein occlusion after uneventful cataract surgery: The MEVO study”
    Xianmei Zhang, Jing Chen
    Indian Journal of Ophthalmology.2025; 73(11): 1698.     CrossRef
  • Prevalence and determinants of comorbidities among patients with type 2 diabetes mellitus in Nepal: a cross-sectional study
    Nitendra Kumar Chaurasia, Md Mothashin, Md Golam Hossain
    BMC Endocrine Disorders.2025;[Epub]     CrossRef
Lifestyle
Article image
Associations of Ultra-Processed Food Intake with Body Fat and Skeletal Muscle Mass by Sociodemographic Factors
Sukyoung Jung, Jaehee Seo, Jee Young Kim, Sohyun Park
Diabetes Metab J. 2024;48(4):780-789.   Published online February 2, 2024
DOI: https://doi.org/10.4093/dmj.2023.0335
  • 9,323 View
  • 332 Download
  • 10 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The effects of excessive ultra-processed food (UPF) consumption on body composition measures or sociodemographic disparities are understudied in Korea. We aimed to investigate the association of UPF intake with percent body fat (PBF) and percent appendicular skeletal muscle mass (PASM) by sociodemographic status in adults.
Methods
This study used data from the Korea National Health and Nutrition Examination Survey 2008–2011 (n=11,123 aged ≥40 years). We used a NOVA system to classify all foods reported in a 24-hour dietary recall, and the percentage of energy intake (%kcal) from UPFs was estimated. PBF and PASM were measured by dual-energy X-ray absorptiometry. Tertile (T) 3 of PBF indicated adiposity and T1 of PASM indicated low skeletal muscle mass, respectively. Multinomial logistic regression models were used to estimate odds ratios (OR) with 95% confidence interval (CI) after adjusting covariates.
Results
UPF intake was positively associated with PBF-defined adiposity (ORper 10% increase, 1.04; 95% CI, 1.002 to 1.08) and low PASM (ORper 10% increase, 1.05; 95% CI, 1.01 to 1.09). These associations were stronger in rural residents (PBF: ORper 10% increase, 1.14; 95% CI, 1.06 to 1.23; PASM: ORper 10% increase, 1.15; 95% CI, 1.07 to 1.23) and not college graduates (PBF: ORper 10% increase, 1.06; 95% CI, 1.02 to 1.11; PASM: ORper 10% increase, 1.07; 95% CI, 1.03 to 1.12) than their counterparts.
Conclusion
A higher UPF intake was associated with higher adiposity and lower skeletal muscle mass among Korean adults aged 40 years and older, particularly in those from rural areas and with lower education levels.

Citations

Citations to this article as recorded by  
  • Food Allergy, Nutrition, Psychology, and Health
    Elena Gupta, Alexandra E. Conway, Marylee Verdi, Marion Groetch, Aikaterini Anagnostou, Elissa M. Abrams, Anna Nowak-Wegrzyn, Don Bukstein, Juliette C. Madan, Matthew Hand, Sarah L. Garnaat, Marcus S. Shaker
    The Journal of Allergy and Clinical Immunology: In Practice.2025; 13(4): 773.     CrossRef
  • Ultra-processed foods and cardio-kidney-metabolic syndrome: A review of recent evidence
    Mehmet Kanbay, Lasin Ozbek, Mustafa Guldan, Sama Mahmoud Abdel-Rahman, Arif E. Narin, Alberto Ortiz
    European Journal of Internal Medicine.2025; 136: 4.     CrossRef
  • The association between ultra-processed food consumption and adiposity indexes in adults living in Tehran: a dose-response analysis within a cross-sectional study
    Mahsa Ranjbar, Neda Asgari Avini, Sakineh Shab-Bidar
    BMC Public Health.2025;[Epub]     CrossRef
  • Consumptıon of ultra-processed foods can accelerate age-related appearance of sarcopenıa
    Hatice Parlak Baskurt, Hulya Yardımcı
    Biogerontology.2025;[Epub]     CrossRef
  • Potential misclassification of ultra-processed foods across studies and the need for a unified classification system: a scoping review
    Sukyoung Jung, Jee Young Kim, Sohyun Park, Jung Eun Lee
    Nutrition Research and Practice.2025; 19(3): 331.     CrossRef
  • Association between consumption of ultra-processed food at midlife and handgrip strength at late life: The Singapore Chinese Health Study
    Yue Li, Kevin Y. Chua, An Pan, Woon-Puay Koh
    The Journal of nutrition, health and aging.2025; 29(9): 100634.     CrossRef
  • Association between ultra-processed foods and adiposity: findings from a Tehran lipid and glucose study
    Mahdieh Golzarand, Nazanin Moslehi, Mohadeseh Aghasi, Parvin Mirmiran, Fereidoun Azizi
    Food & Function.2025; 16(16): 6491.     CrossRef
  • The Impact of Ultra‐Processed Food Consumption on Frailty and Sarcopenia: A Systematic Review
    Mehmet Kanbay, Sama Mahmoud Abdel‐Rahman, Mustafa Guldan, Lasin Ozbek, Adrian Covic, Francesca Mallamaci, Carmine Zoccali
    Journal of Human Nutrition and Dietetics.2025;[Epub]     CrossRef
  • Ultra-Processed Food and Frailty: Evidence from a Prospective Cohort Study and Implications for Future Research
    Elsa M. Konieczynski, Shivani Sahni, Paul F. Jacques, Elena N. Naumova
    Nutrients.2025; 17(16): 2631.     CrossRef
  • Navigating Ultra-Processed Foods with Insight
    Ji A Seo
    Diabetes & Metabolism Journal.2024; 48(4): 713.     CrossRef
Review
Basic Research
Article image
Mitochondrial Stress and Mitokines: Therapeutic Perspectives for the Treatment of Metabolic Diseases
Benyuan Zhang, Joon Young Chang, Min Hee Lee, Sang-Hyeon Ju, Hyon-Seung Yi, Minho Shong
Diabetes Metab J. 2024;48(1):1-18.   Published online January 3, 2024
DOI: https://doi.org/10.4093/dmj.2023.0115
  • 13,067 View
  • 520 Download
  • 19 Web of Science
  • 22 Crossref
AbstractAbstract PDFPubReader   ePub   
Mitochondrial stress and the dysregulated mitochondrial unfolded protein response (UPRmt) are linked to various diseases, including metabolic disorders, neurodegenerative diseases, and cancer. Mitokines, signaling molecules released by mitochondrial stress response and UPRmt, are crucial mediators of inter-organ communication and influence systemic metabolic and physiological processes. In this review, we provide a comprehensive overview of mitokines, including their regulation by exercise and lifestyle interventions and their implications for various diseases. The endocrine actions of mitokines related to mitochondrial stress and adaptations are highlighted, specifically the broad functions of fibroblast growth factor 21 and growth differentiation factor 15, as well as their specific actions in regulating inter-tissue communication and metabolic homeostasis. Finally, we discuss the potential of physiological and genetic interventions to reduce the hazards associated with dysregulated mitokine signaling and preserve an equilibrium in mitochondrial stress-induced responses. This review provides valuable insights into the mechanisms underlying mitochondrial regulation of health and disease by exploring mitokine interactions and their regulation, which will facilitate the development of targeted therapies and personalized interventions to improve health outcomes and quality of life.

Citations

Citations to this article as recorded by  
  • ATF5‐Dependent GDF15 Expression Mediates Anesthesia‐Induced Neuroprotection Against Stroke
    Xianshu Ju, Tao Zhang, Jianchen Cui, Yulim Lee, Suho Lee, Ho Min Kim, Boohwi Hong, Jiho Park, Chul Hee Choi, Hyon‐Seung Yi, Jun Young Heo, Woosuk Chung
    Advanced Science.2026;[Epub]     CrossRef
  • Mitochondrial transfer in cancer: mechanisms, immune evasion, and therapeutic opportunities
    Hye In Ka, Hyun Goo Woo
    Genomics & Informatics.2026;[Epub]     CrossRef
  • Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects
    Hongling Zhong, Renjie Pan, Yuzhen Ouyang, Tengfei Xiao, Wangning Gu, Hongmin Yang, Hui Wang, Hucheng Li, Tianfang Peng, Pan Chen
    Molecular Cancer.2026;[Epub]     CrossRef
  • Decoding the Endocrine Code of Skeletal Muscle: Myokines, Exerkines, and Inter-Organ Crosstalk in Metabolic Health and Disease
    Young-Sool Hah, Jeongyun Hwang, Seung-Jun Lee, Seung-Jin Kwag
    Cells.2026; 15(4): 318.     CrossRef
  • Hepatic mitochondrial signaling as a systemic hub: inter-organ communication networks in aging and aging-related diseases
    Yishuo Ji, Ying Wang, Xiaowei Yu, Yi Jin, Kai Zhao, Yue Hu, Zhenglin He
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
  • Small but mighty: mitochondrial DNA at the centre of retrograde signalling
    Eve Harding, Veronica Bazzani, Carlo Vascotto
    Cell Communication and Signaling.2026;[Epub]     CrossRef
  • GLP-1 and the brain’s powerhouse: a new perspective on the role of mitochondria in neuroprotection
    Tiasha Dasgupta, Hitesh Bhayani, Krishnarup Ghoshdastidar, Kasinath Viswanathan, Mukul Jain
    Metabolic Brain Disease.2026;[Epub]     CrossRef
  • Endoplasmic reticulum stress and unfolded protein response: Roles in skeletal muscle atrophy
    Yanan Ji, Quan Jiang, Bingqian Chen, Xin Chen, Aihong Li, Dingding Shen, Yuntian Shen, Hua Liu, Xiaowei Qian, Xinlei Yao, Hualin Sun
    Biochemical Pharmacology.2025; 234: 116799.     CrossRef
  • Phenylethanoid glycoside-enriched fraction of Clerodendrum glandulosum ameliorates oxidative stress and mitochondrial dysfunction via PGC1α/TFAM upregulation
    Puspanjali Khound, Nonibala Gurumayum, Sagar Ramrao Barge, Partha Pratim Sarma, Rajlakshmi Devi
    3 Biotech.2025;[Epub]     CrossRef
  • BAM8-22 targets spinal MrgC receptors to modulate UPRmt activity in the mechanism of bone cancer pain
    Mingming Xie, Dan Li, Haohao Zeng, Yulin Huang, Rui Xu, Zhen Wang, Jiacheng Yu, Yu’e Sun
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Excessive mitochondrial stress response triggers neuronal injury through the persistent eIF2α phosphorylation in mice exposed to manganese
    Yunfei Jia, Bin He, Keyu Chen, Kuan Liu, Changjiang Yu, Bo Sun, Zhuo Ma, Bin Xu
    Journal of Hazardous Materials.2025; 496: 139407.     CrossRef
  • Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLD
    Miriam Longo, Erika Paolini, Marica Meroni, Michela Ripolone, Laura Napoli, Francesco Gentile, Annalisa Cespiati, Elena Trombetta, Rosa Lombardi, Marco Maggioni, Anna Alisi, Luca Miele, Antonio Liguori, Giorgio Soardo, Antonio Gasbarrini, Maurizio Moggio,
    JHEP Reports.2025; 7(11): 101539.     CrossRef
  • Diagnostic relevance of Humanin, GAS5 and miR-21/miR-103 in prostate disease risk stratification
    Donatella Coradduzza, Sara Cruciani, Leonardo Sibono, Alessandro Tedde, Angelo Zinellu, Margherita Maioli, Alessio Aligi Cogoni, Maria Rosaria De Miglio, Serenella Medici, Massimo Madonia, Andrea Angius, Massimiliano Grosso, Ciriaco Carru
    Clinical and Experimental Medicine.2025;[Epub]     CrossRef
  • From adaptation to exhaustion: defining exposure-related malnutrition as a bioenergetic phenotype of aging
    Torsak Tippairote, Pruettithada Hoonkaew, Aunchisa Suksawang, Prayfan Tippairote
    Biogerontology.2025;[Epub]     CrossRef
  • Evaluation of Serum FGF21 Levels in Patients with Mitochondrial Aminoacyl-tRNA Synthetase Deficiency
    Sebnem Tekin Neijmann, Dilek Gunes, Meryem Karaca, Volkan Karaman, Mehmet Cihan Balci, Gulden Fatma Gokcay, Asuman Gedikbasi
    International Journal of Molecular Sciences.2025; 26(19): 9525.     CrossRef
  • Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines
    Miaomiao Xu, Xiaoguang Liu
    Biomolecules.2025; 15(11): 1495.     CrossRef
  • UPRmt-regulated mitokines: novel strategies for myocardial injury repair
    Weinan Gao, Jia Liu, Wenda Zhang, Bin Liu, Luyan Shen
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • Repeated Heat Stress Modulates the Levels of the Mitokines MOTS-C and FGF21 in Active Men during Calf Muscle Immobilization
    RABIE ELHUSSEINY, MOHAMMED IHSAN, MARIEM LABIDI, MARINE ALHAMMOUD, KHOULOUD MTIBAA, NELDA NADER, NADA NASIR, ABDULAZIZ FAROOQ, EMMANOUI PAPAKOSTAS, BRUNO OLORY, FLAVIO CRUZ, PIETER D’HOOGHE, SEBASTIEN RACINAIS, LOUISE DELDICQUE
    Medicine & Science in Sports & Exercise.2025; 57(12): 2764.     CrossRef
  • Oxytocin, Vasopressin and Stress: A Hormetic Perspective
    Hans P. Nazarloo, Marcy A. Kingsbury, Hannah Lamont, Caitlin V. Dale, Parmida Nazarloo, John M. Davis, Eric C. Porges, Steven P. Cuffe, C. Sue Carter
    Current Issues in Molecular Biology.2025; 47(8): 632.     CrossRef
  • Mitochondria: fundamental characteristics, challenges, and impact on aging
    Runyu Liang, Luwen Zhu, Yongyin Huang, Jia Chen, Qiang Tang
    Biogerontology.2024; 25(6): 923.     CrossRef
  • The Origin of Natural Neurostimulation: A Narrative Review of Noninvasive Brain Stimulation Techniques
    Igor Val Danilov
    OBM Neurobiology.2024; 08(04): 1.     CrossRef
  • A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration
    Finula I. Isik, Shannon Thomson, John F. Cueto, Jessica Spathos, Samuel N. Breit, Vicky W. W. Tsai, David A. Brown, Caitlin A. Finney
    Frontiers in Immunology.2024;[Epub]     CrossRef
Original Articles
Basic Research
Article image
DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis
Dong-Keon Lee, Su Ho Jo, Eun Soo Lee, Kyung Bong Ha, Na Won Park, Deok-Hoon Kong, Sang-In Park, Joon Seok Park, Choon Hee Chung
Diabetes Metab J. 2024;48(1):97-111.   Published online January 3, 2024
DOI: https://doi.org/10.4093/dmj.2022.0367
  • 9,089 View
  • 324 Download
  • 7 Web of Science
  • 8 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Nonalcoholic steatohepatitis (NASH) is a liver disease caused by obesity that leads to hepatic lipoapoptosis, resulting in fibrosis and cirrhosis. However, the mechanism underlying NASH is largely unknown, and there is currently no effective therapeutic agent against it. DWN12088, an agent used for treating idiopathic pulmonary fibrosis, is a selective prolyl-tRNA synthetase (PRS) inhibitor that suppresses the synthesis of collagen. However, the mechanism underlying the hepatoprotective effect of DWN12088 is not clear. Therefore, we investigated the role of DWN12088 in NASH progression.
Methods
Mice were fed a chow diet or methionine-choline deficient (MCD)-diet, which was administered with DWN12088 or saline by oral gavage for 6 weeks. The effects of DWN12088 on NASH were evaluated by pathophysiological examinations, such as real-time quantitative reverse transcription polymerase chain reaction, immunoblotting, biochemical analysis, and immunohistochemistry. Molecular and cellular mechanisms of hepatic injury were assessed by in vitro cell culture.
Results
DWN12088 attenuated palmitic acid (PA)-induced lipid accumulation and lipoapoptosis by downregulating the Rho-kinase (ROCK)/AMP-activated protein kinase (AMPK)/sterol regulatory element-binding protein-1c (SREBP-1c) and protein kinase R-like endoplasmic reticulum kinase (PERK)/α subunit of eukaryotic initiation factor 2 (eIF2α)/activating transcription factor 4 (ATF4)/C/EBP-homologous protein (CHOP) signaling cascades. PA increased but DWN12088 inhibited the phosphorylation of nuclear factor-κB (NF-κB) p65 (Ser536, Ser276) and the expression of proinflammatory genes. Moreover, the DWN12088 inhibited transforming growth factor β (TGFβ)-induced pro-fibrotic gene expression by suppressing TGFβ receptor 1 (TGFβR1)/Smad2/3 and TGFβR1/glutamyl-prolyl-tRNA synthetase (EPRS)/signal transducer and activator of transcription 6 (STAT6) axis signaling. In the case of MCD-diet-induced NASH, DWN12088 reduced hepatic steatosis, inflammation, and lipoapoptosis and prevented the progression of fibrosis.
Conclusion
Our findings provide new insights about DWN12088, namely that it plays an important role in the overall improvement of NASH. Hence, DWN12088 shows great potential to be developed as a new integrated therapeutic agent for NASH.

Citations

Citations to this article as recorded by  
  • Mazdutide Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Endoplasmic Reticulum Stress, Improving Lipid Metabolism and Alleviating Inflammation
    Liangyu Gan, Lengxin Duan, Xueyi Zheng
    Pharmaceuticals.2026; 19(3): 371.     CrossRef
  • Orchestration of Gut–Liver-Associated Transcription Factors in MAFLD: From Cross-Organ Interactions to Therapeutic Innovation
    Ao Liu, Mengting Huang, Yuwen Xi, Xiaoling Deng, Keshu Xu
    Biomedicines.2025; 13(6): 1422.     CrossRef
  • Prolyl-tRNA synthetase inhibitor as a novel first-in-class keloid treatment: downregulation of de novo collagen synthesis and inflammatory cascade
    Sally Min, Ki-Myo Kim, Joseph Hwang, Jaewoo Kim, Jun Ho Park, Joon Seok Park, Caroline H Lee, Ji-Ung Park
    British Journal of Dermatology.2025; 193(2): 298.     CrossRef
  • Hesperidin alleviates nonalcoholic steatohepatitis by inhibiting cellular senescence through regulation of the BMP4/P21 pathway
    Huantian Cui, Huan Pei, Yuming Wang, Jing Wang, Weiquan Xu, Liying Guo, Hui Sun, Li Wang, Ning Wang, Mingxi Lu, Weibo Wen, Jianwei Jia, Jing Miao
    Journal of Future Foods.2025;[Epub]     CrossRef
  • Cranberry improves metabolic syndrome-related organ dysfunction in rats by modulating AMPK/SREBP1, ROCK1 and TGF-β1
    Sahar M. Elashmony, Yosra Alhindi, Dina H. Merzeban, Rehab A. Mohammed, Asmaa Mohamed Elsayed, Marwa A. Sofi, Rania H. Mahmoud, Hanan A. Shamardl, Dina Elsayed Shaker
    Scientific Reports.2025;[Epub]     CrossRef
  • Modulation of STAT6 signaling for hepatoprotection
    Emmanuel Somm, Mahdi Rahman, Ildiko Szanto, Karim Gariani, François R. Jornayvaz
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Restoring metabolic flexibility: targeting organelle interaction networks in the pathogenesis and therapy of MASLD
    Yiming Liu, Yue Wang, Jiaying Zhou, Hong Li, Caiyun Liu, Beilei Zhong, Juan Liu, Leiming Liu, Lingling Zhang, Leimin Sun
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis
    Seung Seob Son, Hee Seul Jeong, Seong-Woo Lee, Eun Soo Lee, Jeong Geon Lee, Ji-Hye Lee, Jawoon Yi, Mi Ju Park, Min Sun Choi, Donghyeong Lee, Sin Young Choi, Jiheon Ha, Jeong Suk Kang, Nam-Jun Cho, Samel Park, Hyo-Wook Gil, Choon Hee Chung, Joon Seok Park,
    Experimental & Molecular Medicine.2024; 56(12): 2673.     CrossRef
Basic Research
Article image
Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification
Jinmi Lee, Seok-Woo Hong, Min-Jeong Kim, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
Diabetes Metab J. 2024;48(1):83-96.   Published online January 3, 2024
DOI: https://doi.org/10.4093/dmj.2022.0363
  • 9,555 View
  • 327 Download
  • 15 Web of Science
  • 15 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Glucagon-like peptide-1 receptor agonist (GLP-1RA), which is a therapeutic agent for the treatment of type 2 diabetes mellitus, has a beneficial effect on the cardiovascular system.
Methods
To examine the protective effects of GLP-1RAs on proliferation and migration of vascular smooth muscle cells (VSMCs), A-10 cells exposed to angiotensin II (Ang II) were treated with either exendin-4, liraglutide, or dulaglutide. To examine the effects of GLP-1RAs on vascular calcification, cells exposed to high concentration of inorganic phosphate (Pi) were treated with exendin-4, liraglutide, or dulaglutide.
Results
Ang II increased proliferation and migration of VSMCs, gene expression levels of Ang II receptors AT1 and AT2, proliferation marker of proliferation Ki-67 (Mki-67), proliferating cell nuclear antigen (Pcna), and cyclin D1 (Ccnd1), and the protein expression levels of phospho-extracellular signal-regulated kinase (p-Erk), phospho-c-JUN N-terminal kinase (p-JNK), and phospho-phosphatidylinositol 3-kinase (p-Pi3k). Exendin-4, liraglutide, and dulaglutide significantly decreased the proliferation and migration of VSMCs, the gene expression levels of Pcna, and the protein expression levels of p-Erk and p-JNK in the Ang II-treated VSMCs. Erk inhibitor PD98059 and JNK inhibitor SP600125 decreased the protein expression levels of Pcna and Ccnd1 and proliferation of VSMCs. Inhibition of GLP-1R by siRNA reversed the reduction of the protein expression levels of p-Erk and p-JNK by exendin-4, liraglutide, and dulaglutide in the Ang II-treated VSMCs. Moreover, GLP-1 (9-36) amide also decreased the proliferation and migration of the Ang II-treated VSMCs. In addition, these GLP-1RAs decreased calcium deposition by inhibiting activating transcription factor 4 (Atf4) in Pi-treated VSMCs.
Conclusion
These data show that GLP-1RAs ameliorate aberrant proliferation and migration in VSMCs through both GLP-1Rdependent and independent pathways and inhibit Pi-induced vascular calcification.

Citations

Citations to this article as recorded by  
  • ATF4 in cardiovascular diseases: an emerging therapeutic target
    Luning Qin, Ruolan Chen, Chao Huang, Xuezhe Wang, Qinghang Song, Zhaoqing Li, Xiaojian Xu, Zhijun Liu, Banghui Wang, Bing Li, Xian-Ming Chu
    Biochemical Pharmacology.2026; 246: 117703.     CrossRef
  • The Effect of GLP-1 Receptor Agonists on Reoperation Following Anterior Cervical Discectomy and Fusion
    Nicholas C. Bank, Daniel Whittingslow, Sam Duggan, Joshua L. Morningstar, Douglas S. Weinberg
    World Neurosurgery.2026; 206: 124751.     CrossRef
  • Liraglutide Ameliorates Injury‐Related Vascular Repair by Activating Autophagy Through Modulation of the PI3K–mTOR Signaling Pathway
    Zongyi Zhang, Guixian Wu, Chaozhi Xu, Shanqian Li, Yulin Zhang, Yue Hu, Wanhua Wu, Hongyu Ding, Yuling Liu, Yue Huang, Wenjun Lu, Meimei Zheng, Yue Zhang, Hongxian Wu, Lina Hu
    The FASEB Journal.2026;[Epub]     CrossRef
  • Association between glucagon-like peptide-1 receptor agonists and femur fracture risk in type 2 diabetes: A large-scale target trial emulation
    Yao-Jen Chang, Chiou-Shann Fuh, Jie-Fan Chang, Meng-Ting Chen, Ming-Hsien Tsai
    Bone.2026; 207: 117851.     CrossRef
  • Cardiometabolic Crossroads: Obesity, Sleep-Disordered Breathing, and Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction – A Mini-Review
    Fulvio Cacciapuoti, Ciro Mauro, Valentina Capone, Angelo Sasso, Luca Gaetano Tarquinio, Federico Cacciapuoti
    Heart and Mind.2025; 9(2): 147.     CrossRef
  • Perioperative Glucagon-Like Peptide-1 Agonist Use and Rates of Pseudarthrosis After Single-Level Lumbar Fusion: A Large Retrospective Cohort Study
    Vedant Agrawal, Saketh Amasa, Mert Karabacak, Konstantinos Margetis
    Neurosurgery.2025; 97(1): 91.     CrossRef
  • ALOX15 Aggravates Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice with Type 2 Diabetes via Activating the PPARγ/CD36 Axis
    Wenhui Yan, Xin Cui, Tingli Guo, Na Liu, Zhuanzhuan Wang, Yuzhuo Sun, Yuanrui Shang, Jieyun Liu, Yuanyuan Zhu, Yangyang Zhang, Lina Chen
    Antioxidants & Redox Signaling.2025; 43(1-3): 37.     CrossRef
  • Targeting the S100A9/P38 MAPK/HSPB1 axis as a novel approach for aortic dissection therapy
    Likang Ma, Linfeng Xie, Qingsong Wu, Lei Jin, Jiakang Li, Lele Tang, Li Zhang, Liangwan Chen, Zhihuang Qiu
    International Immunopharmacology.2025; 149: 114225.     CrossRef
  • Involvement of miRNA-204 carried by the exosomes of macrophages in the AT2 receptor-mediated improvement of vascular calcification
    Hui-Yu Bai, Xiao-Rui Lv, Hai-Bo Gu, Hui Li, Bao-Shuai Shan
    Cellular and Molecular Life Sciences.2025;[Epub]     CrossRef
  • Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease
    Luxcia Kugathasan, Yarden Aronson, Vikas S. Sridhar, Huajing Ni, Jean-Philippe Ouimet, Christine P. Limonte, Shohinee Sarma, David Z. I. Cherney
    Expert Review of Clinical Immunology.2025; 21(8): 1113.     CrossRef
  • Current Perspectives on GLP-1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation
    Husam Abu-Nejim, Richard C. Becker
    Current Atherosclerosis Reports.2025;[Epub]     CrossRef
  • Intracellular angiotensin-II measurement in streptozotocin-induced rat vascular smooth muscle cells and its relationship with angiotensin-II receptors
    Zehra Çiçek, Kübra Akıllıoğlu, Zehra Gül Yaşar, Ayşe Doğan
    The European Research Journal.2025; : 1.     CrossRef
  • Innovative Lipid-Lowering Strategies: RNA-Based, Small Molecule, and Protein-Based Therapies
    Youngwoo Jang, Eun-Jung Rhee, Sung Hee Choi
    Endocrinology and Metabolism.2025; 40(5): 668.     CrossRef
  • Incretin Hormone Secretion in Women with Polycystic Ovary Syndrome: Roles of Obesity, Insulin Sensitivity and Treatment with Metformin and GLP-1s
    Andrea Etrusco, Mislav Mikuš, Antonio D’Amato, Fabio Barra, Petar Planinić, Trpimir Goluža, Giovanni Buzzaccarini, Jelena Marušić, Mara Tešanović, Antonio Simone Laganà
    Biomedicines.2024; 12(3): 653.     CrossRef
  • BRCC36 regulates β-catenin ubiquitination to alleviate vascular calcification in chronic kidney disease
    Yalan Li, Xiaoyue Chen, Yiqing Xiong, Xueqiang Xu, Caidie Xie, Min Min, Dongmei Liang, Cheng Chen, Huijuan Mao
    Journal of Translational Medicine.2024;[Epub]     CrossRef
Basic Research
Article image
Alantolactone Attenuates Renal Fibrosis via Inhibition of Transforming Growth Factor β/Smad3 Signaling Pathway
Kyeong-Min Lee, Yeo Jin Hwang, Gwon-Soo Jung
Diabetes Metab J. 2024;48(1):72-82.   Published online January 3, 2024
DOI: https://doi.org/10.4093/dmj.2022.0231
  • 8,883 View
  • 283 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Renal fibrosis is characterized by the accumulation of extracellular matrix proteins and interstitial fibrosis. Alantolactone is known to exert anticancer, anti-inflammatory, antimicrobial and antifungal effects; however, its effects on renal fibrosis remains unknown. Here, we investigated whether alantolactone attenuates renal fibrosis in mice unilateral ureteral obstruction (UUO) and evaluated the effect of alantolactone on transforming growth factor (TGF) signaling pathway in renal cells.
Methods
To evaluate the therapeutic effect of alantolactone, cell counting kit-8 (CCK-8) assay, histological staining, Western blot analysis, and real-time quantitative polymerase chain reaction were performed in UUO kidneys in vivo and in TGF-β-treated renal cells in vitro.
Results
Alantolactone (0.25 to 4 µM) did not affect the viability of renal cells. Mice orally administered 5 mg/kg of alantolactone daily for 15 days did not show mortality or liver toxicity. Alantolactone decreased UUO-induced blood urea nitrogen and serum creatinine levels. In addition, it significantly alleviated renal tubulointerstitial damage and fibrosis and decreased collagen type I, fibronectin, and α-smooth muscle actin (α-SMA) expression in UUO kidneys. In NRK-49F cells, alantolactone inhibited TGF-βstimulated expression of fibronectin, collagen type I, plasminogen activator inhibitor-1 (PAI-1), and α-SMA. In HK-2 cells, alantolactone inhibited TGF-β-stimulated expression of collagen type I and PAI-1. Alantolactone inhibited UUO-induced phosphorylation of Smad3 in UUO kidneys. In addition, it not only decreased TGF-β secretion but also Smad3 phosphorylation and translocation to nucleus in both kidney cell lines.
Conclusion
Alantolactone improves renal fibrosis by inhibiting the TGF-β/Smad3 signaling pathway in obstructive nephropathy. Thus, alantolactone is a potential therapeutic agent for chronic kidney disease.

Citations

Citations to this article as recorded by  
  • Metixene hydrochloride hydrate mitigates kidney tubulointerstitial fibrosis by inhibiting Smad3 phosphorylation
    Kyeong-Min Lee, Yeo Jin Hwang
    Experimental and Molecular Pathology.2026; 145: 105025.     CrossRef
  • Macrophage erythropoietin receptor signaling drives macrophage-myofibroblast transition via JAK2/STAT3 and TGF-β1/Smad3 pathways to exacerbate pulmonary fibrosis in mice
    Pengfei Wu, Jialin Jia, Tianrong Jin, Xiaofeng Sun, Bangwei Luo, Guansong Wang, Zhiren Zhang
    Biochemical and Biophysical Research Communications.2026; 808: 153453.     CrossRef
  • Artemisinin and Its Derivatives: Promising Therapeutic Agents for Age-Related Macular Degeneration
    Chun Liu, Xiaoqin Liu, Junguo Duan
    Pharmaceuticals.2025; 18(4): 535.     CrossRef
  • Alantolactone protects against doxorubicin-induced nephrotoxicity by modulating Nrf2/HO-1, NF-κB, and Bax/Bcl-2 activity: molecular and in silico insights
    Mohammed F. Abuzinadah, Rasheed A. Shaik, Aftab Ahmad, Mohammed Nazrul Islam, Basma G. Eid
    Molecular Biology Reports.2025;[Epub]     CrossRef
  • Alantolactone mitigates thioacetamide-induced liver fibrosis in mice by inhibiting TLR4/MyD88/NF-κB axis
    Haifa Almukadi, Nabih N. Alotaibi, Rasheed A. Shaik, Ashraf B. Abdel-Naim, Ahmed Esmat, Basma G. Eid
    Asian Pacific Journal of Tropical Biomedicine.2025; 15(8): 333.     CrossRef
  • Combined effects of nanoplastics and 3-BHA at environmentally relevant concentrations significantly aggravated kidney injury via TGF-β/SMAD signaling pathway in mice
    Guanghua Xiong, Huangqi Shi, Yaxuan Jiang, Min Lu, Jinghong Liu, Shangrong Zhang, Xiaoqing Wu, Hongcheng Wang, Hongbo Liu, Yihong Yang, Yong Liu
    Ecotoxicology and Environmental Safety.2025; 303: 119014.     CrossRef
  • Artesunate alleviates kidney fibrosis by restoring klotho protein and suppressing Wnt/β-catenin signalling pathway
    Goran H. Mohammad, Julius Kieswich, Abhishek Kumar, Kieran McCafferty, Ramyangshu Chakraborty, Christoph Thiemermann, Magdi M. Yaqoob
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • Natural products targeting TGF-β/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategies
    Chen-Hui Jiang, Shui-Juan Zhang, Ping Li, Hua Miao, Ying-Yong Zhao
    Phytomedicine.2025; 148: 157496.     CrossRef
  • Alantolactone as a Bioactive Sesquiterpene Lactone: Molecular Mechanisms and Anticancer Potential for Pharmaceutical Development
    Alice Njolke Mafe, Lipana Dorcas Bappa, Javad Sharifi‐Rad, William N. Setzer, Daniela Calina
    Archiv der Pharmazie.2025;[Epub]     CrossRef
  • TGF-β-Based Therapies for Treating Ocular Surface Disorders
    Fernando T. Ogata, Sudhir Verma, Vivien J. Coulson-Thomas, Tarsis F. Gesteira
    Cells.2024; 13(13): 1105.     CrossRef
  • Alantolactone alleviates epithelial-mesenchymal transition by regulating the TGF-β/STAT3 signaling pathway in renal fibrosis
    Yeo Jin Hwang, Gwon-Soo Jung, Kyeong-Min Lee
    Heliyon.2024; 10(16): e36253.     CrossRef
  • Sodium Phenylbutyrate Attenuates Cisplatin-Induced Acute Kidney Injury Through Inhibition of Pyruvate Dehydrogenase Kinase 4
    Chang Joo Oh, Wooyoung Choi, Ha Young Lee, In-Kyu Lee, Min-Ji Kim, Jae-Han Jeon
    Biomedicines.2024; 12(12): 2815.     CrossRef
Review
Cardiovascular Risk/Epidemiology
Article image
The Role of Echocardiography in Evaluating Cardiovascular Diseases in Patients with Diabetes Mellitus
Sun Hwa Lee, Jae-Hyeong Park
Diabetes Metab J. 2023;47(4):470-483.   Published online July 27, 2023
DOI: https://doi.org/10.4093/dmj.2023.0036
  • 13,163 View
  • 554 Download
  • 13 Web of Science
  • 17 Crossref
AbstractAbstract PDFPubReader   ePub   
Patients with diabetes mellitus are highly susceptible to cardiovascular complications, which are directly correlated with cardiovascular morbidity and mortality. In addition to coronary artery disease, there is growing awareness of the risk and prevalence of heart failure (HF) in patients with diabetes. Echocardiography is an essential diagnostic modality commonly performed in patients with symptoms suggestive of cardiovascular diseases (CVD), such as dyspnea or chest pain, to establish or rule out the cause of symptoms. Conventional echocardiographic parameters, such as left ventricular ejection fraction, are helpful not only for diagnosing CVD but also for determining severity, treatment strategy, prognosis, and response to treatment. Echocardiographic myocardial strain, a novel echocardiographic technique, enables the detection of early changes in ventricular dysfunction before HF symptoms develop. This article aims to review the role of echocardiography in evaluating CVD in patients with diabetes mellitus and how to use it in patients with suspected cardiac diseases.

Citations

Citations to this article as recorded by  
  • Reference Echocardiographic Values for Cardiac Chambers in Brazil: A Multiregional, Multi-Racial Study
    Ana Clara Tude Rodrigues, Roberto Magalhães Saraiva, Viviane T. Hotta, Gabriel Doreto Rodrigues, Fabiana Camelier de Assis Cardoso, Anderson da Costa Armstrong, Cláudia Gianini Monaco, Adelino Parro Junior, José Luis de Castro e Silva Pretto, João Marcos
    Arquivos Brasileiros de Cardiologia.2026;[Epub]     CrossRef
  • Valores Ecocardiográficos de Referência para as Câmaras Cardíacas no Brasil: Um Estudo Multirregional e Multirracial
    Ana Clara Tude Rodrigues, Roberto Magalhães Saraiva, Viviane T. Hotta, Gabriel Doreto Rodrigues, Fabiana Camelier de Assis Cardoso, Anderson da Costa Armstrong, Cláudia Gianini Monaco, Adelino Parro Junior, José Luis de Castro e Silva Pretto, João Marcos
    Arquivos Brasileiros de Cardiologia.2026;[Epub]     CrossRef
  • Role of Echocardiography in Detecting Left Ventricular Dysfunction Among Diabetic Patients: A Clinical and Biochemical Perspective
    Chandu Siripuram, K. Balu Mahendran, Shreelaxmi V Hegde, Sanjana Murali Krishna, Shruti Suresh Suvarna, Ramesh Kandimalla
    Cureus.2025;[Epub]     CrossRef
  • Progression of cardiac dysfunction in patients with type 2 diabetes without overt cardiovascular disease: A three‐year follow‐up echocardiographic study (DIACAR)
    Yara Antakly Hanon, Yoann Moeuf, Philippe Garçon, Aline Kalaydjian, Isabela Banu, Adela Voican, Olivier Dupuy, Romain Cador, Michel Komajda
    Diabetes, Obesity and Metabolism.2025; 27(8): 4581.     CrossRef
  • Artificial intelligence algorithm for predicting cardio-cerebrovascular risk in type 2 diabetes: concordance with clinical and instrumental assessments
    Francesco Piarulli, Eugenio Ragazzi, Chiara Celeste Celsan, Annunziata Lapolla, Giovanni Sartore
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Early Detection of Diabetic Cardiomyopathy Using Speckle Tracking Echocardiography: A Systematic Review
    Mohammad Burhanuddin, Zeeshan Ahmed, Ali Hamza, Muhammad Zeeshan, FNU Abdul Rehman , Syed Hassan M Gillani, Aiman Gul, Zara Rabbani, Osarenoma Mathilda Omonfuegbe, Syed Momin Ali
    Cureus.2025;[Epub]     CrossRef
  • Reference values for cardiac dimensions and function in a rural population living in a loiasis-endemic area of the Republic of the Congo: An echocardiographic study
    Guy S. Wafeu, Valentin Dupasquier, Jeremy T. Campillo, Ludovic G. Rancé, Elodie Lebredonchel, Sébastien D. S. Pion, François Missamou, Michel Boussinesq, Marlhand C. Hemilembolo, Cedric B. Chesnais
    Nature Communications.2025;[Epub]     CrossRef
  • Diabetic cardiomyopathy: a comprehensive review of diagnosis, management, and future directions
    Bhagyalakshmi Balakrishnan, Divyashree M. Somashekara, Veena Nayak, Raghu Chandrashekar Hariharapura
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Increased Blood Pressure Variability Over a 16-Year Period Is Associated With Left Ventricular Diastolic Dysfunction in a Population-Based Cohort
    Jae-Hyeong Park, Soon-Ki Ahn, Goo-Yeong Cho, Ki-Chul Sung, Seung Ku Lee, Seong Hwan Kim, Chol Shin
    American Journal of Hypertension.2024; 37(3): 168.     CrossRef
  • Biomarkers and subclinical left ventricular dysfunction in patients with type 2 diabetes without clinical manifestations of cardiovascular diseases
    T. G. Utina, D. U. Akasheva, D. V. Korsunsky, O. N. Dzhioeva, O. M. Drapkina
    Cardiovascular Therapy and Prevention.2024; 23(1): 3914.     CrossRef
  • Cardiovascular risk assessment in inflammatory bowel disease with coronary calcium score
    Waqar Arif Rasool Chaudhry, Muhammad Ashfaq, Parvinder Kaur, Mahendra Kumar, Maria Faraz, Jahanzeb Malik, Amin Mehmoodi
    Annals of Medicine & Surgery.2024; 86(3): 1496.     CrossRef
  • Diabetic cardiomyopathy: Emerging therapeutic options
    Cornelius James Fernandez, Sahana Shetty, Joseph M Pappachan
    World Journal of Diabetes.2024; 15(8): 1677.     CrossRef
  • Subclinical Left Ventricular Dysfunction over Seven-Year Follow-Up in Type 2 Diabetes Patients without Cardiovascular Diseases
    Dariga Uaydinichna Akasheva, Tatyana Gennadyevna Utina, Olga Nikolaevna Dzhioeva, Oxana Mikhailovna Drapkina
    Biomedicines.2024; 12(9): 2031.     CrossRef
  • Realistic Aspects of Cardiac Ultrasound in Rats: Practical Tips for Improved Examination
    Jessica Silva, Tiago Azevedo, Mário Ginja, Paula A. Oliveira, José Alberto Duarte, Ana I. Faustino-Rocha
    Journal of Imaging.2024; 10(9): 219.     CrossRef
  • Paper-based triple-readout nanosensor for point-of-care detection of glucose in urine
    Chengcheng Jin, Shuang Yang, Junlei Zheng, Fang Chai, Miaomiao Tian
    Biosensors and Bioelectronics.2024; : 116931.     CrossRef
  • Risperidone-Induced Hypothermia in a Cerebral Palsy Patient: A Case Report and Literature Review
    Hayfaa T Taner , Thekra I Alsalmi , Alia M Alshalawi, Jehan F Sarriyah
    Cureus.2024;[Epub]     CrossRef
  • Echocardiographic Aspects of Type 2 Diabetics Patients Hospitalized in the Medicine and Endocrinology Department of the Mali Hospital
    Konaté Massama, Mamadou Touré, Mariam Sako, Samba Sidibé, Souleymane Mariko, Djeneba Sylla Sow, Elhaj Mahamane Maiga, Coumba Adiaratou Thiam, Youssouf Camara, Hamidou Oumar Ba, Asmao Keita Maiga, Djenebou Traoré, Zoumana Traoré, Souleymane Coulibaly, Bah
    World Journal of Cardiovascular Diseases.2024; 14(03): 129.     CrossRef
Original Article
Basic Research
Article image
Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis
Kyung Bong Ha, Eun Soo Lee, Na Won Park, Su Ho Jo, Soyeon Shim, Dae-Kee Kim, Chan Mug Ahn, Choon Hee Chung
Diabetes Metab J. 2023;47(4):500-513.   Published online April 25, 2023
DOI: https://doi.org/10.4093/dmj.2022.0110
  • 8,258 View
  • 226 Download
  • 8 Web of Science
  • 9 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Curcumin 2005-8 (Cur5-8), a derivative of curcumin, improves fatty liver disease via AMP-activated protein kinase activation and autophagy regulation. EW-7197 (vactosertib) is a small molecule inhibitor of transforming growth factor β (TGF-β) receptor I and may scavenge reactive oxygen species and ameliorate fibrosis through the SMAD2/3 canonical pathway. This study aimed to determine whether co-administering these two drugs having different mechanisms is beneficial.
Methods
Hepatocellular fibrosis was induced in mouse hepatocytes (alpha mouse liver 12 [AML12]) and human hepatic stellate cells (LX-2) using TGF-β (2 ng/mL). The cells were then treated with Cur5-8 (1 μM), EW-7197 (0.5 μM), or both. In animal experiments were also conducted during which, methionine-choline deficient diet, Cur5-8 (100 mg/kg), and EW-7197 (20 mg/kg) were administered orally to 8-week-old C57BL/6J mice for 6 weeks.
Results
TGF-β-induced cell morphological changes were improved by EW-7197, and lipid accumulation was restored on the administration of EW-7197 in combination with Cur5-8. In a nonalcoholic steatohepatitis (NASH)-induced mouse model, 6 weeks of EW-7197 and Cur5-8 co-administration alleviated liver fibrosis and improved the nonalcoholic fatty liver disease (NAFLD) activity score.
Conclusion
Co-administering Cur5-8 and EW-7197 to NASH-induced mice and fibrotic hepatocytes reduced liver fibrosis and steatohepatitis while maintaining the advantages of both drugs. This is the first study to show the effect of the drug combination against NASH and NAFLD. Similar effects in other animal models will confirm its potential as a new therapeutic agent.

Citations

Citations to this article as recorded by  
  • Precision nutrition for NAFLD: a mechanistic rationale for targeting the cytokine landscape
    Amin Ullah, Shanshan Hu, Bairong Shen
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
  • Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs
    Xing Wan, Jingyuan Ma, He Bai, Xuyang Hu, Yanna Ma, Mingjian Zhao, Jifeng Liu, Zhijun Duan
    Biomolecules.2025; 15(1): 140.     CrossRef
  • Hepatoprotective and Fat-Accumulation-Reductive Effects of Curcumin on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Jasmine Harumi Sabini, Kris Herawan Timotius
    Current Issues in Molecular Biology.2025; 47(3): 159.     CrossRef
  • Thiazole isomers as potential ALK5 inhibitors alleviate P2X7R-mediated inflammation during liver fibrosis
    Xue-Li Jiang, Chuang Liu, Zi-Ying Zhan, Xiao-Qi Lan, Yan-Ling Wu, Ji-Xing Nan, Cheng-Hua Jin, Li-Hua Lian
    International Immunopharmacology.2025; 153: 114472.     CrossRef
  • TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?
    Weili Wang, Yilin Gao, Yizhen Chen, Meng Cheng, Yonghao Sang, Liuting Wei, Rong Dai, Yiping Wang, Lei Zhang
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Multiorgan crosstalk in MASLD/MASH: from hepatic pathogenesis to systemic complications
    Wenhua Bai, Zheng Zhu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Molecular Pathways Governing the Termination of Liver Regeneration
    Lianne R. de Haan, Rowan F. van Golen, Michal Heger
    Pharmacological Reviews.2024; 76(3): 500.     CrossRef
  • Nicotinate-curcumin improves NASH by inhibiting the AKR1B10/ACCα-mediated triglyceride synthesis
    Xiu-lian Lin, Ya-ling Zeng, Jie Ning, Zhe Cao, Lan-lan Bu, Wen-Jing Liao, Zhi-min Zhang, Tan-jun Zhao, Rong-geng Fu, Xue-Feng Yang, Yong-zhen Gong, Li-Mei Lin, De-liang Cao, Cai-ping Zhang, Duan-fang Liao, Ya-Mei Li, Jian-Guo Zeng
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease
    Qiaohui Shen, Ming Yang, Song Wang, Xingyu Chen, Sulan Chen, Rui Zhang, Zhuang Xiong, Yan Leng
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
Reviews
Others
Article image
Current Trends of Big Data Research Using the Korean National Health Information Database
Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
Diabetes Metab J. 2022;46(4):552-563.   Published online July 27, 2022
DOI: https://doi.org/10.4093/dmj.2022.0193
  • 19,900 View
  • 476 Download
  • 127 Web of Science
  • 136 Crossref
AbstractAbstract PDFPubReader   ePub   
Recently, medical research using big data has become very popular, and its value has become increasingly recognized. The Korean National Health Information Database (NHID) is representative of big data that combines information obtained from the National Health Insurance Service collected for claims and reimbursement of health care services and results obtained from general health examinations provided to all Korean adults. This database has several strengths and limitations. Given the large size, various laboratory data, and questionnaires obtained from medical check-ups, their longitudinal nature, and long-term accumulation of data since 2002, carefully designed studies may provide valuable information that is difficult to obtain from other forms of research. However, consideration of possible bias and careful interpretation when defining causal relationships is also important because the data were not collected for research purposes. After the NHID became publicly available, research and publications based on this database have increased explosively, especially in the field of diabetes and metabolism. This article reviews the history, structure, and characteristics of the Korean NHID. Recent trends in big data research using this database, commonly used operational diagnosis, and representative studies have been introduced. We expect further progress and expansion of big data research using the Korean NHID.

Citations

Citations to this article as recorded by  
  • Coronavirus Disease 2019 Risk in Patients With Autoimmune Diseases Using Biologics or Small Molecules: A Population-Based Cohort Study
    Eun Mi Song, Hyung-mi An, Seong-Eun Kim, Ki-Nam Shim, Hye-Kyung Jung, Sung-Ae Jung, Chang Mo Moon
    The Journal of Infectious Diseases.2026; 233(1): 137.     CrossRef
  • Increased atrial fibrillation risk in rheumatoid arthritis: Greater in seropositive than seronegative patients
    Seonyoung Kang, Yeonghee Eun, Kyungdo Han, Jinhyung Jung, Seulkee Lee, Hoon-Suk Cha, Jaejoon Lee, Seonghye Kim, Se Yun Kim, Sung Hea Kim, Dong Wook Shin, Hyungjin Kim
    Heart Rhythm.2026; 23(3): 525.     CrossRef
  • Air pollution and risk of autoimmune thyroid diseases in children and adolescents: Findings from a nationwide cohort study in Korea
    Jung Eun Choi, Jongmin Oh, Do Kyeong Song, Ji Hyen Lee, Kyung Hee Kim, Soontae Kim, Hae Soon Kim, Eunhee Ha
    Ecotoxicology and Environmental Safety.2026; 309: 119617.     CrossRef
  • The Effect of Alcohol Consumption Behavior Changes on Gastric Cancer Risks Stratified by Sex in South Korea
    Yonghoon Choi, Jieun Jang, Hyeong Ho Jo, Nayoung Kim
    Cancer Research and Treatment.2026; 58(1): 232.     CrossRef
  • Reproductive Lifespan and Reproductive Factors in Relation to Dementia Risk in Postmenopausal Women With Type 2 Diabetes
    Jin Yu, Jae-Hyoung Cho, Kyungdo Han, Yong-Moon Mark Park, Seung-Hwan Lee
    Diabetes Care.2026; 49(2): 292.     CrossRef
  • Blood pressure status and risk of cardiovascular disease in older adults aged 75+ without prior cardiovascular events: a nationwide cohort study
    Sangwon Choi, Kyung-Do Han, Kyung-Ho Yu, Byung-Chul Lee, Mi Sun Oh, Dae Young Cheon, Minwoo Lee
    European Journal of Preventive Cardiology.2026;[Epub]     CrossRef
  • Early age at smoking initiation is associated with elevated cardiovascular disease and mortality risk in a nationwide population-based cohort
    Jung Hun Koh, Kyungdo Han, Minsang Kim, Jeong Min Cho, Sehyun Jung, Soojin Lee, Yaerim Kim, Semin Cho, Hyuk Huh, Seong Geun Kim, Eunjeong Kang, Kwon Wook Joo, Dong Ki Kim, Sehoon Park
    Scientific Reports.2026;[Epub]     CrossRef
  • Nationwide analysis of demographic and socioeconomic inequities in air pollution exposure in Korea, 2006–2019
    So Yeon Kim, Sun Ju Nam Goung, Yoon-Hee Kang, Soontae Kim, Seoung Yeon Heo, Min Ji Koo, Jaiyong Kim, Kyoung Sook Jeong
    BMC Public Health.2026;[Epub]     CrossRef
  • Impact of gastrectomy on the risk of alcohol-associated liver disease in patients with gastric cancer
    Sang Yi Moon, Yang Hyun Baek, Dongwoo Kang, Jungkuk Lee, Yeo Wool Kang, Minkook Son, Hongqun Liu, Samuel S. Lee, Junho Park
    Scientific Reports.2026;[Epub]     CrossRef
  • Sex Disparity in Suicide Mortality among Patients with Type 2 Diabetes: A Nationwide Population-Based Cohort Study
    Chaiho Jeong, Bongseong Kim, Dae Jong Oh, Tae-Seo Sohn, Kyungdo Han, Hyuk-Sang Kwon
    Endocrinology and Metabolism.2026;[Epub]     CrossRef
  • Income and risk of type 2 diabetes incidence varied associations according to obesity status: a nationwide study
    Jee Hee Yoo, You-Bin Lee, Ji Eun Jun, Kyu-Na Lee, Kyungdo Han
    BMC Public Health.2026;[Epub]     CrossRef
  • SHAP-explained machine-learning model for high-risk gastric cancer identification
    Hyun Jin Oh, Chung Ho Kim, Jae Kwan Jun, Mina Suh, Kui Son Choi, Il Ju Choi, Bomi Park
    Frontiers in Oncology.2026;[Epub]     CrossRef
  • Underweight Status Amplifies Respiratory Infection Mortality in Diabetes: Findings From a Nationwide Cohort Study
    Hun Jee Choe, Kyong Do Han, Ji‐Hong Park, Jiwoo Lee, Mi Kyung Kwak, Yun Mi Choi, Sun‐Joon Moon, Eun‐Gyoung Hong
    Journal of Cachexia, Sarcopenia and Muscle.2026;[Epub]     CrossRef
  • Big data–driven observational evidence in Korea: challenges in interpreting non-randomized studies
    Jong Han Choi
    Journal of Evidence-Based Practice.2026; 2(1): 16.     CrossRef
  • Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study
    Min Jin Jeong, Yong Seok Lee, Youn Jin Choi, Kyung Do Han
    Cancers.2026; 18(6): 894.     CrossRef
  • Mapping the Landscape of Medical AI Research in Korea Using Topic Modeling
    Heejang Yun, Yoonhee Lee
    Healthcare.2026; 14(4): 549.     CrossRef
  • Long-term risk of offspring type 1 and type 2 diabetes following maternal gestational diabetes mellitus: a nationwide birth cohort study with 10-year follow-up
    Joon Ho Moon, Han Na Jung, Bongseong Kim, Jaehyun Kim, Young Mi Jung, Hyeon Ji Kim, Jee Yoon Park, Tae Jung Oh, Soo Heon Kwak, Kyung-Do Han, Sung Hee Choi
    BMC Medicine.2026;[Epub]     CrossRef
  • All-cause Mortality and Incidence of Cardiovascular Diseases in Lean Patients With Newly Diagnosed Type 2 Diabetes
    Do Kyeong Song, Jongmin Oh, Yeon-Ah Sung, Young Sun Hong, Hyejin Lee, Eunhee Ha
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(5): e1547.     CrossRef
  • Lifestyle Changes and Remission in Patients With New-Onset Type 2 Diabetes: A Nationwide Cohort Study
    Jinyoung Kim, Bongseong Kim, Mee Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Kyungdo Han, Hyuk-Sang Kwon
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • Association between Age-Related Macular Degeneration with Visual Disability and Risk of Dementia: A Nationwide Cohort Study
    Ki Young Son, Yong-Jun Choi, Bongseong Kim, Kyungdo Han, Sungsoon Hwang, Wonyoung Jung, Dong Wook Shin, Dong Hui Lim
    Journal of the American Medical Directors Association.2025; 26(2): 105392.     CrossRef
  • Using Real-World Evidence for Health Technology Assessment in Asia: Suggested Typology and Scoping Review
    Ryan R. Nugraha, Arie Rahadi, Christian Suharlim
    Value in Health Regional Issues.2025; 46: 101068.     CrossRef
  • Different Associations between Lipid Levels and Risk for Heart Failure according to Diabetes Progression
    Seung-Hwan Lee, Kyu Na Lee, Jong-Chan Youn, Hun Sung Kim, Kyungdo Han, Mee Kyoung Kim
    Diabetes & Metabolism Journal.2025; 49(1): 105.     CrossRef
  • Inverse association between obesity and suicidal death risk
    Joonyub Lee, Seung-Hwan Lee, Mee-Kyoung Kim, Hyuk-Sang Kwon, Jae-Seung Yun, Yeoree Yang, Kun-Ho Yoon, Jae-Hyoung Cho, Chi-Un Pae, Kyungdo Han, Jang Won Son
    BMC Psychiatry.2025;[Epub]     CrossRef
  • Big Data Research for Diabetes-Related Diseases Using the Korean National Health Information Database
    Kyung-Soo Kim, Bongseong Kim, Kyungdo Han
    Diabetes & Metabolism Journal.2025; 49(1): 13.     CrossRef
  • Cardiovascular Outcomes With Antidiabetic Drugs in People With Type 2 Diabetes and a Prior Stroke
    Jae Hyun Bae, Jimi Choi, Nam Hoon Kim, Sin Gon Kim
    Mayo Clinic Proceedings.2025; 100(2): 235.     CrossRef
  • The impact of weight change on suicide mortality: a nationwide population-based cohort study of 2 million Koreans
    Kyuho Kim, Jin-Hyung Jung, Yoo Hyun Um, Yu-Bae Ahn, Seung-Hyun Ko, Kyungdo Han, Jae-Seung Yun
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Trends of Pediatric Anterior Cruciate Ligament Reconstruction Surgery in Korea: Nationwide Population-Based Study
    Jihyun Hwang, Young-Min Kwon, Collin Lee, Sung Jae Kim, Young-Jin Seo
    Journal of Clinical Medicine.2025; 14(4): 1389.     CrossRef
  • Leveraging National Health Insurance Service Data for Public Health Research in Korea: Structure, Applications, and Future Directions
    Seung-Ji Lim, Sung-In Jang
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • Differences in the Effect of Physical Activity on the Prevention of Gastric Cancer According to Sex
    Hyeong Ho Jo, Nayoung Kim, Jieun Jang, Yonghoon Choi, Jung Won Lee
    Journal of Gastric Cancer.2025; 25(2): 343.     CrossRef
  • Effects of Pancreatitis and Type 2 Diabetes Mellitus on the Development of Pancreatic Cancer: A Nationwide Nested Case-Control Study
    Young-eun Kim, Min Heui Yu, Chung Mo Nam, Eun Seok Kang
    Diabetes & Metabolism Journal.2025; 49(2): 252.     CrossRef
  • Clinical Course and Prognosis of Long‐Term Survivors of Hepatocellular Carcinoma
    Soon Sun Kim, Jonghyun Lee, Sang Bong Ahn, Young Eun Chon, Eileen Yoon, Soung Won Jeong, Dae Won Jun
    Alimentary Pharmacology & Therapeutics.2025; 61(8): 1333.     CrossRef
  • Prevalence, Incidence, and Metabolic Characteristics of Young Adults with Type 2 Diabetes Mellitus in South Korea (2010–2020)
    Ji Yoon Kim, Jiyoon Lee, Joon Ho Moon, Se Eun Park, Seung-Hyun Ko, Sung Hee Choi, Nam Hoon Kim
    Diabetes & Metabolism Journal.2025; 49(2): 172.     CrossRef
  • Association between glycaemic status and the risk of acromegaly: a nationwide population-based cohort study
    Eun Roh, Ji Hye Heo, Han Na Jung, Kyung Do Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
    BMJ Open.2025; 15(3): e087884.     CrossRef
  • Long-term survival prediction in patients with acute brain lesions using ensemble machine learning algorithms: a cohort study with combined national health insurance service and its self-run hospital database
    Dougho Park, Daeyoung Hong, Suntak Jin, Jong Hun Kim, Hyoung Seop Kim
    Journal of Big Data.2025;[Epub]     CrossRef
  • Risk of Cardiovascular Disease According to the Precedence Relationship Between Hypertension and Diabetes Mellitus
    Junhee Park, Kyungdo Han, Kyuna Lee, Yoosoo Chang, Dong Wook Shin
    Healthcare.2025; 13(7): 796.     CrossRef
  • Association Between Metabolic Syndrome and Young-Onset Dementia
    Jeong-Yoon Lee, Kyungdo Han, Jonguk Kim, Jae-Sung Lim, Dae Young Cheon, Minwoo Lee
    Neurology.2025;[Epub]     CrossRef
  • Association between serum beta-hydroxybutyrate levels and risk of type 2 diabetes mellitus in patients with impaired fasting glucose
    Jaehyun Bae, Young-eun Kim, Keum Ji Jung, Sun Ha Jee, Byung-Wan Lee
    Nutrition & Diabetes.2025;[Epub]     CrossRef
  • Nationwide big data analysis of inguinal hernia surgery trends in South Korea (2016–2022)
    Hyunjeong Ki, Seyoung Koo, Gil Ho Kang, Jiyoung Sul, Junbeom Park
    Annals of Surgical Treatment and Research.2025; 108(4): 211.     CrossRef
  • Associations between non-insulin-based insulin resistance surrogate markers and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study in South Korea
    Sang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Association between mental disorders and suicide risk among people with type 2 diabetes
    Han-Sang Baek, Kyu-Na Lee, Dong Woo Kang, Jae-Seung Yun, Hyuk-Sang Kwon, Kyungdo Han, Seung-Hwan Lee
    Journal of Affective Disorders.2025; 385: 119351.     CrossRef
  • Chronic Kidney Disease Risk Associated With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Cohort Study in Korea
    Dong Wook Kim, Minkook Son, Hye Jung Lee, Chi Hyeon Choi, Yeo Wool Kang, Sang Yi Moon, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek, Won Suk An
    Hepatology Research.2025; 55(9): 1239.     CrossRef
  • Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
    Minji Jung, Mingyi Li, Eunjung Choo, Sukhyang Lee, David Spiegel, Michael Baiocchi, Zhengyi Deng, Jinhui Li, Marvin E. Langston, Melissa L. Bondy, Benjamin I. Chung
    Cancer Epidemiology, Biomarkers & Prevention.2025; 34(6): 1027.     CrossRef
  • The Triglyceride-Glucose Index and Risk of End-Stage Renal Disease across Different Durations of Type 2 Diabetes Mellitus: A Longitudinal Cohort Study
    Mi-sook Kim, Kyu-Na Lee, Jeongmin Lee, Jeongeun Kwak, Seung-Hwan Lee, Hyuk-Sang Kwon, Jing Hughes, Kyung-Do Han, Eun Young Lee
    Endocrinology and Metabolism.2025; 40(5): 718.     CrossRef
  • Trends in surgery and anesthesia practices during the COVID-19 pandemic: a nationwide analysis from South Korea’s Health Insurance Database
    EunJin Ahn, Hyo Jin Kim, Si Ra Bang
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • The impact of blood pressure and its variability on suicide mortality: a nationwide population-based study
    Jeongmin Lee, Jeongeun Kwak, Jin-Hyung Jung, Dong Woo Kang, Mee Kyoung Kim, Dong-Jun Lim, Hyuk-Sang Kwon, Jung Min Lee, Sang-Ah Chang, Kyungdo Han, Seung-Hwan Lee
    Hypertension Research.2025; 48(8): 2173.     CrossRef
  • Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
    Ji-Hyun Kim, Seung-Hwan Lee, Kyu Na Lee, Kyungdo Han, Mee Kyoung Kim
    Journal of Lipid and Atherosclerosis.2025; 14(2): 190.     CrossRef
  • Diabetes Progression and Its Impact on Kidney Cancer Risk: Insights From a Longitudinal Korean Cohort Study
    Jin Yu, Bongseong Kim, Kyungdo Han, Mee Kyoung Kim
    The Journal of Clinical Endocrinology & Metabolism.2025; 111(1): e125.     CrossRef
  • High‐Density Lipoprotein Cholesterol Levels and the Risk of Acromegaly: A Nationwide Cohort Study
    Eun Roh, Ji Hye Heo, Han Na Jung, Kyung‐Do Han, Jun Goo Kang, Seong Jin Lee, Sung‐Hee Ihm
    Clinical Endocrinology.2025; 103(2): 225.     CrossRef
  • Risk of psychiatric disorders in patients with graves' disease: A nationwide population-based analysis
    Ju-Yeun Lee, Minha Hong, Young Hee Jung, Seo Young Sohn
    Journal of Affective Disorders.2025; 385: 119386.     CrossRef
  • Long-term exposure to air pollution and lung cancer incidence: findings from improved exposure assessment and extended population
    Jeongho Park, Ok-Jin Kim, Miyoun Shin, Euijun Choi, Sungchan Kang, Seung-Sik Hwang, Young-Jae Cho, Sun-Young Kim
    Cancer Causes & Control.2025; 36(10): 1119.     CrossRef
  • Impact of type 2 diabetes on the risk of cardiovascular disease and cardiovascular mortality in patients with non-alcoholic fatty liver disease: a nationwide population-based study
    Eun Roh, Han Na Jung, Ji Hye Heo, Kyungdo Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
    BMJ Public Health.2025; 3(1): e002020.     CrossRef
  • Time to Insulin Therapy and Severe Hypoglycemia in Korean Adults Initially Diagnosed with Type 2 Diabetes: A Nationwide Study
    You-Bin Lee, Kyungdo Han, Bongsung Kim, So Hee Park, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim, Sang-Man Jin
    Endocrinology and Metabolism.2025; 40(3): 421.     CrossRef
  • Prevalence of Mortality and Vascular Complications in Older Patients with Diabetes in Korea
    Kwang Joon Kim, Jeongmin Lee, Yang Sun Park, Yong-ho Lee, Kyeong Hye Park, Hee-Won Jung, Chang Oh Kim, Man Young Park, Hun-Sung Kim, Bong-Soo Cha
    Endocrinology and Metabolism.2025; 40(3): 448.     CrossRef
  • Risk of End-Stage Kidney Disease in Individuals with Diabetes Living Alone: A Large-Scale Population-Based Study
    Kyunghun Sung, Jae-Seung Yun, Bongseong Kim, Hun-Sung Kim, Jae-Hyoung Cho, Yong-Moon Mark Park, Kyungdo Han, Seung-Hwan Lee
    Diabetes & Metabolism Journal.2025; 49(4): 862.     CrossRef
  • Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality
    Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Age and sex differences of cardiovascular and mortality risks in Korean type 2 diabetes and prediabetes: An 8 million Korean nationwide population-based cohort study
    Jae-Seung Yun, Jin-Hyung Jung, Bongseong Kim, Kyuho Kim, Yu-Bae Ahn, Seung Yeon Kim, Sooha Jung, Kyungdo Han, Seung-Hyun Ko
    Diabetes Research and Clinical Practice.2025; 227: 112401.     CrossRef
  • Diabetes status, duration and risk of dementia in patients with myocardial infarction
    Dae Young Cheon, Kyungdo Han, Ye Seul Yang, Minwoo Lee, Mi Sun Oh
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Mental Health Impacts of COVID-19 Pandemic by Gender in South Korea: Links to Job Loss and Childcare
    Sunju Lee, HyeSeung Wee, Seungho Jung, Jongmin Lee
    COVID.2025; 5(8): 134.     CrossRef
  • Biological Age Estimation From the Age Gap Using Deep Learning Integrating Morbidity and Mortality: Model Development and Validation Study
    Seong-Eun Moon, Ji Won Yoon, Jae Hyun Bae, Shinyoung Joo, Yoo Hyung Kim, Bon Hyang Lee, Seokho Yoon, Haanju Yoo, Young Min Cho
    Journal of Medical Internet Research.2025; 27: e71592.     CrossRef
  • Association between metabolic dysfunction-associated steatotic liver disease and the risk of thyroid cancer: a nationwide cohort study
    Jeongmin Lee, Jeongeun Kwak, Min-Hee Kim, Seung-Hwan Lee, Jae-Hyoung Cho, Dong-Jun Lim, Jung Min Lee, Sang-Ah Chang, Hun-Sung Kim
    The Korean Journal of Internal Medicine.2025; 40(5): 813.     CrossRef
  • Association between the Triglyceride-Glucose Index and Cardiovascular Risk and Mortality across Different Diabetes Durations: A Nationwide Cohort Study
    Jeongeun Kwak, Kyung-Do Han, Eun Young Lee, Seung-Hwan Lee, Dong-Jun Lim, Hyuk-Sang Kwon, Jeongmin Lee
    Endocrinology and Metabolism.2025; 40(4): 548.     CrossRef
  • Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study
    Eun Roh, Ji Hye Heo, Han Na Jung, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
    Diabetes & Metabolism Journal.2025; 49(5): 1106.     CrossRef
  • Current Status of Continuous Glucose Monitoring Use in South Korean Type 1 Diabetes Mellitus Population–Pronounced Age-Related Disparities: Nationwide Cohort Study
    Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2025; 49(5): 1040.     CrossRef
  • The Severity of Diabetes and the Risk of Diabetic Foot Amputation: A National Cohort Study
    Jin Yu, Ji-Hyun Kim, Bongseong Kim, Kyungdo Han, Seung Hwan Lee, Mee Kyoung Kim
    Endocrinology and Metabolism.2025; 40(4): 574.     CrossRef
  • Medical travel patterns for hepatocellular carcinoma treatment in South Korea: National Health Insurance data from 2013 to 2021
    Sungmin Kim, Naeun Kim, Hyung-Sik Lee, Mina Kim, Hoseob Kim, Youngmin Choi
    World Journal of Gastrointestinal Oncology.2025;[Epub]     CrossRef
  • Cardiovascular risk across blood pressure categories defined by the 2024 ESC and 2023 ESH hypertension guidelines: insights from a Korean nationwide cohort study
    Dae young Cheon, Kyung-do Han, Yeon Jung Lee, Jeen Hwa Lee, Myung Soo Park, Sook Jin Lee, Seongwoo Han, Jae Hyuk Choi, Minwoo Lee
    European Journal of Preventive Cardiology.2025;[Epub]     CrossRef
  • End-stage renal diseases associated with SGLT2 inhibitors versus GLP-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease
    Hwa Yeon Ko, Bin Hong, Sungho Bea, Jae Hyun Bae, Young Min Cho, Yoosoo Chang, Seungho Ryu, Christopher D Byrne, Ju-Young Shin
    Diabetes Research and Clinical Practice.2025; 229: 112921.     CrossRef
  • Contrasting associations of body mass index and waist circumference with cancer incidence in the elderly: a nationwide population-based study
    Soo Yeon Jang, Minwoong Kang, Eyun Song, Ahreum Jang, Min Jeong Park, Kyung Mook Choi, Sei Hyun Baik, Hye Jin Yoo
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Analysis of risk factors for bleeding after gastric endoscopic submucosal dissection with an emphasis on age and sex differences: A nationwide population-based study
    Jae Yong Park, Mi-Sook Kim, Beom Jin Kim, Jae Gyu Kim
    Surgical Endoscopy.2025; 39(12): 8418.     CrossRef
  • Risk of Parkinson Disease Among Patients With Restless Leg Syndrome
    Myeonghwan Bang, Dougho Park, Jong Hun Kim, Hyoung Seop Kim
    JAMA Network Open.2025; 8(10): e2535759.     CrossRef
  • Metabolic Syndrome and Risk of Moyamoya Vasculopathy and Subsequent Stroke in Young Adults
    Joonyub Lee, Minwoo Lee, Seung‐Hwan Lee, Mee‐Kyoung Kim, Hyuk‐Sang Kwon, Jae‐Seung Yun, Yeoree Yang, Kun‐Ho Yoon, Jae‐Hyoung Cho, Suk‐Won Ahn, Kyungdo Han, Jang Won Son
    Journal of the American Heart Association.2025;[Epub]     CrossRef
  • Effect of smoking cessation and post-cessation weight change on suicide mortality in type 2 diabetes: A nationwide cohort study
    Chaiho Jeong, Bongseong Kim, Dae Jong Oh, Tae-Seo Sohn, Kyungdo Han, Hyuk-Sang Kwon
    Diabetes Research and Clinical Practice.2025; 230: 112967.     CrossRef
  • Remnant Cholesterol as an Independent Cardiovascular Risk Factor in Young Adults
    Han Na Jung, Ji Hye Heo, Myung Jin Kim, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee
    JACC.2025; 86(21): 2047.     CrossRef
  • Comparative Efficacy of Initial Statin and Ezetimibe Combination versus Statin Monotherapy on Cardiovascular Outcomes in Diabetes Mellitus: A Nationwide Cohort Study
    Minji Sohn, Young-Hwan Park, Soo Lim
    Diabetes & Metabolism Journal.2025; 49(6): 1318.     CrossRef
  • Impact of ACEI/ARB use on COVID-19 mortality in patients with ischaemic heart disease: insights from South Korean National health insurance service data
    Shin-Woo Kim, Taewan Goo, Seunghwan Noh, Seungyeoun Lee, Bumjo Oh, Taesung Park
    BMC Infectious Diseases.2025;[Epub]     CrossRef
  • Independent associations of physical activity and depression with open-angle glaucoma in a population-based analysis
    Sang Yeop Lee, Sang-Jun Shin, Jeongwoo Lee, David Myung, Hun Lee
    Scientific Reports.2025;[Epub]     CrossRef
  • Differences in cardiovascular disease incidence according to changes in obesity status in young diabetic patients
    Do Kyeong Song, Yeon-Ah Sung, Young Sun Hong, Min-ho Kim, Hyejin Lee
    Cardiovascular Diabetology – Endocrinology Reports.2025;[Epub]     CrossRef
  • Obstructive sleep apnea and venous thromboembolism risk: a nationwide population-based study
    So Yeon Kim, Yong Jin Sim, Jaeyoung Cho
    SLEEPJ.2025;[Epub]     CrossRef
  • Indonesian National Health Insurance scheme longitudinal sample data 2015–2020: overview and potential uses for health policy analysis
    Alfariany Fatimah, Laura Anselmi, Jonathan Gibson, Asri Maharani, Irmansyah Irmansyah, Sri Idaiani, Dwidjo Susilo, Jack Wilkinson, Matt Sutton, Herni Susanti, Helen Brooks, Penny Bee, Hasbullah Thabrany
    BMC Health Services Research.2025;[Epub]     CrossRef
  • Comparison of Methods for Converting Categorical Variables to Continuous Measures: Resolving Temporal Discontinuity in the Smoking Questionnaires in NHIS-National Sample Cohort
    Kang Hee Ha, Hye Ji Yang, Min-Ju Park, Si-Gyeong Lee, Su Hwan Kim
    Journal of Health Informatics and Statistics.2025; 50(4): 441.     CrossRef
  • Fatty Liver Index Dynamics as a Predictor of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus and Non-Cirrhotic Livers
    Eun-Hee Cho, Min Gu Kang, Chang Hun Lee, Shinyoung Oh, Chen Shen, Ha Ram Oh, Young Ran Park, Hyun Lee, Jong Seung Kim, Ji Hyun Park
    Endocrinology and Metabolism.2025; 40(6): 883.     CrossRef
  • Weight change in patients with new‐onset type 2 diabetes mellitus and its association with remission: Comprehensive real‐world data
    Jinyoung Kim, Bongseong Kim, Mee Kyoung Kim, Ki‐Hyun Baek, Ki‐Ho Song, Kyungdo Han, Hyuk‐Sang Kwon
    Diabetes, Obesity and Metabolism.2024; 26(2): 567.     CrossRef
  • Repeated detection of non‐alcoholic fatty liver disease increases the incidence risk of type 2 diabetes in young adults
    Jin Hwa Kim, Young Sang Lyu, Mee Kyoung Kim, Sang Yong Kim, Ki‐Hyun Baek, Ki‐Ho Song, Kyungdo Han, Hyuk‐Sang Kwon
    Diabetes, Obesity and Metabolism.2024; 26(1): 180.     CrossRef
  • Diabetes severity and the risk of depression: A nationwide population-based study
    Yunjung Cho, Bongsung Kim, Hyuk-Sang Kwon, Kyungdo Han, Mee Kyoung Kim
    Journal of Affective Disorders.2024; 351: 694.     CrossRef
  • Diabetes Duration, Cholesterol Levels, and Risk of Cardiovascular Diseases in Individuals With Type 2 Diabetes
    Mee Kyoung Kim, Kyu Na Lee, Kyungdo Han, Seung-Hwan Lee
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(12): e2317.     CrossRef
  • Remnant cholesterol is an independent risk factor for the incidence of chronic kidney disease in newly-diagnosed type 2 diabetes: A nationwide population-based study
    Soo Yeon Jang, Minwoong Kang, Eyun Song, Ahreum Jang, Kyung Mook Choi, Sei Hyun Baik, Hye Jin Yoo
    Diabetes Research and Clinical Practice.2024; 210: 111639.     CrossRef
  • Association of the Intensive Blood Pressure Target and Cardiovascular Outcomes in the Population With Chronic Kidney Disease: A Retrospective Study in Korea
    Soo‐Young Yoon, Ji Yoon Kong, Su Jin Jeong, Jin Sug Kim, Hyeon Seok Hwang, Kyunghwan Jeong
    Journal of the American Heart Association.2024;[Epub]     CrossRef
  • Risk of Depression according to Cumulative Exposure to a Low-Household Income Status in Individuals with Type 2 Diabetes Mellitus: A Nationwide Population- Based Study
    So Hee Park, You-Bin Lee, Kyu-na Lee, Bongsung Kim, So Hyun Cho, So Yoon Kwon, Jiyun Park, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2024; 48(2): 290.     CrossRef
  • Body Weight Variability and Risk of Suicide Mortality: A Nationwide Population-Based Study
    Jeongmin Lee, Jin-Hyung Jung, Dong Woo Kang, Min-Hee Kim, Dong-Jun Lim, Hyuk-Sang Kwon, Jung Min Lee, Sang-Ah Chang, Kyungdo Han, Seung-Hwan Lee, Fuquan Zhang
    Depression and Anxiety.2024; 2024: 1.     CrossRef
  • Effect of body mass index on gastric cancer risk according to sex in Korea: a nationwide cohort study and literature review
    Yonghoon Choi, Jieun Jang, Nayoung Kim
    The Ewha Medical Journal.2024;[Epub]     CrossRef
  • Association between exercise habits and incident type 2 diabetes mellitus in patients with thyroid cancer: nationwide population-based study
    Jiyun Park, Jin-Hyung Jung, Hyunju Park, Young Shin Song, Soo-Kyung Kim, Yong-Wook Cho, Kyungdo Han, Kyung-Soo Kim
    BMC Medicine.2024;[Epub]     CrossRef
  • Association between Body Weight Variability and Mortality in Young Adults: A Nationwide Cohort Study
    Yebin Park, Kyungdo Han
    Korean Journal of Family Practice.2024; 14(2): 105.     CrossRef
  • A systematic review and meta-data analysis of clinical data repositories in Africa and beyond: recent development, challenges, and future directions
    Kayode S. Adewole, Emmanuel Alozie, Hawau Olagunju, Nasir Faruk, Ruqayyah Yusuf Aliyu, Agbotiname Lucky Imoize, Abubakar Abdulkarim, Yusuf Olayinka Imam-Fulani, Salisu Garba, Bashir Abdullahi Baba, Mustapha Hussaini, Abdulkarim A. Oloyede, Aminu Abdullahi
    Discover Data.2024;[Epub]     CrossRef
  • Association between the length of stay in rehabilitation and mortality among the adults with Parkinson’s disease: 2009–2019 Korean National Health Insurance Service Databases
    Suyeong Bae, Ickpyo Hong, Min Seok Baek
    Frontiers in Aging Neuroscience.2024;[Epub]     CrossRef
  • Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study
    Gyuri Kim, Kyung-do Han, So Hyun Cho, Rosa Oh, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
    Diabetes & Metabolism.2024; 50(5): 101569.     CrossRef
  • Beyond breast cancer: role of selective estrogen receptor modulators in reducing systemic malignancies: evidence from population-based data
    Jeongmin Lee, Jinyoung Kim, Chaiho Jeong, Ki-Hyun Baek, Jeonghoon Ha
    Current Medical Research and Opinion.2024; 40(9): 1589.     CrossRef
  • Relationship between smoking experience and risk of suicide mortality in South Korean adults: A nationwide population-based retrospective cohort study
    Hyo Jin Park, Byoungduck Han, Bongseong Kim, Kyungdo Han, Seohwan Kim, Hyunjoo Kim, Kyoungjoon Youn, Hyun Jin Park, Yong-kyun Roh, Youn Seon Choi, Ga Eun Nam, Seon Mee Kim
    Journal of Affective Disorders.2024; 367: 67.     CrossRef
  • Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT
    Eu Jeong Ku, Bongseong Kim, Kyungdo Han, Seung-Hwan Lee, Hyuk-Sang Kwon
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Cancer risk among air transportation industry workers in Korea: a national health registry-based study
    Soojin Park, Ga Bin Lee, Dalnim Lee, Eun-Shil Cha, Kyunghee Han, Minsu Cho, Songwon Seo
    BMC Public Health.2024;[Epub]     CrossRef
  • Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes
    Jiwon Park, Hangyul Song, Shinje Moon, Yumin Kim, Sungsoo Cho, Kyungdo Han, Cheol-Young Park, Sung Woo Cho, Chang-Myung Oh
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Navigating the Realm of Claims-Based Research
    Catherine Q. Sun, Nisha R. Acharya
    Ophthalmology.2024; 131(10): 1139.     CrossRef
  • Sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase IV inhibitors and risk of dementia among patients with type 2 diabetes and comorbid mental disorders: A population-based cohort study
    Bin Hong, Hyesung Lee, Ahhyung Choi, Woo Jung Kim, Young Min Cho, Dong Keon Yon, Ju-Young Shin
    Diabetes & Metabolism.2024; 50(6): 101581.     CrossRef
  • All-cause and cause-specific mortality risks in individuals with diabetes living alone: A large-scale population-based cohort study
    Jae-Seung Yun, Kyungdo Han, Bongseong Kim, Seung-Hyun Ko, Hyuk-Sang Kwon, Yu-Bae Ahn, Yong-Moon Mark Park, Seung-Hwan Lee
    Diabetes Research and Clinical Practice.2024; 217: 111876.     CrossRef
  • Validation and proposal of case definitions for identifying patients with myasthenia gravis
    Bit Na Lee, Kyoungsu Kim, Ha Young Shin, Hyung Jun Park, Seungjin Baek, Namki Hong, Seung Woo Kim
    Current Medical Research and Opinion.2024; 40(11): 1985.     CrossRef
  • Impact of mental disorders on the all-cause mortality and cardiovascular disease outcomes in adults with new-onset type 1 diabetes: A nationwide cohort study
    Seohyun Kim, Gyuri Kim, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
    Psychiatry Research.2024; 342: 116228.     CrossRef
  • The effect of glycemic levels on Doppler indices and pregnancy outcome in pregestational and gestational diabetic pregnant women
    Sohair R.M. Zedan, Nagwa M. El-ghorab, Mona T. El-Ebiary, Yasmine I. El-Masry
    Tanta Medical Journal.2024; 52(4): 362.     CrossRef
  • Cholecystectomy Increases the Risk of Chronic Kidney Disease: A Nationwide Longitudinal Cohort Study
    Ji Hye Heo, Eun Ji Kim, Han Na Jung, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm, Eun Roh
    Journal of Clinical Medicine.2024; 13(21): 6598.     CrossRef
  • Characteristics and impact of real-world evidence studies in oncology: comprehensive mapping review of publications evaluating targeted therapies in solid tumours
    A. Pellat, T. Grinda, P. Cresta Morgado, A. Prelaj, V. Miskovic, A. Valachis, I. Zerdes, D. Martins-Branco, L. Provenzano, A. Spagnoletti, G. Nader-Marta, B.E. Wilson, Y.-H. Yang, G. Pentheroudakis, S. Delaloge, L. Castelo-Branco, M. Koopman
    ESMO Real World Data and Digital Oncology.2024; 6: 100091.     CrossRef
  • PM2.5 and hospitalizations through the emergency department in people with disabilities: a nationwide case-crossover study in South Korea
    Jinah Park, Ayoung Kim, Michelle L. Bell, Ziyad Al-Aly, Seoyeong Ahn, Sooyoung Kim, Dohoon Kwon, Cinoo Kang, Jieun Oh, Ho Kim, Whanhee Lee
    The Lancet Regional Health - Western Pacific.2024; 53: 101256.     CrossRef
  • Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Chronic Periodontitis: A Nationwide Cohort Study
    Bo-Kyung Shine, Minkook Son, Sang Yi Moon, Seong-Ho Han
    Nutrients.2024; 17(1): 125.     CrossRef
  • Risk of Cause-Specific Mortality across Glucose Spectrum in Elderly People: A Nationwide Population-Based Cohort Study
    Joonyub Lee, Hun-Sung Kim, Kee-Ho Song, Soon Jib Yoo, Kyungdo Han, Seung-Hwan Lee
    Endocrinology and Metabolism.2023; 38(5): 525.     CrossRef
  • A nationwide cohort study on diabetes severity and risk of Parkinson disease
    Kyungdo Han, Bongsung Kim, Seung Hwan Lee, Mee Kyoung Kim
    npj Parkinson's Disease.2023;[Epub]     CrossRef
  • Predicting the Risk of Insulin-Requiring Gestational Diabetes before Pregnancy: A Model Generated from a Nationwide Population-Based Cohort Study in Korea
    Seung-Hwan Lee, Jin Yu, Kyungdo Han, Seung Woo Lee, Sang Youn You, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
    Endocrinology and Metabolism.2023; 38(1): 129.     CrossRef
  • Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
    Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
  • Comparison of Operational Definition of Type 2 Diabetes Mellitus Based on Data from Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey
    Jong Ha Baek, Yong-Moon Park, Kyung Do Han, Min Kyong Moon, Jong Han Choi, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2023; 47(2): 201.     CrossRef
  • Comorbidity Differences by Trajectory Groups as a Reference for Identifying Patients at Risk for Late Mortality in Childhood Cancer Survivors: Longitudinal National Cohort Study
    Hyery Kim, Hae Reong Kim, Sung Han Kang, Kyung-Nam Koh, Ho Joon Im, Yu Rang Park
    JMIR Public Health and Surveillance.2023; 9: e41203.     CrossRef
  • Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up
    Ji Young Kang, Kyungdo Han, Seung-Hwan Lee, Mee Kyoung Kim
    Respiratory Research.2023;[Epub]     CrossRef
  • Investigation of the Relationship Between Psychiatry Visit and Suicide After Deliberate Self-harm: Longitudinal National Cohort Study
    Hye Hyeon Kim, Chanyoung Ko, Ji Ae Park, In Han Song, Yu Rang Park
    JMIR Public Health and Surveillance.2023; 9: e41261.     CrossRef
  • Reply
    Yeonghee Eun, Hyungjin Kim, Jaejoon Lee
    Arthritis & Rheumatology.2023; 75(6): 1081.     CrossRef
  • Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
    Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
    Diabetes & Metabolism Journal.2023; 47(3): 347.     CrossRef
  • Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia
    Bo-Guen Kim, Danbee Kang, Kyung Hoon Min, Juhee Cho, Kyeongman Jeon
    Antibiotics.2023; 12(6): 984.     CrossRef
  • Cumulative exposure to metabolic syndrome increases thyroid cancer risk in young adults: a population-based cohort study
    Jinyoung Kim, Kyungdo Han, Mee Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
    The Korean Journal of Internal Medicine.2023; 38(4): 526.     CrossRef
  • Risk of developing chronic kidney disease in young-onset Type 2 diabetes in Korea
    Joonyub Lee, Seung-Hwan Lee, Kun-Ho Yoon, Jae Hyoung Cho, Kyungdo Han, Yeoree Yang
    Scientific Reports.2023;[Epub]     CrossRef
  • Factors Affecting High Body Weight Variability
    Kyungdo Han, Mee Kyoung Kim
    Journal of Obesity & Metabolic Syndrome.2023; 32(2): 163.     CrossRef
  • Physical activity and reduced risk of fracture in thyroid cancer patients after thyroidectomy — a nationwide cohort study
    Jinyoung Kim, Kyungdo Han, Jin-Hyung Jung, Jeonghoon Ha, Chaiho Jeong, Jun-Young Heu, Se-Won Lee, Jeongmin Lee, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Ki-Hyun Baek
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The impact of diabetes status on total and site-specific cancer risk in the elderly population: A nationwide cohort study
    Kyuho Kim, Bongseong Kim, Hyunho Kim, Hyung Soon Park, Yu-Bae Ahn, Seung-Hyun Ko, Kyungdo Han, Jae-Seung Yun
    Diabetes Research and Clinical Practice.2023; 203: 110866.     CrossRef
  • Response to comments of Lai et al. “Proposal of one option for patient-centered, heterogeneous selection of antidiabetic drug”
    Sunyoung Kim, Sang Youl Rhee
    Diabetes Research and Clinical Practice.2023; 203: 110864.     CrossRef
  • Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis
    Mee Kyoung Kim, Kyungdo Han, Hyuk-Sang Kwon, Soon Jib Yoo
    Endocrinology and Metabolism.2023; 38(4): 426.     CrossRef
  • Increased risk of ischemic stroke associated with elevated gamma-glutamyl transferase level in adult cancer survivors: a population-based cohort study
    Kyuwoong Kim, Hyeyun Jung, Edvige Di Giovanna, Tae Joon Jun, Young-Hak Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • Real-world data analysis on effectiveness of integrative therapies: A practical guide to study design and data analysis using healthcare databases
    Ye-Seul Lee, Yoon Jae Lee, In-Hyuk Ha
    Integrative Medicine Research.2023; 12(4): 101000.     CrossRef
  • Possible Applications of the Korean Experience in the Development of Croatian Healthcare System
    Predrag Bejakovic, Romina P Družeta, Ohmin Kwon
    Science, Art and Religion.2023; 2(1--2): 26.     CrossRef
  • Cumulative effect of impaired fasting glucose on the risk of dementia in middle-aged and elderly people: a nationwide cohort study
    Jin Yu, Kyu-Na Lee, Hun-Sung Kim, Kyungdo Han, Seung-Hwan Lee
    Scientific Reports.2023;[Epub]     CrossRef
  • Alcohol consumption and the risk of liver disease: a nationwide, population-based study
    Sang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Long-Term Cumulative Exposure to High γ-Glutamyl Transferase Levels and the Risk of Cardiovascular Disease: A Nationwide Population-Based Cohort Study
    Han-Sang Baek, Bongseong Kim, Seung-Hwan Lee, Dong-Jun Lim, Hyuk-Sang Kwon, Sang-Ah Chang, Kyungdo Han, Jae-Seung Yun
    Endocrinology and Metabolism.2023; 38(6): 770.     CrossRef
  • Sodium-glucose cotransporter 2 inhibitors for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: A nationwide propensity-score matched cohort study
    Jinyoung Kim, Kyungdo Han, Bongsung Kim, Ki-Hyun Baek, Ki-Ho Song, Mee Kyoung Kim, Hyuk-Sang Kwon
    Diabetes Research and Clinical Practice.2022; 194: 110187.     CrossRef
  • Chronic viral hepatitis accelerates lung function decline in smokers
    Suh-Young Lee, Sun-Sin Kim, So-Hee Lee, Heung-Woo Park
    Clinical and Experimental Medicine.2022; 23(6): 2159.     CrossRef
Islet Studies and Transplantation
Article image
Regulation of Pancreatic β-Cell Mass by Gene-Environment Interaction
Shun-ichiro Asahara, Hiroyuki Inoue, Yoshiaki Kido
Diabetes Metab J. 2022;46(1):38-48.   Published online January 27, 2022
DOI: https://doi.org/10.4093/dmj.2021.0045
  • 12,115 View
  • 281 Download
  • 12 Web of Science
  • 11 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
The main pathogenic mechanism of diabetes consists of an increase in insulin resistance and a decrease in insulin secretion from pancreatic β-cells. The number of diabetic patients has been increasing dramatically worldwide, especially in Asian people whose capacity for insulin secretion is inherently lower than that of other ethnic populations. Causally, changes of environmental factors in addition to intrinsic genetic factors have been considered to have an influence on the increased prevalence of diabetes. Particular focus has been placed on “gene-environment interactions” in the development of a reduced pancreatic β-cell mass, as well as type 1 and type 2 diabetes mellitus. Changes in the intrauterine environment, such as intrauterine growth restriction, contribute to alterations of gene expression in pancreatic β-cells, ultimately resulting in the development of pancreatic β-cell failure and diabetes. As a molecular mechanism underlying the effect of the intrauterine environment, epigenetic modifications have been widely investigated. The association of diabetes susceptibility genes or dietary habits with gene-environment interactions has been reported. In this review, we provide an overview of the role of gene-environment interactions in pancreatic β-cell failure as revealed by previous reports and data from experiments.

Citations

Citations to this article as recorded by  
  • High-Fat Diet-Fed Kcnq1 Mutant Mice Have Reduced Pancreatic β-Cell Mass via Gene-Environment Interaction
    Shun-ichiro Asahara, Hiroyuki Inoue, Yuka Ihara, Kyoko Teruyama, Asuka Imai, Chisako Hara, Mizuki Hara, Masako Seike, Aisha Yokoi, Nozomi Kido, Hirotaka Suzuki, Ayumi Kanno, Yuka Inaba, Hitoshi Watanabe, Go Shioi, Maki Kimura-Koyanagi, Michihiro Matsumoto
    Diabetes & Metabolism Journal.2026; 50(1): 77.     CrossRef
  • The usefulness of HbA1c measurement in diabetic mouse models using various devices
    Koya Miyazaki, Aisha Yokoi, Hiroyuki Inoue, Hirotaka Suzuki, Nozomi Kido, Ayumi Kanno, Maki Kimura-Koyanagi, Yoshiaki Kido, Shun-ichiro Asahara
    Experimental Animals.2025; 74(3): 319.     CrossRef
  • Network pharmacology approach to the study of therapeutic role of selected phenolics on diabetic pancreatic islet cells based on multi-omics analysis
    Sai Anand, Kannakazhi Kantari, Piyush Kumar, Sai Sanwid Pradhan, Ashok Agraharam
    Network Modeling Analysis in Health Informatics and Bioinformatics.2025;[Epub]     CrossRef
  • Leptin Rs7799039 polymorphism is associated with type 2 diabetes mellitus Egyptian patients
    Amal Ahmed Mohamed, Dina M. Abo-Elmatty, Alaa S. Wahba, Omnia Ezzat Esmail, Hadeer Saied Mahmoud Salim, Wafaa Salah Mohammed Hegab, Mona Mostafa Farid Ghanem, Nadia Youssef Riad, Doaa Ghaith, Lamiaa I Daker, Shorouk Issa, Noha Hassan Radwan, Eman Sultan,
    Archives of Physiology and Biochemistry.2024; 130(6): 742.     CrossRef
  • Higher Genetic Risk for Type 2 Diabetes Is Associated With a Faster Decline of β-Cell Function in an East Asian Population
    Hyunsuk Lee, Jaewon Choi, Jong-Il Kim, Richard M. Watanabe, Nam H. Cho, Kyong Soo Park, Soo Heon Kwak
    Diabetes Care.2024; 47(8): 1386.     CrossRef
  • Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
    Yan Zhang, Shibo Wei, Eun-Ju Jin, Yunju Jo, Chang-Myung Oh, Gyu-Un Bae, Jong-Sun Kang, Dongryeol Ryu
    Diabetes & Metabolism Journal.2024; 48(4): 487.     CrossRef
  • Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus
    Ji Yoon Kim, Jiyoon Lee, Sin Gon Kim, Nam Hoon Kim
    Diabetes & Metabolism Journal.2024; 48(6): 1135.     CrossRef
  • Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database
    Minyoung Lee, Kyeongseob Jeong, Yu Rang Park, Yumie Rhee
    Metabolism.2023; 138: 155311.     CrossRef
  • The ameliorating effects of mesenchymal stem cells compared to α‐tocopherol on apoptosis and autophagy in streptozotocin‐induced diabetic rats: Implication of PI3K/Akt signaling pathway and entero‐insular axis
    Heba A. Mubarak, Manal M. Kamal, Yossra Mahmoud, Fatma S. Abd‐Elsamea, Eman Abdelbary, Marwa G. Gamea, Reham I. El‐Mahdy
    Journal of Cellular Biochemistry.2023; 124(11): 1705.     CrossRef
  • Association of Polygenic Variants with Type 2 Diabetes Risk and Their Interaction with Lifestyles in Asians
    Haeng Jeon Hur, Hye Jeong Yang, Min Jung Kim, Kyun-Hee Lee, Myung-Sunny Kim, Sunmin Park
    Nutrients.2022; 14(15): 3222.     CrossRef
  • Chemical Compounds and Ambient Factors Affecting Pancreatic Alpha-Cells Mass and Function: What Evidence?
    Gaia Chiara Mannino, Elettra Mancuso, Stefano Sbrignadello, Micaela Morettini, Francesco Andreozzi, Andrea Tura
    International Journal of Environmental Research and Public Health.2022; 19(24): 16489.     CrossRef
Original Articles
Metabolic Risk/Epidemiology
Article image
Sex Differences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus
Eun Hee Kim, Hong-Kyu Kim, Min Jung Lee, Sung-Jin Bae, Jaewon Choe, Chang Hee Jung, Chul-Hee Kim, Joong-Yeol Park, Woo Je Lee
Diabetes Metab J. 2022;46(3):486-498.   Published online November 18, 2021
DOI: https://doi.org/10.4093/dmj.2021.0095
  • 25,071 View
  • 499 Download
  • 54 Web of Science
  • 57 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study aimed to determine the optimal cut-off values of visceral fat area (VFA) and visceral-to-subcutaneous fat ratio (VSR) for predicting incident type 2 diabetes mellitus (T2DM).
Methods
A total of 10,882 individuals (6,835 men; 4,047 women) free of T2DM at baseline aged between 30 and 79 years who underwent abdominal computed tomography scan between 2012 and 2013 as a part of routine health check-ups were included and followed. VFA, subcutaneous fat area, and VSR on L3 vertebral level were measured at baseline.
Results
During a median follow-up of 4.8 years, 730 (8.1% for men; 4.3% for women) incident cases of T2DM were identified. Receiver operating characteristic curve analysis showed that the optimal cut-off values of VFA and VSR for predicting incident T2DM were 130.03 cm2 and 1.08 in men, respectively, and 85.7 cm2 and 0.48 in women, respectively. Regardless of sex, higher VFA and VSR were significantly associated with a higher risk of incident T2DM. Compared with the lowest quartiles of VFA and VSR, the highest quartiles had adjusted odds ratios of 2.62 (95% confidence interval [CI], 1.73 to 3.97) and 1.55 (95% CI, 1.14 to 2.11) in men, respectively, and 32.49 (95% CI, 7.42 to 142.02) and 11.07 (95% CI, 3.89 to 31.50) in women, respectively.
Conclusion
Higher VFA and VSR at baseline were independent risk factors for the development of T2DM. Sex-specific reference values for visceral fat obesity (VFA ≥130 cm2 or VSR ≥1.0 in men; VFA ≥85 cm2 or VSR ≥0.5 in women) are proposed for the prediction of incident T2DM.

Citations

Citations to this article as recorded by  
  • Sex Differences in the Impact of Obesity on Immunity
    Saranya Vijayakumar, Saurav Pantha, Shristy Budha Magar, Santosh Dhakal
    Immunological Reviews.2026;[Epub]     CrossRef
  • The Dietary Index for Gut Microbiota and Live Microbe Intake in Relation to Visceral Fat Obesity: Evidence From NHANES With Vitamin D as a Mediator
    Huiling Zheng, Xiaoying He, Jingyi Xiao, Mei Li, Wei Zhang, Yan Wang
    Food Science & Nutrition.2026;[Epub]     CrossRef
  • Hepatic and abdominal adiposity in type 2 diabetes as assessed with machine learning on computed tomography scans
    Richard H. Tran, Pavan Raghupathy, Mohamad Hazim, Elizabeth Thompson, Sophia Swago, Abhijit Bhattaru, Matthew MacLean, Jeffrey T. Duda, James Gee, Charles Kahn, Daniel J. Rader, Arijitt Borthakur, Walter R. Witschey, Hersh Sagreiya
    Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
  • Myosteatosis Predicts Bariatric Surgery Response: A Longitudinal Study in Patients With Morbid Obesity
    Eugene Han, Mi Kyung Kim, Hye Won Lee, Seungwan Ryu, Hye Soon Kim, Byoung Kuk Jang, Youngsung Suh
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(5): e1385.     CrossRef
  • Comparison of efficacy and safety of pioglitazone and SGLT2 inhibitors in treating Asian patients in MASLD associated with type 2 diabetes: A meta-analysis
    Lingyan Liu, Yongkun Deng, Lijuan Yang, Miaojiao Wang, Yong Lai
    Journal of Diabetes and its Complications.2025; 39(4): 108998.     CrossRef
  • Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis
    Zhang Wen, Shuyue Tuo, Qiuju Ran, Jia Yuan, Yong Li, Ying Zhang, Danyan Chang, Chan Li, Shejiao Dai, Jinhai Wang, Xinxing Tantai
    Annals of Medicine.2025;[Epub]     CrossRef
  • Influence of Maternal Alpha-Lipoic Acid Supplementation on Postpartum Body Weight and Metabolic Health in Rats with Obesity
    Truc T. K. Le, Gabriella A. Andreani, Saleh Mahmood, Mulchand S. Patel, Todd C. Rideout
    Journal of Dietary Supplements.2025; 22(3): 417.     CrossRef
  • Association of gender and metabolic factors with thyroid nodules in T2DM: a retrospective study
    Xi Yuan, Xin Wang, Xinwen Yu, Yuxin Jin, Aili Yang, Xiaorui Jing, Shengru Liang, Chunni Heng, Na Zhang, Lijuan Chao, Langlang Liu, Meiying Wang, Yufei Liu, Guohong Zhao, Bin Gao
    PeerJ.2025; 13: e19068.     CrossRef
  • The Critical Role of Body Composition Assessment in Advancing Research and Clinical Health Risk Assessment across the Lifespan
    Jonathan P. Bennett, Soo Lim
    Journal of Obesity & Metabolic Syndrome.2025; 34(2): 120.     CrossRef
  • Relationship between Helicobacter pylori infection and visceral fat area in diabetic populations: the mediating role of insulin resistance
    Yi Chen, Bingqian Ni, Ningning You, Yahong Chen, Jinshun Zhang
    Frontiers in Cellular and Infection Microbiology.2025;[Epub]     CrossRef
  • Association of Sarcopenia and Visceral Obesity with Clinical Outcomes Among Older Adults with Cardiovascular Disease: A Retrospective Cohort Study
    Hye-Jin Yoon, Keon-Woo Park, Young-Hoon Seo
    Journal of Clinical Medicine.2025; 14(12): 4191.     CrossRef
  • Preoperative prediction for early recurrence in patients with pancreatic ductal adenocarcinoma: combining radiomics and abdominal fat analysis
    Suo Yu Yan, Fang Ming Chen, Bang Jun Guo, Su Hu, Li Lin, Yi Wen Yang, Xin Yu Jiang, Hui Yao, Chun Hong Hu, Yun Yan Su
    BMC Medical Imaging.2025;[Epub]     CrossRef
  • The Association Between the Hemoglobin Glycation Index and Cardiometabolic Diseases: A Mini‐Review
    Qing‐Yun Wu, Li‐Rong Mo, Jing Nan, Wan‐Zhong Huang, Qiang Wu, Qiang Su
    The Journal of Clinical Hypertension.2025;[Epub]     CrossRef
  • The global burden of early-onset type 2 diabetes mellitus caused by high body-mass index from 1990 to 2021 and projection to 2050
    Li Liang, Youhui Lin, Zihao Liu, Yan Jiang, Wei Cheng, Liying Zhao
    Diabetes Research and Clinical Practice.2025; 226: 112368.     CrossRef
  • Visceral fat: the hidden culprit behind thoracolumbar surgery infections
    Dan Su, Ruiling Wang, Jucai Li, Xiaohui An, Lingling Sun, Yi Cui, Di Zhang
    Frontiers in Surgery.2025;[Epub]     CrossRef
  • Identifying gut microbiota Faecalibacterium as a potential biomarker for distinguishing visceral or subcutaneous obese population
    Yi Li, Senlin Wang, Song Zhang, Ergan Li, Meifang Liang, Youqin Li, Anke Liuli, Li Deng, Yanjun Liu, Tongtong Zhang, Di Xin, Yongmei Li, Zhonghui Feng
    Frontiers in Microbiology.2025;[Epub]     CrossRef
  • Ratio of visceral-to-subcutaneous fat area improves long-term mortality prediction over either measure alone: automated CT-based AI measures with longitudinal follow-up in a large adult cohort
    Daniel Liu, Adam J. Kuchnia, Glen M. Blake, Matthew H. Lee, John W Garrett, Perry J. Pickhardt
    Abdominal Radiology.2025; 51(3): 1618.     CrossRef
  • DXA-derived visceral adipose tissue reference values and metabolic syndrome risk threshold in an Algerian adult population
    Mohammed Hadi Bestaoui, Ali Lounici, Amar Tebaibia, Latifa Henaoui, Nawal Brikci-Nigassa, Houssem Baghous, Amel Bensefia, Athanasios G. Pantelis
    PLOS One.2025; 20(9): e0331867.     CrossRef
  • Zinc and Adipose Organ Dysfunction: Molecular Insights into Obesity and Metabolic Disorders
    Zahra Bahadoran, Fateme Ghafouri-Taleghani, Marijana Todorčević
    Current Nutrition Reports.2025;[Epub]     CrossRef
  • Sex‐Specific Differences in Visceral and Subcutaneous Adiposity Accumulation and Their Association With Metabolic Abnormalities
    Isa Galvão Rodrigues, Gabriela Maria Pereira Floro Arcoverde, Camila Lima Chagas do Nascimento, Victoria Domingues Ferraz, Nadja Fernandes da Silva, Ilma Kruze Grande de Arruda, Cláudia Porto Sabino Pinho, Dário Celestino Sobral Filho, Jose Rodrigo Pauli
    Journal of Obesity.2025;[Epub]     CrossRef
  • Sex-specific protective role of lower-body fat in type 2 diabetes: mediation through insulin resistance in a BMI-matched population
    Qiong Wang, Pei-Pei Chen, Wei Wei, Jia-Yu Guo, Yuan-Yuan Bao, Jing Zhang, Kang Yu
    BMJ Open Diabetes Research & Care.2025; 13(6): e005397.     CrossRef
  • Severity of adipose tissue dysfunction is associated with progression of pre-diabetes to type 2 diabetes: the Tehran Lipid and Glucose Study
    Mohammad Jalali, Zahra Bahadoran, Parvin Mirmiran, Fereidoun Azizi, Farhad Hosseinpanah
    BMC Public Health.2024;[Epub]     CrossRef
  • Should insulin resistance (HOMA-IR), insulin secretion (HOMA-β), and visceral fat area be considered for improving the performance of diabetes risk prediction models
    Huan Hu, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Tetsuya Mizoue
    BMJ Open Diabetes Research & Care.2024; 12(1): e003680.     CrossRef
  • Adipose organ dysfunction and type 2 diabetes: Role of nitric oxide
    Zahra Bahadoran, Parvin Mirmiran, Asghar Ghasemi
    Biochemical Pharmacology.2024; 221: 116043.     CrossRef
  • Prediction of high visceral adipose tissue for sex‐specific community residents in Taiwan
    Yu‐Hsuan Chang, Chin‐Sung Chang, Chieh‐Yu Liu, Yin‐Fan Chang, Shiow‐Ching Shun
    Nursing & Health Sciences.2024;[Epub]     CrossRef
  • Guidelines for obesity clinic consultations in primary healthcare clinics
    Jee-Hyun Kang, Kyoung-Kon Kim
    Journal of the Korean Medical Association.2024; 67(4): 240.     CrossRef
  • Correlation between fat-to-muscle mass ratio and cognitive impairment in elderly patients with type 2 diabetes mellitus: a cross-sectional study
    Fan Wu, Yanlan Liu, Chenying Lin, Nahal Haghbin, Longfei Xia, Yaoshuang Li, Tong Chen, Huina Qiu, Weiran Jiang, Jingbo Li, Jingna Lin
    BMC Geriatrics.2024;[Epub]     CrossRef
  • Evaluation of visceral adipose tissue thresholds for elevated metabolic syndrome risk across diverse populations: A systematic review
    Jonathan P. Bennett, Carla M. Prado, Steven B. Heymsfield, John A. Shepherd
    Obesity Reviews.2024;[Epub]     CrossRef
  • Establishment of a novel weight reduction model after laparoscopic sleeve gastrectomy based on abdominal fat area
    Tianyi Feng, Sanyuan Hu, Changrong Song, Mingwei Zhong
    Frontiers in Surgery.2024;[Epub]     CrossRef
  • Combined associations of visceral adipose tissue and adherence to a Mediterranean lifestyle with T2D and diabetic microvascular complications among individuals with prediabetes
    Hao-Wen Chen, Kuan Liu, Bi-Fei Cao, Qi Zhong, Rui Zhou, Liang-Hua Li, Shi-Ao Wang, Yan-Fei Wei, Hua-Min Liu, Xian-Bo Wu
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma
    Eric Robles Garibay, Sylvia M. Cruz, Sean J. Judge, Arta M. Monjazeb, Steven W. Thorpe, William J. Murphy, Jing Lyu, Shuai Chen, Cyrus P. Bateni, Robert J. Canter
    Journal of Surgical Oncology.2024; 130(3): 543.     CrossRef
  • Visceral to subcutaneous fat area ratio predicts severe abdominal adhesions in definitive surgery for anastomotic fistula after small intestine resection
    Fan Yang, Weiliang Tian, Shikun Luo, Wuhan Li, Guoping Zhao, Risheng Zhao, Tao Tian, Yunzhao Zhao, Zheng Yao, Qian Huang
    Scientific Reports.2024;[Epub]     CrossRef
  • Assessing Patients beyond the Simple Optics of BMI: The Concomitant Role of Sarcopenia and BMI in Predicting Kidney Transplant Outcomes
    Christopher Seet, Laura Clementoni, Mohammed Rashid Akhtar, Pankaj Chandak, Mohammed Saoud, Amr Elsaadany, Muhammad Magdi Yaqoob, Ismail Heyder Mohamed, Muhammad Arslan Khurram
    Life.2024; 14(8): 1036.     CrossRef
  • Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver disease
    Tatsuki Ichikawa, Mio Yamashima, Shinobu Yamamichi, Makiko Koike, Yusuke Nakano, Hiroyuki Yajima, Osamu Miyazaki, Tomonari Ikeda, Takuma Okamura, Kazuyoshi Nagata, Kenichi Sawa, Kazutaka Niiya, Kazuhiko Nakao
    Biomedical Reports.2024;[Epub]     CrossRef
  • Body composition as a potential imaging biomarker for predicting the progression risk of chronic kidney disease
    Zhouyan Liao, Guanjie Yuan, Kangwen He, Shichao Li, Mengmeng Gao, Ping Liang, Chuou Xu, Qian Chu, Min Han, Zhen Li
    Insights into Imaging.2024;[Epub]     CrossRef
  • Visceral Obesity and Its Association with Severe Coronary Artery Calcification in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Min Kyu Kang, Jeung Eun Song, Young Oh Kweon, Won Young Tak, Soo Young Park, Yu Rim Lee, Jung Gil Park
    Diagnostics.2024; 14(20): 2305.     CrossRef
  • Gender Differences of Visceral Fat Area to Hip Circumference Ratio for Insulin Resistance
    Huiying Cao, Xuan Huang, Beibei Luo, Wei Shi, Huan Li, Rui Shi
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3935.     CrossRef
  • Microarray Analysis of Visceral Adipose Tissue in Obese Women Reveals Common Crossroads Among Inflammation, Metabolism, Addictive Behaviors, and Cancer
    Rolando Martínez-Romero, Susana Aideé González-Chávez, Victor Roberto Urías-Rubí, Víctor Manuel Gómez-Moreno, Manlio Favio Blanco-Cantero, Héctor Mario Bernal-Velázquez, Arturo Luévano-González, César Pacheco-Tena, Claire Stocker
    Journal of Obesity.2024;[Epub]     CrossRef
  • Sex differences of visceral fat with cardiac structure and function in type 2 diabetes: A cross‐sectional study
    Chen Rui‐hua, Lin Yi, Xu Huan‐bai, Wang Yu‐fan, Peng Yong‐de
    Journal of Diabetes.2024;[Epub]     CrossRef
  • Body fat variation and redistribution across different stages of life measured by dual-energy x-ray absorptiometry
    Hongbo Dong, Hong Cheng, Jingfan Xiong, Li Liu, Yiwen Huang, Xinying Shan, Hongmin Fan, Xi Wang, Xia Wang, Pei Xiao, Fangfang Chen, Jie Mi
    Journal of Global Health.2024;[Epub]     CrossRef
  • Effects of time-restricted feeding (TRF)-model of intermittent fasting on adipose organ: a narrative review
    Zahra Bahadoran, Parvin Mirmiran, Khosrow Kashfi, Asghar Ghasemi
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.2024;[Epub]     CrossRef
  • Body Composition and Metabolic Dysfunction Really Matter for the Achievement of Better Outcomes in High-Grade Serous Ovarian Cancer
    Mauricio A. Cuello, Fernán Gómez, Ignacio Wichmann, Felipe Suárez, Sumie Kato, Elisa Orlandini, Jorge Brañes, Carolina Ibañez
    Cancers.2023; 15(4): 1156.     CrossRef
  • MEDICINAL BIOMAGNETISM FOR THE TREATMENT OF OBESITY
    Ana Vergínia Campagnollo Bueno, Michelli Gonçalves Seneda, Ângela Mara Rambo, Ana Clara Campagnolo Gonçalves Toledo, Caroline Cabral de Azevedo, Adriane Viapiana Bossa
    Health and Society.2023; 3(01): 411.     CrossRef
  • Cumulative exposure to metabolic syndrome in a national population-based cohort of young adults and sex-specific risk for type 2 diabetes
    Min-Kyung Lee, Jae-Hyuk Lee, Seo Young Sohn, Jiyeon Ahn, Oak-Kee Hong, Mee-Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Kyungdo Han, Hyuk-Sang Kwon
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • The correlation between visceral fat/subcutaneous fat area ratio and monocyte/high-density lipoprotein ratio in patients with type 2 diabetes mellitus and albuminuria
    Haiyan Lin, Jun Zhu, Chen Zheng, Xiaoming Xu, Shandong Ye
    Journal of Diabetes and its Complications.2023; 37(11): 108521.     CrossRef
  • Effects of the abdominal fat distribution on the relationship between exposure to air pollutants and thyroid hormones among Korean adult males
    Hyun-Jin Kim, Byungmi Kim, Seyoung Kim, Hyuktae Kwon, Jae Moon Yun, Belong Cho, Jin-Ho Park
    European Journal of Medical Research.2023;[Epub]     CrossRef
  • Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
    Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe
    Clinical and Molecular Hepatology.2023; 29(4): 987.     CrossRef
  • Visceral adipose tissue reference data computed for GE HealthCare DXA from the National Health and Nutrition Examination Survey data set
    Jonathan P. Bennett, Brandon K. Quon, Bo Fan, En Liu, Leila Kazemi, Rosa C. Villegas‐Valle, Raj Ahgun, Xian‐pin Wu, Hou‐De Zhou, Ying Lu, John A. Shepherd
    Obesity.2023; 31(12): 2947.     CrossRef
  • Comparison of bioelectrical body and visceral fat indices and anthropometric measures in relation to type 2 diabetes by sex among Chinese adults, a cross-sectional study
    Jiangshan He, Binbin Zhang, Yaqi Fan, Yuxue Wang, Mianzhi Zhang, Chunjun Li, Li Zhang, Pei Guo, Minying Zhang
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • The predictive significance of lipid accumulation products for future diabetes in a non-diabetic population from a gender perspective: an analysis using time-dependent receiver operating characteristics
    Jiajun Qiu, Maobin Kuang, Yang Zou, Ruijuan Yang, Qing Shangguan, Dingyang Liu, Guotai Sheng, Wei Wang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
    Ren Jie Phang, Rebecca H. Ritchie, Derek J. Hausenloy, Jarmon G. Lees, Shiang Y. Lim
    Cardiovascular Research.2022;[Epub]     CrossRef
  • Implication of Sex Differences in Visceral Fat for the Assessment of Incidence Risk of Type 2 Diabetes Mellitus
    Sang Hyeon Ju, Hyon-Seung Yi
    Diabetes & Metabolism Journal.2022; 46(3): 414.     CrossRef
  • Visceral fat area and body fat percentage measured by bioelectrical impedance analysis correlate with glycometabolism
    Shuying Li, Shaoping Li, Jie Ding, Weihong Zhou
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • The Demographic Specific Abdominal Fat Composition and Distribution Trends in US Adults from 2011 to 2018
    Furong Xu, Jacob E. Earp, Bryan J. Blissmer, Ingrid E. Lofgren, Matthew J. Delmonico, Geoffrey W. Greene
    International Journal of Environmental Research and Public Health.2022; 19(19): 12103.     CrossRef
  • Visceral Obesity Is a More Important Factor for Colorectal Adenomas than Skeletal Muscle or Body Fat
    Ji Yeon Seo, Yoo Min Han, Su Jin Chung, Seon Hee Lim, Jung Ho Bae, Goh Eun Chung
    Cancers.2022; 14(21): 5256.     CrossRef
  • Recent Advances in Visceral Obesity and Related Diseases
    佳佳 魏
    Advances in Clinical Medicine.2022; 12(12): 11686.     CrossRef
  • Gender differences in the ideal cutoffs of visceral fat area for predicting MAFLD in China
    Pingping Yu, Huachao Yang, Xiaoya Qi, Ruixue Bai, Shouqin Zhang, Jianping Gong, Ying Mei, Peng Hu
    Lipids in Health and Disease.2022;[Epub]     CrossRef
Complications
Article image
SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy
Tae Jung Oh, Yoojung Song, Hak Chul Jang, Sung Hee Choi
Diabetes Metab J. 2022;46(2):319-326.   Published online September 16, 2021
DOI: https://doi.org/10.4093/dmj.2021.0014
  • 12,957 View
  • 435 Download
  • 26 Web of Science
  • 27 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Screening for diabetic peripheral neuropathy (DPN) is important to prevent severe foot complication, but the detection rate of DPN is unsatisfactory. We investigated whether SUDOSCAN combined with Michigan Neuropathy Screening Instrument (MNSI) could be an effective tool for screening for DPN in people with type 2 diabetes mellitus (T2DM) in clinical practice.
Methods
We analysed the data for 144 people with T2DM without other cause of neuropathy. The presence of DPN was confirmed according to the Toronto Consensus criteria. Electrochemical skin conductance (ESC) of the feet was assessed using SUDOSCAN. We compared the discrimination power of following methods, MNSI only vs. SUDOSCAN only vs. MNSI plus SUDOSCAN vs. MNSI plus 10-g monofilament test.
Results
Confirmed DPN was detected in 27.8% of the participants. The optimal cut-off value of feet ESC to distinguish DPN was 56 μS. We made the DPN screening scores using the corresponding odds ratios for MNSI-Questionnaire, MNSI-Physical Examination, SUDOSCAN, and 10-g monofilament test. For distinguishing the presence of DPN, the MNSI plus SUDOSCAN model showed higher areas under the receiver operating characteristic curve (AUC) than MNSI only model (0.717 vs. 0.638, P=0.011), and SUDOSCAN only model or MNSI plus 10-g monofilament test showed comparable AUC with MNSI only model.
Conclusion
The screening model for DPN that includes both MNSI and SUDOSCAN can detect DPN with acceptable discrimination power and it may be useful in Korean patients with T2DM.

Citations

Citations to this article as recorded by  
  • Automated Insulin Delivery Beyond Glycemic Outcomes: Endpoints and Evidence
    Hanna C. Jones, Steven Trawley, Alicia J. Jenkins, Richard J. MacIsaac, Yee Wen Kong, Dale Morrison, David N. O’Neal
    Diabetes Technology & Therapeutics.2026; 28(4): 295.     CrossRef
  • Neuropatía diabética y su relación con la calidad de vida en pacientes con diabetes tipo 2
    Jarek Ramón Arévalo Ramírez, Daniela Leticia Castañón Sánchez, Oscar Isaías Vargas Ordoñez, Hilda Sara Camarena Velázquez, María del Carmen Aguirre García, Mónica Catalina Osorio Granjeno
    Atención Primaria.2026; 58(5): 103454.     CrossRef
  • Autonomic Dysfunction and Ocular Complications: The Role of Sudoscan in Diabetic Retinopathy Screening
    Andra-Elena Nica, Emilia Rusu, Carmen Dobjanschi, Florin Rusu, Claudia Sivu, Oana Andreea Parliteanu, Ioana Verde, Andreea Andrita, Gabriela Radulian
    Diabetology.2026; 7(4): 63.     CrossRef
  • Sudoscan® reclassifies cardiovascular risk in patients with type 2 diabetes mellitus according to the ESC 2023
    Cesar Alejandro Figueroa-Perez, Maria Elena Romero-Ibarguengoitia, Arnulfo Garza-Silva, Iván Francisco Fernández-Chau, Andrea Belinda Cepeda-Medina, Sofía Garza-González, Dalia Gutierrez-González, Arnulfo González-Cantú
    Journal of Diabetes & Metabolic Disorders.2025;[Epub]     CrossRef
  • Sensors and Devices Based on Electrochemical Skin Conductance and Bioimpedance Measurements for the Screening of Diabetic Foot Syndrome: Review and Meta-Analysis
    Federica Verdini, Alessandro Mengarelli, Gaetano Chemello, Benedetta Salvatori, Micaela Morettini, Christian Göbl, Andrea Tura
    Biosensors.2025; 15(2): 73.     CrossRef
  • Effect of high-dose N-acetyl cysteine on the clinical outcome of patients with diabetic peripheral neuropathy: a randomized controlled study
    Sherien Mohamed Emara, Sarah Farid Fahmy, Mona Mohamed AbdelSalam, Lamia Mohamed El Wakeel
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Electrochemical skin conductance: a tool for risk stratification and early anticipation of diabetic foot ulcers
    Jean-François Gautier, Jean-Pierre Riveline, Louis Potier, Olivier Bourron, Lyse Bordier, Benjamin Vittrant, Ronan Roussel, Bernard Bauduceau
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Sudomotor Dysfunction as an Early Marker of Autonomic and Cardiovascular Risk in Diabetes: Insights from a Cross-Sectional Study Using SUDOSCAN
    Larisa Anghel, Claudiu Cobuz, Laura-Cătălina Benchea, Vasile Maciuc, Maricela Cobuz, Radu-Andy Sascău, Cristian Stătescu
    Biosensors.2025; 15(6): 372.     CrossRef
  • Evaluation of the efficacy of Yiqi Jiedu decoction on diabetic peripheral neuropathy and related brain function changes: A randomized controlled trial protocol
    Chaofan Sun, Guoxing Ling, Chunquan Sun, Xingzhong Feng
    European Journal of Integrative Medicine.2025; 78: 102543.     CrossRef
  • Sudomotor Dysfunction of Feet Is Associated with Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes: A Cross-Sectional Study
    Alexandra Gogan, Sandra Lazar, Ovidiu Potre, Vlad-Florian Avram, Andreea Herascu, Minodora Andor, Florina Caruntu, Bogdan Timar
    Medicina.2025; 61(10): 1848.     CrossRef
  • The Assessment of the Autonomic Polyneuropathy Through Sudoscan and Vitamin B12 in Patients with Type 2 Diabetes Mellitus and High Cardiovascular Risk or Established Cardiovascular Disease
    Cristina Mocanu (Chitan), Teodor Salmen, Anca Pantea Stoian, Cristian Serafinceanu
    Biomedicines.2025; 14(1): 18.     CrossRef
  • Association of sudomotor dysfunction with risk of diabetic retinopathy in patients with type 2 diabetes
    Ming Wang, Niuniu Chen, Yaxin Wang, Jiaying Ni, Jingyi Lu, Weijing Zhao, Yating Cui, Ronghui Du, Wei Zhu, Jian Zhou
    Endocrine.2024; 84(3): 951.     CrossRef
  • Vitamin D deficiency increases the risk of diabetic peripheral neuropathy in elderly type 2 diabetes mellitus patients by predominantly increasing large-fiber lesions
    Sijia Fei, Jingwen Fan, Jiaming Cao, Huan Chen, Xiaoxia Wang, Qi Pan
    Diabetes Research and Clinical Practice.2024; 209: 111585.     CrossRef
  • Early detection of diabetic neuropathy based on health belief model: a scoping review
    Okti Sri Purwanti, Nursalam Nursalam, Moses Glorino Rumambo Pandin
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Whether coagulation dysfunction influences the onset and progression of diabetic peripheral neuropathy: A multicenter study in middle‐aged and aged patients with type 2 diabetes
    Jiali Xie, Xinyue Yu, Luowei Chen, Yifan Cheng, Kezheng Li, Mengwan Song, Yinuo Chen, Fei Feng, Yunlei Cai, Shuting Tong, Yuqin Qian, Yiting Xu, Haiqin Zhang, Junjie Yang, Zirui Xu, Can Cui, Huan Yu, Binbin Deng
    CNS Neuroscience & Therapeutics.2024;[Epub]     CrossRef
  • From Sudoscan to bedside: theory, modalities, and application of electrochemical skin conductance in medical diagnostics
    Benjamin Vittrant, Hanna Ayoub, Philippe Brunswick
    Frontiers in Neuroanatomy.2024;[Epub]     CrossRef
  • Diagnostic Accuracy of Screening Tests for Diabetic Peripheral Neuropathy: An Umbrella Review
    María Mogilevskaya, Mariana Gaviria-Carrillo, John Edwin Feliciano-Alfonso, Ana M. Barragan, Carlos A. Calderon-Ospina, Mauricio O. Nava-Mesa, Syed Anees Ahmed
    Journal of Diabetes Research.2024;[Epub]     CrossRef
  • Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
    Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Domenico Beccia, Chiara Brin, Maria Alfano, Jessica Di Salvo, Raffaella Epifani, Alessia Piacevole, Giuseppina Tagliaferri, Maria Rocco, Ilaria Iadicicco, Giovanni Docimo, Luca Rinaldi, Celestino Sardu, T
    International Journal of Molecular Sciences.2023; 24(4): 3554.     CrossRef
  • Screening for diabetic peripheral neuropathy in resource-limited settings
    Ken Munene Nkonge, Dennis Karani Nkonge, Teresa Njeri Nkonge
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • The value of electrochemical skin conductance measurement by Sudoscan® for assessing autonomic dysfunction in peripheral neuropathies beyond diabetes
    Jean-Pascal Lefaucheur
    Neurophysiologie Clinique.2023; 53(2): 102859.     CrossRef
  • Electrochemical skin conductances values and clinical factors affecting sudomotor dysfunction in patients with prediabetes, type 1 diabetes, and type 2 diabetes: A single center experience
    Bedia Fulya Calikoglu, Selda Celik, Cemile Idiz, Elif Bagdemir, Halim Issever, Jean-Henri Calvet, Ilhan Satman
    Primary Care Diabetes.2023; 17(5): 499.     CrossRef
  • Autonomic Nerve Function Tests in Patients with Diabetes
    Heung Yong Jin, Tae Sun Park
    The Journal of Korean Diabetes.2023; 24(2): 71.     CrossRef
  • Validation of the Body Scan®, a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan®
    Jean-Pierre Riveline, Roberto Mallone, Clarisse Tiercelin, Fetta Yaker, Laure Alexandre-Heymann, Lysa Khelifaoui, Florence Travert, Claire Fertichon, Jean-Baptiste Julla, Tiphaine Vidal-Trecan, Louis Potier, Jean-Francois Gautier, Etienne Larger, Jean-Pas
    Frontiers in Neurology.2023;[Epub]     CrossRef
  • Electrochemical Skin Conductance by Sudoscan in Non-Dialysis Chronic Kidney Disease Patients
    Liang-Te Chiu, Yu-Li Lin, Chih-Hsien Wang, Chii-Min Hwu, Hung-Hsiang Liou, Bang-Gee Hsu
    Journal of Clinical Medicine.2023; 13(1): 187.     CrossRef
  • The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
    Tae Jung Oh, Han Song, Youngil Koh, Sung Hee Choi
    Endocrinology and Metabolism.2022; 37(2): 243.     CrossRef
  • Case report: Significant relief of linezolid-induced peripheral neuropathy in a pre-XDR-TB case after acupuncture treatment
    Yuping Mo, Zhu Zhu, Jie Tan, Zhilin Liang, Jiahui Wu, Xingcheng Chen, Ming Hu, Peize Zhang, Guofang Deng, Liang Fu
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • Detection of sudomotor alterations evaluated by Sudoscan in patients with recently diagnosed type 2 diabetes
    Ana Cristina García-Ulloa, Paloma Almeda-Valdes, Teresa Enedina Cuatecontzi-Xochitiotzi, Jorge Alberto Ramírez-García, Michelle Díaz-Pineda, Fernanda Garnica-Carrillo, Alejandra González-Duarte, K M Venkat Narayan, Carlos Alberto Aguilar-Salinas, Sergio H
    BMJ Open Diabetes Research & Care.2022; 10(6): e003005.     CrossRef
Complications
Article image
Screening Tools Based on Nomogram for Diabetic Kidney Diseases in Chinese Type 2 Diabetes Mellitus Patients
Ganyi Wang, Biyao Wang, Gaoxing Qiao, Hao Lou, Fei Xu, Zhan Chen, Shiwei Chen
Diabetes Metab J. 2021;45(5):708-718.   Published online April 13, 2021
DOI: https://doi.org/10.4093/dmj.2020.0117
  • 11,511 View
  • 162 Download
  • 13 Web of Science
  • 13 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The influencing factors of diabetic kidney disease (DKD) in Chinese patients with type 2 diabetes mellitus (T2DM) were explored to develop and validate a DKD diagnostic tool based on nomogram approach for patients with T2DM.
Methods
A total of 2,163 in-hospital patients with diabetes diagnosed from March 2015 to March 2017 were enrolled. Specified logistic regression models were used to screen the factors and establish four different diagnostic tools based on nomogram according to the final included variables. Discrimination and calibration were used to assess the performance of screening tools.
Results
Among the 2,163 participants with diabetes (1,227 men and 949 women), 313 patients (194 men and 120 women) were diagnosed with DKD. Four different screening equations (full model, laboratory-based model 1 [LBM1], laboratory-based model 2 [LBM2], and simplified model) showed good discriminations and calibrations. The C-indexes were 0.8450 (95% confidence interval [CI], 0.8202 to 0.8690) for full model, 0.8149 (95% CI, 0.7892 to 0.8405) for LBM1, 0.8171 (95% CI, 0.7912 to 0.8430) for LBM2, and 0.8083 (95% CI, 0.7824 to 0.8342) for simplified model. According to Hosmer-Lemeshow goodness-of-fit test, good agreement between the predicted and observed DKD events in patients with diabetes was observed for full model (χ2=3.2756, P=0.9159), LBM1 (χ2=7.749, P=0.4584), LBM2 (χ2=10.023, P=0.2634), and simplified model (χ2=12.294, P=0.1387).
Conclusion
LBM1, LBM2, and simplified model exhibited excellent predictive performance and availability and could be recommended for screening DKD cases among Chinese patients with diabetes.

Citations

Citations to this article as recorded by  
  • Multi-feature integrated machine learning prediction model for early nephropathy in elderly living with type 2 diabetes mellitus
    Tingting Fang, Yuanyuan Yang, Feng Zhuo, Xinran Xie, Jialun Song, Linghua Kong
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Machine learning-based risk predictive models for diabetic kidney disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis
    Yihan Li, Nan Jin, Qiuzhong Zhan, Yue Huang, Aochuan Sun, Fen Yin, Zhuangzhuang Li, Jiayu Hu, Zhengtang Liu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Deep learning for early detection of chronic kidney disease stages in diabetes patients: A TabNet approach
    Md Nakib Hayat Chowdhury, Mamun Bin Ibne Reaz, Sawal Hamid Md Ali, María Liz Crespo, Shamim Ahmad, Ghassan Maan Salim, Fahmida Haque, Luis Guillermo García Ordóñez, Md. Johirul Islam, Taher Muhammad Mahdee, Kh Shahriya Zaman, Md Shahriar Khan Hemel, Moham
    Artificial Intelligence in Medicine.2025; 166: 103153.     CrossRef
  • The accuracy of Machine learning in the prediction and diagnosis of diabetic kidney Disease: A systematic review and Meta-Analysis
    Changmao Dai, Xiaolan Sun, Jia Xu, Maojun Chen, Wei Chen, Xueping Li
    International Journal of Medical Informatics.2025; 202: 105975.     CrossRef
  • Predictive model combining blood pressure, glycemic and renal markers for diabetic nephropathy in elderly hypertensive patients with type 2 diabetes
    Fengnian Guo, Li Qin, Baoguang Chen, Hongliang Xu, Jinxia Wang, Ran An, Qiuju Zhang
    Clinical and Experimental Hypertension.2025;[Epub]     CrossRef
  • Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus
    Xu Cao, Xiaomei Pei
    Technology and Health Care.2024; 32(3): 1807.     CrossRef
  • Development of Serum Lactate Level-Based Nomograms for Predicting Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
    Chunxia Jiang, Xiumei Ma, Jiao Chen, Yan Zeng, Man Guo, Xiaozhen Tan, Yuping Wang, Peng Wang, Pijun Yan, Yi Lei, Yang Long, Betty Yuen Kwan Law, Yong Xu
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 1051.     CrossRef
  • Two-Dimensional Ultrasound-Based Radiomics Nomogram for Diabetic Kidney Disease: A Pilot Study
    Xingyue Huang, Yugang Hu, Yao Zhang, Qing Zhou
    International Journal of General Medicine.2024; Volume 17: 1877.     CrossRef
  • Risk prediction models for diabetic nephropathy among type 2 diabetes patients in China: a systematic review and meta-analysis
    Wenbin Xu, Yanfei Zhou, Qian Jiang, Yiqian Fang, Qian Yang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Changes in urinary exosomal protein CALM1 may serve as an early noninvasive biomarker for diagnosing diabetic kidney disease
    Tao Li, Tian ci Liu, Na Liu, Man Zhang
    Clinica Chimica Acta.2023; 547: 117466.     CrossRef
  • Development and validation of a novel nomogram to predict diabetic kidney disease in patients with type 2 diabetic mellitus and proteinuric kidney disease
    Hui Zhuan Tan, Jason Chon Jun Choo, Stephanie Fook-Chong, Yok Mooi Chin, Choong Meng Chan, Chieh Suai Tan, Keng Thye Woo, Jia Liang Kwek
    International Urology and Nephrology.2022; 55(1): 191.     CrossRef
  • Nomogram-Based Chronic Kidney Disease Prediction Model for Type 1 Diabetes Mellitus Patients Using Routine Pathological Data
    Nakib Hayat Chowdhury, Mamun Bin Ibne Reaz, Sawal Hamid Md Ali, Shamim Ahmad, María Liz Crespo, Andrés Cicuttin, Fahmida Haque, Ahmad Ashrif A. Bakar, Mohammad Arif Sobhan Bhuiyan
    Journal of Personalized Medicine.2022; 12(9): 1507.     CrossRef
  • Development and assessment of diabetic nephropathy prediction model using hub genes identified by weighted correlation network analysis
    Xuelian Zhang, Yao Wang, Zhaojun Yang, Xiaoping Chen, Jinping Zhang, Xin Wang, Xian Jin, Lili Wu, Xiaoyan Xing, Wenying Yang, Bo Zhang
    Aging.2022; 14(19): 8095.     CrossRef
Basic Research
Article image
Role of Autophagy in Granulocyte-Colony Stimulating Factor Induced Anti-Apoptotic Effects in Diabetic Cardiomyopathy
Guang-Yin Shen, Jeong-Hun Shin, Yi-Sun Song, Hyun-Woo Joo, In-Hwa Park, Jin-Hee Seong, Na-Kyoung Shin, A-Hyeon Lee, Young Jong Cho, Yonggu Lee, Young-Hyo Lim, Hyuck Kim, Kyung-Soo Kim
Diabetes Metab J. 2021;45(4):594-605.   Published online February 26, 2021
DOI: https://doi.org/10.4093/dmj.2020.0049
  • 11,650 View
  • 174 Download
  • 8 Web of Science
  • 8 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
We previously, reported that granulocyte-colony stimulating factor (G-CSF) reduces cardiomyocyte apoptosis in diabetic cardiomyopathy. However, the underlying mechanisms are not yet fully understood. Therefore, we investigated whether the mechanisms underlying of the anti-apoptotic effects of G-CSF were associated with autophagy using a rat model of diabetic cardiomyopathy.
Methods
Diabetic cardiomyopathy was induced in rats through a high-fat diet combined with low-dose streptozotocin and the rats were then treated with G-CSF for 5 days. Rat H9c2 cardiac cells were cultured under high glucose conditions as an in vitro model of diabetic cardiomyopathy. The extent of apoptosis and protein levels related to autophagy (Beclin-1, microtubule-binding protein light chain 3 [LC3]-II/LC3-I ratio, and P62) were determined for both models. Autophagy determination was performed using an Autophagy Detection kit.
Results
G-CSF significantly reduced cardiomyocyte apoptosis in the diabetic myocardium in vivo and led to an increase in Beclin-1 level and the LC3-II/LC3-I ratio, and decreased P62 level. Similarly, G-CSF suppressed apoptosis, increased Beclin-1 level and LC3-II/LC3-I ratio, and decreased P62 level in high glucose-induced H9c2 cardiac cells in vitro. These effects of G-CSF were abrogated by 3-methyladenine, an autophagy inhibitor. In addition, G-CSF significantly increased autophagic flux in vitro.
Conclusion
Our results suggest that the anti-apoptotic effect of G-CSF might be significantly associated with the up-regulation of autophagy in diabetic cardiomyopathy.

Citations

Citations to this article as recorded by  
  • K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy
    Gamze Sanlav, Selen Kum Ozsengezer, Zekiye Altun, Erdal Bedir, Safiye Aktas, Nur Olgun
    Journal of Pharmacy and Pharmacology.2026;[Epub]     CrossRef
  • A new macrocyclic dansyl-cyclen fluorescent probe for the identification of mildly acidic intracellular compartments
    Daniele Paderni, Daniele Lopez, Annarita Ciavarella, Mariele Montanari, Giovanna Panza, Maria Voccia, Mauro Formica, Barbara Canonico, Eleonora Macedi, Stefano Papa, Vieri Fusi
    Inorganica Chimica Acta.2025; 581: 122620.     CrossRef
  • Metformin activates autophagy and inhibits apoptosis and fetal heart abnormalities via the Dnmt3l/Usp18/STAT1 pathway
    Ying Wei, Rui Meng, Xiaofeng Chen, Lina Guan, Jiale Yu, Yifan Wu, Cuige Shi, Jialing He, Dongmei Su, Xu Ma, Lei Sun
    European Journal of Pharmacology.2025; 1005: 177997.     CrossRef
  • Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy
    Jie Li, Yingying Xie, Shuwen Zheng, Haoming He, Zhe Wang, Xuexi Li, Siqi Jiao, Dong Liu, Furong Yang, Hailing Zhao, Ping Li, Yihong Sun
    Biomedicine & Pharmacotherapy.2024; 175: 116790.     CrossRef
  • Knockout of C1q/tumor necrosis factor-related protein-9 aggravates cardiac fibrosis in diabetic mice by regulating YAP-mediated autophagy
    Shiyan Ruan, Jun Li, Shengyun Lei, Shaomeng Zhang, Dan Xu, Anju Zuo, Linxi Li, Yuan Guo
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Ginkgo biloba extract protects against diabetic cardiomyopathy by restoring autophagy via adenosine monophosphate‐activated protein kinase/mammalian target of the rapamycin pathway modulation
    Xueyao Yang, Xin Zhao, Yanfei Liu, Yue Liu, Libo Liu, Ziyu An, Haoran Xing, Jinfan Tian, Xiantao Song
    Phytotherapy Research.2023; 37(4): 1377.     CrossRef
  • Antiatherosclerotic Effect and Molecular Mechanism of Salidroside
    Si-Fan Fei, De-Bing Tong, Fang Jia
    Reviews in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids
    Ronghui Han, Hemeng Huang, Weiyi Xia, Jingjin Liu, Hui Luo, Jing Tang, Zhengyuan Xia
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
Brief Report
Complications
Article image
Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015)
Seong-Su Moon, Chong Hwa Kim, Seon Mee Kang, Eun Sook Kim, Tae Jung Oh, Jae-Seung Yun, Ho Chan Cho, Dae Jung Kim, Tae Sun Park
Diabetes Metab J. 2021;45(1):115-119.   Published online December 18, 2020
DOI: https://doi.org/10.4093/dmj.2020.0120
  • 12,656 View
  • 355 Download
  • 17 Web of Science
  • 16 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
This report presents the status of diabetic neuropathy (DN) in Korea as determined using a National Health Insurance ServiceNational Sample Cohort (NHIS-NSC). Annual prevalences of DN were estimated by age and gender using descriptive statistics. Pharmacological treatments for DN were also analyzed. The annual prevalence of DN increased from 24.9% in 2006 to 26.6% in 2007, and thereafter, gradually subsided to 20.8% in 2015. In most cases, pharmacological treatments involved a single drug, which accounted for 91.6% of total prescriptions in 2015. The most commonly used drugs (in decreasing order) were thioctic acid, an anti-convulsive agent, or a tricyclic antidepressant. In conclusion, the prevalence of DN decreased over the 10-year study period. Thioctic acid monotherapy was usually prescribed for DN. To reduce the socio-economic burden of DN, more attention should be paid to the diagnosis of this condition and to the appropriate management of patients.

Citations

Citations to this article as recorded by  
  • Advances in the Study of the Association between Lumbar Spinal Stenosis and Diabetes Mellitus
    学宇 王
    Advances in Clinical Medicine.2025; 15(03): 1378.     CrossRef
  • The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention
    Soo Hyun Kang, Kilyoon Pack, Jung Ho Kim, Youngwoo Jang
    Scientific Reports.2025;[Epub]     CrossRef
  • Association Between Triglyceride/High-Density Lipoprotein Ratio and Incidence Risk of Heart Failure: A Population-Based Cohort Study
    Yoon-Kyung Chang, Ju-Young Park, Tae-Jin Song
    Journal of Clinical Medicine.2025; 14(3): 950.     CrossRef
  • Comparative Effectiveness of Clopidogrel Versus Aspirin for Primary Prevention in High-Risk Patients with Type 2 Diabetes: A Nationwide Propensity Score–Matched Cohort Study
    Soo Hyun Kang, Joonpyo Lee, Jung Ho Kim, Youngwoo Jang
    Medicina.2025; 61(10): 1730.     CrossRef
  • Diabetic Neuropathy: A Guide to Pain Management
    Emily X. Zhang, Cyrus Yazdi, Rahib K. Islam, Ahmed I. Anwar, Alana Alvares-Amado, Horace Townsend, Kaitlyn E. Allen, Elena Plakotaris, Jon D. Hirsch, Ross G. Rieger, Varsha Allampalli, Jamal Hasoon, Kazi N. Islam, Sahar Shekoohi, Alan D. Kaye, Christopher
    Current Pain and Headache Reports.2024; 28(10): 1067.     CrossRef
  • Recent Trends in Diabetic and Nondiabetic Neuropathies: A Retrospective Hospital-based Nationwide Cohort Study
    Horatiu F. Coman, Adriana Rusu, Norina A. Gavan, Cosmina I. Bondor, Alexandru D. Gavan, Cornelia G. Bala
    Endocrine Practice.2024; 30(10): 901.     CrossRef
  • Risk of cardiovascular events according to the tricyclic antidepressant dosage in patients with chronic pain: a retrospective cohort study
    Hyunji Koo, Seung Hun You, Sewon Park, Kyeong Hye Jeong, Nakyung Jeon, Sun-Young Jung
    European Journal of Clinical Pharmacology.2023; 79(1): 159.     CrossRef
  • How does diabetic peripheral neuropathy impact patients' burden of illness and the economy? A retrospective study in Beijing, China
    Qi Pan, Sijia Fei, Lina Zhang, Huan Chen, Jingyi Luo, Weihao Wang, Fei Xiao, Lixin Guo
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Chronic disease management program applied to type 2 diabetes patients and prevention of diabetic complications: a retrospective cohort study using nationwide data
    Min Kyung Hyun, Jang Won Lee, Seung-Hyun Ko
    BMC Public Health.2023;[Epub]     CrossRef
  • Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
    Han Na Jang, Tae Jung Oh
    Diabetes & Metabolism Journal.2023; 47(6): 743.     CrossRef
  • Are herbal medicines alone or in combination for diabetic peripheral neuropathy more effective than methylcobalamin alone? A systematic review and meta-analysis
    Chang-Woo Lee, Joon-Soo Jin, Seungwon Kwon, Chul Jin, Seung-Yeon Cho, Seong-Uk Park, Woo-Sang Jung, Sang-Kwan Moon, Jung-Mi Park, Chang-Nam Ko, Ki-Ho Cho
    Complementary Therapies in Clinical Practice.2022; 49: 101657.     CrossRef
  • Pathogenesis and Treatment of Diabetic Peripheral Neuropathy
    Seon Mee Kang
    The Journal of Korean Diabetes.2022; 23(4): 222.     CrossRef
  • Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015) (Diabetes Metab J 2021;45:115-9)
    Seong-Su Moon, Chong Hwa Kim, Seon Mee Kang, Eun Sook Kim, Tae Jung Oh, Jae-Seung Yun, Ho Chan Cho, Dae Jung Kim, Tae Sun Park
    Diabetes & Metabolism Journal.2021; 45(3): 459.     CrossRef
  • Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015) (Diabetes Metab J 2021;45:115-9)
    Tímea Csákvári, Diána Elmer, Lilla Horváth, Imre Boncz
    Diabetes & Metabolism Journal.2021; 45(3): 454.     CrossRef
  • Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
    Ja Young Jeon
    Diabetes & Metabolism Journal.2021; 45(4): 613.     CrossRef
  • Diffculties and ways to overcome them in selection of therapy for pain syndromes in patients with diabetes mellitus
    K. A. Makhinov, P. R. Kamchatnov
    Medical alphabet.2021; (22): 25.     CrossRef
Original Articles
Cardiovascular Risk/Epidemiology
Article image
Clinical Significance of Body Fat Distribution in Coronary Artery Calcification Progression in Korean Population
Heesun Lee, Hyo Eun Park, Ji Won Yoon, Su-Yeon Choi
Diabetes Metab J. 2021;45(2):219-230.   Published online October 28, 2020
DOI: https://doi.org/10.4093/dmj.2019.0161
Correction in: Diabetes Metab J 2021;45(6):974
  • 12,221 View
  • 301 Download
  • 16 Web of Science
  • 14 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Although obesity differs according to ethnicity, it is globally established as a solid risk factor for cardiovascular disease. However, it is not fully understood how obesity parameters affect the progression of coronary artery calcification (CAC) in Korean population. We sought to evaluate the association of obesity-related parameters including visceral adipose tissue (VAT) measurement and CAC progression.
Methods
This retrospective observational cohort study investigated 1,015 asymptomatic Korean subjects who underwent serial CAC scoring by computed tomography (CT) with at least 1-year interval and adipose tissue measurement using non-contrast CT at baseline for a routine checkup between 2003 and 2015. CAC progression, the main outcome, was defined as a difference of ≥2.5 between the square roots of the baseline and follow-up CAC scores using Agatston units.
Results
During follow-up (median 39 months), 37.5% of subjects showed CAC progression of a total population (56.4 years, 80.6% male). Body mass index (BMI) ≥25 kg/m2, increasing waist circumferences (WC), and higher VAT/subcutaneous adipose tissue (SAT) area ratio were independently associated with CAC progression. Particularly, predominance of VAT over SAT at ≥30% showed the strongest prediction for CAC progression (adjusted hazard ratio, 2.20; P<0.001) and remained of prognostic value regardless of BMI or WC status. Further, it provided improved risk stratification of CAC progression beyond known prognosticators.
Conclusion
Predominant VAT area on CT is the strongest predictor of CAC progression regardless of BMI or WC in apparently healthy Korean population. Assessment of body fat distribution may be helpful to identify subjects at higher risk.

Citations

Citations to this article as recorded by  
  • A review of cutting-edge biomarkers for diagnosing coronary artery disease
    Pouria Azami, Sahand Mohammadzadeh, Soroush Seirafi, Iman Razeghian-Jahromi
    Medicine.2025; 104(4): e41377.     CrossRef
  • The Close Link Between Obesity and Cardiovascular Disease
    Heesun Lee, Tae-Min Rhee, Ji Min Choi, Su-Yeon Choi, Dong Wook Kim
    Endocrinology and Metabolism Clinics of North America.2025; 54(1): 175.     CrossRef
  • Practical Implications of Obesity for Cardiovascular Diagnostics
    Paul Poirier, Carl J. Lavie, Kim Connelly
    Canadian Journal of Cardiology.2025; 41(9): 1679.     CrossRef
  • Preventing Premature Coronary Artery Disease: The Synergistic Role of Biomarker Screening and Physical Activity
    Gobardhan Kathariya, Jyoti Aggarwal, Rajesh Nandal, Mayank Madan, Sreenivas Reddy
    Journal of The Association of Physicians of India.2025; 73(9): 22.     CrossRef
  • Combined effects of residual cholesterol inflammatory index and triglyceride-glucose-BMI on risk of cardio-cerebrovascular disease: A cohort study
    Hongfei Yang, Chao Sun, Ya Li, You Zhou, Rui Wang, Yingxue Li
    Medicine.2025; 104(43): e45395.     CrossRef
  • Gender-specific abdominal fat distribution and insulin resistance associated with organophosphate esters and phthalate metabolites exposure
    Xiaoliu Shi, Wanyue Wang, Jiafan Feng, Xiaochun Ma, Mengting Xu, Cui Wang
    Environmental Pollution.2024; 349: 123959.     CrossRef
  • The association between C-reactive protein and coronary artery calcification: a systematic review and meta-analysis
    Amirhossein Tajani, Masoumeh Sadeghi, Navid Omidkhoda, Amir Hooshang Mohammadpour, Sara Samadi, Vahid Jomehzadeh
    BMC Cardiovascular Disorders.2024;[Epub]     CrossRef
  • Visceral Obesity and Its Association with Severe Coronary Artery Calcification in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Min Kyu Kang, Jeung Eun Song, Young Oh Kweon, Won Young Tak, Soo Young Park, Yu Rim Lee, Jung Gil Park
    Diagnostics.2024; 14(20): 2305.     CrossRef
  • From Cells to Plaques: The Molecular Pathways of Coronary Artery Calcification and Disease
    Andreas Mitsis, Elina Khattab, Evi Christodoulou, Kimon Myrianthopoulos, Michael Myrianthefs, Stergios Tzikas, Antonios Ziakas, Nikolaos Fragakis, George Kassimis
    Journal of Clinical Medicine.2024; 13(21): 6352.     CrossRef
  • Visceral adipose tissue is an independent predictor and mediator of the progression of coronary calcification: a prospective sub-analysis of the GEA study
    Neftali Eduardo Antonio-Villa, Juan Gabriel Juárez-Rojas, Rosalinda Posadas-Sánchez, Juan Reyes-Barrera, Aida Medina-Urrutia
    Cardiovascular Diabetology.2023;[Epub]     CrossRef
  • Deep learning-based prediction for significant coronary artery stenosis on coronary computed tomography angiography in asymptomatic populations
    Heesun Lee, Bong Gyun Kang, Jeonghee Jo, Hyo Eun Park, Sungroh Yoon, Su-Yeon Choi, Min Joo Kim
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Relationship between a novel non–insulin-based metabolic score for insulin resistance (METS‐IR) and coronary artery calcification
    Zhenwei Wang, Xiaofang Hui, Xu Huang, Jingjie Li, Naifeng Liu
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Association Between Abdominal Adipose Tissue Distribution and Risk of Endometrial Cancer: A Case-Control Study
    Yuan Cheng, Zhongyu Wang, Xiaoxuan Jia, Rong Zhou, Jianliu Wang
    Clinical Medicine Insights: Oncology.2022;[Epub]     CrossRef
  • Sex differences in cardiovascular risk may be related to sex differences in diet patterns: a narrative review
    A. M. Tindall, V. A. Stallings
    Annals of Human Biology.2021; 48(6): 517.     CrossRef
Technology/Device
Article image
Data Configuration and Publication Trends for the Korean National Health Insurance and Health Insurance Review & Assessment Database
Hae Kyung Kim, Sun Ok Song, Junghyun Noh, In-Kyung Jeong, Byung-Wan Lee
Diabetes Metab J. 2020;44(5):671-678.   Published online October 21, 2020
DOI: https://doi.org/10.4093/dmj.2020.0207
  • 14,644 View
  • 302 Download
  • 115 Web of Science
  • 123 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Big data reports related to diseases and health care for the Korean population have been published since the National Health Insurance Service (NHIS) and the Health Insurance Review & Assessment (HIRA) Service provided limited open access to their databases. Here, we reviewed the structure, content, and means of using data from the National Health Insurance (NHI) system for the benefit of Korean researchers and presented the latest publication trends in Korean healthcare data procured from the NHI and HIRA databases.
Methods
Since 2013, researchers have been able to obtain nationwide population-based studies using the NHI and HIRA databases of the insured. We searched publications using the NHI and the HIRA databases between 2013 and 2019 retrieved from PubMed.
Results
The NHI and HIRA databases provide nationwide population-based data. The total number of publications from 2014 to 2019 using NHI and HIRA databases is 2,541 and 655, respectively. A total of 5,465 endocrinology-related studies were performed during 2014 to 2019.
Conclusion
The NHIS and HIRA databases have provided tools for guidelines to approach world-leading population-based epidemiology and disease research.

Citations

Citations to this article as recorded by  
  • Immunosuppressant use and adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective cohort study in Korea
    Yu-Seon Jung, Yeo-Jin Song, Eun Jin Jang, Soo-Kyung Cho, Yoon-Kyoung Sung, Sun-Young Jung
    Rheumatology.2026;[Epub]     CrossRef
  • Coexistence of atrial fibrillation and metabolic dysfunction-associated steatotic liver disease as a high-risk overlap for incident heart failure in older adults
    Jeongin Lee, Sangwook Cheon, Eun Seok Kang, Jihun Song, Hye Jun Kim, Taeho Kwak, Seokjin Kong, Jin-Hyun Park, Minjeong Kang, Seohui Jang, Yihyun Kim, Jinhyeok Choi, Hwamin Lee, Jaewon Khil, Seogsong Jeong
    European Journal of Heart Failure.2026;[Epub]     CrossRef
  • Long-term exposure to fine particle air pollution associated with emergency COVID-19 hospitalizations: A nationwide retrospective Korean cohort study
    Taehee Chang, Jinah Park, Whanhee Lee, Sung-mok Jung, Kyung-Duk Min, Ho Kim, Sung-il Cho, Seoyeong Ahn, Yoonhee Kim
    Public Health.2026; 253: 106189.     CrossRef
  • Psychiatric, Cardiovascular and Skeletal Risks of Codeine versus Oxycodone in Hip Osteoarthritis: A Population-Based Cohort Study
    Jeongmin Lee, Yujin Kim, Eunjung Choo, Sooyoung Shin, Yeo Jin Choi
    Drug Design, Development and Therapy.2026; Volume 20: 1.     CrossRef
  • Longitudinal changes in cardiorespiratory fitness and risk of depressive and anxiety disorders in a nationwide cohort of 7 million participants
    Jin-Hyun Park, Seokjin Kong, Yohwan Lim, Yunhwan Oh, Porwarat Chawanid, Batuhan Gökbulut, Ju-Wan Kim, Sun Jae Park, Hye Jun Kim, Sangwook Cheon, Eun Seok Kang, Seohui Jang, Jeongin Lee, Minjeong Kang, Taeho Kwak, Yihyun Kim, Jihun Song, Jaewon Khil, Su Ky
    Scientific Reports.2026;[Epub]     CrossRef
  • Estimation of healthy worker survivor bias among middle-aged populations in Korea
    Byungyoon Yun, Beom Kyung Kim, Sung-In Jang, Laura S Rozek, Heejin Kimm, Juyeon Oh, Jin-Ha Yoon
    International Journal of Epidemiology.2026;[Epub]     CrossRef
  • Risk of Liver and Kidney Adverse Events After Androgen Deprivation Therapy in Prostate Cancer: A Population-Based Retrospective Cohort Study
    Jiwoo Yun, Ah-Young Kim, Il-Hyung Hwang, Sukhyang Lee, Hankil Lee
    Journal of Urologic Oncology.2026; 24(1): 21.     CrossRef
  • Incidence of systemic vasculitides after Mycobacterium tuberculosis infection: a population-based cohort study in Korea
    Minkyung Han, Jang Woo Ha, Inkyung Jung, Chi Young Kim, Sung Soo Ahn
    Rheumatology.2025; 64(3): 1400.     CrossRef
  • Dementia Incidence in Survivors of Multiple Myeloma: A National Case-Control Study Conducted in Korea (The CAREMM-2106 Study)
    Jeonghoon Ha, Suein Choi, Seulji Moon, Jinseon Han, Jeongyoon Lee, Sung-Soo Park, Sheng-Min Wang, Seunghoon Han, Chang-Ki Min
    Clinical Lymphoma Myeloma and Leukemia.2025; 25(1): e40.     CrossRef
  • Autophagy activation in response to cigarette smoke: Exploring the disparity in laryngeal cancer incidence and outcomes between sexes in South Korea
    Min Ji Kim, Jisu Hong, Hyo Won Chang, Yun-Hee Lee, Jun-Pyo Myong, Ah Ra Jung, Yoon Se Lee, Minsu Kwon
    Translational Oncology.2025; 52: 102229.     CrossRef
  • Big Data Research for Diabetes-Related Diseases Using the Korean National Health Information Database
    Kyung-Soo Kim, Bongseong Kim, Kyungdo Han
    Diabetes & Metabolism Journal.2025; 49(1): 13.     CrossRef
  • The impact of the COVID-19 pandemic on clinical practices related to colorectal cancer and colonoscopy in South Korea: a nationwide population-based study
    Jin Young Yoon, Moon Hyung Lee, Min Seob Kwak, Jae Myung Cha
    Intestinal Research.2025; 23(1): 85.     CrossRef
  • Facilitators and Barriers to Multidisciplinary Teamwork in Adolescent and Young Adult Oncology Care: A Descriptive Qualitative Study
    Hyewon Shin, Jin Young Seo, Eun Seok Choi, Jennie De Gagne
    Journal of Multidisciplinary Healthcare.2025; Volume 18: 917.     CrossRef
  • Differential Pattern of Symptom Correlation With Acute Respiratory Infections in Korea
    Jinsoo Kim, Gyoohwan Jung, Soyeoun Kim
    Pediatric Infectious Disease Journal.2025; 44(7): 609.     CrossRef
  • The Impact of COVID-19 on Admissions and In-hospital Mortality of Patients With Stroke in Korea: An Interrupted Time Series Analysis
    Youngs Chang, Soo-Hee Hwang, Haibin Bai, Seowoo Park, Eunbyul Cho, Dohoung Kim, Hyejin Lee, Jin Yong Lee
    Journal of Preventive Medicine and Public Health.2025; 58(1): 60.     CrossRef
  • Impact of COVID-19 on admission and in-hospital mortality of patients with acute myocardial infarction in Korea: An interrupted time series analysis
    Soo-Hee Hwang, Youngs Chang, Haibin Bai, Jieun Yun, Hyejin Lee, Jin Yong Lee, Dong Keon Yon
    PLOS ONE.2025; 20(2): e0316943.     CrossRef
  • Risk of cardiovascular diseases and gastrointestinal bleeding is comparable between celecoxib and non-selective non-steroidal anti-inflammatory drugs in patients with ankylosing spondylitis: a nationwide retrospective cohort study
    A Kim, SC Kim, J Kim, MW So, S-G Lee
    Scandinavian Journal of Rheumatology.2025; 54(3): 204.     CrossRef
  • Mortality and cardiovascular disease after cholecystectomy in type 2 diabetes: A nationwide longitudinal cohort study
    Han Na Jung, Ji Hye Heo, Eun Roh, Kyung‐Do Han, Jun Goo Kang, Seong Jin Lee, Sung‐Hee Ihm
    Journal of Hepato-Biliary-Pancreatic Sciences.2025; 32(7): 514.     CrossRef
  • Double disparities of the excess risks and costs of extreme temperatures on hospitalization between Medical Aid and non-Medical Aid populations in South Korea
    Ayoung Kim, Jinah Park, Cinoo Kang, Ho Kim, Whanhee Lee
    International Journal of Epidemiology.2025;[Epub]     CrossRef
  • Longitudinal association between consecutive moderate-to-vigorous physical activity and the risk of depression among depressed and non-depressed participants: A nationally representative cohort study
    Yohwan Lim
    Journal of Affective Disorders.2025; 381: 475.     CrossRef
  • Risk of Gout Among Patients With Tuberculosis: A Nationwide Cohort Study in South Korea
    Chi Young Kim, Jang Woo Ha, Inkyung Jung, Minkyung Han, Sung Soo Ahn
    International Journal of Rheumatic Diseases.2025;[Epub]     CrossRef
  • Association of Metabolic Dysfunction‐Associated Steatotic Liver Disease With Sudden Sensorineural Hearing Loss Among Older Adults
    Eun Seok Kang, Seohui Jang, Hye Jun Kim, Kyuwoong Kim, Meng Sha, Yun Hwan Oh, Michelle J. Suh, Seogsong Jeong
    Laryngoscope Investigative Otolaryngology.2025;[Epub]     CrossRef
  • Association between temporomandibular disorders and mental and behavioural disorders - a nationwide population-based cross-sectional study
    Younjung Park, Sora Yoon, Joon-Ho Yoon, Jin-Joo Yoo
    Clinical Oral Investigations.2025;[Epub]     CrossRef
  • Intellectual developmental disability and all-cause and cause-specific mortality among individuals with type 2 diabetes mellitus
    Jun-Hyuk Lee, Yong-Moon Mark Park, Kyungdo Han, Ye-Bin Park, Bong-Seong Kim, Jin-Hyung Jung, Ga Eun Nam
    Diabetes Research and Clinical Practice.2025; 226: 112305.     CrossRef
  • The Effectiveness of Operative Fixation for Comminuted Distal Radial Fractures in the Hyper-aged Patients Over 75 Years Old in South Korea
    Jisu PARK, Jaemin LEE, Jin Rok OH
    The Journal of Hand Surgery (Asian-Pacific Volume).2025; 30(03): 271.     CrossRef
  • Association between osteoporosis and mortality in Parkinson's disease with mediating effect of hip fractures: a Korean nationwide population-based study
    Yeonju Jin, Bo Kyu Choi, Jong Woo Lee, Jin Yong Hong, Ickpyo Hong, Min Seok Baek
    Frontiers in Aging Neuroscience.2025;[Epub]     CrossRef
  • Association between inhaled corticosteroids and incidence of idiopathic pulmonary fibrosis: nationwide population-based study
    Hyewon Lee, Hee-Young Yoon
    BMJ Open Respiratory Research.2025; 12(1): e002566.     CrossRef
  • Prescribing Patterns of SGLT2 Inhibitors and GLP‐1 Receptor Agonists in Patients With T2DM and ASCVD in South Korea
    Yeong Rok Eom, Hajung Joo, Seung Eun Chae, Nam Kyung Je
    Pharmacoepidemiology and Drug Safety.2025;[Epub]     CrossRef
  • Risk of pancreatic cancer according to glycemic status in nonalcoholic fatty liver disease: a nationwide cohort study
    Han Na Jung, Ji Hye Huh, Eun Roh, Bum Jun Kim, Minwoo Lee, Jwa-Kyung Kim, Joo-Hee Kim, Boram Han, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
    Scientific Reports.2025;[Epub]     CrossRef
  • Older Age Threshold for Oxaliplatin Benefit in Stage II to III Colorectal Cancer
    Jun Woo Bong, Hwamin Lee, Seogsong Jeong, Sanghee Kang
    JAMA Network Open.2025; 8(8): e2525660.     CrossRef
  • Fractures incidence and its association on mortality in multiple myeloma patients: a nationwide cohort study (CAREMM-2105 study)
    Jeonghoon Ha, Suein Choi, Sung-Soo Park, Seulji Moon, Jinseon Han, Jeongyoon Lee, Ki-Hyun Baek, Seunghoon Han, Chang-Ki Min
    Scientific Reports.2025;[Epub]     CrossRef
  • Patterns of spinal injections following lumbar fusion surgery: a nationwide cohort study with 3-year follow-up
    Yong Jae Na, Beom Suk Kim, Woo-Keun Kwon
    European Spine Journal.2025; 34(9): 4205.     CrossRef
  • Real-World Utilization Patterns of Immune Checkpoint Inhibitors Based on the National Health Insurance Service Data in Korea
    Eunji Kim, Yu-Seon Jung, Jongmin Lee, Dal Ri Nam, Seung-Hun You, Ju Won Lee, Sook Ryun Park, Ji Seon Oh, Ye-Jee Kim, Eun-Jung Jo, Nakyung Jeon, Won-Jung Jung, Sun-Young Jung
    Clinical Therapeutics.2025; 47(10): 837.     CrossRef
  • Overall survival following radical surgery and postoperative chemotherapy in colorectal cancer patients aged ≥ 70 years: a population-based retrospective cohort study
    Ji-Yeon Mun, Kyungdo Han, Nina Yoo, Bong-Hyeon Kye, InKyu Lee
    BMC Cancer.2025;[Epub]     CrossRef
  • Real-world evidence on the additional cancer risk reduction of ezetimibe: a 10-year nationwide retrospective cohort study emulating a target trial
    Yohwan Lim, Eunji Kim, Eunjung Hwang, Koanhoi Kim, Yonghae Son, Sang Yeoup Lee, Young Hye Cho, Eun-Ju Park, Youngin Lee, Sae Rom Lee, Jung-In Choi, Han-Sol Jeong, Su-Jung Park, Soo Min Son, Ryuk Jun Kwon
    Journal of Cancer Research and Clinical Oncology.2025;[Epub]     CrossRef
  • Latent tuberculosis infection screening in patients with inflammatory bowel disease: a nationwide retrospective cohort study in South Korea comparing IGRA alone versus a combination of TST and IGRA
    Ye-Jee Kim, Jiyeon Kim, Jiwon Lee, Tae Sun Shim, Sang Hyoung Park, Kyung-Wook Jo
    Intestinal Research.2025; 23(4): 541.     CrossRef
  • Triglyceride-glucose index variability and risk of all-cause and cardiovascular mortality
    Jimin Park, Duk Ho Kim, Jun-Hyuk Lee
    Scientific Reports.2025;[Epub]     CrossRef
  • Metabolic Dysfunction-Associated Steatotic Liver Disease and Risk of Hepatocellular Carcinoma in Type 2 Diabetes Mellitus
    So Hyun Cho, Gyuri Kim, Kyu-na Lee, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2025; 49(6): 1298.     CrossRef
  • Dementia in older adults with schizophrenia: a 12-year analysis of prevalence, incidence, and treatment patterns in South Korea
    Jung Su Park, Sangwan Kim, Donghoon Jeong, Jeong Pil Choi, Hyunsu Jeong, Alan Jung Park, Yong Sik Kim, Joongyub Lee, Se Hyun Kim
    Schizophrenia.2025;[Epub]     CrossRef
  • Nationwide health claims analysis of phenothiazine‐associated retinopathy risk in chlorpromazine and perphenazine users
    Jiyeong Kim, Jee-Eun Chung, Seong Joon Ahn
    Scientific Reports.2025;[Epub]     CrossRef
  • Impact of Type 2 Diabetes Mellitus on Age at Death in the Hemodialysis Population: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Ji Hong You, Kang Ju Son, Kyoung Sook Park, Byung-Wan Lee, Sun Ok Song
    Diabetology.2025; 6(12): 145.     CrossRef
  • Epidemiology and sociodemographic determinants of chronic temporomandibular disorders in South Korea: a nationwide population-based study
    Younjung Park, Sora Yoon, Joon-Ho Yoon, Jin-Joo Yoo
    BMC Oral Health.2025;[Epub]     CrossRef
  • Comparative Cardiovascular Safety of Duloxetine and Gabapentin in Patients with Hip Osteoarthritis
    Suhyeon Moon, Eunjung Choo, Yeo Jin Choi, Sooyoung Shin
    Journal of Pain Research.2025; Volume 18: 6437.     CrossRef
  • Continuity of care for patients with hypertension or diabetes mellitus reduced medical utilization, total medical costs, and cardiovascular events based on the Korean NHIS-HEALS cohort
    Eun-Kyeong Yun, Jae Yong Shim, Sang-Jun Shin, Hee-Taik Kang
    Nutrition, Metabolism and Cardiovascular Diseases.2025; : 104527.     CrossRef
  • The delayed cancer treatment and economic inequality in Korea: results of common cancers by the time-to-surgery
    Noorhee Son, Woo-Ri Lee, Dong-Woo Choi, Kyu-Tae Han
    Epidemiology and Health.2025; 47: e2025056.     CrossRef
  • Data profile: cancer sample cohorts (stomach, breast, colorectal, and liver) in Korea
    Daewoo Pak, Suk Yong Jang, Jin-Ha Yoon, Dong Wook Kim, Jin-Won Noh, Dong-Woo Choi, Minyeong Guk, Hyeri Kim, Ju-Won Oh, Heejung Chae, Hyun-Joo Kong, Gi Hyun Kim, Ji Woong Nam, Ga Ram Lee, Dayun Park, Jehoo Jeon, Byungyoon Yun, Ki-Bong Yoo, Kui Son Choi
    Epidemiology and Health.2025; 47: e2025058.     CrossRef
  • Various Antihypertensive Drug Compliance Models and Cardiovascular Prognosis of People With Incidentally Detected High Blood Pressure During Health Check‐Up in Korea
    Jong-Kwan Park, Sungyoun Chun, Joongmin Kim, Hancheol Lee, Ji-Yong Jang, Kyeong-Hyeon Chun, Hyeongsoo Kim, Seung-Jin Oh, Geunhee Park, Se-Jung Yoon, Peng Geng
    International Journal of Hypertension.2025;[Epub]     CrossRef
  • Medical service utilization patterns among adults with insomnia: A retrospective cohort study
    Min Kyung Hyun, Jang Won Lee
    European Journal of Integrative Medicine.2024; 67: 102325.     CrossRef
  • COVID-19-related cardiovascular disease risk due to weight gain: a nationwide cohort study
    Su Kyoung Lee, Yohwan Lim, Seogsong Jeong, Hyun Wook Han
    European Journal of Medical Research.2024;[Epub]     CrossRef
  • Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
    Do Hyoung Kim, Young Youl Hyun, Jin Joo Cha, Sua Lee, Hyun Kyung Lee, Jong Wook Choi, Su-Hyun Kim, Sang Youb Han, Cheol Whee Park, Eun Young Lee, Dae Ryong Cha, Sung Gyun Kim, Chun Soo Lim, Sun-Hee Park
    Kidney Research and Clinical Practice.2024; 43(1): 8.     CrossRef
  • Bipolar disorder and the risk of cardiometabolic diseases, heart failure, and all-cause mortality: a population-based matched cohort study in South Korea
    You-Bin Lee, Hyewon Kim, Jungkuk Lee, Dongwoo Kang, Gyuri Kim, Sang-Man Jin, Jae Hyeon Kim, Hong Jin Jeon, Kyu Yeon Hur
    Scientific Reports.2024;[Epub]     CrossRef
  • Evidence for the biopsychosocial model of suicide: a review of whole person modeling studies using machine learning
    Earvin S. Tio, Melissa C. Misztal, Daniel Felsky
    Frontiers in Psychiatry.2024;[Epub]     CrossRef
  • Nationwide Study of the Epidemiology, Diagnosis, and Treatment of Hypersensitivity Pneumonitis in Korea
    Hae In Jung, Dal Ri Nam, Seung-Hun You, Jae-Woo Jung, Kang-Mo Gu, Sun-Young Jung
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study
    Suein Choi, Eunjin Kim, Jinhee Jung, Sung-Soo Park, Chang-Ki Min, Seunghoon Han
    Scientific Reports.2024;[Epub]     CrossRef
  • Association of physical activity with fractures in kidney transplant recipients: A Korean nationwide cohort study
    Sungmi Kim, Jin‐Hyung Jung, Kyungho Lee, Junseok Jeon, Dong Wook Shin, Hye Ryoun Jang, Jung Eun Lee, Kyungdo Han, Wooseong Huh
    Clinical Transplantation.2024;[Epub]     CrossRef
  • Impact of an expanded reimbursement policy on utilization of implantable loop recorders in patients with cryptogenic stroke in Korea
    Hye Bin Gwag, Nak Gyeong Ko, Mihyeon Jin
    The Korean Journal of Internal Medicine.2024; 39(3): 469.     CrossRef
  • Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study
    Hee-Young Yoon, Hoseob Kim, Yoonjong Bae, Jin Woo Song
    Respiratory Research.2024;[Epub]     CrossRef
  • Data Resource Profile: Health Insurance Review and Assessment Service Covid-19 Observational Medical Outcomes Partnership (HIRA Covid-19 OMOP) database in South Korea
    Chungsoo Kim, Dong Han Yu, Hyeran Baek, Jaehyeong Cho, Seng Chan You, Rae Woong Park
    International Journal of Epidemiology.2024;[Epub]     CrossRef
  • Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis
    Min Wook So, A-Ran Kim, Seung-Geun Lee
    Rheumatology and Therapy.2024; 11(4): 881.     CrossRef
  • Body mass index is associated with clinical outcomes in idiopathic pulmonary fibrosis
    Hee-Young Yoon, Hoseob Kim, Yoonjong Bae, Jin Woo Song
    Scientific Reports.2024;[Epub]     CrossRef
  • DA-9601 has protective effects comparable to those of proton pump inhibitor and rebamipide against nonsteroidal anti-inflammatory drugs-induced upper and lower gastrointestinal bleeding in patients with rheumatoid arthritis: A nationwide study using Korea
    Min Wook So, Aran Kim, Seung-Geun Lee
    Medicine.2024; 103(27): e38801.     CrossRef
  • Prescription patterns and effectiveness of medications for chronic obstructive pulmonary disease: A retrospective study of real-world settings
    Hye Jung Park, Jae Uk Lee, Soyoung Jeon, Hye Sun Lee, Bo Yeon Kim, Yu Jin Chae, Gui Ok Kim, Jung-Won Park, Jae-Hyun Lee, Ai Theng Cheong
    PLOS ONE.2024; 19(6): e0304362.     CrossRef
  • High remnant-cholesterol levels increase the risk for end-stage renal disease: a nationwide, population-based, cohort study
    Han Na Jung, Ji Hye Huh, Eun Roh, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Major cardiovascular events in long-term multiple myeloma survivors: a Korean case–control study (the CAREMM-2105 study)
    Jeonghoon Ha, Suein Choi, Seulji Moon, Jinseon Han, Jeongyoon Lee, Ki-Hyun Baek, Seunghoon Han, Sung-Soo Park, Chang-Ki Min
    Clinical and Experimental Medicine.2024;[Epub]     CrossRef
  • Association between exercise habits and incident type 2 diabetes mellitus in patients with thyroid cancer: nationwide population-based study
    Jiyun Park, Jin-Hyung Jung, Hyunju Park, Young Shin Song, Soo-Kyung Kim, Yong-Wook Cho, Kyungdo Han, Kyung-Soo Kim
    BMC Medicine.2024;[Epub]     CrossRef
  • Big Data Research on Severe Asthma
    Sang Hyuk Kim, Youlim Kim
    Tuberculosis and Respiratory Diseases.2024; 87(3): 213.     CrossRef
  • Detecting spatial heat vulnerability in the city considering spatiotemporal population distribution: A focus on the elderly during daytime
    Seunghyun Lee, Jae Seung Lee, Saehoon Kim
    Urban Climate.2024; 56: 102054.     CrossRef
  • Real‐World Incidence of Incident Noninfectious Uveitis in Patients Treated With BRAF Inhibitors: A Nationwide Clinical Cohort Study
    HYUNJEAN JUNG, SUNYEUP KIM, CHRISTOPHER SEUNGKYU LEE, SUK HO BYEON, SUNG SOO KIM, SEUNG WON LEE, YONG JOON KIM
    American Journal of Ophthalmology.2024; 267: 142.     CrossRef
  • Incidence of hearing loss following COVID-19 among young adults in South Korea: a nationwide cohort study
    Hye Jun Kim, Seogsong Jeong, Kyuwoong Kim, Joon Don Lee, Yun Hwan Oh, Michelle J. Suh
    eClinicalMedicine.2024; 75: 102759.     CrossRef
  • Comparative risk of serious infections and tuberculosis in Korean patients with inflammatory bowel disease treated with non-anti-TNF biologics or anti-TNF-α agents: a nationwide population-based cohort study
    Min Jee Kim, Ye-Jee Kim, Daehyun Jeong, Seonok Kim, Seokchan Hong, Sang Hyoung Park, Kyung-Wook Jo
    Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
  • Cancer risk among air transportation industry workers in Korea: a national health registry-based study
    Soojin Park, Ga Bin Lee, Dalnim Lee, Eun-Shil Cha, Kyunghee Han, Minsu Cho, Songwon Seo
    BMC Public Health.2024;[Epub]     CrossRef
  • The Impact of Infectious Mononucleosis History on the Risk of Developing Lymphoma and Nasopharyngeal Carcinoma: A Retrospective Large-Scale Cohort Study Using National Health Insurance Data in South Korea
    So Hee Kang, Yun-Hee Lee, Jun-Pyo Myong, Minsu Kwon
    Cancer Research and Treatment.2024; 56(4): 1077.     CrossRef
  • Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study
    Si Nae Oh, Hye Jun Kim, Jae Yong Shim, Kyuwoong Kim, Seogsong Jeong, Sun Jae Park, Sang Hyun Lee, Joong Won Ha, Sang Min Park
    Scientific Reports.2024;[Epub]     CrossRef
  • Impact of mental disorders on the all-cause mortality and cardiovascular disease outcomes in adults with new-onset type 1 diabetes: A nationwide cohort study
    Seohyun Kim, Gyuri Kim, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
    Psychiatry Research.2024; 342: 116228.     CrossRef
  • Nationwide study of chronic codeine use and its impact on cough related diseases in South Korea
    Tai Joon An, Yun-Hee Lee, Joon-Sung Joh, Jun-Pyo Myong
    Scientific Reports.2024;[Epub]     CrossRef
  • Association of age at menopause and suicide risk in postmenopausal women: a nationwide cohort study
    Daa Un Moon, Hyewon Kim, Jin-Hyung Jung, Kyungdo Han, Hong Jin Jeon
    Frontiers in Psychiatry.2024;[Epub]     CrossRef
  • Does endometriosis increase the risks of endometrial hyperplasia and endometrial cancer?
    Hoon Kim, Hyun Jung Kim, Hyeong Sik Ahn
    Gynecologic Oncology.2023; 169: 147.     CrossRef
  • Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
    Min Kyong Moon, Junghyun Noh, Eun-Jung Rhee, Sang Hyun Park, Hyeon Chang Kim, Byung Jin Kim, Hae Jin Kim, Seonghoon Choi, Jin Oh Na, Young Youl Hyun, Bum Joon Kim, Kyung-Do Han, In-Kyung Jeong
    Diabetes & Metabolism Journal.2023; 47(1): 45.     CrossRef
  • Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study
    Junghyun Noh, Min Kyong Moon, Eun-Jung Rhee, Sang Hyun Park, Hyeon Chang Kim, Byung Jin Kim, Hae Jin Kim, Seonghoon Choi, Jin Oh Na, Young Youl Hyun, Bum Joon Kim, Kyung-Do Han, In-Kyung Jeong
    Diabetes & Metabolism Journal.2023; 47(1): 59.     CrossRef
  • Predicting the Risk of Insulin-Requiring Gestational Diabetes before Pregnancy: A Model Generated from a Nationwide Population-Based Cohort Study in Korea
    Seung-Hwan Lee, Jin Yu, Kyungdo Han, Seung Woo Lee, Sang Youn You, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
    Endocrinology and Metabolism.2023; 38(1): 129.     CrossRef
  • Genital tract infection and pelvic surgery contribute to the development of endometriosis
    Ae Ra Han, Suehyun Lee, Jaehun Cha, Jong-Yeup Kim, Dong-Kyu Kim, Jae Won Han, Chul Jung Kim, Sung Ki Lee
    Journal of Reproductive Immunology.2023; 156: 103831.     CrossRef
  • Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
    Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
  • Comorbidity Differences by Trajectory Groups as a Reference for Identifying Patients at Risk for Late Mortality in Childhood Cancer Survivors: Longitudinal National Cohort Study
    Hyery Kim, Hae Reong Kim, Sung Han Kang, Kyung-Nam Koh, Ho Joon Im, Yu Rang Park
    JMIR Public Health and Surveillance.2023; 9: e41203.     CrossRef
  • Investigation of the Relationship Between Psychiatry Visit and Suicide After Deliberate Self-harm: Longitudinal National Cohort Study
    Hye Hyeon Kim, Chanyoung Ko, Ji Ae Park, In Han Song, Yu Rang Park
    JMIR Public Health and Surveillance.2023; 9: e41261.     CrossRef
  • Long-term exposure to particulate matter and risk of Alzheimer’s disease and vascular dementia in Korea: a national population-based Cohort Study
    Jung-Im Shim, Garam Byun, Jong-Tae T. Lee
    Environmental Health.2023;[Epub]     CrossRef
  • Association of Physical Activity With SARS-CoV-2 Infection and Severe Clinical Outcomes Among Patients in South Korea
    YoHwan Lim, Myeong Hoon Lee, Seogsong Jeong, Hyun Wook Han
    JAMA Network Open.2023; 6(4): e239840.     CrossRef
  • Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Sun Ok Song, Eugene Han, Kang Ju Son, Bong-Soo Cha, Byung-Wan Lee
    Journal of Clinical Medicine.2023; 12(9): 3160.     CrossRef
  • Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus
    Jae-Eun Lee, Dal Ri Nam, Yoon-Kyoung Sung, Yu Jeong Kim, Sun-Young Jung
    Scientific Reports.2023;[Epub]     CrossRef
  • Associations of updated cardiovascular health metrics, including sleep health, with incident diabetes and cardiovascular events in older adults with prediabetes: A nationwide population-based cohort study
    Kyoung Hwa Ha, Dae Jung Kim, Seung Jin Han
    Diabetes Research and Clinical Practice.2023; 203: 110820.     CrossRef
  • Association of Socioeconomic Status With Long-Term Outcome in Survivors After Out-of-Hospital Cardiac Arrest: Nationwide Population-Based Longitudinal Study
    Kyung Hun Yoo, Yongil Cho, Jaehoon Oh, Juncheol Lee, Byuk Sung Ko, Hyunggoo Kang, Tae Ho Lim, Sang Hwan Lee
    JMIR Public Health and Surveillance.2023; 9: e47156.     CrossRef
  • Antimicrobial and Antibiofilm Effects of Lactiplantibacillus plantarum THK-j112 Isolated from Kimchi against Streptococcus mutans
    Du-Na Yu, Eun-Ji Yi, Je-Yong Jung, Tae-Hoo Yi, Moochang Kook
    Current Topic in Lactic Acid Bacteria and Probiotics.2023; 9(1): 9.     CrossRef
  • The Risk of Type 2 Diabetes Mellitus according to Changes in Obesity Status in Late Middle-Aged Adults: A Nationwide Cohort Study of Korea
    Joon Ho Moon, Yeonhoon Jang, Tae Jung Oh, Se Young Jung
    Diabetes & Metabolism Journal.2023; 47(4): 514.     CrossRef
  • Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population‐based cohort study
    Eun Jeong Gong, Hye‐Kyung Jung, Bora Lee, Jitaek Hong, Jong Wook Kim, Cheol Min Shin, Young Hoon Youn, Kwang Jae Lee
    Alimentary Pharmacology & Therapeutics.2023; 58(7): 668.     CrossRef
  • Risk Factors for Lower Extremity Amputation in Patients with End-Stage Kidney Disease: A Nationwide Cohort Study
    Min Jun Seo, Dong Geon Lee, Se Yun Ko, Ga Yeong Song, Geon Yeong Lee, Sung Hwa Kim, Dae Ryong Kang, Jiye Kim, Jun Young Lee
    Journal of Clinical Medicine.2023; 12(17): 5641.     CrossRef
  • Poorer outcomes following COVID-19 infection for patients with depression: A cohort analysis in South Korea
    Su Kyoung Lee, Yohwan Lim, Seogsong Jeong, Hyun Wook Han
    Annals of the Academy of Medicine, Singapore.2023; 52(8): 411.     CrossRef
  • The role of income and frequency of dental visits in the relationship between dental sealant use and resin fillings after extended coverage: a retrospective cohort study
    Dong-Hun Han, Hee-Yeon Kang, Jae-In Ryu
    BMC Oral Health.2023;[Epub]     CrossRef
  • Effect of changes in the hearing aid subsidy on the prevalence of hearing loss in South Korea
    Chul Young Yoon, Junhun Lee, Tae Hoon Kong, Young Joon Seo
    Frontiers in Neurology.2023;[Epub]     CrossRef
  • Visual Impairment Risk After Alcohol Abstinence in Patients With Newly Diagnosed Open-Angle Glaucoma
    Yoon Jeong, Su Hwan Kim, Goneui Kang, Hyung-Jin Yoon, Young Kook Kim, Ahnul Ha
    JAMA Network Open.2023; 6(10): e2338526.     CrossRef
  • Impact of statin treatment on cardiovascular risk in patients with type 1 diabetes: a population-based cohort study
    Joonsang Yoo, Jimin Jeon, Minyoul Baek, Sun Ok Song, Jinkwon Kim
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • Socioeconomic Disparities in the Association Between All-Cause Mortality and Health Check-Up Participation Among Healthy Middle-Aged Workers: A Nationwide Study
    Byungyoon Yun, Juyeon Oh, Jaesung Choi, Laura S. Rozek, Heejoo Park, Juho Sim, Yangwook Kim, Jongmin Lee, Jin-Ha Yoon
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Increased Estimated GFR Is Negatively Associated With the Risk of SARS-CoV-2 Infection and Severe COVID-19 Within Normal to Mildly Decreased Levels: Nested Case-Control Study
    Yohwan Lim, Myeong Hoon Lee, Su Kyoung Lee, Seogsong Jeong, Hyun Wook Han
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Risk of Pregnancy Complications and Low Birth Weight Offsprings in Korean Women With Rheumatic Diseases: A Nationwide Population-Based Study
    Jin-Su Park, Min Kyung Chung, Hyunsun Lim, Jisoo Lee, Chan Hee Lee
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Associations of variability in body weight and glucose levels with the risk of hip fracture in people with diabetes
    Jeongmin Lee, Kyungdo Han, Sang Hyun Park, Mee Kyoung Kim, Dong-Jun Lim, Kun-Ho Yoon, Moo-Il Kang, Seung-Hwan Lee
    Metabolism.2022; 129: 155135.     CrossRef
  • Travel Time for Dental Care Services Based on Patient Preference in South Korea
    Han-A Cho, Bo-Ra Kim, Hosung Shin
    International Journal of Environmental Research and Public Health.2022; 19(4): 2051.     CrossRef
  • The Basic Concept of Claim Data-based Research
    Su Bee Park, Jae Myung Cha
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(1): 70.     CrossRef
  • Trends of severe hypoglycemia in patients with type 2 diabetes in Korea: A longitudinal nationwide cohort study
    Jae‐Seung Yun, Kyungdo Han, Seung‐Hyun Ko
    Journal of Diabetes Investigation.2022; 13(8): 1438.     CrossRef
  • National General Health Screening Program in Korea: history, current status, and future direction
    Dong Wook Shin, Juhee Cho, Jae Hyun Park, BeLong Cho
    Precision and Future Medicine.2022; 6(1): 9.     CrossRef
  • Cumulative Exposure to High γ-Glutamyl Transferase Level and Risk of Diabetes: A Nationwide Population-Based Study
    Ji-Yeon Park, Kyungdo Han, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim, Seung-Hwan Lee
    Endocrinology and Metabolism.2022; 37(2): 272.     CrossRef
  • Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research
    Dae-Sung Kyoung, Hun-Sung Kim
    Journal of Lipid and Atherosclerosis.2022; 11(2): 103.     CrossRef
  • Clinical and Cost-Saving Effects of the Drug Utilization Review Modernization Project in Inpatient and Outpatient Settings in Korea
    Dongwon Yoon, Inmyung Song, Ha-Lim Jeon, Sungho Bea, Ahhyung Choi, Hyesung Lee, Ju-Young Shin
    Journal of Patient Safety.2022; 18(6): 605.     CrossRef
  • Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study
    Jae‐Seung Yun, Kyungdo Han, Yong‐Moon Park, Eugene Han, Yong‐ho Lee, Seung‐Hyun Ko
    Journal of Diabetes Investigation.2022; 13(9): 1533.     CrossRef
  • Analysis of sedation and general anesthesia in patients with special needs in dentistry using the Korean healthcare big data
    Jieun Kim, Hyuk Kim, Kwang-Suk Seo, Hyun Jeong Kim
    Journal of Dental Anesthesia and Pain Medicine.2022; 22(3): 205.     CrossRef
  • Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
    Endocrinology and Metabolism.2022; 37(3): 466.     CrossRef
  • Visual Acuity Outcomes in Diseases Associated with Reduced Visual Acuity: An Analysis of the National Health Insurance Service Database in Korea
    Sang-Yeob Kim, Byeong-Yeon Moon, Hyun-Gug Cho, Dong-Sik Yu
    International Journal of Environmental Research and Public Health.2022; 19(14): 8689.     CrossRef
  • Reproductive Life Span and Severe Hypoglycemia Risk in Postmenopausal Women with Type 2 Diabetes Mellitus
    Soyeon Kang, Yong-Moon Park, Dong Jin Kwon, Youn-Jee Chung, Jeong Namkung, Kyungdo Han, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2022; 46(4): 578.     CrossRef
  • Lipid cutoffs for increased cardiovascular disease risk in non-diabetic young people
    Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Kun-Ho Yoon, Seung-Hwan Lee
    European Journal of Preventive Cardiology.2022; 29(14): 1866.     CrossRef
  • Current Trends of Big Data Research Using the Korean National Health Information Database
    Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
    Diabetes & Metabolism Journal.2022; 46(4): 552.     CrossRef
  • Increasing trends in mortality and costs of infectious diseases in Korea: trends in mortality and costs of infectious diseases
    Dahye Baik, Byung-Woo Kim, Moran Ki
    Epidemiology and Health.2022; 44: e2022010.     CrossRef
  • How to Use Health Insurance Data Effectively for Healthcare Research
    Ilsu Park
    Journal of Health Informatics and Statistics.2022; 47(Suppl 2): S31.     CrossRef
  • Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study
    Ji Hye Huh, Kyung-do Han, Yun Kyung Cho, Eun Roh, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
    Cardiovascular Diabetology.2022;[Epub]     CrossRef
  • Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea
    Hyun Min Kim, Min Jin Kang, Sun Ok Song
    Endocrinology and Metabolism.2022; 37(6): 929.     CrossRef
  • Effect of Sex on Clinical Outcomes in Patients with Coronavirus Disease: A Population-Based Study
    Kyu Hyang Cho, Sang Won Kim, Jong Won Park, Jun Young Do, Seok Hui Kang
    Journal of Clinical Medicine.2020; 10(1): 38.     CrossRef
  • Increased Age of Death and Change in Causes of Death Among Persons With Diabetes Mellitus From the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
    SSRN Electronic Journal .2020;[Epub]     CrossRef
Brief Report
Complications
Article image
Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis
Yoo-Ri Chung, Kyoung Hwa Ha, Kihwang Lee, Dae Jung Kim
Diabetes Metab J. 2020;44(6):928-932.   Published online July 10, 2020
DOI: https://doi.org/10.4093/dmj.2020.0096
  • 10,159 View
  • 245 Download
  • 13 Web of Science
  • 14 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   

We performed a retrospective cohort study including people diagnosed with diabetes from 2006 to 2015 according to the Korean National Health Insurance Service-National Sample Cohort database, to analyze the changes in the prevalence, screening rate, and treatment patterns for diabetic retinopathy (DR) over 10 years. The proportion of people who underwent fundus screening for DR steadily increased over the past decade. The prevalence of DR increased from 13.4% in 2006 to 15.9% in 2015, while that of proliferative DR steadily decreased from 1.29% in 2006 to 1.16% in 2015. The proportion of patients undergoing retinal photocoagulation constantly decreased. The prevalence of DR increased over the past decade, while its severity seemed to have improved, with a decreased rate of proliferative DR and retinal photocoagulation. A higher proportion of patients underwent ophthalmic screening using fundus examination, but still less than 30% of patients with diabetes underwent comprehensive examination in 2015.

Citations

Citations to this article as recorded by  
  • Nationwide Trends and Future Projections of Diabetes and Diabetic Retinopathy Prevalence in Korea: Korean National Health and Nutrition Examination Survey Study
    Min Seok Kim, Seonghee Nam, Jeongwoo Lee, Se Joon Woo
    Journal of Korean Medical Science.2026;[Epub]     CrossRef
  • Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
    Kyoung Hwa Ha, Soyoung Shin, EunJi Na, Dae Jung Kim
    Journal of Diabetes Investigation.2025; 16(2): 215.     CrossRef
  • Ten-Year Trends of Fluorescein Angiography in Korea Using Data From the Health Insurance Review and Assessment Service
    Dong Woo Kim, Min Seok Kim
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention
    Soo Hyun Kang, Kilyoon Pack, Jung Ho Kim, Youngwoo Jang
    Scientific Reports.2025;[Epub]     CrossRef
  • To Determine the Risk-Based Screening Interval for Diabetic Retinopathy: Development and Validation of Risk Algorithm from a Retrospective Cohort Study
    Jinxiao Lian, Ching So, Sarah Morag McGhee, Thuan-quoc Thach, Cindy Lo Kuen Lam, Colman Siu Cheung Fung, Alfred Siu Kei Kwong, Jonathan Cheuk Hung Chan
    Diabetes & Metabolism Journal.2025; 49(2): 286.     CrossRef
  • Comparative Effectiveness of Clopidogrel Versus Aspirin for Primary Prevention in High-Risk Patients with Type 2 Diabetes: A Nationwide Propensity Score–Matched Cohort Study
    Soo Hyun Kang, Joonpyo Lee, Jung Ho Kim, Youngwoo Jang
    Medicina.2025; 61(10): 1730.     CrossRef
  • Variations in Electronic Health Record-Based Definitions of Diabetic Retinopathy Cohorts
    Jimmy S. Chen, Ivan A. Copado, Cecilia Vallejos, Fritz Gerald P. Kalaw, Priyanka Soe, Cindy X. Cai, Brian C. Toy, Durga Borkar, Catherine Q. Sun, Jessica G. Shantha, Sally L. Baxter
    Ophthalmology Science.2024; 4(4): 100468.     CrossRef
  • Present and future screening programs for diabetic retinopathy: a narrative review
    Andreas Abou Taha, Sebastian Dinesen, Anna Stage Vergmann, Jakob Grauslund
    International Journal of Retina and Vitreous.2024;[Epub]     CrossRef
  • Trends and Barriers in Diabetic Retinopathy Screening: Korea National Health and Nutritional Examination Survey 2016–2021
    Min Seok Kim, Sang Jun Park, Kwangsic Joo, Se Joon Woo
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Chronic disease management program applied to type 2 diabetes patients and prevention of diabetic complications: a retrospective cohort study using nationwide data
    Min Kyung Hyun, Jang Won Lee, Seung-Hyun Ko
    BMC Public Health.2023;[Epub]     CrossRef
  • Visual Acuity Outcomes in Diseases Associated with Reduced Visual Acuity: An Analysis of the National Health Insurance Service Database in Korea
    Sang-Yeob Kim, Byeong-Yeon Moon, Hyun-Gug Cho, Dong-Sik Yu
    International Journal of Environmental Research and Public Health.2022; 19(14): 8689.     CrossRef
  • Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study
    Han Na Jang, Min Kyong Moon, Bo Kyung Koo
    Diabetes & Metabolism Journal.2022; 46(4): 620.     CrossRef
  • Prevalence and Risk Factors of Diabetic Retinopathy in Diabetes People using Korean National Health and Nutrition Examination Survey VII
    Ihn Sook Jeong, Chan Mi Kang
    Journal of Korean Academy of Community Health Nursing.2022; 33(4): 408.     CrossRef
  • Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
    Ja Young Jeon
    Diabetes & Metabolism Journal.2021; 45(4): 613.     CrossRef
Original Articles
Basic Research
Article image
MondoA Is Required for Normal Myogenesis and Regulation of the Skeletal Muscle Glycogen Content in Mice
Hui Ran, Yao Lu, Qi Zhang, Qiuyue Hu, Junmei Zhao, Kai Wang, Xuemei Tong, Qing Su
Diabetes Metab J. 2021;45(3):439-451.   Published online May 18, 2020
DOI: https://doi.org/10.4093/dmj.2019.0212
Correction in: Diabetes Metab J 2021;45(5):797Correction in: Diabetes Metab J 2025;49(2):331
  • 10,933 View
  • 222 Download
  • 7 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Skeletal muscle is the largest tissue in the human body, and it plays a major role in exerting force and maintaining metabolism homeostasis. The role of muscle transcription factors in the regulation of metabolism is not fully understood. MondoA is a glucose-sensing transcription factor that is highly expressed in skeletal muscle. Previous studies suggest that MondoA can influence systemic metabolism homeostasis. However, the function of MondoA in the skeletal muscle remains unclear.

Methods

We generated muscle-specific MondoA knockout (MAKO) mice and analyzed the skeletal muscle morphology and glycogen content. Along with skeletal muscle from MAKO mice, C2C12 myocytes transfected with small interfering RNA against MondoA were also used to investigate the role and potential mechanism of MondoA in the development and glycogen metabolism of skeletal muscle.

Results

MAKO caused muscle fiber atrophy, reduced the proportion of type II fibers compared to type I fibers, and increased the muscle glycogen level. MondoA knockdown inhibited myoblast proliferation, migration, and differentiation by inhibiting the phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K)/Akt pathway. Further mechanistic experiments revealed that the increased muscle glycogen in MAKO mice was caused by thioredoxin-interacting protein (TXNIP) downregulation, which led to upregulation of glucose transporter 4 (GLUT4), potentially increasing glucose uptake.

Conclusion

MondoA appears to mediate mouse myofiber development, and MondoA decreases the muscle glycogen level. The findings indicate the potential function of MondoA in skeletal muscle, linking the glucose-related transcription factor to myogenesis and skeletal myofiber glycogen metabolism.

Citations

Citations to this article as recorded by  
  • Mondo family proteins in diabetes
    Sandeep Kumar Barodia, Maria B. Grant, Marina S. Gorbatyuk
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • The Function of MondoA and ChREBP Nutrient—Sensing Factors in Metabolic Disease
    Byungyong Ahn
    International Journal of Molecular Sciences.2023; 24(10): 8811.     CrossRef
  • Normal and Neoplastic Growth Suppression by the Extended Myc Network
    Edward V. Prochownik, Huabo Wang
    Cells.2022; 11(4): 747.     CrossRef
  • The Role of Mondo Family Transcription Factors in Nutrient-Sensing and Obesity
    Huiyi Ke, Yu Luan, Siming Wu, Yemin Zhu, Xuemei Tong
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
Complications
Article image
Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
Wenya Weng, Tingwen Ge, Yi Wang, Lulu He, Tinghao Liu, Wanning Wang, Zongyu Zheng, Lechu Yu, Chi Zhang, Xuemian Lu
Diabetes Metab J. 2020;44(4):566-580.   Published online May 15, 2020
DOI: https://doi.org/10.4093/dmj.2019.0089
  • 10,628 View
  • 135 Download
  • 17 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Fibroblast growth factor 21 (FGF21) has been only reported to prevent type 1 diabetic nephropathy (DN) in the streptozotocin-induced type 1 diabetes mellitus (T1DM) mouse model. However, the FVB (Cg)-Tg (Cryaa-Tag, Ins2-CALM1) 26OVE/PneJ (OVE26) transgenic mouse is a widely recommended mouse model to recapture the most important features of T1DM nephropathy that often occurs in diabetic patients. In addition, most previous studies focused on exploring the preventive effect of FGF21 on the development of DN. However, in clinic, development of therapeutic strategy has much more realistic value compared with preventive strategy since the onset time of DN is difficult to be accurately predicted. Therefore, in the present study OVE26 mice were used to investigate the potential therapeutic effects of FGF21 on DN.

Methods

Four-month-old female OVE26 mice were intraperitoneally treated with recombinant FGF21 at a dose of 100 µg/kg/day for 3 months. The diabetic and non-diabetic control mice were treated with phosphate-buffered saline at the same volume. Renal functions, pathological changes, inflammation, apoptosis, oxidative stress and fibrosis were examined in mice of all groups.

Results

The results showed that severe renal dysfunction, morphological changes, inflammation, apoptosis, and fibrosis were observed in OVE26 mice. However, all the renal abnormalities above in OVE26 mice were significantly attenuated by 3-month FGF21 treatment associated with improvement of renal adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) activity and sirtuin 1 (SIRT1) expression.

Conclusion

Therefore, this study demonstrated that FGF21 might exert therapeutic effects on DN through AMPK-SIRT1 pathway.

Citations

Citations to this article as recorded by  
  • Immune-metabolic interactions shape the fibrotic landscape of diabetic kidney disease: emerging mechanisms and therapeutic prospects
    Yachan Gao, Xinxin Pang, Huichao Zhang, Dongdong Li, Jiarui Han, Zhenyi Chen, Xiaoyong Chen, Dongyang Li
    Frontiers in Physiology.2026;[Epub]     CrossRef
  • FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle
    Yudie Zhang, Fan Wang, Chongyang Zhang, Fan Yao, Bin Zhang, Yongping Zhang, Xiaobo Sun
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • The Role of Sirtuins in Diabetic Nephropathy: A Comprehensive Review
    Pranay Wal, Tarannum Tarannum, Lalji Baldaniya, Kiranjeet Kaur, Priyanka Singh, Namra Aziz, Komal Singh, Amin Gasmi
    Current Protein & Peptide Science.2025; 26(6): 407.     CrossRef
  • Role of Liver-Derived Ketones, Hepatokines, and Metabolites in the Regulation of Renal Function
    Gertrude Arthur, Michael I. Adenawoola, Sally Wahba, Bentley S. Montgomery, David E. Stec
    Kidney360.2025; 6(9): 1609.     CrossRef
  • FGF21-engineered ADSCs promote diabetic wound healing by mitigating ferroptosis and oxidative stress via the SIRT1/NRF2/GPX4 signaling pathway
    Zhen Liang, Yanan Gu, Yutao Li, Ziyu Wu, Xianghao Xu, Guizhi Wei, Na Wang, Zhaoxiang Zhang, Qianqian Hao, Yizhi Peng, Hanli Wang, Zhou Yu, Baoqiang Song
    Stem Cell Research & Therapy.2025;[Epub]     CrossRef
  • Fibroblast growth factor 21 alleviates unilateral ureteral obstruction-induced renal fibrosis by inhibiting Wnt/β-catenin signaling pathway
    Wenhui Zhong, Yuheng Jiang, Huizhen Wang, Xiang Luo, Tao Zeng, Huimi Huang, Ling Xiao, Nan Jia, Aiqing Li
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119620.     CrossRef
  • Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease
    Anton I. Korbut, Vyacheslav V. Romanov, Vadim V. Klimontov
    Biomedicines.2024; 12(3): 487.     CrossRef
  • New developments in the biology of fibroblast growth factors
    David M. Ornitz, Nobuyuki Itoh
    WIREs Mechanisms of Disease.2022;[Epub]     CrossRef
  • SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
    Wenxiu Qi, Cheng Hu, Daqing Zhao, Xiangyan Li
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
    Min-Qi Jia, Cha-Xiang Guan, Jia-Hao Tao, Yong Zhou, Liang-Jun Yan
    Oxidative Medicine and Cellular Longevity.2022;[Epub]     CrossRef
  • Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study
    Yutong Zou, Lijun Zhao, Junlin Zhang, Yiting Wang, Yucheng Wu, Honghong Ren, Tingli Wang, Yuancheng Zhao, Huan Xu, Lin Li, Nanwei Tong, Fang Liu
    Acta Diabetologica.2022; 60(2): 225.     CrossRef
  • FGF21 and Chronic Kidney Disease
    João Victor Salgado, Miguel Angelo Goes, Natalino Salgado Filho
    Metabolism.2021; 118: 154738.     CrossRef
  • The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
    Junyu Deng, Ye Liu, Yiqiu Liu, Wei Li, Xuqiang Nie
    Journal of Inflammation Research.2021; Volume 14: 5273.     CrossRef
  • Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy
    Fanrui Meng, Yukai Cao, Mir Hassan Khoso, Kai Kang, Guiping Ren, Wei Xiao, Deshan Li
    Archives of Biochemistry and Biophysics.2021; 713: 109063.     CrossRef
  • FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
    Emma Henriksson, Birgitte Andersen
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
    Erik J. Tillman, Tim Rolph
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
Complications
Article image
Deterioration of Sleep Quality According to Glycemic Status
Myung Haeng Hur, Mi-Kyoung Lee, Kayeon Seong, Jun Hwa Hong
Diabetes Metab J. 2020;44(5):679-686.   Published online April 17, 2020
DOI: https://doi.org/10.4093/dmj.2019.0125
  • 12,464 View
  • 163 Download
  • 12 Web of Science
  • 18 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Type 2 diabetes mellitus (T2DM) is a progressive disease with multiple complications. The present study aimed to determine the effects of glycemic status on sleep quality in individuals with T2DM, prediabetes, and normal glucose tolerance (NGT).

Methods

A total of 90 participants were categorized into three groups, T2DM (n=30), prediabetes (n=30), and NGT (n=30). Objective sleep quality was measured with the actigraph wrist-worn device over 3 nights and subjective sleep quality was evaluated with a questionnaire.

Results

The duration of diabetes in the T2DM group was 2.23 years and the glycosylated hemoglobin (HbA1c) levels in the T2DM, prediabetes, and NGT groups were 7.83%, 5.80%, and 5.31%, respectively. Sleep efficiency decreased across the T2DM, prediabetes, and NGT groups (86.25%, 87.99%, and 90.22%, respectively; P=0.047). Additionally, HbA1c levels revealed a significant negative correlation with sleep efficiency (r=−0.348, P=0.001). The sleep quality questionnaire results were similar among the three groups.

Conclusion

Although the participants in the present study were not necessarily conscious of their sleep disturbances, deterioration in sleep quality progressed according to glycemic status.

Citations

Citations to this article as recorded by  
  • The interface of depression and diabetes: treatment considerations
    Giuseppe Fanelli, Emanuel Raschi, Gaye Hafez, Silke Matura, Carmen Schiweck, Elisabetta Poluzzi, Carlotta Lunghi
    Translational Psychiatry.2025;[Epub]     CrossRef
  • The association between insomnia (related symptoms) and glycaemic control: a systematic review and meta-analysis
    Yiming Chen, Enyu Tong, Yufeng Rao, Evan YW Yu, Maurice Zeegers, Anke Wesselius
    Journal of Global Health.2025;[Epub]     CrossRef
  • The potential impact of habitual sleep quality on glycaemic control and inflammation: A study on geriatric patients recently diagnosed with type 2 diabetes mellitus (T2DM)
    Nadia Hussain, Amal Hussain Ibrahim Al Haddad, Saima Abbass, Zina Alfahl
    Sleep Medicine: X.2025; 9: 100139.     CrossRef
  • Diyabet Tiplerine Göre Yaşam Kalitesi, Fiziksel Aktivite ve Uyku Düzeylerinin Karşılaştırılması
    Abdurrahim Yıldız, Salih Buğra Özdemir, Emircan Kökcü, Fevziye Türkoğlu Genç
    Journal of Innovative Healthcare Practices.2025; 6(1): 19.     CrossRef
  • Association Between Non-adherence to Diabetes Management and Poor Sleep Quality Based on the Korean Community Health Survey
    Horim A. Hwang, Hyunsuk Jeong, Hyeon Woo Yim
    Journal of Preventive Medicine and Public Health.2025; 58(3): 260.     CrossRef
  • Diabetic kidney disease in rural Australia: prevention, management, treatment and way forward
    Allen G. Ross, Utpal K. Mondal, Anayochukwu E. Anyasodor, Shakeel Mahmood, Feleke H. Astawesegn, M. Mamun Huda, Subash Thapa, Setognal B. Aychiluhm, Santosh Giri, Md. Ferdous Rahman, Muhammad J. A. Shiddiky, Mohammad A. Moni, Kedir Y. Ahmed
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Insulin resistance, depression, and type 2 diabetes
    A.A. Serhiyenko, O.M. Chemerys, V.I. Pankiv, V.A. Serhiyenko
    INTERNATIONAL NEUROLOGICAL JOURNAL.2025; 21(6): 431.     CrossRef
  • Risk factors of non communicable diseases among recently diagnosed diabetic patients in a tertiary care Hospital
    Yusra Amin, Sonia Mushtaq, Rukhsana Farooq
    Indian Journal of Clinical Anatomy and Physiology.2024; 10(4): 205.     CrossRef
  • Metabolic health tracking using Ultrahuman M1 continuous glucose monitoring platform in non- and pre-diabetic Indians: a multi-armed observational study
    Monik Chaudhry, Mohit Kumar, Vatsal Singhal, Bhuvan Srinivasan
    Scientific Reports.2024;[Epub]     CrossRef
  • Influence of sleep quality and other associated factors on glycemic control among diabetic patients: A hospital-based study
    Sonia Mushtaq, Yusra Amin, Rukhsana Taj, Umara Giyas, Sunil Sachadev
    Indian Journal of Clinical Anatomy and Physiology.2024; 11(1): 32.     CrossRef
  • Interventional effects of Pueraria oral liquid on T2DM rats and metabolomics analysis
    Hong-Bo Yang, Jie-Yu Song, Chan Xu, Jin Li, Chan Zhang, Sun Xie, Chun-li Teng
    Biomedicine & Pharmacotherapy.2024; 175: 116780.     CrossRef
  • Replacing sedentary time with sleep and physical activity: associations with physical function and wellbeing in Type 2 diabetes
    Alix Covenant, Thomas Yates, Alex V. Rowlands, Paddy C. Dempsey, Charlotte L. Edwardson, Andrew P. Hall, Melanie J. Davies, Joseph Henson
    Diabetes Research and Clinical Practice.2024; 217: 111886.     CrossRef
  • Relation between sleep quality and glycemic control among type 2 diabetic patients
    Asmaa Ali Elsayed Ali
    Frontiers of Nursing.2023; 10(1): 115.     CrossRef
  • Heart rate variability in different sleep stages is associated with metabolic function and glycemic control in type 2 diabetes mellitus
    Wenquan Cheng, Hongsen Chen, Leirong Tian, Zhimin Ma, Xingran Cui
    Frontiers in Physiology.2023;[Epub]     CrossRef
  • Association Between Diabetic Retinopathy and Insomnia Risk: A Nationwide Population-Based Study
    Yoo Hyun Um, Tae-Won Kim, Jong-Hyun Jeong, Seung-Chul Hong, Ho-Jun Seo, Kyung-Do Han
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Nutritional Biomarkers and Factors Correlated with Poor Sleep Status among Young Females: A Case-Control Study
    Sara AL-Musharaf, Lama AlAjllan, Ghadeer Aljuraiban, Munirah AlSuhaibani, Noura Alafif, Syed Danish Hussain
    Nutrients.2022; 14(14): 2898.     CrossRef
  • The impact of sleep disorders on microvascular complications in patients with type 2 diabetes (SLEEP T2D): the protocol of a cohort study and feasibility randomised control trial
    Christina Antza, Ryan Ottridge, Smitaa Patel, Gemma Slinn, Sarah Tearne, Matthew Nicholls, Brendan Cooper, Asad Ali, Abd A. Tahrani
    Pilot and Feasibility Studies.2021;[Epub]     CrossRef
  • Early Development of Bidirectional Associations between Sleep Disturbance and Diabetes
    Yongin Cho
    Diabetes & Metabolism Journal.2020; 44(5): 668.     CrossRef
Metabolic Risk/Epidemiology
Association between the Thigh Muscle and Insulin Resistance According to Body Mass Index in Middle-Aged Korean Adults
Ji Eun Heo, Jee-Seon Shim, Hokyou Lee, Hyeon Chang Kim
Diabetes Metab J. 2020;44(3):446-457.   Published online April 16, 2020
DOI: https://doi.org/10.4093/dmj.2019.0110
  • 11,624 View
  • 110 Download
  • 12 Web of Science
  • 13 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

We examined the associations between thigh muscle area (TMA) and insulin resistance (IR) according to body mass index (BMI) in middle-aged Korean general population.

Methods

TMA was measured using quantitative computed tomography and corrected by body weight (TMA/Wt) in 1,263 men, 788 premenopausal women, and 1,476 postmenopausal women all aged 30 to 64 years. The tertiles of TMA/Wt were calculated separately for men and for premenopausal and postmenopausal women. Homeostatic model assessment for insulin resistance (HOMA-IR) was performed using fasting blood glucose and insulin levels, and increased IR was defined according to sex-specific, top quartiles of HOMA-IR. Associations between the TMA/Wt tertiles and increased IR according to the BMI categories (<25 and ≥25 kg/m2) were assessed using multivariable logistic regression analysis.

Results

In men with higher BMIs, but not in those with lower BMIs, the presence of an increased IR had significantly higher odds ratios in the lower TMA/Wt tertiles, even after adjustment for visceral fat area. However, in premenopausal and postmenopausal women, there was no significant inverse association between TMA/Wt tertiles and increased IR, regardless of BMI category.

Conclusion

Our findings suggest that the thigh muscle is inversely associated with IR in men, particularly in those with higher BMIs.

Citations

Citations to this article as recorded by  
  • The dynamics of appendicular muscle mass after strength training with blood flow restriction in individuals with metabolic syndrome
    Vadim Sverchkov, Evgeniy Bykov
    Scientific notes of P. F. Lesgaft University.2025; 0(5): 215.     CrossRef
  • 3D Body Scanning–Derived Normative Values of Appendicular Circumferences: A Novel Tool for Sarcopenia Screening in Chinese Adults
    Huijing He, Qiaolu Cheng, Zhiyue Zhang, Yaoda Hu, Zhiming Lu, Wei Han, Ji Tu, Ang Li, Zhen Song, Yawen Liu, Tan Xu, Qing Chang, Qiong Ou, Hui Pan, Zichao Wang, Guangliang Shan
    Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub]     CrossRef
  • Immune activation induced by dysregulated lipid metabolism in the pathogenesis of type 2 diabetes
    Hao-Yu Yang, Yu Wei, Qin Mao, Lin-Hua Zhao
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • Risk of sleep apnea associated with higher blood pressure among Chinese and Korean Americans
    Brittany N. Morey, Yuxi Shi, Soomin Ryu, Susan Redline, Ichiro Kawachi, Hye Won Park, Sunmin Lee
    Ethnicity & Health.2024; 29(3): 295.     CrossRef
  • Associations of muscle mass, strength, and quality with diabetes and the mediating role of inflammation in two National surveys from China and the United states
    Zhiming Lu, Yaoda Hu, Huijing He, Xingming Chen, Qiong Ou, Yawen Liu, Tan Xu, Ji Tu, Ang Li, Binbin Lin, Qihang Liu, Tianshu Xi, Weihao Wang, Haibo Huang, Da Xu, Zhili Chen, Zichao Wang, Guangliang Shan
    Diabetes Research and Clinical Practice.2024; 214: 111783.     CrossRef
  • The Correlation Between Visceral Fat Area to Skeletal Muscle Mass Ratio and Multiorgan Insulin Resistance in Chinese Population With Obesity
    Yanju Zhang, Meiyang Du, Zhouhuiling Li, Xincheng Wang, Mingxin Leng, Yaping Huang, Libin Li, Shi Zhang, Chunjun Li, Faustino R. Perez-Lopez
    International Journal of Endocrinology.2024;[Epub]     CrossRef
  • Sex-specific equations to estimate body composition: Derivation and validation of diagnostic prediction models using UK Biobank
    Yueqi Lu, Ying Shan, Liang Dai, Xiaosen Jiang, Congying Song, Bangwei Chen, Jingwen Zhang, Jing Li, Yue Zhang, Junjie Xu, Tao Li, Zuying Xiong, Yong Bai, Xiaoyan Huang
    Clinical Nutrition.2023; 42(4): 511.     CrossRef
  • Gender Differences in Relation to Body Composition, Insulin Resistance, and Islet Beta Cell Function in Newly Diagnosed Diabetic or Pre-Diabetic Patients
    Minglei Ma, Tao Jiang, Zhen Wen, Dongxue Zhang, Lei Xiu
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 723.     CrossRef
  • Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus
    Yongin Cho, Hye-Sun Park, Byung Wook Huh, Yong-ho Lee, Seong Ha Seo, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, So Hun Kim
    Diabetes & Metabolism Journal.2023; 47(2): 232.     CrossRef
  • Prospective External Validation of an Algorithm Predicting Hourly Basal Insulin Infusion Rates from Characteristics of Patients with Type 1 Diabetes Treated with Insulin Pumps
    Jana S. Schmelzer, Melanie Kahle-Stephan, Juris J. Meier, Michael A. Nauck
    Experimental and Clinical Endocrinology & Diabetes.2023; 131(10): 539.     CrossRef
  • Establishing reference values for percentage of appendicular skeletal muscle mass and their association with metabolic syndrome in Korean adolescents
    Da Hye Lee, Sung-Chan Kang, Seung-Sik Hwang, Yun Jeong Lee, Hwa Young Kim, Seong Yong Lee, Choong Ho Shin, Jaehyun Kim
    Annals of Pediatric Endocrinology & Metabolism.2023; 28(4): 237.     CrossRef
  • Evaluating Triglyceride and Glucose Index as a Simple and Easy-to-Calculate Marker for All-Cause and Cardiovascular Mortality
    Kyung-Soo Kim, Sangmo Hong, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park
    Journal of General Internal Medicine.2022; 37(16): 4153.     CrossRef
  • Association between Lower-to-Upper Ratio of Appendicular Skeletal Muscle and Metabolic Syndrome
    Hyun Eui Moon, Tae Sic Lee, Tae-Ha Chung
    Journal of Clinical Medicine.2022; 11(21): 6309.     CrossRef
Metabolic Risk/Epidemiology
Article image
A Comparison of Predictive Performances between Old versus New Criteria in a Risk-Based Screening Strategy for Gestational Diabetes Mellitus
Subeen Hong, Seung Mi Lee, Soo Heon Kwak, Byoung Jae Kim, Ja Nam Koo, Ig Hwan Oh, Sohee Oh, Sun Min Kim, Sue Shin, Won Kim, Sae Kyung Joo, Errol R. Norwitz, Souphaphone Louangsenlath, Chan-Wook Park, Jong Kwan Jun, Joong Shin Park
Diabetes Metab J. 2020;44(5):726-736.   Published online April 13, 2020
DOI: https://doi.org/10.4093/dmj.2019.0126
  • 10,800 View
  • 138 Download
  • 11 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

The definition of the high-risk group for gestational diabetes mellitus (GDM) defined by the American College of Obstetricians and Gynecologists was changed from the criteria composed of five historic/demographic factors (old criteria) to the criteria consisting of 11 factors (new criteria) in 2017. To compare the predictive performances between these two sets of criteria.

Methods

This is a secondary analysis of a large prospective cohort study of non-diabetic Korean women with singleton pregnancies designed to examine the risk of GDM in women with nonalcoholic fatty liver disease. Maternal fasting blood was taken at 10 to 14 weeks of gestation and measured for glucose and lipid parameters. GDM was diagnosed by the two-step approach.

Results

Among 820 women, 42 (5.1%) were diagnosed with GDM. Using the old criteria, 29.8% (n=244) of women would have been identified as high risk versus 16.0% (n=131) using the new criteria. Of the 42 women who developed GDM, 45.2% (n=19) would have been mislabeled as not high risk by the old criteria versus 50.0% (n=21) using the new criteria (1-sensitivity, 45.2% vs. 50.0%, P>0.05). Among the 778 patients who did not develop GDM, 28.4% (n=221) would have been identified as high risk using the old criteria versus 14.1% (n=110) using the new criteria (1-specificity, 28.4% vs. 14.1%, P<0.001).

Conclusion

Compared with the old criteria, use of the new criteria would have decreased the number of patients identified as high risk and thus requiring early GDM screening by half (from 244 [29.8%] to 131 [16.0%]).

Citations

Citations to this article as recorded by  
  • Effects of steatotic liver disease and cardiometabolic risk factors in MASLD on adverse pregnancy outcomes
    Shuhan Yang, Huimin Guan, Youxin Wang, Mingyue Wang, Antje Hebestreit, Yuying Wu, Yifan Yang, Lei Yang, Hui Wang
    Metabolism and Target Organ Damage.2025;[Epub]     CrossRef
  • Влияние неалкогольной жировой болезни печени на течение беременности и неонатальные исходы: обзор литературы
    Виталий Анатольевич Резник, Юрий Павлович Успенский, Полина Юрьевна Бухмирова, Александр Александрович Гнутов, Виталий Антонович Добренко
    University therapeutic journal.2025; 7(3): 7.     CrossRef
  • Multi-omics reveals the beneficial effect of Scytosiphon lomentaria fucoidan on glucose and lipid metabolism disorders via regulation of the gut-liver axis in pregnant mice
    Shuangru Tang, Weiyun Zheng, Xiaomeng Ren, Shuang Song, Chunqing Ai
    Food Bioscience.2024; 62: 105436.     CrossRef
  • Predicting the Risk of Insulin-Requiring Gestational Diabetes before Pregnancy: A Model Generated from a Nationwide Population-Based Cohort Study in Korea
    Seung-Hwan Lee, Jin Yu, Kyungdo Han, Seung Woo Lee, Sang Youn You, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
    Endocrinology and Metabolism.2023; 38(1): 129.     CrossRef
  • Metabolic Dysfunction-Associated Fatty Liver Disease and Subsequent Development of Adverse Pregnancy Outcomes
    Seung Mi Lee, Young Mi Jung, Eun Saem Choi, Soo Heon Kwak, Ja Nam Koo, Ig Hwan Oh, Byoung Jae Kim, Sun Min Kim, Sang Youn Kim, Gyoung Min Kim, Sae Kyung Joo, Bo Kyung Koo, Sue Shin, Errol R. Norwitz, Chan-Wook Park, Jong Kwan Jun, Won Kim, Joong Shin Park
    Clinical Gastroenterology and Hepatology.2022; 20(11): 2542.     CrossRef
  • Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods
    Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park
    Clinical and Molecular Hepatology.2022; 28(1): 105.     CrossRef
  • Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
    Seung Mi Lee, Won Kim
    Clinical and Molecular Hepatology.2022; 28(1): 47.     CrossRef
  • Postprandial Free Fatty Acids at Mid-Pregnancy Increase the Risk of Large-for-Gestational-Age Newborns in Women with Gestational Diabetes Mellitus
    So-Yeon Kim, Young Shin Song, Soo-Kyung Kim, Yong-Wook Cho, Kyung-Soo Kim
    Diabetes & Metabolism Journal.2022; 46(1): 140.     CrossRef
  • Effect of Different Types of Diagnostic Criteria for Gestational Diabetes Mellitus on Adverse Neonatal Outcomes: A Systematic Review, Meta-Analysis, and Meta-Regression
    Fahimeh Ramezani Tehrani, Marzieh Saei Ghare Naz, Razieh Bidhendi-Yarandi, Samira Behboudi-Gandevani
    Diabetes & Metabolism Journal.2022; 46(4): 605.     CrossRef
  • Development of early prediction model for pregnancy-associated hypertension with graph-based semi-supervised learning
    Seung Mi Lee, Yonghyun Nam, Eun Saem Choi, Young Mi Jung, Vivek Sriram, Jacob S. Leiby, Ja Nam Koo, Ig Hwan Oh, Byoung Jae Kim, Sun Min Kim, Sang Youn Kim, Gyoung Min Kim, Sae Kyung Joo, Sue Shin, Errol R. Norwitz, Chan-Wook Park, Jong Kwan Jun, Won Kim,
    Scientific Reports.2022;[Epub]     CrossRef
  • The Clinical Characteristics of Gestational Diabetes Mellitus in Korea: A National Health Information Database Study
    Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
    Endocrinology and Metabolism.2021; 36(3): 628.     CrossRef
  • The risk of pregnancy‐associated hypertension in women with nonalcoholic fatty liver disease
    Young Mi Jung, Seung Mi Lee, Subeen Hong, Ja Nam Koo, Ig Hwan Oh, Byoung Jae Kim, Sun Min Kim, Sang Youn Kim, Gyoung Min Kim, Sae Kyung Joo, Sue Shin, Errol R. Norwitz, Chan‐Wook Park, Jong Kwan Jun, Won Kim, Joong Shin Park
    Liver International.2020; 40(10): 2417.     CrossRef
Brief Report
Drug/Regimen
Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
Mi-Jin Kim, Na-young Kim, Yun-A Jung, Seunghyeong Lee, Gwon-Soo Jung, Jung-Guk Kim, In-Kyu Lee, Sungwoo Lee, Yeon-Kyung Choi, Keun-Gyu Park
Diabetes Metab J. 2020;44(1):186-192.   Published online October 31, 2019
DOI: https://doi.org/10.4093/dmj.2018.0271
  • 9,380 View
  • 127 Download
  • 13 Web of Science
  • 13 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   

Renal fibrosis is considered to be the final common outcome of chronic kidney disease. Dipeptidyl peptidase-4 (DPP-4) inhibitors have demonstrated protective effects against diabetic kidney disease. However, the anti-fibrotic effect of evogliptin, a DPP-4 inhibitor, has not been studied. Here, we report the beneficial effects of evogliptin on unilateral ureteral obstruction (UUO)-induced renal fibrosis in mice. Evogliptin attenuated UUO-induced renal atrophy and tubulointerstitial fibrosis. Immunohistochemistry and Western blotting demonstrated that evogliptin treatment inhibits pro-fibrotic gene expressions and extracellular matrix production. In vitro findings showed that the beneficial effects of evogliptin on renal fibrosis are mediated by inhibition of the transforming growth factor-β/Smad3 signaling pathway. The present study demonstrates that evogliptin is protective against UUO-induced renal fibrosis, suggesting that its clinical applications could extend to the treatment of kidney disease of non-diabetic origin.

Citations

Citations to this article as recorded by  
  • Combined Treatment with Evogliptin and Temozolomide Alters miRNA Expression but Shows Limited Additive Effect on Glioma
    Seung Yoon Song, Keun Soo Lee, Jung Eun Lee, Juwon Ahn, Jaejoon Lim, Seung Ho Yang
    International Journal of Molecular Sciences.2025; 26(19): 9508.     CrossRef
  • Gemigliptin Alleviates Succinate Induced Endoplasmic Reticulum Stress and Activation of Hepatic Stellate Cells
    Dinh-Vinh Do, Giang Nguyen, So Young Park, Eun-Hee Cho
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • Design, Optimization, and Biological Evaluation of First-in-Class Triple Inhibitors of SGLT1, SGLT2, and DPP4 for Type 2 Diabetes Mellitus
    Fernando de Souza Gama, Marcos Ferreira, Natanael Dante Segretti, Mariana C. F. C. B. Damião, Cristiano R. W. Guimarães, Alessandra Mascarello, Hatylas Azevedo
    Journal of Medicinal Chemistry.2025; 68(24): 26121.     CrossRef
  • Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis
    Birte Ohm, Isabelle Moneke, Wolfgang Jungraithmayr
    British Journal of Pharmacology.2023; 180(22): 2846.     CrossRef
  • Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition
    Biwei Pei, Na Zhang, Tingting Pang, Gengyun Sun
    Molecular and Cellular Biochemistry.2022; 477(4): 995.     CrossRef
  • Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes
    Yewon Na, Soo Wan Kim, Ie Byung Park, Soo Jung Choi, Seungyoon Nam, Jaehun Jung, Dae Ho Lee
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(11): 3022.     CrossRef
  • Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver Cells
    Hye-Young Seo, So-Hee Lee, Eugene Han, Jae Seok Hwang, Sol Han, Mi Kyung Kim, Byoung Kuk Jang
    International Journal of Molecular Sciences.2022; 23(19): 11636.     CrossRef
  • Optimization and validation of a fluorogenic dipeptidyl peptidase 4 enzymatic assay in human plasma
    Hyunyee Yoon, Su Hee Cho, Yu Rim Seo, Kyung-Sang Yu, Sung Sup Park, Moon Jung Song
    Analytical Biochemistry.2021; 612: 113952.     CrossRef
  • Use of Anti-Diabetic Agents in Non-Diabetic Kidney Disease: From Bench to Bedside
    Sungjin Chung, Gheun-Ho Kim
    Life.2021; 11(5): 389.     CrossRef
  • Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?
    Xin Huang, Yimin Khoong, Chengyao Han, Dai Su, Hao Ma, Shuchen Gu, Qingfeng Li, Tao Zan
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)
    Gyuri Kim, Soo Lim, Hyuk‐Sang Kwon, Ie B. Park, Kyu J. Ahn, Cheol‐Young Park, Su K. Kwon, Hye S. Kim, Seok W. Park, Sin G. Kim, Min K. Moon, Eun S. Kim, Choon H. Chung, Kang S. Park, Mikyung Kim, Dong J. Chung, Chang B. Lee, Tae H. Kim, Moon‐Kyu Lee
    Diabetes, Obesity and Metabolism.2020; 22(9): 1527.     CrossRef
  • Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus


    Eugene Han, Minyoung Lee, Yong-ho Lee, Hye Soon Kim, Byung-wan Lee, Bong-Soo Cha, Eun Seok Kang
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4113.     CrossRef
  • Efficacy and safety of novel dipeptidyl-peptidase-4 inhibitor evogliptin in the management of type 2 diabetes mellitus: A meta-analysis
    Deep Dutta, Saptarshi Bhattacharya, Aishwarya Krishnamurthy, LokeshKumar Sharma, Meha Sharma
    Indian Journal of Endocrinology and Metabolism.2020; 24(5): 434.     CrossRef
Original Articles
Basic Research
Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT
Sundong Lin, Lechu Yu, Yongqing Ni, Lulu He, Xiaolu Weng, Xuemian Lu, Chi Zhang
Diabetes Metab J. 2020;44(1):158-172.   Published online October 28, 2019
DOI: https://doi.org/10.4093/dmj.2018.0235
  • 10,900 View
  • 142 Download
  • 48 Web of Science
  • 46 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Epithelial-to-mesenchymal transition (EMT) is required for renal fibrosis, which is a characteristic of diabetic nephropathy (DN). Our previous study demonstrated that fibroblast growth factor 21 (FGF21) prevented DN associated with the suppressing renal connective tissue growth factor expression, a key marker of renal fibrosis. Therefore, the effects of FGF21 on renal fibrosis in a DN mouse model and the underlying mechanisms were investigated in this study.

Methods

Type 1 diabetes mellitus was induced in C57BL/6J mice by intraperitoneal injections of multiple low doses of streptozotocin. Then, diabetic and non-diabetic mice were treated with or without FGF21 in the presence of pifithrin-α (p53 inhibitor) or 10-[4′-(N,N-Diethylamino)butyl]-2-chlorophenoxazine hydrochloride (10-DEBC) hydrochloride (Akt inhibitor) for 4 months.

Results

DN was diagnosed by renal dysfunction, hypertrophy, tubulointerstitial lesions, and glomerulosclerosis associated with severe fibrosis, all of which were prevented by FGF21. FGF21 also suppressed the diabetes-induced renal EMT in DN mice by negatively regulating transforming growth factor beta (TGF-β)-induced nuclear translocation of Smad2/3, which is required for the transcription of multiple fibrotic genes. The mechanistic studies showed that FGF21 attenuated nuclear translocation of Smad2/3 by inhibiting renal activity of its conjugated protein p53, which carries Smad2/3 into the nucleus. Moreover pifithrin-α inhibited the FGF21-induced preventive effects on the renal EMT and subsequent renal fibrosis in DN mice. In addition, 10-DEBC also blocked FGF21-induced inhibition of renal p53 activity by phosphorylation of mouse double minute-2 homolog (MDM2).

Conclusion

FGF21 prevents renal fibrosis via negative regulation of the TGF-β/Smad2/3-mediated EMT process by activation of the Akt/MDM2/p53 signaling pathway.

Citations

Citations to this article as recorded by  
  • Diabetes and its complications: molecular mechanisms, prevention and treatment
    Lijun Zhao, Jiamin Yuan, Qing Yang, Jing Ma, Fenghao Yang, Yutong Zou, Ke Liu, Fang Liu
    Signal Transduction and Targeted Therapy.2026;[Epub]     CrossRef
  • IL‐15 Links Muscle–Kidney Crosstalk to Preserving Podocyte Mitochondrial Fusion and Attenuating Diabetic Nephropathy
    Yin Li, Jialing Rao, Weiyan Lai, Yuxiang Sun, Hongchun Lin, Jun Zhang, Zengchun Ye, Zhaoyong Hu, Hui Peng
    Journal of Cachexia, Sarcopenia and Muscle.2026;[Epub]     CrossRef
  • Mouse Models of Diabetic Complications: Dissecting Molecular Mechanisms of Disease Progression
    Aejin Lee
    Frontiers in Bioscience-Landmark.2026;[Epub]     CrossRef
  • Elevation of p53 sensitizes obese kidney to adriamycin-induced aberrant lipid homeostasis via repressing HNF4α-mediated FGF21 sensitivity
    Jiahao Li, Yufeng Tang, Guangping Lu, Qingbo Liu, Yuanfang Guo, Jie Wang, Mengjie Xiao, Ting Gao, Xiaohui Zhang, Junlian Gu
    Journal of Advanced Research.2025; 72: 165.     CrossRef
  • RhFGF21 protected PC12 cells against mitochondrial apoptosis triggered by H2O2 via the AKT-mediated ROS signaling pathway
    Jingjing Lin, Junyi Wu, Yifan Xu, Yeli Zhao, Shasha Ye
    Experimental Cell Research.2025; 445(1): 114417.     CrossRef
  • Airway stenosis: classification, pathogenesis, and clinical management
    Pengwei Zhao, Zheng Jiang, Xuexin Li, Mailudan Ainiwaer, Leyu Li, Dejuan Wang, Lixiao Fan, Fei Chen, Jun Liu
    MedComm.2025;[Epub]     CrossRef
  • FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis
    Mada Ghanem, Gabrielle Archer, Aurélien Justet, Madeleine Jaillet, Eirini Vasarmidi, Pierre Mordant, Yves Castier, Hervé Mal, Aurélie Cazes, Nicolas Poté, Bruno Crestani, Arnaud Mailleux
    American Journal of Respiratory and Critical Care Medicine.2025; 211(3): 486.     CrossRef
  • Nucleic acid coated photothermal nanoregulator for multiple therapy of drug-resistant breast cancer
    Yuxin Shen, Yixin Wen, Sen Li, Xuefeng Ding, Yanfei Cai, Jian Jin, Zhaoqi Yang
    International Journal of Biological Macromolecules.2025; 308: 142592.     CrossRef
  • Epithelial–mesenchymal plasticity in kidney fibrosis
    Sudarat Hadpech, Visith Thongboonkerd
    genesis.2024;[Epub]     CrossRef
  • Fibroblast growth factor 21 alleviates unilateral ureteral obstruction-induced renal fibrosis by inhibiting Wnt/β-catenin signaling pathway
    Wenhui Zhong, Yuheng Jiang, Huizhen Wang, Xiang Luo, Tao Zeng, Huimi Huang, Ling Xiao, Nan Jia, Aiqing Li
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119620.     CrossRef
  • MAP3K19 Promotes the Progression of Tuberculosis-Induced Pulmonary Fibrosis Through Activation of the TGF-β/Smad2 Signaling Pathway
    Yu Xia, Haiyue Wang, Meihua Shao, Xuemei Liu, Feng Sun
    Molecular Biotechnology.2024; 66(11): 3300.     CrossRef
  • Platelet concentrates may affect the formation of pathological scars by regulating epithelial to mesenchymal transition
    Ju Tian, Dandan Shi, Chenyan Long, Jing Ding, Huimin You, Xiaoying He, Biao Cheng
    Medical Hypotheses.2024; 182: 111227.     CrossRef
  • Cadherin-responsive hydrogel combined with dental pulp stem cells and fibroblast growth factor 21 promotes diabetic scald repair via regulating epithelial-mesenchymal transition and necroptosis
    Wenjie Lu, Juan Zhao, Xiong Cai, Yutian Wang, Wenwei Lin, Yaoping Fang, Yunyang Wang, Jinglei Ao, Jiahui Shou, Jiake Xu, Sipin Zhu
    Materials Today Bio.2024; 24: 100919.     CrossRef
  • Sodium butyrate ameliorated diabetic nephropathy-associated tubulointerstitial inflammation by modulating the tight junctions of renal tubular epithelial cells
    Tingting Yang, Lin Li, Cai Heng, Pian Sha, Yiying Wang, Jiaming Shen, Zhenzhou Jiang, Sitong Qian, Chujing Wei, Hao Yang, Xia Zhu, Tao Wang, Mengying Wu, Jianyun Wang, Qian Lu, Xiaoxing Yin
    Food & Function.2024; 15(5): 2628.     CrossRef
  • Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease
    Anton I. Korbut, Vyacheslav V. Romanov, Vadim V. Klimontov
    Biomedicines.2024; 12(3): 487.     CrossRef
  • FGF21 Inhibits Hypoxia/Reoxygenation-induced Renal Tubular Epithelial Cell Injury by Regulating the PPARγ/NF-κB Signaling Pathway
    Ruixue Li, Xi Liu
    Cell Biochemistry and Biophysics.2024; 82(2): 909.     CrossRef
  • Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells
    Shivam Rajput, Rishabha Malviya, Prerna Uniyal
    Current Pharmaceutical Design.2024; 30(11): 825.     CrossRef
  • The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
    Mada Ghanem, Gabrielle Archer, Bruno Crestani, Arnaud A. Mailleux
    Pharmacology & Therapeutics.2024; 259: 108669.     CrossRef
  • Gemigliptin mitigates TGF-β-induced renal fibrosis through FGF21-mediated inhibition of the TGF-β/Smad3 signaling pathway
    Jun-Kyu Byun, Gwon-Soo Jung
    Biochemical and Biophysical Research Communications.2024; 733: 150425.     CrossRef
  • Myostatin regulates energy homeostasis through autocrine- and paracrine-mediated microenvironment communication
    Hui Wang, Shanshan Guo, Huanqing Gao, Jiyang Ding, Hongyun Li, Xingyu Kong, Shuang Zhang, Muyang He, Yonghao Feng, Wei Wu, Kexin Xu, Yuxuan Chen, Hanyin Zhang, Tiemin Liu, Xingxing Kong
    Journal of Clinical Investigation.2024;[Epub]     CrossRef
  • The Potential Protective Mechanisms of Exercise-Responsive Molecules in Chronic Kidney Disease
    Jae Seung Chang
    Exercise Science.2024; 33(4): 366.     CrossRef
  • Timosaponin BII inhibits TGF‐β mediated epithelial‐mesenchymal transition through Smad‐dependent pathway during pulmonary fibrosis
    Dali Ding, Xuebin Shen, Lizhen Yu, Yueyue Zheng, Yao Liu, Wei Wang, Li Liu, Zitong Zhao, Sihui Nian, Limin Liu
    Phytotherapy Research.2023; 37(7): 2787.     CrossRef
  • Fibroblast growth factors (FGFs) endocrines et fibrogenèse pulmonaire
    M. Ghanem, A. Mailleux, B. Crestani
    Revue des Maladies Respiratoires.2023; 40(3): 239.     CrossRef
  • Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges
    Fukun Chen, NaNa Chen, Chunjuan Xia, Hongyue Wang, Lishi Shao, Chen Zhou, Jiaping Wang
    Cell Transplantation.2023;[Epub]     CrossRef
  • MicroRNA functional metal-organic framework nanocomposite for efficient inhibition of drug-resistant breast cancer cells
    Yuxin Shen, Yao Zhang, Xiyue Gao, Mengdi Shang, Yanfei Cai, Zhaoqi Yang
    Emergent Materials.2023; 6(5): 1537.     CrossRef
  • Downregulation of a potential therapeutic target NPAS2, regulated by p53, alleviates pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via suppressing HES1
    Yingying Chen, Zhong He, Bo Zhao, Rui Zheng
    Cellular Signalling.2023; 109: 110795.     CrossRef
  • KLF5/MDM2 Axis Modulates Oxidative Stress and Epithelial-Mesenchymal Transition in Human Lens Epithelial Cells: The Role in Diabetic Cataract
    Xiao Li, Doudou Chen, Bowen Ouyang, Shengnan Wang, Yawei Li, Li Li, Siquan Zhu, Guangying Zheng
    Laboratory Investigation.2023; 103(11): 100226.     CrossRef
  • Exploring the pathogenesis of type 2 diabetes mellitus intestinal damp-heat syndrome and the therapeutic effect of Gegen Qinlian Decoction from the perspective of exosomal miRNA
    LiSha He, Tingting Bao, Yingying Yang, Han Wang, Chengjuan Gu, Jia Chen, Tiangang Zhai, Xinhui He, Mengyi Wu, Linhua Zhao, Xiaolin Tong
    Journal of Ethnopharmacology.2022; 285: 114786.     CrossRef
  • Cardamomin protects from diabetes-induced kidney damage through modulating PI3K/AKT and JAK/STAT signaling pathways in rats
    Chan Gao, Xiao Fei, Ming Wang, Qi Chen, Ning Zhao
    International Immunopharmacology.2022; 107: 108610.     CrossRef
  • Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study
    Guihai Wu, Shenglin Wu, Jingyi Yan, Shanshan Gao, Jinxiu Zhu, Minghui Yue, Zexin Li, Xuerui Tan
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
    Min-Qi Jia, Cha-Xiang Guan, Jia-Hao Tao, Yong Zhou, Liang-Jun Yan
    Oxidative Medicine and Cellular Longevity.2022;[Epub]     CrossRef
  • Circ_FOXP1 promotes the growth and survival of high glucose-treated human trophoblast cells through the regulation of miR-508-3p/SMAD family member 2 pathway
    Mingqun Li, Yuqin Huang, Hongli Xi, Wei Zhang, Ziwu Xiang, Lingyun Wang, Xuanyu Li, Hongyan Guo
    Endocrine Journal.2022; 69(9): 1067.     CrossRef
  • Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation, fibrosis and oxidative stress
    Xinghao Jiang, Qing Wu, Yeboah Kwaku Opoku, Yimeng Zou, Dan Wang, Changhui Hu, Guiping Ren
    Basic & Clinical Pharmacology & Toxicology.2022; 131(6): 474.     CrossRef
  • Myokines: Novel therapeutic targets for diabetic nephropathy
    Ming Yang, Shilu Luo, Jinfei Yang, Wei Chen, Liyu He, Di Liu, Li Zhao, Xi Wang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk
    Songling Jiang, Dal-Seok Oh, Debra Dorotea, Eunjung Son, Dong-Seon Kim, Hunjoo Ha
    Phytomedicine.2021; 80: 153393.     CrossRef
  • Chromatin accessibility of kidney tubular cells under stress reveals key transcription factor mediating acute and chronic kidney disease
    Yuexian Xing, Qi Wang, Jing Zhang, Wenju Li, Aiping Duan, Jingping Yang, Zhihong Liu
    The FEBS Journal.2021; 288(18): 5446.     CrossRef
  • Small molecules against the origin and activation of myofibroblast for renal interstitial fibrosis therapy
    Ya-long Feng, Wen-bo Wang, Yue Ning, Hua Chen, Pei Liu
    Biomedicine & Pharmacotherapy.2021; 139: 111386.     CrossRef
  • FGF21 prevents low-protein diet-induced renal inflammation in aged mice
    Han Fang, Sujoy Ghosh, Landon C. Sims, Kirsten P. Stone, Cristal M. Hill, Denisha Spires, Daria V. Ilatovskaya, Christopher D. Morrison, Thomas W. Gettys, Krisztian Stadler
    American Journal of Physiology-Renal Physiology.2021; 321(3): F356.     CrossRef
  • IFN-α-2b Inhibits the Proliferation and Migration of Fibroblasts via the TGFβ/Smad Signaling Pathway to Reduce Postoperative Epidural Fibrosis
    Zhendong Liu, Hui Chen, Zhehao Fan, Jihang Dai, Yu Sun, Lianqi Yan, Rui Wang, Xiaolei Li, Jingcheng Wang
    Journal of Interferon & Cytokine Research.2021; 41(8): 271.     CrossRef
  • FOXN3 inhibits cell proliferation and invasion via modulating the AKT/MDM2/p53 axis in human glioma
    Chaojia Wang, Hanjun Tu, Ling Yang, Chunming Ma, Juntao Hu, Jie Luo, Hui Wang
    Aging.2021; 13(17): 21587.     CrossRef
  • Regulation and Potential Biological Role of Fibroblast Growth Factor 21 in Chronic Kidney Disease
    Xue Zhou, Yuefeng Zhang, Ning Wang
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
    Junyu Deng, Ye Liu, Yiqiu Liu, Wei Li, Xuqiang Nie
    Journal of Inflammation Research.2021; Volume 14: 5273.     CrossRef
  • Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction
    Yixuan Ma, Yixin Kuang, Wenyan Bo, Qiaoqin Liang, Wenfei Zhu, Mengxin Cai, Zhenjun Tian
    International Journal of Molecular Sciences.2021; 22(22): 12341.     CrossRef
  • Snai1-induced partial epithelial–mesenchymal transition orchestrates p53–p21-mediated G2/M arrest in the progression of renal fibrosis via NF-κB-mediated inflammation
    Ruochen Qi, Jiyan Wang, Yamei Jiang, Yue Qiu, Ming Xu, Ruiming Rong, Tongyu Zhu
    Cell Death & Disease.2021;[Epub]     CrossRef
  • Destruction of the blood-retina barrier in diabetic retinopathy depends on angiotensin-converting enzyme-mediated TGF-β1/Smad signaling pathway activation
    Ping Sun, Ning Xu, Yan Li, Yang Han
    International Immunopharmacology.2020; 85: 106686.     CrossRef
  • Chrysophanol Inhibits the Progression of Diabetic Nephropathy via Inactivation of TGF-β Pathway


    Chuan Guo, Yarong Wang, Yuanlin Piao, Xiangrong Rao, Dehai Yin
    Drug Design, Development and Therapy.2020; Volume 14: 4951.     CrossRef
Technology/Device
Role of MicroRNA-34a in Anti-Apoptotic Effects of Granulocyte-Colony Stimulating Factor in Diabetic Cardiomyopathy
In-Hwa Park, Yi-Sun Song, Hyun-Woo Joo, Guang-Yin Shen, Jin-Hee Seong, Na-Kyoung Shin, Young Jong Cho, Yonggu Lee, Jeong Hun Shin, Young-Hyo Lim, Hyuck Kim, Kyung-Soo Kim
Diabetes Metab J. 2020;44(1):173-185.   Published online April 23, 2019
DOI: https://doi.org/10.4093/dmj.2018.0211
  • 9,359 View
  • 89 Download
  • 17 Web of Science
  • 15 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Recent studies have shown that microRNAs (miRNAs) are involved in the process of cardiomyocyte apoptosis. We have previously reported that granulocyte-colony stimulating factor (G-CSF) ameliorated diastolic dysfunction and attenuated cardiomyocyte apoptosis in a rat model of diabetic cardiomyopathy. In this study, we hypothesized a regulatory role of cardiac miRNAs in the mechanism of the anti-apoptotic effect of G-CSF in a diabetic cardiomyopathy rat model.

Methods

Rats were given a high-fat diet and low-dose streptozotocin injection and then randomly allocated to receive treatment with either G-CSF or saline. H9c2 rat cardiomyocytes were cultured under a high glucose (HG) condition to induce diabetic cardiomyopathy in vitro. We examined the extent of apoptosis, miRNA expression, and miRNA target genes in the myocardium and H9c2 cells.

Results

G-CSF treatment significantly decreased apoptosis and reduced miR-34a expression in diabetic myocardium and H9c2 cells under the HG condition. G-CSF treatment also significantly increased B-cell lymphoma 2 (Bcl-2) protein expression as a target for miR-34a. In addition, transfection with an miR-34a mimic significantly increased apoptosis and decreased Bcl-2 luciferase activity in H9c2 cells.

Conclusion

Our results indicate that G-CSF might have an anti-apoptotic effect through down-regulation of miR-34a in a diabetic cardiomyopathy rat model.

Citations

Citations to this article as recorded by  
  • Targeting mitochondrial microRNAs in cardiovascular pathologies: A new frontier in precision cardiology
    Satinder Kaur, Gurjit Kaur Bhatti, Naina Khullar, Jasvinder Singh Bhatti
    Ageing Research Reviews.2026; 113: 102920.     CrossRef
  • Non-coding RNA as a key regulator and novel target of apoptosis in diabetic cardiomyopathy: Current status and future prospects
    Yicheng Liu, Jie Yuan, Yuhang Zhang, Ting Ma, Qianqian Ji, Sheng Tian, Chunxiao Liu
    Cellular Signalling.2025; 128: 111632.     CrossRef
  • A Combined Therapy of Pegylated G-CSF with Ciprofloxacin Mitigates Damage Induced by Lethal Ionizing Radiation to the Bone Marrow, Spleen, and Ileum by Increasing AKT Activation but Decreasing IL-18, C3, and miR-34a
    Juliann G. Kiang, Georgetta Cannon, Min Zhai, Matthew G. Olson, Akeylah K. Woods, Katherine S. Cleveland, Hengying Ellery, Feng Xu, Mang Xiao
    Radiation Research.2025;[Epub]     CrossRef
  • From Type 2 Diabetes Mellitus To Diabetic Cardiomyopathy – A Systematic Review On The Role Of MicroRNA
    Anna Żarek-Starzewska, Dominika Klimczak-Tomaniak, Amelia Mądrecka, Grażyna Sygitowicz, Maciej Janiszewski, Marek Kuch
    Current Diabetes Reports.2025;[Epub]     CrossRef
  • The study of the mechanism of non-coding RNA regulation of programmed cell death in diabetic cardiomyopathy
    Bingrui Zhang, Hua Wu, Jingwen Zhang, Cong Cong, Lin Zhang
    Molecular and Cellular Biochemistry.2024; 479(7): 1673.     CrossRef
  • Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
    Elisabeth A. Jalink, Amber W. Schonk, Reinier A. Boon, Rio P. Juni
    Frontiers in Cardiovascular Medicine.2024;[Epub]     CrossRef
  • The interregulatory circuit between non-coding RNA and apoptotic signaling in diabetic cardiomyopathy
    Hao Wu, Yan Liu, Chunli Liu
    Non-coding RNA Research.2024; 9(4): 1080.     CrossRef
  • Dynamic interplay of microRNA in diseases and therapeutic
    Neha Kargutkar, Priya Hariharan, Anita Nadkarni
    Clinical Genetics.2023; 103(3): 268.     CrossRef
  • LGR5+ Intestinal Stem Cells Display Sex-Dependent Radiosensitivity
    Ryan C. Zitter, Rishi Man Chugh, Payel Bhanja, Bruce F. Kimler, Subhrajit Saha
    Cells.2023; 13(1): 46.     CrossRef
  • Female Mice are More Resistant to the Mixed-Field (67% Neutron + 33% Gamma) Radiation-Induced Injury in Bone Marrow and Small Intestine than Male Mice due to Sustained Increases in G-CSF and the Bcl-2/Bax Ratio and Lower miR-34a and MAPK Activation
    Juliann G. Kiang, Georgetta Cannon, Matthew G. Olson, Joan T. Smith, Marsha N. Anderson, Min Zhai, M. Victoria Umali, Kevin Ho, Connie Ho, Wanchang Cui, Mang Xiao
    Radiation Research.2022;[Epub]     CrossRef
  • Potential Role of Natural Plant Medicine Cyclocarya paliurus in the Treatment of Type 2 Diabetes Mellitus
    Han Wang, Cheng Tang, Zezheng Gao, Yishan Huang, Boxun Zhang, Jiahua Wei, Linhua Zhao, Xiaolin Tong, Yong Xu
    Journal of Diabetes Research.2021; 2021: 1.     CrossRef
  • Ghrelin, a novel therapy, corrects cytokine and NF-κB-AKT-MAPK network and mitigates intestinal injury induced by combined radiation and skin-wound trauma
    Juliann G. Kiang, Joan T. Smith, Georgetta Cannon, Marsha N. Anderson, Connie Ho, Min Zhai, Wanchang Cui, Mang Xiao
    Cell & Bioscience.2020;[Epub]     CrossRef
  • Evaluation of biomarkers in liver following Solanum melongena green calyx administration in diabetic rats
    Shiva Roshankhah, Ahmad Shabanizadeh, Amir Abdolmaleki, Mohammad Reza Gholami, Mohammad Reza Salahshoor
    Journal of Diabetes & Metabolic Disorders.2020; 19(2): 1115.     CrossRef
  • Diabetic cardiomyopathy: definition, diagnosis criteria, treatment directions and prevention of heart failure
    N. A. Koziolova, P. G. Karavaev, A. S. Veklich
    South Russian Journal of Therapeutic Practice.2020; 1(2): 93.     CrossRef
  • The Potential Role of MicroRNA in Diabetic Cardiomyopathy
    Jin Hwa Kim
    Diabetes & Metabolism Journal.2020; 44(1): 54.     CrossRef
Obesity and Metabolic Syndrome
The Risk of Myocardial Infarction and Ischemic Stroke According to Waist Circumference in 21,749,261 Korean Adults: A Nationwide Population-Based Study
Jung-Hwan Cho, Eun-Jung Rhee, Se-Eun Park, Hyemi Kwon, Jin-Hyung Jung, Kyung-Do Han, Yong-Gyu Park, Hye Soon Park, Yang-Hyun Kim, Soon-Jib Yoo, Won-Young Lee
Diabetes Metab J. 2019;43(2):206-221.   Published online December 27, 2018
DOI: https://doi.org/10.4093/dmj.2018.0039
  • 10,385 View
  • 122 Download
  • 44 Web of Science
  • 46 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Waist circumference (WC) is a well-known obesity index that predicts cardiovascular disease (CVD). We studied the relationship between baseline WC and development of incident myocardial infarction (MI) and ischemic stroke (IS) using a nationwide population-based cohort, and evaluated if its predictability is better than body mass index (BMI).

Methods

Our study included 21,749,261 Koreans over 20 years of age who underwent the Korean National Health Screening between 2009 and 2012. The occurrence of MI or IS was investigated until the end of 2015 using National Health Insurance Service data.

Results

A total of 127,289 and 181,637 subjects were newly diagnosed with MI and IS. The incidence rate and hazard ratio of MI and IS increased linearly as the WC level increased, regardless of adjustment for BMI. When the analyses were performed according to 11 groups of WC, the lowest risk of MI was found in subjects with WC of 70 to 74.9 and 65 to 69.9 cm in male and female, and the lowest risk of IS in subjects with WC of 65 to 69.9 and 60 to 64.9 cm in male and female, respectively. WC showed a better ability to predict CVD than BMI with smaller Akaike information criterion. The optimal WC cutoffs were 84/78 cm for male/female for predicting MI, and 85/78 cm for male/female for predicting IS.

Conclusion

WC had a significant linear relationship with the risk of MI and IS and the risk began to increase from a WC that was lower than expected.

Citations

Citations to this article as recorded by  
  • Joint effects of waist circumference trajectories and aging with risk of heart disease
    Xiaodi Tang, Rong He, Ping Zhang
    BMC Cardiovascular Disorders.2026;[Epub]     CrossRef
  • Waist circumference trajectory and its association with cardiovascular disease in patients with hypertension: A retrospective primary-care cohort study
    Zhen Liu, Xinfeng Zhang, Hongbin Xu
    Nutrition, Metabolism and Cardiovascular Diseases.2026; : 104605.     CrossRef
  • Epidemiology and characteristics of obesity in Koreans based on the 2024 Obesity Fact Sheet
    Eun-Jung Rhee
    Journal of the Korean Medical Association.2026; 69(1): 4.     CrossRef
  • Positive correlation between n−6 : n−3 PUFA ratio intake with serum oxHDL/HDL-c ratio in patients with coronary artery disease
    Sissi Godinez-Mora, Wendy Campos-Perez, Mariana Perez-Robles, Cesar Robles-Jimarez, Alejandra Muñoz-Hernandez, Joel Torres-Vanegas, Erika Martinez-Lopez
    Coronary Artery Disease.2025; 36(3): 190.     CrossRef
  • General obesity, abdominal obesity, and the risk of cardiovascular disease including stroke in 5-year breast cancer survivors
    Ji Soo Kim, Jihun Song, Seulggie Choi, Sang Min Park
    The Breast.2025; 79: 103857.     CrossRef
  • Morbidity and Mortality Risk Among People With HIV and Central or Visceral Adiposity: A Targeted Literature Review
    Alison M Bjornson, Roger J Bedimo, Shelagh M Szabo, Hannah Rochon, Daniel Lee
    Clinical Infectious Diseases.2025; 80(6): 1306.     CrossRef
  • Associations of waist circumference and BMI with the trajectory of cardiometabolic multimorbidity in hypertensive patients: A multi-state model
    Lisha Xu, Jie Qiu, Peng Shen, Yixing Wang, Yonghao Wu, Jingjing Hu, Zongming Yang, Zhanghang Zhu, Hongbo Lin, Liming Shui, Zhiqin Jiang, Mengling Tang, Mingjuan Jin, Feng Tong, Kun Chen, Jianbing Wang
    Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(5): 103851.     CrossRef
  • Lifestyle risk factors and stroke: findings from the national health and nutrition examination survey (1999–2020) and a Mendelian randomization analysis
    Xiaomin Feng, Zhangping He, Zuoyu Qin, Jing Lu, Chao Qin, Yanyan Tang
    Neurological Research.2025; 47(7): 582.     CrossRef
  • Hypertension mediates the association between weight-adjusted waist index and new onset stroke risk in middle-aged and older Chinese adults: evidence from the CHARLS study
    Fei Xu, Hongwei Liu, Meng Li, Minheng Zhang, Xuan Chen, Miaomiao Hou
    Frontiers in Neurology.2025;[Epub]     CrossRef
  • Exploring the link between A Body Shape Index and abdominal aortic calcification in chronic kidney disease: a cross-sectional analysis from 2013–2014 National Health and Nutrition Examination Survey
    Yang Li, Kun Zou, Yixuan Wang, Yucheng Zhang, Jingtao Zhong, Wu Zhou, Fang Tang, Lu Peng, Xusheng Liu, Lili Deng
    Renal Failure.2025;[Epub]     CrossRef
  • Multimodal machine learning-based marker enables the link between obesity-related indices and future stroke: a prospective cohort study
    Beilei Hu, Xuan Chen, Tingyang Chen, Tong Xu, Yungang Cao, Jing Sun, Xuanyu Chen, Songfang Chen, Keyang Chen
    eClinicalMedicine.2025; 85: 103331.     CrossRef
  • Levelling the field? A cross-sectional study exploring potentially equigenic effects of green space on socioeconomic inequalities in adult body mass index
    Tanya Pritchard, Thomas Astell-Burt, Brenda Lin, Belinda Parmenter, Lennert Veerman, Xiaoqi Feng
    Urban Forestry & Urban Greening.2025; 112: 128984.     CrossRef
  • Association between delayed statin initiation after high LDL-cholesterol detection and cardiovascular risk in general health screening examinees
    Jinsun Lee, Min Woo Kang, Jae-ik Oh, Minsang Kim, Jung Hun Koh, Eunjeong Kang, Jeong Min Cho, Semin Cho, Seong Geun Kim, Soojin Lee, Yaerim Kim, Sehyun Jung, Hyeok Huh, Dong Ki Kim, Kyungdo Han, Sehoon Park
    European Heart Journal - Quality of Care and Clinical Outcomes.2025; 11(8): 1377.     CrossRef
  • Dynamic waist circumference change: A superior predictor of incident stroke compared to novel and traditional obesity indices
    Huizhen Liu, Ting Wang, Xiaoqin Zhou, Deying Kang
    Journal of Stroke and Cerebrovascular Diseases.2025; 34(12): 108496.     CrossRef
  • Cross sectional analysis of the association between extreme climate events and stroke incidence in middle aged and older Chinese adults
    Xia Jiang, Shixuan Chen, Wenci Chen, Pingping Ruan, Jing Ji
    Scientific Reports.2025;[Epub]     CrossRef
  • Association between the cumulative estimated glucose disposal rate and incident stroke in adults aged 50 and above without diabetes: a prospective nationwide cohort study in China
    Ran Yan, Yawen Yin, Yizhen Hu, Juxiang Yang, Jindong Chang, Yi Wang, Gang Song
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese
    Yurie Yamazaki, Kazuya Fujihara, Takaaki Sato, Mayuko Harada Yamada, Yuta Yaguchi, Yasuhiro Matsubayashi, Takaho Yamada, Satoru Kodama, Kiminori Kato, Hitoshi Shimano, Hirohito Sone
    Journal of Atherosclerosis and Thrombosis.2024; 31(4): 382.     CrossRef
  • Association between body composition and subsequent cardiovascular diseases among 5-year breast cancer survivors
    Ji Soo Kim, Jihun Song, Seulggie Choi, Sung Min Kim, Young Jun Park, Sun Jae Park, Yoosun Cho, Yun Hwan Oh, Seogsong Jeong, Kyae Hyung Kim, Sang Min Park
    Nutrition, Metabolism and Cardiovascular Diseases.2024;[Epub]     CrossRef
  • Association between physical activity changes and incident myocardial infarction after ischemic stroke: a nationwide population-based study
    Dae Young Cheon, Kyung do Han, Yeon Jung Lee, Jeen Hwa Lee, Myung Soo Park, Do Young Kim, Jae Hyuk Choi, Sook Jin Lee, Kyung-Ho Yu, Seongwoo Han, Sunki Lee, Minwoo Lee
    BMC Public Health.2024;[Epub]     CrossRef
  • Conventional and genetic associations of BMI with major vascular and non-vascular disease incidence and mortality in a relatively lean Chinese population: U-shaped relationship revisited
    Andri Iona, Fiona Bragg, Zammy Fairhurst-Hunter, Iona Y Millwood, Neil Wright, Kuang Lin, Ling Yang, Huaidong Du, Yiping Chen, Pei Pei, Liang Cheng, Dan Schmidt, Daniel Avery, Canqing Yu, Jun Lv, Robert Clarke, Robin Walters, Liming Li, Sarah Parish, Zhen
    International Journal of Epidemiology.2024;[Epub]     CrossRef
  • Association Between Overweight/Obesity Metabolic Phenotypes Defined by Two Criteria of Metabolic Abnormality and Cardiovascular Diseases: A Cross‐Sectional Analysis in a Chinese Population
    Yue Qiu, Shujin Fan, Jing Liu, Xiaodan He, Tianxin Zhu, Li Yan, Meng Ren
    Clinical Cardiology.2024;[Epub]     CrossRef
  • Sex-differential effect of waist circumference on new-onset cerebral infarction: a nationwide cohort study
    Sang Min Lee, Minha Hong, Jae-Hong Ryoo
    Frontiers in Neurology.2024;[Epub]     CrossRef
  • Metabolic Syndrome in Non-diabetic Stroke Patients
    Ahmed Wahab, Jamil Muqtadir, Abdul R Ansari , Muhammad Tahseen, Kashif Ayoob, Syed Haris M Zaidi, Arhama S Muhammad, Aisha Khan, Sehar Ahmed
    Cureus.2024;[Epub]     CrossRef
  • Association between weight-adjusted waist circumference index and myocardial infarction: results from the national health and nutrition examination survey, 1999–2014
    Jian-hong Yu, Ming-gang Yin
    Frontiers in Cardiovascular Medicine.2024;[Epub]     CrossRef
  • 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association
    Cheryl Bushnell, Walter N. Kernan, Anjail Z. Sharrief, Seemant Chaturvedi, John W. Cole, William K. Cornwell, Christine Cosby-Gaither, Sarah Doyle, Larry B. Goldstein, Olive Lennon, Deborah A. Levine, Mary Love, Eliza Miller, Mai Nguyen-Huynh, Jennifer Ra
    Stroke.2024;[Epub]     CrossRef
  • Body mass index, waist circumference and cardiovascular diseases in transitional ages (40 and 66 years)
    Jung Eun Yoo, Kyungdo Han, Jin‐Hyung Jung, Yang‐Im Hur, Yang Hyun Kim, Eun Sook Kim, Jang Won Son, Eun‐Jung Rhee, Won‐Young Lee, Ga Eun Nam
    Journal of Cachexia, Sarcopenia and Muscle.2023; 14(1): 369.     CrossRef
  • Risk factors for stroke among anthropometric indices and lipid profiles in the Korean population: a large-scale cross-sectional study
    Mi Hong Yim, Young Ju Jeon, Bum Ju Lee
    Scientific Reports.2023;[Epub]     CrossRef
  • Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
    Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
  • Research on obesity using the National Health Information Database: recent trends
    Eun-Jung Rhee
    Cardiovascular Prevention and Pharmacotherapy.2023; 5(2): 35.     CrossRef
  • Association between the weight-adjusted waist index and stroke: a cross-sectional study
    Jiayi Ye, Yanjie Hu, Xinrong Chen, Zhe Yin, Xingzhu Yuan, Liping Huang, Ka Li
    BMC Public Health.2023;[Epub]     CrossRef
  • Increased risk of ischemic stroke associated with elevated gamma-glutamyl transferase level in adult cancer survivors: a population-based cohort study
    Kyuwoong Kim, Hyeyun Jung, Edvige Di Giovanna, Tae Joon Jun, Young-Hak Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • Changes in body composition and subsequent cardiovascular disease risk among 5-year breast cancer survivors
    Ji Soo Kim, Jihun Song, Seulggie Choi, Sang Min Park
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Association between Stroke and Abdominal Obesity in the Middle-Aged and Elderly Korean Population: KNHANES Data from 2011–2019
    Jong Yeon Kim, Sung Min Cho, Youngmin Yoo, Taesic Lee, Jong Koo Kim
    International Journal of Environmental Research and Public Health.2022; 19(10): 6140.     CrossRef
  • Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort
    Nathalia Garrido-Torres, Miguel Ruiz-Veguilla, Luis Alameda, Manuel Canal-Rivero, María Juncal Ruiz, Marcos Gómez-Revuelta, Rosa Ayesa-Arriola, Ana Rubio-García, Benedicto Crespo-Facorro, Javier Vázquez-Bourgon
    Schizophrenia Research.2022; 246: 277.     CrossRef
  • Development and validation of risk prediction models for stroke and mortality among patients with type 2 diabetes in northern China
    X. Shao, H. Liu, F. Hou, Y. Bai, Z. Cui, Y. Lin, X. Jiang, P. Bai, Y. Wang, Y. Zhang, C. Lu, H. Liu, S. Zhou, P. Yu
    Journal of Endocrinological Investigation.2022; 46(2): 271.     CrossRef
  • Neck circumference for predicting the occurrence of future cardiovascular events: A 7.6-year longitudinal study
    Tingting Hu, Yun Shen, Weijie Cao, Yiting Xu, Yufei Wang, Xiaojing Ma, Yuqian Bao
    Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(12): 2830.     CrossRef
  • A prospective study of waist circumference trajectories and incident cardiovascular disease in China: the Kailuan Cohort Study
    Liang Wang, Yujin Lee, Yuntao Wu, Xinyuan Zhang, Cheng Jin, Zhe Huang, Yixin Wang, Zhiyi Wang, Penny Kris-Etherton, Shouling Wu, Xiang Gao
    The American Journal of Clinical Nutrition.2021; 113(2): 338.     CrossRef
  • The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study
    Chang-Hoon Lee, Kyung-Do Han, Da Hye Kim, Min-Sun Kwak
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Obesity Degree and Glycemic Status: Factors That Should Be Considered in Heart Failure
    Hye Soon Kim
    Diabetes & Metabolism Journal.2020; 44(4): 529.     CrossRef
  • Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study
    Eun Young Lee, Kyungdo Han, Da Hye Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Mee Kyoung Kim, Seung-Hwan Lee
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Predicting the Development of Myocardial Infarction in Middle-Aged Adults with Type 2 Diabetes: A Risk Model Generated from a Nationwide Population-Based Cohort Study in Korea
    Seung-Hwan Lee, Kyungdo Han, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
    Endocrinology and Metabolism.2020; 35(3): 636.     CrossRef
  • Obesity Fact Sheet in Korea, 2018: Data Focusing on Waist Circumference and Obesity-Related Comorbidities
    Ga Eun Nam, Yang-Hyun Kim, Kyungdo Han, Jin-Hyung Jung, Yong Gyu Park, Kwan-Woo Lee, Eun-Jung Rhee, Jang Won Son, Seong-Su Lee, Hyuk-Sang Kwon, Won-Young Lee, Soon Jib Yoo
    Journal of Obesity & Metabolic Syndrome.2019; 28(4): 236.     CrossRef
  • Simply the Best: Anthropometric Indices for Predicting Cardiovascular Disease
    Jie-Eun Lee
    Diabetes & Metabolism Journal.2019; 43(2): 156.     CrossRef
  • Association and Interaction Analysis of Lipid Accumulation Product with Impaired Fasting Glucose Risk: A Cross-Sectional Survey
    Jian Song, Xue Chen, Yuhong Jiang, Jing Mi, Yuyuan Zhang, Yingying Zhao, Xuesen Wu, Huaiquan Gao
    Journal of Diabetes Research.2019; 2019: 1.     CrossRef
  • Letter: Association of Z-Score of the Log-Transformed A Body Shape Index with Cardiovascular Disease in People Who Are Obese but Metabolically Healthy: The Korea National Health and Nutrition Examination Survey 2007-2010 (J Obes Metab Syndr 2018;27:158-65
    Eun-Jung Rhee
    Journal of Obesity & Metabolic Syndrome.2019; 28(2): 139.     CrossRef
  • Response: The Differential Association between Muscle Strength and Diabetes Mellitus According to the Presence or Absence of Obesity (J Obes Metab Syndr 2019;28:46-52)
    Bo Kyung Koo
    Journal of Obesity & Metabolic Syndrome.2019; 28(4): 297.     CrossRef
Reviews
Complications
Pathophysiology of Diabetic Retinopathy: The Old and the New
Sentaro Kusuhara, Yoko Fukushima, Shuntaro Ogura, Naomi Inoue, Akiyoshi Uemura
Diabetes Metab J. 2018;42(5):364-376.   Published online October 22, 2018
DOI: https://doi.org/10.4093/dmj.2018.0182
  • 49,018 View
  • 1,492 Download
  • 175 Web of Science
  • 180 Crossref
AbstractAbstract PDFPubReader   ePub   

Vision loss in diabetic retinopathy (DR) is ascribed primarily to retinal vascular abnormalities—including hyperpermeability, hypoperfusion, and neoangiogenesis—that eventually lead to anatomical and functional alterations in retinal neurons and glial cells. Recent advances in retinal imaging systems using optical coherence tomography technologies and pharmacological treatments using anti-vascular endothelial growth factor drugs and corticosteroids have revolutionized the clinical management of DR. However, the cellular and molecular mechanisms underlying the pathophysiology of DR are not fully determined, largely because hyperglycemic animal models only reproduce limited aspects of subclinical and early DR. Conversely, non-diabetic mouse models that represent the hallmark vascular disorders in DR, such as pericyte deficiency and retinal ischemia, have provided clues toward an understanding of the sequential events that are responsible for vision-impairing conditions. In this review, we summarize the clinical manifestations and treatment modalities of DR, discuss current and emerging concepts with regard to the pathophysiology of DR, and introduce perspectives on the development of new drugs, emphasizing the breakdown of the blood-retina barrier and retinal neovascularization.

Citations

Citations to this article as recorded by  
  • Yellow lupine extract modulates diabetes-induced extracellular matrix changes in ocular tissue
    Maha Sayari, Kais Abderrahim, Abdelmajid Khabir, Houcine Dab
    Proceedings of the Indian National Science Academy.2026; 92(1): 340.     CrossRef
  • Emerging innovations in ophthalmic drug delivery for diabetic retinopathy: a translational perspective
    Souvik Adak, Vaishnavi Suresh Jadhav, Dharmendra Kumar Khatri
    Drug Delivery and Translational Research.2026; 16(4): 1064.     CrossRef
  • Choroidal vascularity index as a marker of health and disease: systematic review and meta-analyses
    Nicholas Chieh Loh, William Rojas-Carabali, Yuan Heng Lim, Jo Earn Bong, Valeria Villabona-Martinez, Carlos Cifuentes-González, Meenakshi Kumar, Srinivas Sadda, Leopold Schmetterer, Chui Ming Gemmy Cheung, Vishali Gupta, Dilraj S. Grewal, Sharon Fekrat, A
    Survey of Ophthalmology.2026; 71(1): 35.     CrossRef
  • Core-shell nanotherapeutics for diabetic cataract and retinopathy: current state-of-the-art and translational challenges
    Gitika Kumari, Sourabh Kundu, Paras Famta, Krishna K. Kalahasti, Saurabh Srivastava, Geereddy Bhanuprakash Reddy, Dadi A. Srinivasarao
    Drug Delivery and Translational Research.2026; 16(4): 1188.     CrossRef
  • Predicting intravitreal treatment response using ultrawide-field angiographic biomarkers in diabetic retinopathy
    Karthik Reddy, Callie Deng, Boonkit Purt, Yue Liang, Nikhil Bommakanti, Gina Yu, Julie Rosenthal, Yannis M. Paulus
    Advances in Ophthalmology Practice and Research.2026; 6(1): 20.     CrossRef
  • The role of blood pressure stability in diabetic retinopathy development
    Chin-Chih Shih, Ling-Na Shih, Hung-An Lin, Yi-Ting Hsieh
    Eye.2026; 40(2): 245.     CrossRef
  • Phase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedema
    Zilin Wang, Junran Sun, Kun Liu, Liming Tao, Qinghuai Liu, Miaoqin Wu, Shujie Lu, Junjie Deng, Li Li, Lei Qian, Xiaorong Li, Xiaodong Sun
    BMJ Open Ophthalmology.2026; 11(1): e002035.     CrossRef
  • Non-neuronal cell microenvironment control retinal vascular remodeling by CST3 in the oxygen-induced retinopathy in mice
    Ming-yan Du, Chao Qu, Tu-jing Zhao, Yan-hui Deng, Lin Ye, Hua-ping Tian, Run-ze Li, Zheng Li, Hao-jue Xu, Jie Li, Liang Zhou, Yi Shi, Lu-lin Huang
    Experimental Eye Research.2026; 264: 110860.     CrossRef
  • αA-Crystallin Attenuates Retinal Ischemia-Reperfusion Injury
    Huihang Wang, Yihua Zhu
    Current Eye Research.2026; : 1.     CrossRef
  • Erythrocyte deformability correlates with microvascular ischemia and disease severity in diabetic retinopathy
    Ye Eun Han, Joon Seo Lim, Yulim Kim, Inhye Kim, Jun Sung Moon, Junyeop Lee
    Journal of Diabetes Investigation.2026; 17(3): 483.     CrossRef
  • Ocular Complications Associated with GLP1 Agonist Therapy
    Jimmy J. Thomas, Nidhi Mathews
    Open Journal of Internal Medicine.2026; 16(01): 21.     CrossRef
  • Towards trustworthy digital health: reliability of uncertainty-aware convolutional neural networks
    Luigi Di Biasi, Fabiola De Marco, Matteo Ruggiero, Alessia Auriemma Citarella, Genoveffa Tortora
    PeerJ Computer Science.2026; 12: e3414.     CrossRef
  • Evaluation of EB-203 as a potential treatment for non-proliferative diabetic retinopathy using a zebrafish model
    Yujin Lee, Jaewook Yang
    Biomedicine & Pharmacotherapy.2026; 196: 119035.     CrossRef
  • NOP14 promotes proliferative diabetic retinopathy through ribosome biogenesis and endothelial dysfunction via Wnt/β-catenin signaling activation
    Yanhui Lin, Wenjie Li, Zhigang Fei, Kun Xiong, Yanbing Wang, Yezhen Yang, Sha Ouyang, Yi-ni Yang, Yu Liu
    Experimental Cell Research.2026; 457(1): 114922.     CrossRef
  • Expanding the horizon of oculomics: A narrative review on the emerging roles of the anterior segment and mobile health
    Jaemyoung Sung, Akie Midorikawa-Inomata, Kenta Fujio, Takenori Inomata
    Survey of Ophthalmology.2026;[Epub]     CrossRef
  • The role of deep learning-based algorithms in retinal image processing: a review
    Canan Celik, İbrahim Yücedağ
    Multimedia Tools and Applications.2026;[Epub]     CrossRef
  • Artificial intelligence in the management of ocular diseases: opportunities, challenges, and future directions
    Sanshita, Kapil Chaudhari, Lavanya Sinha, V R Sinha
    Expert Review of Ophthalmology.2026; 21(2): 149.     CrossRef
  • Protective effect of Humic acid against Diabetic Retinopathy in streptozotocin-induced diabetic rats
    Pratixa Patel, Arindam Paul
    Hacettepe University Journal of the Faculty of Pharmacy.2026; 46(1): 27.     CrossRef
  • Custom Deep Learning Framework for Interpreting Diabetic Retinopathy in Healthcare Diagnostics
    Tamoor Aziz, Chalie Charoenlarpnopparut, Srijidtra Mahapakulchai, Babatunde Oluwaseun Ajayi, Mayowa Emmanuel Bamisaye
    Signals.2026; 7(2): 34.     CrossRef
  • Stratified choroidal vascular structure in treatment-naïve diabetic retinopathy
    Hiroaki Endo, Satoru Kase, Mitsuo Takahashi, Yuki Ito, Shozo Sonoda, Tomonori Sakoguchi, Taiji Sakamoto, Satoshi Katsuta, Susumu Ishida, Manabu Kase
    Canadian Journal of Ophthalmology.2025; 60(1): e73.     CrossRef
  • Foveal avascular zone area measurement in diabetic patients: Superficial, deep or combined retinal vascular complex?
    Bruno Pereira, Ross Faria, Cátia Domingues, Ana Barros, Teresa Varandas, José Henriques, João Nascimento, Elisabete Carolino, Pedro Camacho
    Microvascular Research.2025; 157: 104743.     CrossRef
  • N 6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy
    Siguo Feng, Qiuyang Zhang, Qing Liu, Chang Huang, Huiying Zhang, Fengsheng Wang, Yue Zhu, Qizhi Jian, Xue Chen, Qin Jiang, Biao Yan
    Diabetes.2025; 74(1): 82.     CrossRef
  • HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy
    Jun-Sik Kim, Jae Hyun Jun, Jeongmi Lee, Sunyoung Park, Eunae Kim, Su Jung Hwang, Heesu Moon, Seung Hyun Baek, Hark Kyun Kim, Jinsu Park, Yoonsuk Cho, Jihoon Han, Chanhee Kim, Jongho Kim, Hyun-Mo Yang, Changsik Lee, Yeonseok Chung, Hyo-Jong Lee, Dong-Gyu J
    Metabolism.2025; 164: 156108.     CrossRef
  • Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort’s analysis
    Mansour Bahardoust, Yadollah Mehrabi, Farzad Hadaegh, Davood Khalili, Ali Delpisheh
    International Journal of Retina and Vitreous.2025;[Epub]     CrossRef
  • Activated Growth Factor From Platelets as Treatment for Diabetic Retinopathy Through Antioxidant-Oxidative Stress Pathway
    Ramzi Amin, Rachmat Hidayat, Ziske Maritska, Trisa Putri
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 305.     CrossRef
  • NLRP3 inflammasomes pathway: a key target for Metformin
    Yasamin Hosseini, Amirhossein Niknejad, Ayeh Sabbagh Kashani, Mahsa Gholami, Mahtab Roustaie, Mohammad Mohammadi, Saeideh Momtaz, Stephen L. Atkin, Tannaz Jamialahmadi, Amir Hossein Abdolghaffari, Amirhossein Sahebkar
    Inflammopharmacology.2025; 33(4): 1729.     CrossRef
  • Cd248a regulates pericyte development and viability in zebrafish
    Chao Wang, Yinming Zhong, Yi Zhang, Yiyang Jiang, Chenshiyu Wang, Lele An, Chunhua Luo, Lan Yang, Zhicheng He, Ying Yang, Min Luo, Min Mao, Wenying Wang, Qing Liu, Yu Shi, Yi-Fang Ping
    Communications Biology.2025;[Epub]     CrossRef
  • Caveolae: Metabolic Platforms at the Crossroads of Health and Disease
    Dante Maria Stea, Alessio D’Alessio
    International Journal of Molecular Sciences.2025; 26(7): 2918.     CrossRef
  • Advancing ophthalmology with large language models: Applications, challenges, and future directions
    Qi Zhang, Shaopan Wang, Xu Wang, Changsheng Xu, Jiajun Liang, Zuguo Liu
    Survey of Ophthalmology.2025; 70(5): 1019.     CrossRef
  • Targeting therapy of PI3K/AKT signaling pathway via non-coding RNAs in diabetic retinopathy
    Shuai Lu, Jian Cai
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(9): 11493.     CrossRef
  • Novel Therapeutic Approaches for Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration
    Deokho Lee, Soo Jin Kim, Junyeop Lee
    Vision.2025; 9(2): 35.     CrossRef
  • Increased fatty acid-binding protein 4 levels are associated with the risk of developing retinopathy in type 2 diabetes mellitus patients
    Yan Liu, Kaihui Ma, Aiying Zhang, Yun Cui, Hui Zhao, Xinhua Li, Ke Zhao
    Diabetes & Metabolism.2025; 51(4): 101653.     CrossRef
  • Short-term real-world outcomes of diabetic macular edema treated with intravitreal faricimab
    Toshiaki Hirakata, Fumihiro Hara, Yuta Nochi, Daisuke Shinohara, Shutaro Yamamoto, Yoshimune Hiratsuka, Shintaro Nakao, Jiro Kogo
    PLOS One.2025; 20(5): e0323088.     CrossRef
  • Automated detection of hard exudates in retinal fundus images for diabetic retinopathy screening using textural-based radon transform and morphology reconstruction
    Esmat Ramezanzadeh, Naser Shoeibi, Akram Feizabadi, Touka Banaee, Mohammad Hossein Bahreyni Tussi, Meysam Tavakoli
    Biomedical Engineering Advances.2025; 9: 100180.     CrossRef
  • Emerging liposomal therapies for diabetic retinopathy: a review of novel targeting approaches and advances in retinal health outcomes
    Ravi Parashar, Preeti K. Suresh
    Drug Delivery.2025;[Epub]     CrossRef
  • Targeting neurotrophic dysregulation in diabetic retinopathy: a novel therapeutic avenue
    Divya Rana, Sanchit Dhankhar, Rupali Chauhan, Monika Saini, Randhir Singh, Parveen Kumar, Thakur Gurjeet Singh, Samrat Chauhan, Sushma Devi
    Molecular Biology Reports.2025;[Epub]     CrossRef
  • Integration of Immunometabolic Composite Indices and Machine Learning for Diabetic Retinopathy Risk Stratification: Insights from NHANES 2011 – 2020
    Cui Xuehao, Wen Dejia, Li Xiaorong
    Ophthalmology Science.2025; 5(6): 100854.     CrossRef
  • Switching to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular edema: a systematic review and meta-analysis
    Ali Tahmasebi, Nazanin Ebrahimiadib, Mohammadreza Niyousha, Narges Hassanpoor
    Graefe's Archive for Clinical and Experimental Ophthalmology.2025; 263(10): 2693.     CrossRef
  • Inhibition of retinal neovascularization by Dendrobium polysaccharides: a review
    Dan Liu, Xingwang Chen, Shanjun Cai
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress
    Bipradas Roy
    Medical Sciences.2025; 13(3): 87.     CrossRef
  • The role of gut microbiota dysbiosis in the inflammatory pathogenesis of diabetic retinopathy
    Liqing Xie, Wenjian Lin
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Risk of Systemic Health Events and Mortality After Vitrectomy for Diabetic Retinopathy in Patients with Type 2 Diabetes
    Dane A. Jester, Muhammad Z. Chauhan, Zain S. Hussain, Sam Karimaghaei, Jawad Muayad, Asad Loya, Ahmed F. Shakarchi, Ahmed B. Sallam
    Ophthalmology Science.2025; 5(6): 100880.     CrossRef
  • Inhibition of Endothelial HIF-1α by IDF-11774 Attenuates Retinal Neovascularization and Vascular Leakage
    Fengmei Yang, Jicheng Lin, Boyu Yang, Andina Hu, Kaixuan Cui, Peiqi Wu, Haolin Kong, Changxuan Liu, Kun Xu, Xi Lu, Shanshan Yu, Xiaoyu Tang, Yue Xu, Xiaoling Liang
    Investigative Ophthalmology & Visual Science.2025; 66(9): 47.     CrossRef
  • Recent advances in engineered exosome-based therapies for ocular vascular disease
    Jian Guan, Fanhe Meng, Chuanzhuo Wang, Binglun Zhang, Jun Chen, Jingnan Han
    Journal of Nanobiotechnology.2025;[Epub]     CrossRef
  • Revolutionizing Diabetic Macular Edema Treatment: FDA Approval of Susvimo
    Dinesh Kumar, Vrinda Gupta, Rajni Tanwar, Nicky Kumar Jaiswal
    SN Comprehensive Clinical Medicine.2025;[Epub]     CrossRef
  • Hyaluronic acid based light responsive long acting hydrogel for the intraocular delivery of spironolactone
    Sai Shreya Cheruvu, Shruthi Merugu, Manisha Malani, Onkar Kulkarni, Jayabalan Nirmal
    International Journal of Biological Macromolecules.2025; 321: 146451.     CrossRef
  • Fenofibrate and Diabetic Retinopathy
    A. Parra-Pineda, S. Lizarazo-Bocanegra, L. F. Villalba-Montero, C. C. Ayala-Quintero, F. Losada-Díaz, I. Correa-Osio, L. A. Lizarazo-Rojas, C. O. Mendivil
    Diabetes Therapy.2025; 16(9): 1763.     CrossRef
  • Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context
    Xue Mi, Zi-Ling Ye, Xu-Jun Zhang, Xiao-Chun Chen, Xiao-Man Dai
    Biology of Sex Differences.2025;[Epub]     CrossRef
  • Anthocyanin-Rich Berries and Their Bioactive Compounds in Ocular Health: Mechanisms and Therapeutic Potential
    Long Zuo, Mingjun Ye, Long Chen, Xiaohong Xu, Shengquan Huang, Xusheng Li, Weibin Bai
    Journal of Agricultural and Food Chemistry.2025; 73(38): 23724.     CrossRef
  • Transpupillary in vivo two-photon imaging reveals enhanced surveillance of retinal microglia in diabetic mice
    Noriyuki Sotani, Sentaro Kusuhara, Ryuto Nishisho, Hiroto Kuno, Hidenori Shima, Koichiro Haruwaka, Yuka Mori, Maya Kishi, Tomoyuki Furuyashiki, Kenta Kobayashi, Hiroaki Wake, Toru Takumi, Makoto Nakamura, Yoshihisa Tachibana
    Proceedings of the National Academy of Sciences.2025;[Epub]     CrossRef
  • PXN + monocytes accelerate diabetic retinopathy progression and inflammaging via SELPLG-SELL axis-mediated immune chemotaxis and RAS modulation
    Na Liang, Jing Li, Wenting Wang, Huifang Xu, Shaomin Peng
    Journal of the Renin-Angiotensin-Aldosterone System.2025;[Epub]     CrossRef
  • Evidence Supporting Autotaxin as a Potential New Drug Treatment Target in Patients With Advanced Diabetic Retinopathy
    Harumasa Yokota, Hiroki Hayashi, Hironori Nakagami, Akifumi Kushiyama, Junya Hanaguri, Megumi Honjo, Makoto Aihara, Makoto Kurano, Koji Igarashi, Sakura Kushiyam, Satoru Yamagami, Taiji Nagaoka
    Investigative Ophthalmology & Visual Science.2025; 66(15): 49.     CrossRef
  • Insights from RNA sequencing techniques revealing the molecular mechanisms associated with diabetic retinopathy
    Larwubah Kollie, Serina L. Gaye, Siyu Chen, Zongsuo Liang, Meilan Yu, Fei Gao
    Journal of Diabetes & Metabolic Disorders.2025;[Epub]     CrossRef
  • Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management
    Arpon Biswas, Abhijit Deb Choudhury, Sristi Agrawal, Amol Chhatrapati Bisen, Sachin Nashik Sanap, Sarvesh Kumar Verma, Mukesh Kumar, Anjali Mishra, Shivansh Kumar, Mridula Chauhan, Rabi Sankar Bhatta
    Journal of Ocular Pharmacology and Therapeutics.2024; 40(1): 13.     CrossRef
  • GMFB/AKT/TGF‐β3 in Müller cells mediated early retinal degeneration in a streptozotocin‐induced rat diabetes model
    Tong Zhu, Yingao Li, Lilin Zhu, Jinyuan Xu, Zijun Feng, Hao Chen, Si Shi, Caiying Liu, Qingjian Ou, Furong Gao, Jieping Zhang, Caixia Jin, Jingying Xu, Jiao Li, Jingfa Zhang, Yanlong Bi, Guo‐tong Xu, Juan Wang, Haibin Tian, Lixia Lu
    Glia.2024; 72(3): 504.     CrossRef
  • The significance of glutaredoxins for diabetes mellitus and its complications
    Mengmeng Zhou, Eva-Maria Hanschmann, Axel Römer, Thomas Linn, Sebastian Friedrich Petry
    Redox Biology.2024; 71: 103043.     CrossRef
  • Proteomic analysis of diabetic retinopathy identifies potential plasma-protein biomarkers for diagnosis and prognosis
    Bent Honoré, Javad Nouri Hajari, Tobias Torp Pedersen, Tomas Ilginis, Hajer Ahmad Al-Abaiji, Claes Sepstrup Lønkvist, Jon Peiter Saunte, Dorte Aalund Olsen, Ivan Brandslund, Henrik Vorum, Carina Slidsborg
    Clinical Chemistry and Laboratory Medicine (CCLM).2024; 62(6): 1177.     CrossRef
  • Next generation therapeutics for retinal neurodegenerative diseases
    Matthew B. Appell, Jahnavi Pejavar, Ashwin Pasupathy, Sri Vishnu Kiran Rompicharla, Saed Abbasi, Kiersten Malmberg, Patricia Kolodziejski, Laura M. Ensign
    Journal of Controlled Release.2024; 367: 708.     CrossRef
  • Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip
    Thomas L. Maurissen, Alena J. Spielmann, Gabriella Schellenberg, Marc Bickle, Jose Ricardo Vieira, Si Ying Lai, Georgios Pavlou, Sascha Fauser, Peter D. Westenskow, Roger D. Kamm, Héloïse Ragelle
    Nature Communications.2024;[Epub]     CrossRef
  • Emerging role of ferroptosis in diabetic retinopathy: a review
    Ruohong Wang, Suyun Rao, Zheng Zhong, Ke Xiao, Xuhui Chen, Xufang Sun
    Journal of Drug Targeting.2024; 32(4): 393.     CrossRef
  • Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients
    Yong Zhuang, Zihao Zhuang, Qingyan Cai, Xin Hu, Huibin Huang
    Journal of Diabetes Investigation.2024; 15(7): 867.     CrossRef
  • Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study
    Maria Consiglia Trotta, Carlo Gesualdo, Caterina Claudia Lepre, Marina Russo, Franca Ferraraccio, Iacopo Panarese, Ernesto Marano, Paolo Grieco, Francesco Petrillo, Anca Hermenean, Francesca Simonelli, Michele D’Amico, Claudio Bucolo, Francesca Lazzara, F
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Berberine alleviates diabetic retinopathy by regulating the Th17/Treg ratio
    Yi Yang, Zexin Wen, Yanli Zhang, Pengfei Li, Junyao Zhao, Yujie Sun, Peng Wang, Wei Lin
    Immunology Letters.2024; 267: 106862.     CrossRef
  • Diabetic Retinopathy: Clinical Features, Risk Factors, and Treatment Options
    Sudhanshu Mishra, Pratik Kumar Vishwakarma, Mridani Tripathi, Smriti Ojha, Shivendra Mani Tripathi
    Current Diabetes Reviews.2024;[Epub]     CrossRef
  • RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models
    Uwe Grether, Richard H. Foxton, Sabine Gruener, Claudia Korn, Atsushi Kimbara, Anja Osterwald, Elisabeth Zirwes, Sabine Uhles, Janina Thoele, Nadine Colé, Mark Rogers-Evans, Stephan Röver, Matthias Nettekoven, Rainer E. Martin, Jean-Michel Adam, Jürgen Fi
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Diabetic retinopathy incidence, predictors and its association with longitudinal fasting blood sugar level changes among diabetes mellitus patients in Ethiopia: joint model
    Habtamu Wagnew Abuhay, Ayenew Molla Lakew, Haileab Fekadu Wolde, Berhanu Mengistu, Mandefro Tadesse Legesse, Melaku Kindie Yenit
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology
    Shintaro Nakao, Sentaro Kusuhara, Tomoaki Murakami
    Graefe's Archive for Clinical and Experimental Ophthalmology.2024; 262(12): 3749.     CrossRef
  • Relationship between VEGF expression and ganglion and photoreceptor cell densities in diabetic retinal layers
    Aswira ASLAM, Habibah S. MUHIDDIN, Andi M. ICHSAN
    Gazzetta Medica Italiana Archivio per le Scienze Mediche.2024;[Epub]     CrossRef
  • Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3
    Pear Ferreira Pongsachareonnont, Phantipa Sakthong, Voraporn Chaikitmongkol, Wantanee Dangboon Tsutsumi, Chavakij Bhoomibunchoo, Cameron P. Hurst, Yot Teerawattananon, Kittisak Kulvichit
    Value in Health Regional Issues.2024; 44: 101030.     CrossRef
  • Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer’s Disease: The Potential Role of a Novel Nano-Compound—The Transdermal Glutathione–Cyclodextrin Complex
    Ray Yutani, Vishwanath Venketaraman, Nisar Sheren
    Antioxidants.2024; 13(9): 1106.     CrossRef
  • Vitamin D levels and risk of ocular disorders: insights from bidirectional and multivariable Mendelian randomization analysis
    Shipei Fan, Xing-yu Shi, Xia Li, Jun Li, Song-ping Yu
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Methylglyoxal: A Key Factor for Diabetic Retinopathy and Its Effects on Retinal Damage
    Vladlen Klochkov, Chi-Ming Chan, Wan-Wan Lin
    Biomedicines.2024; 12(11): 2512.     CrossRef
  • Prevalence and its associated factors of diabetic retinopathy among type 1 and type 2 diabetic patients at public hospitals in Eastern Ethiopia, 2023: a hospital-based comparative cross-sectional study
    Feyisa Shasho Bayisa, Teshome Demis Nimani, Samuel Demissie Darcho
    Frontiers in Clinical Diabetes and Healthcare.2024;[Epub]     CrossRef
  • Prevalence of diabetic retinopathy and its associated risk factors among adults in Ethiopia: a systematic review and meta-analysis
    Temesgen Gebeyehu Wondmeneh, Jemal Abdu Mohammed
    Scientific Reports.2024;[Epub]     CrossRef
  • Advanced drug delivery strategies for diabetic retinopathy: current therapeutic advancement, and delivery methods overcoming barriers, and experimental modalities
    Mengistie Diress, Susbin Raj Wagle, Patrick Lim, Thomas Foster, Bozica Kovacevic, Corina Mihaela Ionescu, Armin Mooranian, Hani Al-Salami
    Expert Opinion on Drug Delivery.2024; 21(12): 1859.     CrossRef
  • Evaluating deep learning models for classifying OCT images with limited data and noisy labels
    Aleksandar Miladinović, Alessandro Biscontin, Miloš Ajčević, Simone Kresevic, Agostino Accardo, Dario Marangoni, Daniele Tognetto, Leandro Inferrera
    Scientific Reports.2024;[Epub]     CrossRef
  • Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema
    Kim Lien Huber, Heiko Stino, Irene Steiner, Philipp Fuchs, Felix Goldbach, Julia Mai, Bianca S. Gerendas, Katharina Kriechbaum, Ursula Schmidt-Erfurth, Andreas Pollreisz
    Investigative Ophthalmology & Visual Science.2024; 65(14): 46.     CrossRef
  • Comparison of retrobulbar circulation in type 2 diabetics and non-diabetics using color Doppler imaging
    Rachana Kotian, Thanuja G Pradeep, Raghav Venkatesh
    Indian Journal of Clinical and Experimental Ophthalmology.2024; 10(4): 655.     CrossRef
  • Diabetic Retinopathy Requiring Vitrectomy: Epidemiology and Pathology
    Ayman Ahmed Alkawas, Mahmoud Ali El Aswad, Mohamed Anas Hussein Awnallah, Khaled Salah El Din Abd El Kader
    Cuestiones de Fisioterapia.2024; 53(02): 695.     CrossRef
  • Pharmacological mechanism and clinical study of Qiming granules in treating diabetic retinopathy based on network pharmacology and literature review
    Yuxia Huang, Jia Wang, Yu Wang, Wei Kuang, Mengjun Xie, Mei Zhang
    Journal of Ethnopharmacology.2023; 302: 115861.     CrossRef
  • Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases
    Fátima Milhano dos Santos, Sergio Ciordia, Joana Mesquita, João Paulo Castro de Sousa, Alberto Paradela, Cândida Teixeira Tomaz, Luís António Paulino Passarinha
    Cellular and Molecular Life Sciences.2023;[Epub]     CrossRef
  • Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
    Gabriella Lupo, Aleksandra Agafonova, Alessia Cosentino, Giovanni Giurdanella, Giuliana Mannino, Debora Lo Furno, Ivana Roberta Romano, Rosario Giuffrida, Floriana D’Angeli, Carmelina Daniela Anfuso
    International Journal of Molecular Sciences.2023; 24(2): 913.     CrossRef
  • Predictive factors for microvascular recovery after treatments for diabetic retinopathy
    Junyeop Lee, Yoon-Jeon Kim, Joo-Yong Lee, Young Hee Yoon, June-Gone Kim
    BMC Ophthalmology.2023;[Epub]     CrossRef
  • Pathophysiology and diagnosis of diabetic retinopathy: a narrative review
    Mohadese Estaji, Bita Hosseini, Saeed Bozorg-Qomi, Babak Ebrahimi
    Journal of Investigative Medicine.2023; 71(3): 265.     CrossRef
  • Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases
    Fátima M. Santos, Sergio Ciordia, Joana Mesquita, Carla Cruz, João Paulo Castro e Sousa, Luís A. Passarinha, Cândida T. Tomaz, Alberto Paradela
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Hypoxia-induced transcriptional differences in African and Asian versus European diabetic cybrids
    Andrew H. Dolinko, Marilyn Chwa, Kevin Schneider, Mithalesh K. Singh, Shari Atilano, Jie Wu, M. Cristina Kenney
    Scientific Reports.2023;[Epub]     CrossRef
  • Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy
    Bora TORUS, Hakan KORKMAZ, Kuyaş H. OZTURK, Fevziye B. ŞİRİN, Mehmet ARGUN, Sonmez ŞEVİK, Levent TÖK
    Minerva Endocrinology.2023;[Epub]     CrossRef
  • Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
    Sentaro Kusuhara, Maya Kishimoto-Kishi, Wataru Matsumiya, Akiko Miki, Hisanori Imai, Makoto Nakamura
    Medicina.2023; 59(4): 665.     CrossRef
  • L-type calcium channel blocker increases VEGF concentrations in retinal cells and human serum
    Anmol Kumar, Stefan Mutter, Erika B. Parente, Valma Harjutsalo, Raija Lithovius, Sinnakaruppan Mathavan, Markku Lehto, Timo P. Hiltunen, Kimmo K. Kontula, Per-Henrik Groop, Satyajit Mohapatra
    PLOS ONE.2023; 18(4): e0284364.     CrossRef
  • Efficacy and safety of curcumin in diabetic retinopathy: A protocol for systematic review and meta-analysis
    Liyuan Wang, Jiayu Xu, Tianyang Yu, Hanli Wang, Xiaojun Cai, He Sun, Godwin Ovenseri-Ogbomo
    PLOS ONE.2023; 18(4): e0282866.     CrossRef
  • Highly water-soluble diacetyl chrysin ameliorates diabetes-associated renal fibrosis and retinal microvascular abnormality in db/db mice
    Young-Hee Kang, Sin-Hye Park, Young Eun Sim, Moon-Sik Oh, Hong Won Suh, Jae-Yong Lee, Soon Sung Lim
    Nutrition Research and Practice.2023; 17(3): 421.     CrossRef
  • Preventive and management approach of triptonide, a diterpenoid compound against streptozotocin-induced diabetic retinopathy in Wistar rat model
    Chandramohan Govindasamy, Khalid S. Al-Numair, Jun Li, Weibai Chen, Guoqiang Wu
    Arabian Journal of Chemistry.2023; 16(9): 105034.     CrossRef
  • New Insights on Dietary Polyphenols for the Management of Oxidative Stress and Neuroinflammation in Diabetic Retinopathy
    Gustavo Bernardes Fanaro, Marcelo Rodrigues Marques, Karin da Costa Calaza, Rafael Brito, André Moreira Pessoni, Henrique Rocha Mendonça, Deborah Emanuelle de Albuquerque Lemos, José Luiz de Brito Alves, Evandro Leite de Souza, Marinaldo Pacífico Cavalcan
    Antioxidants.2023; 12(6): 1237.     CrossRef
  • Evaluation of Social Platform-Based Continuity of Care in Improving Cognitive and Prognostic Effects of Young Patients with Diabetic Retinopathy
    Guo-lan Cao, Ke-jian Chen
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1931.     CrossRef
  • Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
    Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li
    World Journal of Hepatology.2023; 15(6): 786.     CrossRef
  • The rs1800469 T/T and rs1800470 C/C genotypes of the TGFB1 gene confer protection against diabetic retinopathy in a Southern Brazilian population
    Aline Rodrigues Costa, Cristine Dieter, Luís Henrique Canani, Taís Silveira Assmann, Daisy Crispim
    Genetics and Molecular Biology.2023;[Epub]     CrossRef
  • Evaluation of Self-Care in Patients with Diabetic Retinopathy
    Songül BİLTEKİN, Züleyha KILIÇ, Şefika Dilek GÜVEN
    Turkish Journal of Diabetes and Obesity.2023; 7(3): 214.     CrossRef
  • Diabetes mellitus and its influence on the incidence and process of diabetic retinopathy
    Janka Poráčová, Melinda Nagy, Marta Mydlárová Blaščáková, Mária Konečná, Vincent Sedlák, Mária Zahatňanská, Tatiana Kimáková, Hedviga Vašková, Viktória Rybárová, Mária Majherová, Ivan Uher
    Central European Journal of Public Health.2023; 31(Suppl 1): S4.     CrossRef
  • Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets
    Karanvir S. Raman, Joanne A. Matsubara
    Ocular Immunology and Inflammation.2022; 30(2): 470.     CrossRef
  • Adult-induced genetic ablation distinguishes PDGFB roles in blood-brain barrier maintenance and development
    Elisa Vazquez-Liebanas, Khayrun Nahar, Giacomo Bertuzzi, Annika Keller, Christer Betsholtz, Maarja Andaloussi Mäe
    Journal of Cerebral Blood Flow & Metabolism.2022; 42(2): 264.     CrossRef
  • Investigation on the Q-markers of Bushen Huoxue Prescriptions for DR treatment based on chemometric methods and spectrum-effect relationship
    Yueting Yu, Ziyu Zhu, Mengjun Xie, Liping Deng, Xuejun Xie, Mei Zhang
    Journal of Ethnopharmacology.2022; 285: 114800.     CrossRef
  • Corneal Confocal Microscopy in Type 1 Diabetes Mellitus: A Six-Year Longitudinal Study
    Stuti L. Misra, James A. Slater, Charles N. J. McGhee, Monika Pradhan, Geoffrey D. Braatvedt
    Translational Vision Science & Technology.2022; 11(1): 17.     CrossRef
  • Microphysiological Neurovascular Barriers to Model the Inner Retinal Microvasculature
    Thomas L. Maurissen, Georgios Pavlou, Colette Bichsel, Roberto Villaseñor, Roger D. Kamm, Héloïse Ragelle
    Journal of Personalized Medicine.2022; 12(2): 148.     CrossRef
  • Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice
    Fei Yao, Xinyi Jiang, Ling Qiu, Zixuan Peng, Wei Zheng, Lexi Ding, Xiaobo Xia
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Classification of macular abnormalities using a lightweight CNN-SVM framework
    Xuqian Wang, Yu Gu
    Measurement Science and Technology.2022; 33(6): 065702.     CrossRef
  • Chorioretinal Hypoxia Detection Using Lipid-Polymer Hybrid Organic Room-Temperature Phosphorescent Nanoparticles
    Yingying Zeng, Van Phuc Nguyen, Yanxiu Li, Do Hyun Kang, Yannis M. Paulus, Jinsang Kim
    ACS Applied Materials & Interfaces.2022; 14(16): 18182.     CrossRef
  • LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis
    Rong Luo, Lan Li, Fan Xiao, Jinsong Fu
    Inflammation.2022; 45(5): 1936.     CrossRef
  • Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review
    Charisse Y. J. Kuo, Rinki Murphy, Ilva D. Rupenthal, Odunayo O. Mugisho
    BMC Ophthalmology.2022;[Epub]     CrossRef
  • The relationship between the neutrophil-to-lymphocyte ratio and diabetic retinopathy in adults from the United States: results from the National Health and nutrition examination survey
    Xiaojie He, Shanshan Qi, Xi Zhang, Jiandong Pan
    BMC Ophthalmology.2022;[Epub]     CrossRef
  • Th22 cells induce Müller cell activation via the Act1/TRAF6 pathway in diabetic retinopathy
    Yufei Wang, Hongdan Yu, Jing Li, Wenqiang Liu, Shengxue Yu, Pan Lv, Lipan Zhao, Xiaobai Wang, Zhongfu Zuo, Xuezheng Liu
    Cell and Tissue Research.2022; 390(3): 367.     CrossRef
  • Prevalence and Factors Associated with Diabetic Retinopathy among Adult Diabetes Patients in Southeast Ethiopia: A Hospital-Based Cross-Sectional Study
    Biniyam Sahiledengle, Tesfaye Assefa, Wogene Negash, Anwar Tahir, Tadele Regasa, Yohannes Tekalegn, Ayele Mamo, Zinash Teferu, Damtew Solomon, Habtamu Gezahegn, Kebebe Bekele, Demisu Zenbaba, Alelign Tasew, Fikreab Desta, Zegeye Regassa, Zegeye Feleke, Ch
    Clinical Ophthalmology.2022; Volume 16: 3527.     CrossRef
  • Diabetic Retinopathy: Are lncRNAs New Molecular Players and Targets?
    Simona Cataldi, Mariagiovanna Tramontano, Valerio Costa, Marianna Aprile, Alfredo Ciccodicola
    Antioxidants.2022; 11(10): 2021.     CrossRef
  • Diosgenin protects retinal pigment epithelial cells from inflammatory damage and oxidative stress induced by high glucose by activating AMPK/Nrf2/HO‐1 pathway
    Yang Hao, Xuefeng Gao
    Immunity, Inflammation and Disease.2022;[Epub]     CrossRef
  • Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases
    Huy Nguyen, Sung-Jin Lee, Yang Li
    Pharmaceutics.2022; 14(11): 2476.     CrossRef
  • Development and validation of a predictive risk model based on retinal geometry for an early assessment of diabetic retinopathy
    Minglan Wang, Xiyuan Zhou, Dan Ning Liu, Jieru Chen, Zheng Zheng, Saiguang Ling
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
    Charisse Y-J. Kuo, Jack J. Maran, Emma G. Jamieson, Ilva D. Rupenthal, Rinki Murphy, Odunayo O. Mugisho
    International Journal of Molecular Sciences.2022; 23(22): 14471.     CrossRef
  • VEGF Gene Polymorphism Among Diabetes Mellitus and Diabetic Retinopathy
    Samra Anees, Saima Shareef, Muhammad Roman, Shah Jahan
    Futuristic Biotechnology.2022; : 02.     CrossRef
  • Th22 Cells Induce Müller Cells Activation Via the Act1/Traf6 Pathway in Diabetic Retinopathy
    YuFei Wang, Hongdan Yu, Jing Li, Wenqiang Liu, Shengxue Yu, Pan Lv, Lipan Zhao, Xiaobai Wang, Zhongfu Zuo, Xuezheng Liu
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Pathogenesis of diabetic macular edema: the role of pro-inflammatory and vascular factors. Aliterature review
    M.L. Kyryliuk, S.A. Suk
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(3): 180.     CrossRef
  • Potential of the Triad of Fatty Acids, Polyphenols, and Prebiotics from Cucurbita against COVID-19 in Diabetic Patients
    Qushmua E. Alzahrani, Richard B. Gillis, Stephen E. Harding, Luciano Henrique Pinto, Monica Gulati, Bhupinder Kapoor, Pooja Rani, Sachin Kumar Singh, Gary G. Adams
    Journal of Reports in Pharmaceutical Sciences.2022; 11(1): 28.     CrossRef
  • Effects of emixustat hydrochloride in patients with proliferative diabetic retinopathy: a randomized, placebo-controlled phase 2 study
    Ryo Kubota, Chirag Jhaveri, John M. Koester, Jeffrey K. Gregory
    Graefe's Archive for Clinical and Experimental Ophthalmology.2021; 259(2): 369.     CrossRef
  • Transient receptor potential vanilloid 4 channel deletion regulates pathological but not developmental retinal angiogenesis
    Holly C. Cappelli, Brianna D. Guarino, Anantha K. Kanugula, Ravi K. Adapala, Vidushani Perera, Matthew A. Smith, Sailaja Paruchuri, Charles K. Thodeti
    Journal of Cellular Physiology.2021; 236(5): 3770.     CrossRef
  • Involvement of miR‐126 rs4636297 and miR‐146a rs2910164 polymorphisms in the susceptibility for diabetic retinopathy: a case–control study in a type 1 diabetes population
    Eloísa Toscan Massignam, Cristine Dieter, Felipe Mateus Pellenz, Taís Silveira Assmann, Daisy Crispim
    Acta Ophthalmologica.2021;[Epub]     CrossRef
  • Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients
    Malgorzata Mrugacz, Anna Bryl, Katarzyna Zorena
    Journal of Clinical Medicine.2021; 10(3): 458.     CrossRef
  • Factors based on optical coherence tomography correlated with vision impairment in diabetic patients
    Hiroaki Endo, Satoru Kase, Hikari Tanaka, Mitsuo Takahashi, Satoshi Katsuta, Yasuo Suzuki, Minako Fujii, Susumu Ishida, Manabu Kase
    Scientific Reports.2021;[Epub]     CrossRef
  • Class-3 semaphorins: Potent multifunctional modulators for angiogenesis-associated diseases
    Bo Jiao, Shiyang Liu, Xi Tan, Pei Lu, Danning Wang, Hui Xu
    Biomedicine & Pharmacotherapy.2021; 137: 111329.     CrossRef
  • Single-Cell Analysis of Blood-Brain Barrier Response to Pericyte Loss
    Maarja A. Mäe, Liqun He, Sofia Nordling, Elisa Vazquez-Liebanas, Khayrun Nahar, Bongnam Jung, Xidan Li, Bryan C. Tan, Juat Chin Foo, Amaury Cazenave-Gassiot, Markus R. Wenk, Yvette Zarb, Barbara Lavina, Susan E. Quaggin, Marie Jeansson, Chengua Gu, David
    Circulation Research.2021;[Epub]     CrossRef
  • VEGFR1 signaling in retinal angiogenesis and microinflammation
    Akiyoshi Uemura, Marcus Fruttiger, Patricia A. D'Amore, Sandro De Falco, Antonia M. Joussen, Florian Sennlaub, Lynne R. Brunck, Kristian T. Johnson, George N. Lambrou, Kay D. Rittenhouse, Thomas Langmann
    Progress in Retinal and Eye Research.2021; 84: 100954.     CrossRef
  • Changes in Gene Expression Profiling and Phenotype in Aged Multidrug Resistance Protein 4-Deficient Mouse Retinas
    Kyung Woo Kim, Sentaro Kusuhara, Atsuko Katsuyama-Yoshikawa, Sho Nobuyoshi, Megumi Kitamura, Sotaro Mori, Noriyuki Sotani, Kaori Ueda, Wataru Matsumiya, Akiko Miki, Takuji Kurimoto, Hisanori Imai, Makoto Nakamura
    Antioxidants.2021; 10(3): 455.     CrossRef
  • Circular RNAs: Novel target of diabetic retinopathy
    Huan-ran Zhou, Hong-yu Kuang
    Reviews in Endocrine and Metabolic Disorders.2021; 22(2): 205.     CrossRef
  • MicroRNA-431-5p encapsulated in serum extracellular vesicles as a biomarker for proliferative diabetic retinopathy
    Bo Yu, Mengran Xiao, Fuhua Yang, Jing Xiao, Hui Zhang, Lin Su, Xiaomin Zhang, Xiaorong Li
    The International Journal of Biochemistry & Cell Biology.2021; 135: 105975.     CrossRef
  • EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress
    Roberta Giordo, Yusra M. A. Ahmed, Hilda Allam, Salah Abusnana, Lucia Pappalardo, Gheyath K. Nasrallah, Arduino Aleksander Mangoni, Gianfranco Pintus
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Pharmacokinetics of genistein distribution in blood and retinas of diabetic and non-diabetic rats
    T. Hakami, M.I. Mahmoud, E. de Juan, M. Cooney
    Drug Metabolism and Pharmacokinetics.2021; 39: 100404.     CrossRef
  • Nimbolide ameliorates the streptozotocin-induced diabetic retinopathy in rats through the inhibition of TLR4/NF-κB signaling pathway
    Xiangwen Shu, Yali Hu, Chao Huang, Ning Wei
    Saudi Journal of Biological Sciences.2021; 28(8): 4255.     CrossRef
  • Basic regulatory effects and clinical value of metalloproteinase-14 and extracellular matrix metalloproteinase inducer in diabetic retinopathy
    Shuyan Li, Shiheng Lu, Lei Zhang, Shasha Liu, Lei Wang, Kai Lin, Jialun Du, Meixia Song
    Materials Express.2021; 11(6): 873.     CrossRef
  • Reduced Acrolein Detoxification in akr1a1a Zebrafish Mutants Causes Impaired Insulin Receptor Signaling and Microvascular Alterations
    Haozhe Qi, Felix Schmöhl, Xiaogang Li, Xin Qian, Christoph T. Tabler, Katrin Bennewitz, Carsten Sticht, Jakob Morgenstern, Thomas Fleming, Nadine Volk, Ingrid Hausser, Elena Heidenreich, Rüdiger Hell, Peter Paul Nawroth, Jens Kroll
    Advanced Science.2021;[Epub]     CrossRef
  • The Metaflammatory and Immunometabolic Role of Macrophages and Microglia in Diabetic Retinopathy
    Honglian Wu, Mengqi Wang, Xiaorong Li, Yan Shao
    Human Cell.2021; 34(6): 1617.     CrossRef
  • Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury
    Steven F. Abcouwer, Sumathi Shanmugam, Arivalagan Muthusamy, Cheng-mao Lin, Dejuan Kong, Heather Hager, Xuwen Liu, David A. Antonetti
    Journal of Neuroinflammation.2021;[Epub]     CrossRef
  • Diferenças de mensuração de acuidade visual e velocidade de leitura para perto entre pacientes com retinopatia diabética. Repercussão entre conceitos de deficiência visual parcial e cegueira legal
    Roberta Freitas Momenté, Isabella Couto Amaral, Luiz Guilherme Coimbra de Brito, João Gabriel Volpato Ferraresi, Maria Luisa Gois da Fonsêca, Nadyr Antônia Damasceno, Luiz Claudio Santos de Souza Lima, Mauricio Bastos Pereira, Eduardo de França Damasceno
    Revista Brasileira de Oftalmologia.2021;[Epub]     CrossRef
  • Maintaining blood retinal barrier homeostasis to attenuate retinal ischemia-reperfusion injury by targeting the KEAP1/NRF2/ARE pathway with lycopene
    Hao Huang, Xielan Kuang, Xiaobo Zhu, Hao Cheng, Yuxiu Zou, Han Du, Han Tang, Linbin Zhou, Jingshu Zeng, Huijun Liu, Jianhua Yan, Chongde Long, Huangxuan Shen
    Cellular Signalling.2021; 88: 110153.     CrossRef
  • Luteolin, an aryl hydrocarbon receptor antagonist, alleviates diabetic retinopathy by regulating the NLRP/NOX4 signalling pathway: Experimental and molecular docking study
    Y. Yang, M. Zhou, H. Liu
    Physiology International.2021; 108(2): 172.     CrossRef
  • ALDH2/SIRT1 Contributes to Type 1 and Type 2 Diabetes‐Induced Retinopathy through Depressing Oxidative Stress
    Mengshan He, Pan Long, Tao Chen, Kaifeng Li, Dongyu Wei, Yufei Zhang, Wenjun Wang, Yonghe Hu, Yi Ding, Aidong Wen, Daniela Ribeiro
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Looking Ahead: Visual and Anatomical Endpoints in Future Trials of Diabetic Macular Ischemia
    Chui Ming Gemmy Cheung, Elizabeth Pearce, Beau Fenner, Piyali Sen, Victor Chong, Sobha Sivaprasad
    Ophthalmologica.2021; 244(5): 451.     CrossRef
  • The effect of psychotherapy on anxiety, depression, and quality of life in patients with diabetic retinopathy
    Suiping Li, Hong Liu, Xian Zhu
    Medicine.2021; 100(51): e28386.     CrossRef
  • Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
    Lisa Toto, Federica Evangelista, Pasquale Viggiano, Emanuele Erroi, Giada D’Onofrio, Daniele Libertini, Annamaria Porreca, Rossella D’Aloisio, Parravano Mariacristina, Luca Di Antonio, Marta Di Nicola, Rodolfo Mastropasqua, Maurizio Battaglia Parodi
    BioMed Research International.2020;[Epub]     CrossRef
  • microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy
    Julian Friedrich, David H. W. Steel, Reinier O. Schlingemann, Michael J. Koss, Hans-Peter Hammes, Guido Krenning, Ingeborg Klaassen
    Translational Vision Science & Technology.2020; 9(6): 16.     CrossRef
  • Update on the Effects of Antioxidants on Diabetic Retinopathy: In Vitro Experiments, Animal Studies and Clinical Trials
    Jose Javier Garcia-Medina, Elena Rubio-Velazquez, Elisa Foulquie-Moreno, Ricardo P Casaroli-Marano, Maria Dolores Pinazo-Duran, Vicente Zanon-Moreno, Monica del-Rio-Vellosillo
    Antioxidants.2020; 9(6): 561.     CrossRef
  • Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases
    C. G. Schalkwijk, C. D. A. Stehouwer
    Physiological Reviews.2020; 100(1): 407.     CrossRef
  • Pericytes, inflammation, and diabetic retinopathy
    Benjamin G. Spencer, Jose J. Estevez, Ebony Liu, Jamie E. Craig, John W. Finnie
    Inflammopharmacology.2020; 28(3): 697.     CrossRef
  • Eye hemodynamic data and biochemical parameters of the lacrimal fluid of patients with non-proliferative diabetic retinopathy
    Guzal Kangilbaeva, Fazilat Bakhritdinova, Iroda Nabieva, Aziza Jurabekova
    Data in Brief.2020; 32: 106237.     CrossRef
  • Endocannabinoids in aqueous humour of patients with or without diabetes
    Patrick Richardson, Catherine Ortori, Dave Barrett, Saoirse O'Sullivan, Iskandar Idris
    BMJ Open Ophthalmology.2020; 5(1): e000425.     CrossRef
  • A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
    Kota Sato, Seiya Mochida, Daisuke Tomimoto, Takahiro Konuma, Naoki Kiyota, Satoru Tsuda, Yukihiro Shiga, Kazuko Omodaka, Toru Nakazawa
    Experimental Eye Research.2020; 193: 107997.     CrossRef
  • The Role of Bone Morphogenetic Proteins in Diabetic Complications
    Nimna Perera, Rebecca H. Ritchie, Mitchel Tate
    ACS Pharmacology & Translational Science.2020; 3(1): 11.     CrossRef
  • Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents
    Maha Coucha, Amy C. Barrett, Joseph Bailey, Maryam Abdelghani, Mohammed Abdelsaid
    Vascular Pharmacology.2020; 131: 106761.     CrossRef
  • Mitochondrial Defects Drive Degenerative Retinal Diseases
    Deborah A. Ferrington, Cody R. Fisher, Renu A. Kowluru
    Trends in Molecular Medicine.2020; 26(1): 105.     CrossRef
  • Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis
    Takuya Miyagawa, Takashi Taniguchi, Ryosuke Saigusa, Maiko Fukayama, Takehiro Takahashi, Takashi Yamashita, Megumi Hirabayashi, Shunsuke Miura, Kouki Nakamura, Ayumi Yoshizaki, Shinichi Sato, Yoshihide Asano
    Rheumatology.2020; 59(8): 2005.     CrossRef
  • Natriuretic Peptides Attenuate Retinal Pathological Neovascularization Via Cyclic Guanosine Monophosphate Signaling in Pericytes and Astrocytes
    Katarina Špiranec Spes, Sabrina Hupp, Franziska Werner, Franziska Koch, Katharina Völker, Lisa Krebes, Ulrike Kämmerer, Katrin G. Heinze, Barbara M. Braunger, Michaela Kuhn
    Arteriosclerosis, Thrombosis, and Vascular Biology.2020; 40(1): 159.     CrossRef
  • Therapeutic investigation of quercetin nanomedicine in a zebrafish model of diabetic retinopathy
    Shuai Wang, Shanshan Du, Wenzhan Wang, Fengyan Zhang
    Biomedicine & Pharmacotherapy.2020; 130: 110573.     CrossRef
  • The role of CD44 in pathological angiogenesis
    Li Chen, Chenying Fu, Qing Zhang, Chengqi He, Feng Zhang, Quan Wei
    The FASEB Journal.2020; 34(10): 13125.     CrossRef
  • Associations between alcohol intake and diabetic retinopathy risk: a systematic review and meta-analysis
    Chen Chen, Zhaojun Sun, Weigang Xu, Jun Tan, Dan Li, Yiting Wu, Ting Zheng, Derong Peng
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Alpha-Smooth Muscle Actin-Positive Perivascular Cells in Diabetic Retina and Choroid
    Soo Jin Kim, Sang A. Kim, Yeong A. Choi, Do Young Park, Junyeop Lee
    International Journal of Molecular Sciences.2020; 21(6): 2158.     CrossRef
  • The G‐protein‐coupled chemoattractant receptor Fpr2 exacerbates neuroglial dysfunction and angiogenesis in diabetic retinopathy
    Ying Yu, Shengding Xue, Keqiang Chen, Yingying Le, Rongrong Zhu, Shiyi Wang, Shuang Liu, Xinliang Cheng, Huaijin Guan, Ji Ming Wang, Hui Chen
    FASEB BioAdvances.2020; 2(10): 613.     CrossRef
  • Dual-Acting Antiangiogenic Gene Therapy Reduces Inflammation and Regresses Neovascularization in Diabetic Mouse Retina
    Rute S. Araújo, Diogo B. Bitoque, Gabriela A. Silva
    Molecular Therapy Nucleic Acids.2020; 22: 329.     CrossRef
  • The cells involved in the pathological process of diabetic retinopathy
    Songtao Yang, Jiaoyue Zhang, Lulu Chen
    Biomedicine & Pharmacotherapy.2020; 132: 110818.     CrossRef
  • The Role of Transforming Growth Factor-Beta in Retinal Ganglion Cells with Hyperglycemia and Oxidative Stress
    Hsin-Yi Chen, Yi-Jung Ho, Hsiu-Chuan Chou, En-Chi Liao, Yi-Ting Tsai, Yu-Shan Wei, Li-Hsun Lin, Meng-Wei Lin, Yi-Shiuan Wang, Mei-Lan Ko, Hong-Lin Chan
    International Journal of Molecular Sciences.2020; 21(18): 6482.     CrossRef
  • Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs
    Ashay D. Bhatwadekar, Varun Rameswara
    Expert Opinion on Investigational Drugs.2020; 29(12): 1431.     CrossRef
  • Blood-retinal barrier as a converging pivot in understanding the initiation and development of retinal diseases
    Xue Yang, Xiao-Wei Yu, Dan-Dan Zhang, Zhi-Gang Fan
    Chinese Medical Journal.2020; 133(21): 2586.     CrossRef
  • Immunosubunit β5i Knockout Suppresses Neovascularization and Restores Autophagy in Retinal Neovascularization by Targeting ATG5 for Degradation
    Liyang Ji, Li Li, Ying Zhao, Shengqiang Liu, Jingmin Li, Jinsong Zhang, Qi Zhao, Shuai Wang
    Investigative Opthalmology & Visual Science.2020; 61(14): 30.     CrossRef
  • En face slab optical coherence tomography imaging successfully monitors progressive degenerative changes in the innermost layer of the diabetic retina
    Atsuko Katsuyama, Sentaro Kusuhara, Shun-Ichiro Asahara, Shun-Ichiro Nakai, Sotaro Mori, Wataru Matsumiya, Akiko Miki, Takuji Kurimoto, Hisanori Imai, Yoshiaki Kido, Wataru Ogawa, Makoto Nakamura
    BMJ Open Diabetes Research & Care.2020; 8(1): e001120.     CrossRef
  • Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
    Yoo-Ri Chung, Kyoung Hwa Ha, Hyeon Chang Kim, Sang Jun Park, Kihwang Lee, Dae Jung Kim
    Diabetes & Metabolism Journal.2019; 43(5): 640.     CrossRef
  • Age-related changes of the human retinal vessels: Possible involvement of lipid peroxidation
    Tapas Chandra Nag, Meenakshi Maurya, Tara Sankar Roy
    Annals of Anatomy - Anatomischer Anzeiger.2019; 226: 35.     CrossRef
  • Human iPSCs-Derived Endothelial Cells with Mutation in HNF1A as a Model of Maturity-Onset Diabetes of the Young
    Neli Kachamakova-Trojanowska, Jacek Stepniewski, Jozef Dulak
    Cells.2019; 8(11): 1440.     CrossRef
  • Diabetic Retinopathy–An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes
    Stephen H. Sinclair, Stanley S. Schwartz
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Identification of Diagnostic and Prognostic microRNAs for Recurrent Vitreous Hemorrhage in Patients with Proliferative Diabetic Retinopathy
    Parviz Mammadzada, Juliette Bayle, Johann Gudmundsson, Anders Kvanta, Helder André
    Journal of Clinical Medicine.2019; 8(12): 2217.     CrossRef
  • RANKL blockade suppresses pathological angiogenesis and vascular leakage in ischemic retinopathy
    Sangmi Ock, Soyoung Park, Junyeop Lee, Jaetaek Kim
    Biochemical and Biophysical Research Communications.2019; 516(2): 350.     CrossRef
  • EndogenousClostridium perfringensPanophthalmitis with Potential Entry Port from Diverticulitis Exacerbated by Proliferative Diabetic Retinopathy
    Vamsee Neerukonda, Anny M. S. Cheng, Swetha Dhanireddy, Samuel Alpert, Han Y. Yin
    Case Reports in Ophthalmological Medicine.2019; 2019: 1.     CrossRef
  • Attenuation of Retinal Endothelial Vasodilator Function in a Rat Model of Retinopathy of Prematurity
    Ayuki Nakano, Asami Mori, Shiho Arima, Daiki Asano, Akane Morita, Kenji Sakamoto, Tohru Nagamitsu, Tsutomu Nakahara
    Current Eye Research.2019; 44(12): 1360.     CrossRef
  • Efficacy of fenofibrate for diabetic retinopathy
    Xing-jie Su, Lin Han, Yan-Xiu Qi, Hong-wei Liu
    Medicine.2019; 98(14): e14999.     CrossRef
  • Nutraceuticals for the Treatment of Diabetic Retinopathy
    Maria Grazia Rossino, Giovanni Casini
    Nutrients.2019; 11(4): 771.     CrossRef
  • Efficacy of ranibizumab for the treatment of diabetic retinopathy
    Yong-bo Ren, Xing-jie Su, Yan-xiu Qi, He-qun Luan, Qi Sun
    Medicine.2019; 98(17): e15409.     CrossRef
Clinical Diabetes & Therapeutics
Diabetes and Subclinical Coronary Atherosclerosis
Chang Hoon Lee, Seung-Whan Lee, Seong-Wook Park
Diabetes Metab J. 2018;42(5):355-363.   Published online October 22, 2018
DOI: https://doi.org/10.4093/dmj.2018.0041
  • 9,289 View
  • 97 Download
  • 13 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   

It is well known that diabetic patients have a high risk of cardiovascular events, and although there has been a tremendous effort to reduce these cardiovascular risks, the incidence of cardiovascular morbidity and mortality in diabetic patients remains high. Therefore, the early detection of coronary artery disease (CAD) is necessary in those diabetic patients who are at risk of cardiovascular events. Significant medical and radiological advancements, including coronary computed tomography angiography (CCTA), mean that it is now possible to investigate the characteristics of plaques, instead of solely evaluating the calcium level of the coronary artery. Recently, several studies reported that the prevalence of subclinical coronary atherosclerosis (SCA) is higher than expected, and this could impact on CAD progression in asymptomatic diabetic patients. In addition, several reports suggest the potential benefit of using CCTA for screening for SCA in asymptomatic diabetic patients, which might dramatically decrease the incidence of cardiovascular events. For these reasons, the medical interest in SCA in diabetic patients is increasing. In this article, we sought to review the results of studies on CAD in asymptomatic diabetic patients and discuss the clinical significance and possibility of using CCTA to screen for SCA.

Citations

Citations to this article as recorded by  
  • Prevalence of Antinuclear Antibodies in Patients With Coronary Artery Disease: A Scoping Review
    Manisha Antony, Christina Thymalil, Stephanie Nagy, Kayvan Amini, Marc M Kesselman
    Cureus.2025;[Epub]     CrossRef
  • Coronary Artery Calcium Score directed risk stratification of patients with Type-2 diabetes mellitus
    Mahmoud Nassar, Nso Nso, Kelechi Emmanuel, Mohsen Alshamam, Most Sirajum Munira, Anoop Misra
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2022; 16(6): 102503.     CrossRef
  • Association between carotid atherosclerosis and presence of intracranial atherosclerosis using three-dimensional high-resolution vessel wall magnetic resonance imaging in asymptomatic patients with type 2 diabetes
    Ji Eun Jun, You-Cheol Hwang, Kyu Jeong Ahn, Ho Yeon Chung, Geon-Ho Jahng, Soonchan Park, In-Kyung Jeong, Chang-Woo Ryu
    Diabetes Research and Clinical Practice.2022; 191: 110067.     CrossRef
  • Serum metabolic signatures of subclinical atherosclerosis in patients with type 2 diabetes mellitus: a preliminary study
    Jiaorong Su, Qing Zhao, Aihua Zhao, Wei Jia, Wei Zhu, Jingyi Lu, Xiaojing Ma
    Acta Diabetologica.2021; 58(9): 1217.     CrossRef
  • Atherogenic Index of Plasma, Triglyceride-Glucose Index and Monocyte-to-Lymphocyte Ratio for Predicting Subclinical Coronary Artery Disease
    Yueqiao Si, Wenjun Fan, Chao Han, Jingyi Liu, Lixian Sun
    The American Journal of the Medical Sciences.2021; 362(3): 285.     CrossRef
  • Cardiologist's approach to the diabetic patient: No further delay for a paradigm shift
    Francesco Maranta, Lorenzo Cianfanelli, Carlo Gaspardone, Vincenzo Rizza, Rocco Grippo, Marco Ambrosetti, Domenico Cianflone
    International Journal of Cardiology.2021; 338: 248.     CrossRef
  • Co‐expression of glycosylated aquaporin‐1 and transcription factor NFAT5 contributes to aortic stiffness in diabetic and atherosclerosis‐prone mice
    Rosalinda Madonna, Vanessa Doria, Anikó Görbe, Nino Cocco, Péter Ferdinandy, Yong‐Jian Geng, Sante Donato Pierdomenico, Raffaele De Caterina
    Journal of Cellular and Molecular Medicine.2020; 24(5): 2857.     CrossRef
  • Recent Updates on Vascular Complications in Patients with Type 2 Diabetes Mellitus
    Chan-Hee Jung, Ji-Oh Mok
    Endocrinology and Metabolism.2020; 35(2): 260.     CrossRef
  • Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient setting
    Samit Ghosal, Binayak Sinha, Jignesh Ved, Mansij Biswas
    Indian Heart Journal.2020; 72(2): 119.     CrossRef
  • Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review
    Vitaris Kodogo, Feriel Azibani, Karen Sliwa
    Clinical Research in Cardiology.2019; 108(8): 831.     CrossRef
  • Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J2019;43:582–9)
    Tae Seo Sohn
    Diabetes & Metabolism Journal.2019; 43(6): 909.     CrossRef
  • Effects of Diabetes on Motor Recovery After Cerebral Infarct: A Diffusion Tensor Imaging Study
    Jun Sung Moon, Seung Min Chung, Sung Ho Jang, Kyu Chang Won, Min Cheol Chang
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(9): 3851.     CrossRef
Brief Report
Others
Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
Ji Min Kim, Sorim Choung, Kyong Hye Joung, Ju Hee Lee, Hyun Jin Kim, Bon Jeong Ku
Diabetes Metab J. 2018;42(4):343-347.   Published online May 2, 2018
DOI: https://doi.org/10.4093/dmj.2017.0082
  • 7,369 View
  • 61 Download
  • 8 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   ePub   

We analyzed circulating soluble epidermal growth factor receptor (sEGFR) levels in humans. Serum sEGFR levels were higher in subjects with newly diagnosed type 2 diabetes mellitus compared with controls. Serum sEGFR was positively correlated with glycosylated hemoglobin and serum glucose and negatively correlated with serum insulin and C-peptide levels.

Citations

Citations to this article as recorded by  
  • Cutaneous epidermal growth factor receptor expression (EGFR) and soluble EGFR levels are elevated in patients with pemphigus vulgaris: a longitudinal study
    Kanmani Indra Couppoussamy, Medha Rajappa, Laxmisha Chandrashekar
    Archives of Dermatological Research.2025;[Epub]     CrossRef
  • Type 2 diabetes mellitus and non-muscle invasive bladder cancer: characteristics of the epidermal growth factor system components content in blood, urine, and tumor
    I. V. Kaplieva, E. M. Ataeva, E. M. Frantsiyants, L. K. Trepitaki, Yu. A. Petrova, A. N. Shewchenko, P. S. Kachesova, D. A. Shvyrev, S. G. Vlasov
    Cancer Urology.2025; 21(2): 48.     CrossRef
  • Increased serum extrachromosomal circular DNA SORBS1circle level is associated with insulin resistance in patients with newly diagnosed type 2 diabetes mellitus
    Xiang Kong, Shu-jun Wan, Tian-bing Chen, Lan Jiang, Yu-jie Xing, Ya-ping Bai, Qiang Hua, Xin-ming Yao, Yong-li Zhao, Hong-mei Zhang, De-guo Wang, Qing Su, Kun Lv
    Cellular & Molecular Biology Letters.2024;[Epub]     CrossRef
  • A Pilot Genome-Wide Association Study Identifies Novel Markers of Metabolic Syndrome in Patients with Psoriasis
    Seung-Min Oh, Su-Kang Kim, Hye-Jin Ahn, Ki-Heon Jeong
    Annals of Dermatology.2023; 35(4): 285.     CrossRef
  • Effect of cholesterol-lowering agents on soluble epidermal growth factor receptor level in type 2 diabetes and hypercholesterolemia
    Jun Choul Lee, Kyong Hye Joung, Ji Min Kim, Seon Mee Kang, Hyun Jin Kim, Bon Jeong Ku
    Medicine.2022; 101(34): e30287.     CrossRef
  • Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects
    Mayu Kyohara, Jun Shirakawa, Tomoko Okuyama, Yu Togashi, Ryota Inoue, Jinghe Li, Daisuke Miyashita, Yasuo Terauchi
    Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
  • Epidermal growth factor protects against myocardial ischaemia reperfusion injury through activating Nrf2 signalling pathway
    Jun Ma, Ge Jin
    Free Radical Research.2019; 53(3): 313.     CrossRef
Original Articles
Complications
Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome
Kwi-Hyun Bae, Sung Woo Kim, Yeon-Kyung Choi, Jung Beom Seo, Namkyun Kim, Chang-Yeon Kim, Won Kee Lee, Sungwoo Lee, Jung Guk Kim, In-Kyu Lee, Jang Hoon Lee, Keun-Gyu Park
Diabetes Metab J. 2018;42(3):207-214.   Published online May 2, 2018
DOI: https://doi.org/10.4093/dmj.2017.0081
  • 9,037 View
  • 84 Download
  • 30 Web of Science
  • 30 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a circulating protein that promotes degradation of the low density lipoprotein receptor. PCSK9 has emerged as a target for lipid-lowering therapy, but the predictive value of the serum level of PCSK9 for the severity of coronary disease is largely unknown.

Methods

From December 2009 to July 2012, 121 individuals who underwent coronary angiography (CAG) because of clinically suspected acute coronary syndrome were enrolled in this study. Serum levels of PCSK9 and metabolic parameters were measured. SYNTAX (SYNergy between percutaneous coronary intervention with [paclitaxel-eluting] TAXUS stent and cardiac surgery) and GRACE (Global Registry of Acute Coronary Events) scores were calculated.

Results

Individuals with CAG lesions (n=100) had significantly higher levels of PCSK9 than those without lesions (n=21). The study population was stratified into three groups according to serum levels of PCSK9. The odds radio for occurrence of one or more CAG lesions was significantly higher in the group with the highest level of PCSK9 (odds ratio, 7.468; P=0.011) than in the group with the lowest level of PCSK9. Serum PCSK9 was positively associated with the number of involved coronary arteries. Multivariable linear regression indicated that levels of PCSK9 were positively correlated with GRACE risk scores and SYNTAX scores.

Conclusion

Serum PCSK9 concentrations are higher in patients with coronary artery lesions, and are associated with SYNTAX and GRACE scores, suggesting that PCSK9 is a potential biomarker of the severity of coronary artery disease.

Citations

Citations to this article as recorded by  
  • A study of extended lipid profile in patients with acute coronary syndrome: Focus on Lipoprotein(a) and PCSK9
    Pradeep Kumar, Sudesh Prajapathi, Abhishek Singh, Akshyaya Pradhan, Ayush Shukla, Monika Bhandari, Akhil Sharma, Pravesh Vishwakarma, Gaurav Chaudhary, Sharad Chandra, Rishi Sethi, Sudhanshu Dwivedi, Raman Puri
    International Journal of Cardiology Cardiovascular Risk and Prevention.2026; 28: 200558.     CrossRef
  • PCSK9 in metabolism and diseases
    Amir Ajoolabady, Domenico Pratico, Mohsen Mazidi, Ian G. Davies, Gregory Y.H. Lip, Nabil Seidah, Peter Libby, Guido Kroemer, Jun Ren
    Metabolism.2025; 163: 156064.     CrossRef
  • The correlation between serum MHR and NLR and the severity of coronary lesions in NSTE-ACS patients of different genders
    Yanping Yang, Xiaobing Lv, Kai Tan, Kai Li, Shaohua Li, Xia Meng, Yunyun Chen, Fuqing Wang, Hui Xin
    Frontiers in Cardiovascular Medicine.2025;[Epub]     CrossRef
  • Clinical Significance of PCSK9 and Soluble P-selectin in Predicting Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
    Yao Yao, Qining Qiu, Xiaoye Li, Zi Wang, Shikun Xu, Qianzhou Lv
    Cardiovascular Innovations and Applications.2024;[Epub]     CrossRef
  • The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol
    Mieczysław Dutka, Karolina Zimmer, Michał Ćwiertnia, Tomasz Ilczak, Rafał Bobiński
    Heart Failure Reviews.2024; 29(5): 917.     CrossRef
  • Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease
    Kiyoshi Hibi, Masaomi Gohbara, Kohei Uemura, Noriaki Iwahashi, Kozo Okada, Hiroshi Iwata, Yoshihiro Fukumoto, Takafumi Hiro, Yukio Ozaki, Satoshi Iimuro, Ichiro Sakuma, Seiji Hokimoto, Katsumi Miyauchi, Yutaka Matsuyama, Yoshihisa Nakagawa, Hisao Ogawa, H
    Journal of Clinical Lipidology.2024; 18(5): e844.     CrossRef
  • Lipoprotein transport and metabolism markers in patients with myocardial infarction in the Biobank of Yugra blood sample collection
    A. S. Vorobyov, M. Yu. Donnikov, O. S. Glotov, L. V. Kovalenko, K. Yu. Nikolaev, I. A. Urvantseva, Yu. A. Drenina, A. V. Morozkina, G. N. Chernysheva
    Cardiovascular Therapy and Prevention.2024; 23(11): 4178.     CrossRef
  • Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing
    Pablo Corral, Carlos A. Aguilar Salinas, María Gabriela Matta, Valeria Zago, Laura Schreier
    Current Atherosclerosis Reports.2023; 25(12): 899.     CrossRef
  • Evaluation of Proprotein Convertase Subtilisin/Kexin Type 9 in Patients with Acute Coronary Syndrome: An Observational Study
    Arshi Sanober, M Noorjahan, J Ashwini Kumari, Oruganti Sai Satish, N N Sreedevi, M Vijaya Bhaskar, Sai Baba S S Kompella, Siraj Ahmed Khan
    Journal of Clinical and Preventive Cardiology.2023; 12(1): 3.     CrossRef
  • Relationship of sortilin and proprotein convertase subtilisin/kexin type 9 in blood serum with the severity of carotid and coronary atherosclerosis in hypertensive patients
    Yu. Yu. Vukolova, I. V. Gubareva
    Russian Journal of Cardiology.2022; 27(2S): 4903.     CrossRef
  • PCSK9 Inhibition could be Effective for Acute Myocardial Infarction
    Baris Gencer, François Mach
    Current Medicinal Chemistry.2022; 29(6): 1016.     CrossRef
  • Peri-event plasma PCSK9 and hsCRP after an acute myocardial infarction correlate with early deterioration of left ventricular ejection fraction: a cohort study
    Lina S. Silva-Bermúdez, Andrea Vargas-Villanueva, Carlos A. Sánchez-Vallejo, Ana C. Palacio, Andrés F. Buitrago, Carlos O. Mendivil
    Lipids in Health and Disease.2022;[Epub]     CrossRef
  • Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women
    Francesco Spannella, Federico Giulietti, Roberta Galeazzi, Anna Passarelli, Serena Re, Chiara Di Pentima, Massimiliano Allevi, Paolo Magni, Riccardo Sarzani
    Biomedicines.2022; 10(8): 1961.     CrossRef
  • Sex difference in circulating PCSK9 and its clinical implications
    Fang Jia, Si-Fan Fei, De-Bing Tong, Cong Xue, Jian-Jun Li
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall
    Yanan Guo, Binjie Yan, Yu Gui, Zhihan Tang, Shi Tai, Shenghua Zhou, Xi‐Long Zheng
    Journal of Cellular Physiology.2021; 236(4): 2333.     CrossRef
  • PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction
    Marianne Zeller, Gilles Lambert, Michel Farnier, Maud Maza, Brice Nativel, Luc Rochette, Catherine Vergely, Yves Cottin
    Nutrition, Metabolism and Cardiovascular Diseases.2021; 31(3): 880.     CrossRef
  • Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction
    Jing Gao, Ya-Nan Yang, Zhuang Cui, Si-Yuan Feng, Jing Ma, Chang-Ping Li, Yin Liu
    Lipids in Health and Disease.2021;[Epub]     CrossRef
  • Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
    Yuen-Kwun Wong, Hung-Fat Tse
    Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
  • Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations and Cardiovascular Events in Cardiovascular Disease: A Systemic Review and Meta-Analysis
    Jiahui Liu, Fangfang Fan, Xingyu Luo, Wenjun Ji, Yaokun Liu, Yan Zhang, Bo Zheng
    Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
  • PCSK9 in acute coronary syndrome: analysis of associations with clinical and laboratory characteristics
    Yu. A. Drenina, K. Yu. Nikolaev
    Cardiovascular Therapy and Prevention.2020; 19(4): 2484.     CrossRef
  • Relation of Proprotein Convertase Subtilisin/Kexin Type 9 to Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
    Ik Jun Choi, Sungmin Lim, Dongjae Lee, Won Jik Lee, Kwan Yong Lee, Mi-Jeong Kim, Doo Soo Jeon
    The American Journal of Cardiology.2020; 133: 54.     CrossRef
  • A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America
    Ashraf Reda, Wael Almahmeed, Idit Dobrecky-Mery, Po-Hsun Huang, Ursulo Juarez-Herrera, Naresh Ranjith, Tobias Sayre, Miguel Urina-Triana
    Advances in Therapy.2020; 37(5): 1754.     CrossRef
  • PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
    Štefan Tóth, Peter Olexa, Zdenka Hertelyová, Peter Štefanič, Ivan Kopolovets, Peter Berek, Vladimir Filip, Ryan Chakravarty, Monika Široká, Daniel Pella
    Open Chemistry.2020; 18(1): 1011.     CrossRef
  • Association of serum proprotein convertase subtilisin/kexin type 9 with early atherosclerosis in newly diagnosed type 2 diabetes mellitus
    Wen Guo, Yingyun Gong, Jie Li, Pei Qin, Jing Lu, Xiaona Li, Wenfang Zhu, Nianzhen Xu, Hongwen Zhou, Qun Zhang
    Nutrition, Metabolism and Cardiovascular Diseases.2019; 29(8): 815.     CrossRef
  • PCSK9 and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography
    Yunes Panahi, Mohsen Sadeghi Ghahrodi, Mohsen Jamshir, Mohammad Amin Safarpour, Vanessa Bianconi, Matteo Pirro, Maryam Moshkani Farahani, Amirhossein Sahebkar
    Clinical Biochemistry.2019; 74: 12.     CrossRef
  • Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
    Chiara Caselli, Serena Del Turco, Rosetta Ragusa, Valentina Lorenzoni, Michiel De Graaf, Giuseppina Basta, Arthur Scholte, Raffaele De Caterina, Danilo Neglia
    Cardiovascular Diabetology.2019;[Epub]     CrossRef
  • PCSK9 inhibition and inflammation: A narrative review
    Massimiliano Ruscica, Lale Tokgözoğlu, Alberto Corsini, Cesare R. Sirtori
    Atherosclerosis.2019; 288: 146.     CrossRef
  • Letter: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
    Jin Hwa Kim
    Diabetes & Metabolism Journal.2018; 42(4): 348.     CrossRef
  • Response: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
    Sung Woo Kim, Keun-Gyu Park
    Diabetes & Metabolism Journal.2018; 42(4): 350.     CrossRef
  • Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population
    Gaojun Cai, Lei Yu, Zhiying Huang, Li Li, Xingli Fu
    Lipids in Health and Disease.2018;[Epub]     CrossRef
Complications
Color Doppler Ultrasonography Is a Useful Tool for Diagnosis of Peripheral Artery Disease in Type 2 Diabetes Mellitus Patients with Ankle-Brachial Index 0.91 to 1.40
Kyu Yeon Hur, Ji Eun Jun, Young Ju Choi, Yong-ho Lee, Dae Jung Kim, Seok Won Park, Byung Wook Huh, Eun Jig Lee, Sun-Ha Jee, Kap Bum Huh, Sung Hee Choi
Diabetes Metab J. 2018;42(1):63-73.   Published online February 23, 2018
DOI: https://doi.org/10.4093/dmj.2018.42.1.63
  • 12,323 View
  • 126 Download
  • 29 Web of Science
  • 33 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The clinical utility of ankle-brachial index (ABI) is not clear in subjects with less severe or calcified vessel. Therefore, we investigated the usefulness of color Doppler ultrasonography for diagnosing peripheral artery disease (PAD) in type 2 diabetes mellitus (T2DM) subjects.

Methods

We analyzed 324 T2DM patients who concurrently underwent ABI and carotid intima-media thickness (CIMT) measurements and color Doppler ultrasonography from 2003 to 2006. The degree of stenosis in patients with PAD was determined according to Jager's criteria, and PAD was defined as grade III (50% to 99% stenosis) or IV stenosis (100% stenosis) by color Doppler ultrasonography. Logistic regression analysis and receiver operating characteristic curve analysis were performed to evaluate the risk factors for PAD in patients with ABI 0.91 to 1.40.

Results

Among the 324 patients, 77 (23.8%) had ABI 0.91 to 1.40 but were diagnosed with PAD. Color Doppler ultrasonography demonstrated that suprapopliteal arterial stenosis, bilateral lesions, and multivessel involvement were less common in PAD patients with ABI 0.91 to 1.40 than in those with ABI ≤0.90. A multivariate logistic regression analysis demonstrated that older age, current smoking status, presence of leg symptoms, and high CIMT were significantly associated with the presence of PAD in patients with ABI 0.91 to 1.40 after adjusting for conventional risk factors. CIMT showed significant power in predicting the presence of PAD in patients with ABI 0.91 to 1.40.

Conclusion

Color Doppler ultrasonography is a useful tool for the detection of PAD in T2DM patients with ABI 0.91 to 1.40 but a high CIMT.

Citations

Citations to this article as recorded by  
  • Camera-Based Bipedal Plantar Pulse Transit Time Difference Measurement for Lower Limb Arterial Stenosis Detection
    Zhiyuan Xu, Shuhan Yi, Yukai Huang, Dongmin Huang, Zi Luo, Ningbo Zhao, Wenjin Wang
    IEEE Transactions on Biomedical Engineering.2026; 73(1): 255.     CrossRef
  • Value and Comparison of Insulin Resistance-Related Indexes as Biomarkers in Predicting Peripheral Artery Disease in Type 2 Diabetes Mellitus
    莉 马
    Advances in Clinical Medicine.2026; 16(01): 2527.     CrossRef
  • Doppler sonographic evaluation of peripheral arterial disease and its associated factors among diabetes mellitus patients at Muhimbili National Hospital, Tanzania: A hospital-based cross-sectional study
    James Alex Sumawe, Lilian Salingwa, Esha Arora
    PLOS One.2026; 21(4): e0328852.     CrossRef
  • Burden of peripheral artery disease and risk factors among patients with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis
    Kirubel Eshetu Haile, Yordanos Sisay Asgedom, Gedion Asnake Azeze, Atitegeb Alebachew Amsalu, Gizachew Ambaw Kassie, Amanuel Yosef Gebrekidan
    BMC Endocrine Disorders.2025;[Epub]     CrossRef
  • Determinants of poor health-related quality of life in people with peripheral arterial disease in Nepal
    Prabha Shrestha, Robin Man Karmacharya, Brajesh Shrestha
    Journal of Vascular Nursing.2025; 43(3): 136.     CrossRef
  • Exploring the prevalence and risk factors of peripheral artery disease in patients with type 2 diabetes in sub-Saharan Africa: a systematic review and meta-analysis
    Kirubel Eshetu Haile, Atitegeb Alebachew Amsalu, Gizachew Ambaw Kassie, Yordanos Sisay Asgedom, Gedion Asnake Azeze, Amanuel Yosef Gebrekidan
    Frontiers in Clinical Diabetes and Healthcare.2025;[Epub]     CrossRef
  • Peripheral vascular disease and its associated factors among diabetic patients on follow-up at Ras Desta Damtew Memorial Hospital, Addis Ababa, Ethiopia
    Zerihun Chala Deme, Getchew Fekadu Feda, Dereje Tsegaye, Agumasie Semahegn
    Endocrine and Metabolic Science.2025; 19: 100271.     CrossRef
  • Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review
    Vivienne Chuter, Nicolaas Schaper, Joseph Mills, Robert Hinchliffe, David Russell, Nobuyoshi Azuma, Christian‐Alexander Behrendt, Edward J. Boyko, Michael S. Conte, Misty Humphries, Lee Kirksey, Katharine C. McGinigle, Sigrid Nikol, Joakim Nordanstig, Vin
    Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
  • The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer
    Robert Fitridge, Vivienne Chuter, Joseph Mills, Robert Hinchliffe, Nobuyoshi Azuma, Christian‐Alexander Behrendt, Edward J. Boyko, Michael S. Conte, Misty Humphries, Lee Kirksey, Katharine C. McGinigle, Sigrid Nikol, Joakim Nordanstig, Vincent Rowe, David
    Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
  • Diabetic Foot Complications in Saudi Arabia: A Retrospective Study
    Sherif M Zaki, Dina S El Karsh, Tuleen M Faden, Leen T Almghamsi, Joud O Fathaldin, Omar A Alhazmi
    Cureus.2024;[Epub]     CrossRef
  • Role of Color Doppler Ultrasound to Evaluate the Lower Limb Deep Venous Thrombosis in Diabetic Patients
    Muhammad Ahmad Raza, Abdul Rauf, Bushra Akmal Khan, Muhammad Asad Alam, Laamia Altuf, Aftab Alloudin, Saman Fatima
    Pakistan Journal of Health Sciences.2024; : 03.     CrossRef
  • Risk factors of peripheral occlusive arterial disease in patients with diabetic retinopathy due to type 2 diabetes
    Milos Maksimovic
    Srpski arhiv za celokupno lekarstvo.2024; 152(1-2): 50.     CrossRef
  • Current Opinion on Diagnosis of Peripheral Artery Disease in Diabetic Patients
    Francesca Ghirardini, Romeo Martini
    Medicina.2024; 60(7): 1179.     CrossRef
  • A Review of Peripheral Artery Disease in Diabetic Patients in Sub-Saharan Africa
    Ayoyimika O Okunlola, Temitope O Ajao, Abbas Karim, Mwila Sabi, Olayinka Kolawole, Kenneth Ugwoke, Manoj K Mahadevaswamysusheela
    Cureus.2024;[Epub]     CrossRef
  • Comparison of Color Doppler Ultrasound and Ankle-Brachial Pressure Index Measurement in Peripheral Vascular Diseases
    Shradha Gupta, Amit Mahajan, Anil Luther, Shubhra Rathore
    Indian Journal of Surgery.2023; 85(S1): 177.     CrossRef
  • Are portable ankle brachial pressure index measurement devices suitable for hypertension screening?
    Justyna Janus, Jennifer K. Nicholls, Edward Pallett, Matthew Bown, Emma M. L. Chung, Mohamed Yacin Sikkandar
    PLOS ONE.2023; 18(3): e0283281.     CrossRef
  • Clinical characteristics and risk factors of lower extremity amputation in the diabetic inpatients with foot ulcers
    Hongping Gong, Yan Ren, Zhenyi Li, Panpan Zha, Raju Bista, Yan Li, Dawei Chen, Yun Gao, Lihong Chen, Xingwu Ran, Chun Wang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Diabetes mellitus and long-time outcomes of autovenous femoro-popliteal bypass
    A. S. Artemova, M. A. Chernyavskiy
    Diabetes mellitus.2023; 26(2): 182.     CrossRef
  • Association between carotid ultrasonographic parameters and microvascular and macrovascular complications in diabetes: A systematic review and meta-analysis
    Meimei Liao, Sen Chen, Ruiqiang Guo
    Journal of Diabetes and its Complications.2023; 37(8): 108554.     CrossRef
  • The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer
    Robert Fitridge, Vivienne Chuter, Joseph Mills, Robert Hinchliffe, Nobuyoshi Azuma, Christian-Alexander Behrendt, Edward J. Boyko, Michael S. Conte, Misty Humphries, Lee Kirksey, Katharine C. McGinigle, Sigrid Nikol, Joakim Nordanstig, Vincent Rowe, David
    Journal of Vascular Surgery.2023; 78(5): 1101.     CrossRef
  • Editor's Choice – The Intersocietal IWGDF, ESVS, SVS Guidelines on Peripheral Artery Disease in People With Diabetes Mellitus and a Foot Ulcer
    Robert Fitridge, Vivienne Chuter, Joseph Mills, Robert Hinchliffe, Nobuyoshi Azuma, Christian-Alexander Behrendt, Edward J. Boyko, Michael S. Conte, Misty Humphries, Lee Kirksey, Katharine C. McGinigle, Sigrid Nikol, Joakim Nordanstig, Vincent Rowe, David
    European Journal of Vascular and Endovascular Surgery.2023; 66(4): 454.     CrossRef
  • Peripheral Artery Disease: A Comprehensive Updated Review
    Garba Rimamskep Shamaki, Favour Markson, Demilade Soji-Ayoade, Chibuike Charles Agwuegbo, Michael Olaseni Bamgbose, Bob-Manuel Tamunoinemi
    Current Problems in Cardiology.2022; 47(11): 101082.     CrossRef
  • Reliability of bedside tests for diagnosing peripheral arterial disease in patients prone to medial arterial calcification: A systematic review
    Jeroen J.W.M. Brouwers, Siem A. Willems, Lauren N. Goncalves, Jaap F. Hamming, Abbey Schepers
    eClinicalMedicine.2022; 50: 101532.     CrossRef
  • Comparative Doppler Ultrasound Findings of Foot Arteries in Patients with Type 2 Diabetes Mellitus and Normoglycaemic Patients
    Latifat Tunrayo Oduola-Owoo, Adekunle Ayokunle Adeyomoye, Omodele Abosede Olowoyeye, Ifedayo Adeola Odeniyi, Bukunmi Michael Idowu, Badmus Babatunde Oduola-Owoo, Adeniyi Sunday Aderibigbe
    Journal of West African College of Surgeons.2022; 12(1): 55.     CrossRef
  • Reliability of Bedside Tests for Diagnosing Peripheral Arterial Disease in Patients Prone to Medial Arterial Calcification: A Systematic Review
    Jeroen Brouwers, Siem Willems, Lauren Goncalves, Jaap Hamming, Abbey Schepers
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Estimating the diagnostic accuracy of the ankle–brachial pressure index for detecting peripheral arterial disease in people with diabetes: A systematic review and meta‐analysis
    V. H. Chuter, A. Searle, A. Barwick, J. Golledge, L. Leigh, C. Oldmeadow, B. Peterson, P. Tehan, S. M. Twigg
    Diabetic Medicine.2021;[Epub]     CrossRef
  • Prevalence of peripheral arterial disease and associated factors in people with type 2 diabetes
    Pedro José da Silva Filho, Elaine Cristina Martinez Teodoro, Elaine Cristina Alves Pereira, Vania Cristina dos Reis Miranda
    Fisioterapia em Movimento.2021;[Epub]     CrossRef
  • Peripheral Arterial Disease and Its Associated Factors among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia
    Yonas Akalu, Ambaye Birhan
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Critical analysis and limitations of resting ankle-brachial index in the diagnosis of symptomatic peripheral arterial disease patients and the role of diabetes mellitus and chronic kidney disease
    Ali F. AbuRahma, Elliot Adams, Joseph AbuRahma, Luis A. Mata, L. Scott Dean, Cristyn Caron, Jennifer Sloan
    Journal of Vascular Surgery.2020; 71(3): 937.     CrossRef
  • Association of Time in Range levels with Lower Extremity Arterial Disease in patients with type 2 diabetes
    Jinfeng Li, Ya Li, Weiguo Ma, Yishan Liu, Xiaohong Yin, Chuanqing Xie, Jiao Bai, Min Zhang
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(6): 2081.     CrossRef
  • The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: A systematic review and meta-analysis
    Ángel Herraiz-Adillo, Iván Cavero-Redondo, Celia Álvarez-Bueno, Diana P. Pozuelo-Carrascosa, Montserrat Solera-Martínez
    Atherosclerosis.2020; 315: 81.     CrossRef
  • Exercise-induced calf muscle hyperemia: quantitative mapping with low-dose dynamic contrast enhanced magnetic resonance imaging
    Jeff L. Zhang, Gwenael Layec, Christopher Hanrahan, Christopher C. Conlin, Corey Hart, Nan Hu, Lillian Khor, Michelle Mueller, Vivian S. Lee
    American Journal of Physiology-Heart and Circulatory Physiology.2019; 316(1): H201.     CrossRef
  • Comparison of different methods of ABI acquisition for detection of peripheral artery disease in diabetic patients
    Miroslav Homza, Ondrej Machaczka, Martin Porzer, Milan Kozak, Jiri Plasek, David Sipula
    Biomedical Papers.2019; 163(3): 227.     CrossRef
Reviews
Clinical Diabetes & Therapeutics
The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis
Jinyue Yu, Peige Song, Rachel Perry, Chris Penfold, Ashley R. Cooper
Diabetes Metab J. 2017;41(4):251-262.   Published online August 22, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.4.251
  • 24,243 View
  • 196 Download
  • 63 Web of Science
  • 66 Crossref
AbstractAbstract PDFPubReader   ePub   

Green tea or green tea extract (GT/GTE) has been demonstrated to reduce insulin resistance and improve glycemic control. However, evidence for this health beneficial effect is inconsistent. This systematic review evaluated the effect of GT/GTE on insulin resistance and glycemic control in people with pre-diabetes/type 2 diabetes mellitus (T2DM). Ovid MEDLINE, Embase, AMED, Web of Science, and the Cochrane Library were searched up to April 2017 for randomised controlled trials of participants with pre-diabetes or T2DM, where the intervention was GT/GTE. Meta-analysis was performed to assess the standardised mean difference (SMD) in biomarkers of insulin resistance and glycemic control between GT/GTE and placebo groups. Six studies (n=382) were pooled into random-effects meta-analysis. Overall, no differences were found between GT/GTE and the placebo for glycosylated hemoglobin (HbA1c: SMD, −0.32; 95% confidence interval [CI], −0.86 to 0.23), homeostatic model assessment for insulin resistance (HOMA-IR: SMD, 0.10; 95% CI, −0.17 to 0.38), fasting insulin (SMD, −0.25; 95% CI, −0.64 to 0.15), and fasting glucose (SMD, −0.10; 95% CI, −0.50 to 0.30). No evidence support the consumption of GT/GTE could reduce the levels of HbA1c, HOMA-IR, fasting insulin, or fasting glucose in people with pre-diabetes/T2DM. However, the studies included were small and of varying quality.

Citations

Citations to this article as recorded by  
  • Identification of green tea varieties and origins based on fused surface enhanced Raman spectra from different extraction solvent
    Su-Ming Dai, Yu Shen, Jing-Xiang Wang, Xin-Xin Zhang, Yao-Yao Zhang, Ya-Ying Huang, Ri-Hui Su, Jun Yan
    Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2026; 348: 127220.     CrossRef
  • Harnessing Phytochemicals and Nanotechnology Synergy for Molecular, Epigenetic, and Microbiota-Driven Regulation in Type 2 Diabetes Mellitus
    Gagan Prakash, Anis Ahmad Chaudhary, Ruchita Tanu, Mohamed A. M. Ali, Fehmi Boufahja, Pushpender K. Sharma, Sudarshan Singh Lakhawat, Tejpal Yadav, Navneet Kumar Upadhyay, Vikram Kumar
    Pharmaceutics.2026; 18(1): 113.     CrossRef
  • Mechanisms of green tea-induced attenuation of osteoporosis and skeletal muscle atrophy: current status and future study recommendations for clinical application
    Youngjoo Kwon
    Critical Reviews in Food Science and Nutrition.2026; : 1.     CrossRef
  • Green Tea Catechin Plus Inulin Improves Insulin Resistance Without Reducing Visceral Fat and Shows Exploratory Gut Microbiota Signals in Adults with Visceral Obesity: A Double-Blind Randomized Controlled Trial
    Chikara Iino, Keita Mikami, Keisuke Furusawa, Satoshi Sato, Kenta Yoshida, Tohru Yamaguchi, Hiroto Bushita, Keita Kinoshita, Yuji Matsui, Seiya Imoto, Takuro Iwane, Yoshinori Tamada, Koichi Murashita, Shigeyuki Nakaji, Tatsuya Mikami, Hirotake Sakuraba
    Nutrients.2026; 18(5): 851.     CrossRef
  • Understanding the role of green tea and matcha consumption in cardiovascular health, obesity, and diabetes: Insights from a Saudi Arabian population
    Faisal Alsenani, Nasser Alotaiq, Doni Dermawan, Nasr Eldin Elwali, Mohammed Z. Nasrullah, Rashed H. Almalki, Nahar T. Alfarsi, Alwaleed S. Almatrafi, Muhannad S. Alsulami
    Human Nutrition & Metabolism.2025; 40: 200302.     CrossRef
  • The effect of green tea supplementation on body composition, muscle damage, and maximal oxygen consumption: a systematic review and meta-analysis of clinical trials
    Nastaran Mahmoudi Shirkoohi, Haniyeh Lorzadeh Amin, Salih M. S. Zebari, Fatemeh Naeini, Parisa Karimi, Sakineh Shab-Bidar, Kurosh Djafarian
    Sport Sciences for Health.2025; 21(4): 2407.     CrossRef
  • Matcha Green Tea Improves Cafeteria-Diet-Induced NAFLD by Modulating the Gut Microbiota in Rats
    Ho-Ching Chong, Shu-Ting Tang, Yu-Chieh Tseng, Suh-Ching Yang, Yasuo Watanabe, Shizuo Yamada, Yu-Chen S. H. Yang, Ya-Ling Chen
    Nutrients.2025; 17(19): 3051.     CrossRef
  • Beneficial health effects and possible health concerns of tea consumption: a review
    Mingchuan Yang, Li Zhou, Zhipeng Kan, Zhoupin Fu, Xiangchun Zhang, Chung S. Yang
    Beverage Plant Research.2025;[Epub]     CrossRef
  • Acute Effect of Black Tea, Green Tea, and Coffee on Blood Pressure and Blood Glucose in Healthy Female Subjects
    Esther Oluwasola Aluko, Ezekiel Etim Ben, Grace Edet Bassy
    Cardiovascular & Hematological Agents in Medicinal Chemistry.2025; 23(4): 276.     CrossRef
  • Mechanistic Insights into Antioxidant Interventions Targeting Obesity-Induced Oxidative Stress in the Pathogenesis and Complications of Type 2 Diabetes Mellitus
    Fani-Niki Varra, Panagiotis Theodosis-Nobelos, Viktoria-Konstantina Varra, Michail Varras
    Current Issues in Molecular Biology.2025; 47(12): 1063.     CrossRef
  • Quercetin and Catechin Modulate Alloxan-Induced Nephrotoxicity in Mice by Affecting Oxidative Stress, Inflammation and COX-2 Protein Expression
    Amir Hossein Rastineh, Maryam Khamisi Pour, Ali Vadizadeh, Masoud Mahdavinia, Fereshtesadat Fakhredini, Mahdieh Sadat Badiee
    Jundishapur Journal of Natural Pharmaceutical Products.2025;[Epub]     CrossRef
  • Is breakfast consumption detrimental, unnecessary, or an opportunity for health promotion? A review of cardiometabolic outcomes and functional food choices
    Heitor O. Santos, Grant M. Tinsley
    Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
  • The effect of green tea supplementation on the anthropometric outcomes in overweight and obese women: a time and dose-response meta-analysis of randomized controlled trials
    Yiyi Zhang, Nie Tang, Wei Xia, Shaikh Sanjid Seraj, Marcos Pereira, Periyannan Velu, Hui Zhou, Hanshu Yang, Guanggang Du
    Critical Reviews in Food Science and Nutrition.2024; 64(28): 10138.     CrossRef
  • A comparison of the effects of green tea and cocoa on glycaemic control and insulin sensitivity in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Hind Mesfer S. Alkhudaydi, Jeremy P.E. Spencer
    Nutrition and Healthy Aging.2024; 9(1): 17.     CrossRef
  • Association between green tea intake and digestive system cancer risk in European and East Asian populations: a Mendelian randomization study
    Duorui Nie, Xiaoyu He, Hao Zheng, Deyu Deng, Fanghui He, Ruyi Li, Xiaoting Ni, Shunxiang Li, Fei Xu
    European Journal of Nutrition.2024; 63(4): 1103.     CrossRef
  • From Gut to Glucose: A Comprehensive Review on Functional Foods and Dietary Interventions for Diabetes Management
    Nirali Patel, Susha Dinesh, Sameer Sharma
    Current Diabetes Reviews.2024;[Epub]     CrossRef
  • Anti-atherogenic role of green tea (Camellia sinensis) in South Indian smokers
    Venkateswarlu Reddy Kanu, Swetha Pulakuntla, Gouthami Kuruvalli, Sree Latha Aramgam, Shakeela Begum Marthadu, Padmavathi Pannuru, Ananda Vardhan Hebbani, Padma Priya Dharmavaram Desai, Kameswara Rao Badri, Damodara Reddy Vaddi
    Journal of Ethnopharmacology.2024; 332: 118298.     CrossRef
  • A novel green tea extract-loaded nanofiber coating for kiwi fruit: Improved microbial stability and nutritional quality
    Aslıhan Alav, Nazan Kutlu, Erol Kına, Raciye Meral
    Food Bioscience.2024; 62: 105043.     CrossRef
  • From a Cup of Tea to Cardiovascular Care: Vascular Mechanisms of Action
    Marios Sagris, Panayotis K. Vlachakis, Spyridon Simantiris, Panagiotis Theofilis, Maria Gerogianni, Paschalis Karakasis, Konstantinos Tsioufis, Dimitris Tousoulis
    Life.2024; 14(9): 1168.     CrossRef
  • How to better consider and understand interindividual variability in response to polyphenols in clinical trials
    Christine Morand
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • Gut microbiota as a driver of the interindividual variability of cardiometabolic effects from tea polyphenols
    Qiqiong Li, Tom Van de Wiele
    Critical Reviews in Food Science and Nutrition.2023; 63(11): 1500.     CrossRef
  • Recent insights on tea metabolites, their biosynthesis and chemo-preventing effects: A review
    Ramkumar Samynathan, Muthu Thiruvengadam, Shivraj Hariram Nile, Mohammad Ali Shariati, Maksim Rebezov, Raghvendra Kumar Mishra, Baskar Venkidasamy, Sureshkumar Periyasamy, Ill-Min Chung, Mirian Pateiro, José M. Lorenzo
    Critical Reviews in Food Science and Nutrition.2023; 63(18): 3130.     CrossRef
  • Tea's anti‐obesity properties, cardiometabolic health‐promoting potentials, bioactive compounds, and adverse effects: A review focusing on white and green teas
    Behnaz Abiri, Shirin Amini, Mahdi Hejazi, Farhad Hosseinpanah, Afshin Zarghi, Faeze Abbaspour, Majid Valizadeh
    Food Science & Nutrition.2023; 11(10): 5818.     CrossRef
  • An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes
    Anns Mahboob, Degiri Kalana Lasanga Senevirathne, Pradipta Paul, Faisal Nabi, Rizwan Hasan Khan, Ali Chaari
    International Journal of Biological Macromolecules.2023; 225: 318.     CrossRef
  • Association between green tea consumption and metabolic syndrome among Korean adults: results from the Health Examinees study
    Hyeonjin Cho, Sunwoo Han, Jiwon Jeong, Hyein Jung, Sangah Shin
    Journal of Nutrition and Health.2023; 56(1): 70.     CrossRef
  • Relevance of Indian traditional tisanes in the management of type 2 diabetes mellitus: A review
    Devi Datt Joshi, Lokesh Deb, Bharat G. Somkuwar, Virendra Singh Rana
    Saudi Pharmaceutical Journal.2023; 31(5): 626.     CrossRef
  • Evaluation the Effect of Chronic Obestatin Therapy on the Serum Glucose, Insulin And Lipid Levels in Type 2 Diabetic Rats
    Safa Al-Halbouni, Shadi Homsi, Nabil koshji
    The Open Public Health Journal.2023;[Epub]     CrossRef
  • Supplementation with a New Standardized Extract of Green and Black Tea Exerts Antiadipogenic Effects and Prevents Insulin Resistance in Mice with Metabolic Syndrome
    Mario De la Fuente-Muñoz, María De la Fuente-Fernández, Marta Román-Carmena, Sara Amor, María C. Iglesias-de la Cruz, Guillermo García-Laínez, Silvia Llopis, Patricia Martorell, David Verdú, Eva Serna, Ángel L. García-Villalón, Sonia I. Guilera, Antonio M
    International Journal of Molecular Sciences.2023; 24(10): 8521.     CrossRef
  • Ampelopsis grossedentata improves type 2 diabetes mellitus through modulating the gut microbiota and bile acid metabolism
    Yu-li Hu, Mei Li, Lei Ding, Chuan Peng, You Wu, Wei Liu, Dan Zhao, Ling-ling Qin, Xiang-yu Guo, Li-li Wu, Tong-hua Liu
    Journal of Functional Foods.2023; 107: 105622.     CrossRef
  • Green Tea and Decaffeinated Light Roasted Green Coffee Extract Combination Improved Cardiac Insulin Resistance through Free Fatty Acids and Adiponectin/FAS Pathways Amelioration in Metabolic Syndrome Rat Model
    Mifetika Lukitasari, Mohammad Saifur Rohman, Dwi Adi Nugroho, Mukhamad Nur Kholis, Nila Aisyah Wahyuni, Nashi Widodo
    F1000Research.2023; 10: 990.     CrossRef
  • Impact of Polyphenols on Inflammatory and Oxidative Stress Factors in Diabetes Mellitus: Nutritional Antioxidants and Their Application in Improving Antidiabetic Therapy
    Michal Krawczyk, Izabela Burzynska-Pedziwiatr, Lucyna A. Wozniak, Malgorzata Bukowiecka-Matusiak
    Biomolecules.2023; 13(9): 1402.     CrossRef
  • Research progress on the antidiabetic activities of tea and its bioactive components
    Jianjian Gao, Dan Chen, Zhiyuan Lin, Jiakun Peng, Shuai Yu, Chuang Zhou, Huimin Jiang, Ruofan Sun, Zhi Lin, Weidong Dai
    Beverage Plant Research.2023;[Epub]     CrossRef
  • Identifying Glucose Metabolism Status in Nondiabetic Japanese Adults Using Machine Learning Model with Simple Questionnaire
    Tomoki Uchida, Takeshi Kanamori, Takanori Teramoto, Yuji Nonaka, Hiroki Tanaka, Satoshi Nakamura, Norihito Murayama, Rajesh Kaluri
    Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
  • Potential Bioactive Components and Health Promotional Benefits of Tea ( Camellia sinensis )
    Saptadip Samanta
    Journal of the American Nutrition Association.2022; 41(1): 65.     CrossRef
  • A Mendelian Randomization Study of the Effect of Tea Intake on Type 2 Diabetes
    Yanan Zhang, Ruiqing Wang, Xinhua Tang, Yanjun Wang, Ping Guo, Shukang Wang, Jing Liu
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Dietary Supplements for Weight Management: A Narrative Review of Safety and Metabolic Health Benefits
    Eunice Mah, Oliver Chen, DeAnn J. Liska, Jeffrey B. Blumberg
    Nutrients.2022; 14(9): 1787.     CrossRef
  • Antioxidative, Anti-Inflammatory, Anti-Obesogenic, and Antidiabetic Properties of Tea Polyphenols—The Positive Impact of Regular Tea Consumption as an Element of Prophylaxis and Pharmacotherapy Support in Endometrial Cancer
    Piotr Olcha, Anna Winiarska-Mieczan, Małgorzata Kwiecień, Łukasz Nowakowski, Andrzej Miturski, Andrzej Semczuk, Bożena Kiczorowska, Krzysztof Gałczyński
    International Journal of Molecular Sciences.2022; 23(12): 6703.     CrossRef
  • Herbal tea, a novel adjuvant therapy for treating type 2 diabetes mellitus: A review
    Xiangyuan Zhang, Lili Zhang, Boxun Zhang, Ke Liu, Jun Sun, Qingwei Li, Linhua Zhao
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence
    Sarah Krull Abe, Manami Inoue
    European Journal of Clinical Nutrition.2021; 75(6): 865.     CrossRef
  • Green and white teas as health-promoting foods
    Daniel Hinojosa-Nogueira, Sergio Pérez-Burillo, Silvia Pastoriza de la Cueva, José Ángel Rufián-Henares
    Food & Function.2021; 12(9): 3799.     CrossRef
  • A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile
    Milad Davarpanah, Nafiseh Shokri-mashhadi, Rahele Ziaei, Parvane Saneei
    Scientific Reports.2021;[Epub]     CrossRef
  • Maltodextrin encapsulation improves thermal and pH stability of green tea extract catechins
    Aimara V. De La Cruz‐Molina, Jesus F. Ayala Zavala, Ariadna T. Bernal Mercado, Manuel R. Cruz Valenzuela, Gustavo A. González‐Aguilar, Jaime Lizardi‐Mendoza, Francisco Brown‐Bojorquez, Brenda A. Silva‐Espinoza
    Journal of Food Processing and Preservation.2021;[Epub]     CrossRef
  • Camellia sinensis in Dentistry: Technological Prospection and Scientific Evidence
    Lídia Audrey Rocha Valadas, Rosueti Diógenes de Oliveira Filho, Edilson Martins Rodrigues Neto, Mary Anne Medeiros Bandeira, Marta Maria de França Fonteles, Vanara Florêncio Passos, Ana Cristina de Mello Fiallos, Mara Assef Leitao Lotif, Nara Juliana Cust
    Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
  • A comprehensive insight into effects of green tea extract in polycystic ovary syndrome: a systematic review
    Vahid Maleki, Ehsaneh Taheri, Parisa Varshosaz, Fatemeh Pourteymour Fard Tabrizi, Jalal Moludi, Hamed Jafari-Vayghan, Mahdi Shadnoush, Seyed Hossein Yahyazadeh Jabbari, Mehri Seifoleslami, Mohammad Alizadeh
    Reproductive Biology and Endocrinology.2021;[Epub]     CrossRef
  • Green Tea and Decaffeinated Light Roasted Green Coffee Extract Combination Improved Cardiac Insulin Resistance through Free Fatty Acids and Adiponectin/FAS Pathway Amelioration in Metabolic Syndrome Rat Model
    Mifetika Lukitasari, Mohammad Saifur Rohman, Dwi Adi Nugroho, Mukhamad Nur Kholis, Nila Aisyah Wahyuni, Nashi Widodo
    F1000Research.2021; 10: 990.     CrossRef
  • Mechanisms Underlying the Antidiabetic Activities of Polyphenolic Compounds: A Review
    Tina Nie, Garth J. S. Cooper
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Green tea and selenium-enriched green tea ameliorates non-alcoholic fatty liver disease through peripheral 5-hydroxytryptamine signals in high-fat diet-fed mice
    Lin Zhang, Jia-Ying Xu, Ya-Fang Du, Zhang-Min Wang, Jian-Xiang Li, N. Ou-Yang, Yan Wang, Xue-Bin Yin, Li-Qiang Qin
    International Food Research Journal.2021; 28(5): 996.     CrossRef
  • Green Tea Consumption May Be Associated with Cardiovascular Disease Risk and Nonalcoholic Fatty Liver Disease in Type 2 Diabetics: A Cross-Sectional Study in Southeast China
    Huan-Huan Yang, Hui Zhou, Wan-Zhan Zhu, Cai-Long Chen, Guo-Chong Chen, Lu-Gang Yu, Li-Qiang Qin
    Journal of Medicinal Food.2020; 23(10): 1120.     CrossRef
  • The effect of green coffee extract supplementation on lipid profile: A systematic review of clinical trial and in-vivo studies
    Omid Nikpayam, Amir Hossein Faghfouri, Omid Mohammad Tavakoli-Rouzbehani, Seyyed-Mostafa Jalali, Marziyeh Najafi, Golbon Sohrab
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(5): 1521.     CrossRef
  • Biological fates of tea polyphenols and their interactions with microbiota in the gastrointestinal tract: implications on health effects
    Tingting Chen, Chung S. Yang
    Critical Reviews in Food Science and Nutrition.2020; 60(16): 2691.     CrossRef
  • Effects of Timing of Acute and Consecutive Catechin Ingestion on Postprandial Glucose Metabolism in Mice and Humans
    Masaki Takahashi, Mamiho Ozaki, Miku Tsubosaka, Hyeon-Ki Kim, Hiroyuki Sasaki, Yuji Matsui, Masanobu Hibi, Noriko Osaki, Masashi Miyashita, Shigenobu Shibata
    Nutrients.2020; 12(2): 565.     CrossRef
  • Green tea (Camellia sinensis) for the prevention of cancer
    Tommaso Filippini, Marcella Malavolti, Francesca Borrelli, Angelo A Izzo, Susan J Fairweather-Tait, Markus Horneber, Marco Vinceti
    Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
  • Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral
    Viviana Sandoval, Hèctor Sanz-Lamora, Giselle Arias, Pedro F. Marrero, Diego Haro, Joana Relat
    Nutrients.2020; 12(8): 2393.     CrossRef
  • Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
    Amir M. Al Hroob, Mohammad H. Abukhalil, Omnia E. Hussein, Ayman M. Mahmoud
    Biomedicine & Pharmacotherapy.2019; 109: 2155.     CrossRef
  • Effects and Mechanisms of Tea for the Prevention and Management of Diabetes Mellitus and Diabetic Complications: An Updated Review
    Jin-Ming Meng, Shi-Yu Cao, Xin-Lin Wei, Ren-You Gan, Yuan-Feng Wang, Shu-Xian Cai, Xiao-Yu Xu, Pang-Zhen Zhang, Hua-Bin Li
    Antioxidants.2019; 8(6): 170.     CrossRef
  • Improvement in fasting blood sugar, anthropometric measurement and hs-CRP after consumption of epigallocatechin-3-gallate (EGCG) in patients with type 2 diabetes mellitus
    Said Hadi, Meysam Alipour, Vahideh Aghamohammadi, Sahar Shahemi, Fatemeh Ghafouri-Taleghani, Niloufar Pourjavidi, Mona Foroughi, Mackaan Chraqipoor
    Nutrition & Food Science .2019; 50(2): 348.     CrossRef
  • The Phosphorylation of IRS1S307 and AktS473 Molecules in Insulin‐Resistant C2C12 Cells Induced with Palmitate Is Influenced by Epigallocatechin Gallate from Green Tea
    Salar Bakhtiyari, Motahareh Zaherara, Karimeh Haghani, Mehrdad Khatami, Ali Rashidinejad
    Lipids.2019; 54(2-3): 141.     CrossRef
  • Effect of annatto-extracted tocotrienols and green tea polyphenols on glucose homeostasis and skeletal muscle metabolism in obese male mice
    Eunhee Chung, Salvatore N. Campise, Hayli E. Joiner, Michael D. Tomison, Gurvinder Kaur, Jannette M. Dufour, Lillian Cole, Latha Ramalingam, Naima Moustaid-Moussa, Chwan-Li Shen
    The Journal of Nutritional Biochemistry.2019; 67: 36.     CrossRef
  • Studies on the Prevention of Cancer and Cardiometabolic Diseases by Tea: Issues on Mechanisms, Effective Doses, and Toxicities
    Chung S. Yang, Jinsong Zhang
    Journal of Agricultural and Food Chemistry.2019; 67(19): 5446.     CrossRef
  • Salvianolic acid B plays an anti-obesity role in high fat diet-induced obese mice by regulating the expression of mRNA, circRNA, and lncRNA
    Tian An, Jing Zhang, Bohan Lv, Yufei Liu, Jiangpinghao Huang, Juan Lian, Yanxiang Wu, Sihua Gao, Guangjian Jiang
    PeerJ.2019; 7: e6506.     CrossRef
  • Popular functional foods and herbs for the management of type-2-diabetes mellitus: A comprehensive review with special reference to clinical trials and its proposed mechanism
    Kamesh Venkatakrishnan, Hui-Fang Chiu, Chin-Kun Wang
    Journal of Functional Foods.2019; 57: 425.     CrossRef
  • Green Tea Polyphenols Modify the Gut Microbiome in db/db Mice as Co‐Abundance Groups Correlating with the Blood Glucose Lowering Effect
    Tingting Chen, Anna B. Liu, Shili Sun, Nadim J. Ajami, Matthew C. Ross, Hong Wang, Le Zhang, Kenneth Reuhl, Koichi Kobayashi, Janet C. Onishi, Liping Zhao, Chung S. Yang
    Molecular Nutrition & Food Research.2019;[Epub]     CrossRef
  • Effect of herbal tea on glycemic control in patients with type 2 diabetes
    Boxun Zhang, Rensong Yue, Xiaoying Huang, Ying Wang, Yayi Jiang, Jiawei Chin
    Medicine.2019; 98(50): e18346.     CrossRef
  • Effects of polysaccharides and polyphenolics fractions of Zijuan tea (Camellia sinensis var. kitamura) on α‐glucosidase activity and blood glucose level and glucose tolerance of hyperglycaemic mice
    Dejing Chen, Jingyuan Sun, Weixue Dong, Yixiao Shen, Zhimin Xu
    International Journal of Food Science & Technology.2018; 53(10): 2335.     CrossRef
  • Green tea consumption reduces apelin and orexin-A in overweight and obese women with different training modalities
    Rahman Soori, Azadeh Safei, Parisa Pournemati, Amine Ghram
    Sport Sciences for Health.2018; 14(2): 421.     CrossRef
  • Green tea consumption and risk of type 2 diabetes in Chinese adults: the Shanghai Women’s Health Study and the Shanghai Men’s Health Study
    Xiaona Liu, Wanghong Xu, Hui Cai, Yu-Tang Gao, Honglan Li, Bu-Tian Ji, Xiang Shu, Thomas Wang, Robert E Gerszten, Wei Zheng, Yong-Bing Xiang, Xiao-Ou Shu
    International Journal of Epidemiology.2018; 47(6): 1887.     CrossRef
Clinical Care/Education
A Clinical Practice Guideline to Guide a System Approach to Diabetes Care in Hong Kong
Ip Tim Lau
Diabetes Metab J. 2017;41(2):81-88.   Published online April 14, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.2.81
  • 9,915 View
  • 90 Download
  • 51 Web of Science
  • 51 Crossref
AbstractAbstract PDFPubReader   ePub   

The Hospital Authority of Hong Kong is a statutory body that manages all the public medical care institutions in Hong Kong. There are currently around 400,000 diabetic patients under its care at 17 hospitals (providing secondary care for 40%) and 73 General Outpatient Clinics (providing primary care for 60%). The patient population has been growing at 6% to 8% per year over the past 5 years, estimated to include over 95% of all diagnosed patients in Hong Kong. In order to provide equitable and a minimal level of care within resources and local system factors constraints, a Clinical Practice Guideline on the management of type 2 diabetes mellitus was drawn in 2013 to guide a system approach to providing diabetes care. There is an algorithm for the use of various hypoglycemic agents. An organizational drug formulary governs that less expansive options have to be used first. A number of clinical care and patient empowerment programs have been set up to support structured and systematic diabetes care. With such a system approach, there have been overall improvements in diabetes care with the percentage of patients with glycosylated hemoglobin <7% rising from 40% in 2010 to 52% in 2015.

Citations

Citations to this article as recorded by  
  • Differences in clinical profiles and cancer incidence among patients with type 2 diabetes in primary care: Comparison between multidisciplinary and usual management
    Sarah Tsz Yui Yau, Chi Tim Hung, Eman Yee Man Leung, Albert Lee, Eng Kiong Yeoh
    Journal of Multimorbidity and Comorbidity.2026;[Epub]     CrossRef
  • Age-specific associations between blood pressure and cardiovascular disease, kidney disease, and death among individuals with type 2 diabetes: a population-based cohort study
    Edith W. K. Chow, Yingnan Fan, Hongjiang Wu, Eric S. H. Lau, Aimin Yang, Elaine Chow, Alice P. S. Kong, Ronald C. W. Ma, Juliana C. N. Chan, Andrea O. Y. Luk
    Cardiovascular Diabetology.2026;[Epub]     CrossRef
  • Optimising lipid monitoring interval for primary prevention of cardiovascular disease in patients with type-2 diabetes: A target trial emulation study
    Boyuan Wang, Emily Tsui Yee Tse, Celine Sze Ling Chui, Cindy Lo Kuen Lam, Eric Yuk Fai Wan
    Diabetes Research and Clinical Practice.2026; 234: 113156.     CrossRef
  • Risk Prediction of Chronic Kidney Disease Progression in Type 2 Diabetes Mellitus Across Diverse Populations
    Yubo Zhao, Shuya Lu, Jiqiao Lu, Lin Yang, Cheuk Wai Lo, Man Kin Wong, Ting Li, Hui Ren, Xiang Li, Lin Xu, Furong Wang, Jun Liang, Daihai He, David H. K. Shum
    npj Digital Medicine.2026;[Epub]     CrossRef
  • Machine Learning Models and Risk Scoring System for Survival in Bladder Cancer Patients With Type 2 Diabetes: A 20‐Year Territory‐Wide Cohort Study
    Claire Chenwen Zhong, Junjie Huang, Zhaojun Li, Yu Jiang, Zehuan Yang, Jinqiu Yuan, Xiaodan Huang, Xiaofang Liu, Queran Lin, Han Wang, Jonathan Poon, Anthony Chi-Fai Ng, Martin C. S. Wong, Mohammad H. Ather
    Advances in Urology.2026;[Epub]     CrossRef
  • Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study
    Oscar Hou In Chou, Lei Lu, Cheuk To Chung, Jeffrey Shi Kai Chan, Raymond Ngai Chiu Chan, Athena Yan Hiu Lee, Edward Christopher Dee, Kenrick Ng, Hugo Hok Him Pui, Sharen Lee, Bernard Man Yung Cheung, Gary Tse, Jiandong Zhou
    Diabetes & Metabolism.2025; 51(1): 101571.     CrossRef
  • An electronic health record-linked machine learning tool for diabetes risk assessment in adults with prediabetes
    Jiqiao Lu, Shuya Lu, Yubo Zhao, Lin Yang, Wing Chi Chan, Jinxiao Lian, Cheuk Wai Lo, Man Kin Wong, Ting Li, Ren Hui, Xiang Li, Lin Xu, Jun Liang, David H.K. Shum
    The Innovation Medicine.2025; 3(1): 100106.     CrossRef
  • To Determine the Risk-Based Screening Interval for Diabetic Retinopathy: Development and Validation of Risk Algorithm from a Retrospective Cohort Study
    Jinxiao Lian, Ching So, Sarah Morag McGhee, Thuan-quoc Thach, Cindy Lo Kuen Lam, Colman Siu Cheung Fung, Alfred Siu Kei Kwong, Jonathan Cheuk Hung Chan
    Diabetes & Metabolism Journal.2025; 49(2): 286.     CrossRef
  • Early onset of hypertension and increased relative risks of chronic kidney disease and mortality: two population-based cohort studies in United Kingdom and Hong Kong
    Kiki SN Liu, Boyuan Wang, Ivy L Mak, Edmond PH Choi, Cindy LK Lam, Eric YF Wan
    Hypertension Research.2025; 48(6): 1963.     CrossRef
  • Survival Tree Analysis of Interactions Among Factors Associated With Colorectal Cancer Risk in Patients With Type 2 Diabetes: Retrospective Cohort Study
    Sarah Tsz Yui Yau, Chi Tim Hung, Eman Yee Man Leung, Albert Lee, Eng Kiong Yeoh
    JMIR Public Health and Surveillance.2025; 11: e62756.     CrossRef
  • Indirect effect of the COVID-19 pandemic on cardiovascular diseases incidence, mortality, and healthcare use among patients with hypertension but without SARS-CoV-2 infection in Hong Kong: an interrupted time series analysis
    Zhuoran Hu, Yuk Kam Yau, Jianchao Quan, Karen Ann Grépin, Ivy Lynn Mak, Gary Kui Kai Lau, Ian Chi Kei Wong, David Vai Kiong Chao, Welchie Wai Kit Ko, Chak Sing Lau, Cindy Lo Kuen Lam, Eric Yuk Fai Wan
    Hypertension Research.2025; 48(8): 2197.     CrossRef
  • Disrupted specialist outpatient services and alternative modes of service for patients with diabetes mellitus: A population‐based, retrospective cohort study in Hong Kong
    Yuk Kam Yau, Meijiao Li, Jianchao Quan, Karen Ann Grépin, Gary Kui Kai Lau, Ivy Lynn Mak, Chak Sing Lau, Ian Chi Kei Wong, David Vai Kiong Chao, Welchie Wai Kit Ko, Cindy Lo Kuen Lam, Eric Yuk Fai Wan
    Diabetes, Obesity and Metabolism.2025; 27(11): 6615.     CrossRef
  • The healthcare and economic burden associated with inadequate risk factor control for type 2 diabetes in Hong Kong: A population‐based modelling study
    Aidi Liu, Yumeng Shao, Jiayin Chen, Carmen S. Ng, Yanyan Wu, Xuechen Xiong, Cindy L. K. Lam, Eric Y. F. Wan, Jianchao Quan
    Diabetes, Obesity and Metabolism.2025; 27(11): 6705.     CrossRef
  • Machine Learning–Predictive Models for Survival in Uterine Cancer Patients With Type 2 Diabetes: A Territory‐Wide Cohort Study
    Claire Chenwen Zhong, Junjie Huang, Zehuan Yang, Zhaojun Li, Yu Jiang, Jinqiu Yuan, Xiaodan Huang, Xiaofang Liu, Queran Lin, Han Wang, Jonathan Poon, Qi Dou, Irene Xin Yin Wu, Martin C. S. Wong
    Journal of Obstetrics and Gynaecology Research.2025;[Epub]     CrossRef
  • Machine Learning Predictive Models for Survival in Gastric Cancer Patients with Diabetes: A Population-Based Cohort Study
    Junjie Huang, Claire Chenwen Zhong, Zhaojun Li, Yu Jiang, Zehuan Yang, Jinqiu Yuan, Jonathan Poon, Qi Dou, Martin C.S. Wong
    Oncology.2025; : 1.     CrossRef
  • Machine Learning Predictive Models for Survival in Colorectal Cancer Patients With Diabetes: A Cohort Study of 10 749 Subjects
    Junjie Huang, Claire Chenwen Zhong, Zhaojun Li, Yu Jiang, Zehuan Yang, Jinqiu Yuan, Jonathan Poon, Qi Dou, Martin C. S. Wong
    Journal of Digestive Diseases.2025; 26(11-12): 477.     CrossRef
  • Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program
    Kailu Wang, Shi Zhao, Eric Kam-Pui Lee, Susan Zi-May Yau, Yushan Wu, Chi-Tim Hung, Eng-Kiong Yeoh
    JAMA Network Open.2024; 7(2): e2355733.     CrossRef
  • Evaluating different low‐density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study
    Eric Yuk Fai Wan, Wanchun Xu, Anna Hoi Ying Mok, Weng Yee Chin, Esther Yee Tak Yu, Celine Sze Ling Chui, Esther Wai Yin Chan, Ian Chi Kei Wong, Cindy Lo Kuen Lam, Goodarz Danaei
    Diabetes, Obesity and Metabolism.2024; 26(5): 1877.     CrossRef
  • Prevalence and factors associated with diabetes-related distress in type 2 diabetes patients: a study in Hong Kong primary care setting
    Man Ho Wong, Sin Man Kwan, Man Chi Dao, Sau Nga Fu, Wan Luk
    Scientific Reports.2024;[Epub]     CrossRef
  • Optimizing physician‐encounter frequency for type 2 diabetes patients in primary care based on cardiovascular risk assessment: A target trial emulation study
    Wanchun Xu, Yuan Wang, Peter Tanuseputro, Cindy Lo Kuen Lam, Eric Yuk Fai Wan
    Diabetes, Obesity and Metabolism.2024; 26(11): 5358.     CrossRef
  • SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong
    Chi-Ho Lee, Lung-Yi Mak, Eric Ho-Man Tang, David Tak-Wai Lui, Jimmy Ho-Cheung Mak, Lanlan Li, Tingting Wu, Wing Lok Chan, Man-Fung Yuen, Karen Siu-Ling Lam, Carlos King Ho Wong
    Hepatology.2023; 78(5): 1569.     CrossRef
  • Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review
    Calvin Ke, Emaad Mohammad, Juliana C. N. Chan, Alice P. S. Kong, Fok-Han Leung, Baiju R. Shah, Douglas Lee, Andrea O. Luk, Ronald C. W. Ma, Elaine Chow, Xiaolin Wei
    Current Diabetes Reports.2023; 23(7): 135.     CrossRef
  • Association of eGFR slope with all-cause mortality, macrovascular and microvascular outcomes in people with type 2 diabetes and early-stage chronic kidney disease
    Qiao Jin, Cindy Lo Kuen Lam, Eric Yuk Fai Wan
    Diabetes Research and Clinical Practice.2023; 205: 110924.     CrossRef
  • Association Between SGLT2 Inhibitors vs DPP-4 Inhibitors and Risk of Pneumonia Among Patients With Type 2 Diabetes
    Philip C M Au, Kathryn C B Tan, Bernard M Y Cheung, Ian C K Wong, Ying Wong, Ching-Lung Cheung
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(4): e1719.     CrossRef
  • Effectiveness of Integrative Chinese–Western Medicine for Chronic Kidney Disease and Diabetes: A Retrospective Cohort Study
    Kam Wa Chan, Tak Yee Chow, Kam Yan Yu, Yibin Feng, Lixing Lao, Zhaoxiang Bian, Vivian Taam Wong, Sydney Chi-Wai Tang
    The American Journal of Chinese Medicine.2022; 50(02): 371.     CrossRef
  • Association Between SGLT2 Inhibitors vs DPP4 Inhibitors and Renal Outcomes Among Patients With Type 2 Diabetes
    Philip C M Au, Kathryn C B Tan, Bernard M Y Cheung, Ian C K Wong, Hang-Long Li, Ching-Lung Cheung
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(7): e2962.     CrossRef
  • Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients With Diabetes: A Retrospective Cohort Study
    Kam Suen Chan, Eric Yuk Fai Wan, Weng Yee Chin, Esther Yee Tak Yu, Ivy Lynn Mak, Will Ho Gi Cheng, Margaret Kay Ho, Cindy Lo Kuen Lam
    Diabetes Care.2022; 45(5): 1162.     CrossRef
  • mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
    Eric Yuk Fai Wan, Celine Sze Ling Chui, Anna Hoi Ying Mok, Wanchun Xu, Vincent Ka Chun Yan, Francisco Tsz Tsun Lai, Xue Li, Carlos King Ho Wong, Esther Wai Yin Chan, David Tak Wai Lui, Kathryn Choon Beng Tan, Ivan Fan Ngai Hung, Cindy Lo Kuen Lam, Gabriel
    Drug Safety.2022; 45(12): 1477.     CrossRef
  • Evaluation of Fracture Risk Among Patients With Type 2 Diabetes and Nonvalvular Atrial Fibrillation Receiving Different Oral Anticoagulants
    David Tak Wai Lui, Eric Ho Man Tang, Ivan Chi Ho Au, Tingting Wu, Chi Ho Lee, Chun Ka Wong, Chloe Yu Yan Cheung, Carol Ho Yi Fong, Wing Sun Chow, Yu Cho Woo, Kathryn Choon Beng Tan, Karen Siu Ling Lam, Carlos King Ho Wong
    Diabetes Care.2022; 45(11): 2620.     CrossRef
  • Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study
    Eric Ho Man Tang, Ivy Lynn Mak, Emily Tsui Yee Tse, Eric Yuk Fai Wan, Esther Yee Tak Yu, Julie Yun Chen, Weng Yee Chin, David Vai Kiong Chao, Wendy Wing Sze Tsui, Tony King Hang Ha, Carlos King Ho Wong, Cindy Lo Kuen Lam
    Diabetes Care.2022; 45(12): 2871.     CrossRef
  • An Intervention to Change Illness Representations and Self-Care of Individuals With Type 2 Diabetes: A Randomized Controlled Trial
    Virginia W.Y. Chan, Alice P.S. Kong, Joseph T.F. Lau, Winnie W.S. Mak, Linda D. Cameron, Phoenix K.H. Mo
    Psychosomatic Medicine.2021; 83(1): 71.     CrossRef
  • Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study
    Joe Kwun Nam Chan, Corine Sau Man Wong, Philip Chi Fai Or, Eric Yu Hai Chen, Wing Chung Chang
    The British Journal of Psychiatry.2021; 219(1): 375.     CrossRef
  • Screening for diabetic retinopathy with different levels of financial incentive in a randomized controlled trial
    Jin Xiao Lian, Sarah Morag McGhee, Ching So, Alfred Siu Kei Kwong, Rita Sum, Wendy Wing Sze Tsui, David Vai Kiong Chao, Jonathan Cheuk Hung Chan
    Journal of Diabetes Investigation.2021; 12(9): 1632.     CrossRef
  • Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Christie Sze Ting Lau, Anna Hoi Ying Mok, Yuan Wang, Ian Chi Kei Wong, Esther Wai Yin Chan, Cindy Lo Kuen Lam
    Scientific Reports.2021;[Epub]     CrossRef
  • Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study
    Jianchao Quan, Carmen S. Ng, Harley H. Y. Kwok, Ada Zhang, Yuet H. Yuen, Cheung-Hei Choi, Shing-Chung Siu, Simon Y. Tang, Nelson M. Wat, Jean Woo, Karen Eggleston, Gabriel M. Leung, Weiping Jia
    PLOS Medicine.2021; 18(6): e1003692.     CrossRef
  • Age‐Specific Associations of Usual Blood Pressure Variability With Cardiovascular Disease and Mortality: 10‐Year Diabetes Mellitus Cohort Study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Jessica K. Barrett, Ian Chi Kei Wong, Esther Wai Yin Chan, Celine Sze Ling Chui, Shiqi Chen, Cindy Lo Kuen Lam
    Journal of the American Heart Association.2021;[Epub]     CrossRef
  • Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up
    Joe Kwun Nam Chan, Corine Sau Man Wong, Philip Chi Fai Or, Eric Yu Hai Chen, Wing Chung Chang
    European Neuropsychopharmacology.2021; 53: 79.     CrossRef
  • Age‐specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10‐ year cohort study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Florence Ting Yan Ng, Shu Ming Cheryl Chia, Ian Chi Kei Wong, Esther Wai Yin Chan, Cindy Lo Kuen Lam
    Diabetes, Obesity and Metabolism.2020; 22(8): 1316.     CrossRef
  • The Impact of Cardiovascular Disease and Chronic Kidney Disease on Life Expectancy and Direct Medical Cost in a 10-Year Diabetes Cohort Study
    Eric Yuk Fai Wan, Weng Yee Chin, Esther Yee Tak Yu, Ian Chi Kei Wong, Esther Wai Yin Chan, Shirley Xue Li, Nico Kwan Lok Cheung, Yuan Wang, Cindy Lo Kuen Lam
    Diabetes Care.2020; 43(8): 1750.     CrossRef
  • Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10‐year diabetes cohort study
    Eric Y. F. Wan, Esther Y. T. Yu, Weng Y. Chin, Jessica K. Barrett, Anna H. Y. Mok, Christie S. T. Lau, Yuan Wang, Ian C. K. Wong, Esther W. Y. Chan, Cindy L. K. Lam
    Diabetes, Obesity and Metabolism.2020; 22(10): 1777.     CrossRef
  • Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study
    Calvin Ke, Thérèse A. Stukel, Baiju R. Shah, Eric Lau, Ronald C. Ma, Wing-Yee So, Alice P. Kong, Elaine Chow, Juliana C. N. Chan, Andrea Luk, Sanjay Basu
    PLOS Medicine.2020; 17(9): e1003316.     CrossRef
  • Age‐Specific Associations Between Systolic Blood Pressure and Cardiovascular Disease: A 10‐Year Diabetes Mellitus Cohort Study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Ian Chi Kei Wong, Esther Wai Yin Chan, Shiqi Chen, Cindy Lo Kuen Lam
    Journal of the American Heart Association.2020;[Epub]     CrossRef
  • Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10‐year diabetes cohort study
    Eric YF Wan, Esther YT Yu, Julie Y Chen, Ian CK Wong, Esther WY Chan, Cindy LK Lam
    Diabetes, Obesity and Metabolism.2020; 22(12): 2325.     CrossRef
  • Cultural adaptation and psychometric properties of the Chinese Burden of Treatment Questionnaire (C-TBQ) in primary care patients with multi-morbidity
    Weng Yee Chin, Carlos King Ho Wong, Cherry Cheuk Wai Ng, Edmond Pui Hang Choi, Cindy Lo Kuen Lam
    Family Practice.2019; 36(5): 657.     CrossRef
  • Association of Blood Pressure and Risk of Cardiovascular and Chronic Kidney Disease in Hong Kong Hypertensive Patients
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Daniel Yee Tak Fong, Edmond Pui Hang Choi, Cindy Lo Kuen Lam
    Hypertension.2019; 74(2): 331.     CrossRef
  • Burden of CKD and Cardiovascular Disease on Life Expectancy and Health Service Utilization: a Cohort Study of Hong Kong Chinese Hypertensive Patients
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Daniel Yee Tak Fong, Edmond Pui Hang Choi, Eric Ho Man Tang, Cindy Lo Kuen Lam
    Journal of the American Society of Nephrology.2019; 30(10): 1991.     CrossRef
  • Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Colman Siu Cheung Fung, Daniel Yee Tak Fong, Edmond Pui Hang Choi, Anca Ka Chun Chan, Cindy Lo Kuen Lam
    Diabetes Care.2018; 41(6): 1134.     CrossRef
  • Evolution of Diabetes Care in Hong Kong: From the Hong Kong Diabetes Register to JADE-PEARL Program to RAMP and PEP Program
    Ivy H.Y. Ng, Kitty K.T. Cheung, Tiffany T.L. Yau, Elaine Chow, Risa Ozaki, Juliana C.N. Chan
    Endocrinology and Metabolism.2018; 33(1): 17.     CrossRef
  • Relation between HbA1c and incident cardiovascular disease over a period of 6 years in the Hong Kong population
    E.Y.F. Wan, E.Y.T. Yu, C.S.C. Fung, W.Y. Chin, D.Y.T. Fong, A.K.C. Chan, C.L.K. Lam
    Diabetes & Metabolism.2018; 44(5): 415.     CrossRef
  • Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses—A Population-Based and Propensity-Matched Cohort Study
    Eric Yuk Fai Wan, Colman Siu Cheung Fung, Fang Fang Jiao, Esther Yee Tak Yu, Weng Yee Chin, Daniel Yee Tak Fong, Carlos King Ho Wong, Anca Ka Chun Chan, Karina Hiu Yen Chan, Ruby Lai Ping Kwok, Cindy Lo Kuen Lam
    Diabetes Care.2018; 41(1): 49.     CrossRef
  • Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Colman Siu Cheung Fung, Weng Yee Chin, Daniel Yee Tak Fong, Anca Ka Chun Chan, Cindy Lo Kuen Lam
    Hypertension.2017; 70(6): 1273.     CrossRef
Obesity and Metabolic Syndrome
Diabetes Prevention in Australia: 10 Years Results and Experience
James A. Dunbar
Diabetes Metab J. 2017;41(3):160-167.   Published online February 2, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.3.160
  • 10,957 View
  • 112 Download
  • 16 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   ePub   

Clinical trials have demonstrated the efficacy of lifestyle modification for the prevention of type 2 diabetes mellitus but it was achieved at higher cost than can be sustained in routine health services. The first clinical trial to report was the Finnish Diabetes Prevention Study. This paper describes how Australia worked with Finnish colleagues to adapt the findings of that study to achieve a statewide diabetes prevention program. Small evaluative, effectiveness trials have been conducted in a number of countries to see if the results of the clinical trials can be replicated in routine health services. The Australian evaluative trial, Greater Green Triangle Diabetes Prevention Program is described in detail to demonstrate the ingredients for success in moving a program from one country to another. Few countries have managed to scale up from evaluative trials to statewide or national programs. The Australian experience is described in detail including lessons learned about what reduced the effectiveness, particularly the need for policy makers in government, people from the implementing organisation and researchers to work together from the start of the evaluative trial and throughout the first 5 years of a national program.

Citations

Citations to this article as recorded by  
  • Recruitment of individuals into a type 2 diabetes prevention program: the relative effectiveness and cost of different recruitment strategies used for the randomised controlled trial testing an Australian Lifestyle Change Program (AUS2PREVENT)
    Amy Kaim, Fiona Benton, Hossein Haji Ali Afzali, Shahid Ullah, Clarabelle Pham, Paul Ward, Natalie Luscombe-Marsh
    Pilot and Feasibility Studies.2026;[Epub]     CrossRef
  • Understanding diabetes risk in the Y Community of Greater Brisbane: Findings from a cross‐sectional survey
    Lucy E. Campbell, Sjaan R. Gomersall, Michael Tsiamis, Ana D. Goode, Genevieve N. Healy
    Health Promotion Journal of Australia.2025;[Epub]     CrossRef
  • Characteristics of participants in the first fully online National Diabetes Prevention Programme: A quantitative survey
    Clair Haseldine, Gráinne O'Donoghue, Patricia M Kearney, Fiona Riordan, Margaret Humphreys, Liz Kirby, Sheena M. McHugh
    HRB Open Research.2025; 6: 61.     CrossRef
  • Clinically Practical and Affordable Lifestyle Modification to Prevent Diabetes Mellitus in Real Practice
    Inji Lee, Minji Kang, Ji Hye Choi, Hyunjung Lim, Suk Chon
    Diabetes & Metabolism Journal.2025; 49(5): 951.     CrossRef
  • Characteristics of participants in the first fully online National Diabetes Prevention Programme: A quantitative survey
    Clair Haseldine, Gráinne O'Donoghue, Patricia M Kearney, Fiona Riordan, Margaret Humphreys, Liz Kirby, Sheena M. McHugh
    HRB Open Research.2024; 6: 61.     CrossRef
  • Lifestyle interventions for cardiometabolic health
    Femke Rutters, Nicolette R. den Braver, Jeroen Lakerveld, Joreintje D. Mackenbach, Hidde P. van der Ploeg, Simon Griffin, Petra J. M. Elders, Joline W. J. Beulens
    Nature Medicine.2024; 30(12): 3455.     CrossRef
  • Characteristics of participants in the first fully online National Diabetes Prevention Programme: A quantitative survey
    Clair Haseldine, Gráinne O'Donoghue, Patricia M Kearney, Fiona Riordan, Margaret Humphreys, Liz Kirby, Sheena M. McHugh
    HRB Open Research.2024; 6: 61.     CrossRef
  • Miscarriage, stillbirth and the risk of diabetes in women: A systematic review and meta-analysis
    Qiqi You, Qingqing Jiang, Irakoze Shani, Yiling Lou, Shen Huang, Shiqi Wang, Shiyi Cao
    Diabetes Research and Clinical Practice.2023; 195: 110224.     CrossRef
  • A multiple case study of pre-diabetes care undertaken by general practice in Aotearoa/New Zealand: de-incentivised and de-prioritised work
    Christine Barthow, Jeremy Krebs, Eileen McKinlay
    BMC Primary Care.2023;[Epub]     CrossRef
  • Implementation of a diabetes prevention programme in a multi-ethnic community in primary care in England: An evaluation using constructs from the RE-AIM Framework
    Helen Dallosso, Kamlesh Khunti, Laura J. Gray, Kerry Hulley, Mel Ghaly, Naina Patel, Joe Kai, Navneet Aujla, Melanie J. Davies, Tom Yates
    Primary Care Diabetes.2023; 17(4): 309.     CrossRef
  • A critical realist exploration of factors influencing engagement in diabetes prevention programs in rural settings
    Britney McMullen, Kerith Duncanson, David Schmidt, Clare Collins, Lesley MacDonald-Wicks
    Australian Journal of Primary Health.2023; 29(5): 510 .     CrossRef
  • Characteristics of participants in the first fully online National Diabetes Prevention Programme: A quantitative survey
    Clair Haseldine, Gráinne O'Donoghue, Patricia M Kearney, Fiona Riordan, Margaret Humphreys, Liz Kirby, Sheena M. McHugh
    HRB Open Research.2023; 6: 61.     CrossRef
  • Delivering the Diabetes Remission Clinical Trial (DiRECT) in primary care: Experiences of healthcare professionals
    Lucia Rehackova, Roy Taylor, Mike Lean, Alison Barnes, Louise McCombie, George Thom, Naomi Brosnahan, Wilma S. Leslie, Falko F. Sniehotta
    Diabetic Medicine.2022;[Epub]     CrossRef
  • It is time for a more targeted approach to prediabetes in primary care in Aotearoa New Zealand
    Christine Barthow, Sue Pullon, Eileen McKinlay, Jeremy Krebs, Stokes Tim
    The Journal of Primary Health Care.2022; 14(4): 372.     CrossRef
  • Implementing a national diabetes prevention programme in England: lessons learned
    Jonathan Stokes, Judith Gellatly, Peter Bower, Rachel Meacock, Sarah Cotterill, Matt Sutton, Paul Wilson
    BMC Health Services Research.2019;[Epub]     CrossRef
  • How do we identify people at high risk of Type 2 diabetes and help prevent the condition from developing?
    J. Fagg, J. Valabhji
    Diabetic Medicine.2019; 36(3): 316.     CrossRef
  • Associations between physical activity and cataract treated surgically in patients with diabetes: findings from the 45 and Up Study
    Changfan Wu, Xiaotong Han, Xixi Yan, Xianwen Shang, Lei Zhang, Mingguang He
    British Journal of Ophthalmology.2019; 103(8): 1099.     CrossRef
  • Usefulness of a Novel Mobile Diabetes Prevention Program Delivery Platform With Human Coaching: 65-Week Observational Follow-Up
    Andreas Michaelides, Jennifer Major, Edmund Pienkosz Jr, Meghan Wood, Youngin Kim, Tatiana Toro-Ramos
    JMIR mHealth and uHealth.2018; 6(5): e93.     CrossRef
Obesity and Metabolic Syndrome
Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia
Wei-Jei Lee, Lwin Aung
Diabetes Metab J. 2016;40(6):433-443.   Published online December 2, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.6.433
  • 8,850 View
  • 101 Download
  • 16 Web of Science
  • 19 Crossref
AbstractAbstract PDFPubReader   ePub   

Type 2 diabetes mellitus (T2DM) is a current global health priority and Asia is the epicenter of this epidemic disease. Unlike in the west, where older population is most affected, the burden of diabetes in Asian countries is disproportionately high in young to middle-age adults. The incidence of diabetic nephropathy is alarmingly high in patients with early onset T2DM, especially in those with poor glycemic control. How to control this chronic and debilitating disease is currently a very important health issue in Asia. Bariatric surgery has proven successful in treating not just obesity but also T2DM in morbid obese patients (body mass index [BMI] >35 kg/m2). Gastrointestinal metabolic surgery recently has been proposed as a new treatment modality for obesity related T2DM for patients with BMI <35 kg/m2. Many studies from Asia reported promising results of metabolic surgery to treat obese patients with T2DM which is not well controlled. It has been demonstrated that changes in gastrointestinal hormone secretion after gastrointestinal surgery would favor an early improvement of T2DM in Asians. New procedures have also been designed and proposed specifically for the treatment of diabetes in Asia. This article examines clinical trial data and accepted algorithms with a view toward elucidating the application of metabolic surgery for the treatment of T2DM in the Asia. We propose a systematic approach to surgical treatment, addressing current evidences, patient selection, procedure of choice, and timing and guideline for new procedures.

Citations

Citations to this article as recorded by  
  • Association of Total Small Bowel Length with Glycaemic Control and Metabolic Syndrome in Metabolic and Bariatric Surgery Patients: A Cross-Sectional Study in a Taiwanese Cohort
    Choon Woon Ngo, Nilay Rai, Mohd Kamarulariffin Kamarudin, Ming-Che Hsin, Chih-Kun Huang
    Obesity Surgery.2026;[Epub]     CrossRef
  • Long-Term Efficacy of Bariatric Surgery Compared to Modern Medical Therapy in Type 2 Diabetes and Obesity: A Systematic Review
    Ateeq Afzal, Jaya Ram Pandey, Tehreem Ashraf, Ali Jamal Ashraf Bagri, Mehak Kumari, Shivam Singla, Bhavna Singla, Nabila N Anika, Ahmad Irshad
    Cureus.2025;[Epub]     CrossRef
  • Insulin resistance levels predicted metabolic improvement and weight loss after metabolic surgery in Chinese patients with type 2 diabetes
    Yaoquan Cao, Ping Luo, Haibo Tang, Pengzhou Li, Guohui Wang, Weizheng Li, Zhi Song, Zhihong Su, Xulong Sun, Xianhao Yi, Zhibing Fu, Beibei Cui, Shaihong Zhu, Liyong Zhu
    Surgery for Obesity and Related Diseases.2024; 20(1): 80.     CrossRef
  • Long‐term outcomes of metabolic surgery in overweight and obese patients with type 2 diabetes in Asia
    Yu‐Min Huang, Yen‐Kuang Lin, Wei‐Jei Lee, Kyoung Yul Hur, Kazunori Kasama, Anton Kui Sing Cheng, Ming‐Hsien Lee, Simon Kin‐Hung Wong, Tien‐Chou Soong, Kuo‐Ting Lee, Davide Lomanto, Muffazal Lakdawala, Yen‐Hao Su, Weu Wang
    Diabetes, Obesity and Metabolism.2021; 23(3): 742.     CrossRef
  • Vertical sleeve gastrectomy induces distinctive transcriptomic responses in liver, fat and muscle
    Chang Ho Ahn, Eun Hye Choi, Hyunjung Lee, Woochan Lee, Jong-Il Kim, Young Min Cho
    Scientific Reports.2021;[Epub]     CrossRef
  • Insulin Resistance Remission Following Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy in Chinese Type 2 Diabetes Mellitus Patients With a Body Mass Index of 27.5–32.5 kg/m2
    Ping Luo, Yaoquan Cao, Pengzhou Li, Guohui Wang, Zhi Song, Weizheng Li, Zhihong Su, Hui Zhou, Xianhao Yi, Zhibing Fu, Xulong Sun, Haibo Tang, Beibei Cui, Qianqian Yu, Liyong Zhu, Shaihong Zhu
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Pre- and postoperative respiratory muscle strength, body mass index and fasting glucose profile of patients with type 2 diabetes mellitus submitted to metabolic surgery
    Ariana de Melo Tosta, Marisa de Carvalho Borges, Élida Mara Carneiro da Silva, Alex Augusto da Silva, Eduardo Crema
    Fisioterapia em Movimento.2020;[Epub]     CrossRef
  • Outcomes After Metabolic Surgery in Asians—a Meta-analysis
    Danson Yeo, Charleen Yeo, Tze Yi Low, Saleem Ahmed, Sheena Phua, Aung Myint Oo, Jaideepraj Rao, Aaryan Koura, Kavita Venkataraman, Sanghvi Kaushal
    Obesity Surgery.2019; 29(1): 114.     CrossRef
  • Diabetes resolution after one anastomosis gastric bypass
    Adam Abu-Abeid, Yonatan Lessing, Niv Pencovich, Danit Dayan, Joseph M. Klausner, Subhi Abu-Abeid
    Surgery for Obesity and Related Diseases.2018; 14(2): 181.     CrossRef
  • Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis
    Zhiyong Dong, Sheikh Mohammed Shariful Islam, Ashley M. Yu, Rui Qu, Bingsheng Guan, Junchang Zhang, Zhao Hong, Cunchuang Wang
    BMC Surgery.2018;[Epub]     CrossRef
  • Clinical Practice Recommendations for the Management of Obesity in the United Arab Emirates
    Salahedeen Abusnana, Mohammad Fargaly, Shaima Hasan Alfardan, Fatema Hasan Al Hammadi, Alaaeldin Bashier, Ghaida Kaddaha, Barbara McGowan, Rita Nawar, Amena Sadiya
    Obesity Facts.2018; 11(5): 413.     CrossRef
  • Laparoscopic sleeve gastrectomy combined with single-anastomosis duodenal-jejunal bypass in the treatment of type 2 diabetes mellitus of patients with body mass index higher than 27.5 kg/m2 but lower than 32.5 kg/m2
    Ying-Xu Li, Deng-Hua Fang, Tian-Xi Liu
    Medicine.2018; 97(31): e11537.     CrossRef
  • Comparison of Great Curvature Plication with Duodenal-Jejunal Bypass (GCP-DJB) and Sleeve Gastrectomy (SG) on Metabolic Indices and Gut Hormones in Type 2 Diabetes Mellitus Rats
    Nian-Cun Qiu, Wei Li, Miao-E Liu, Xiao-Xia Cen, Cheng-Xiang Shan, Wei Zhang, Qing Liu, Yang Wang, Ya-Ting Zhu, Ming Qiu
    Obesity Surgery.2018; 28(12): 4014.     CrossRef
  • Evolution of Diabetes Care in Hong Kong: From the Hong Kong Diabetes Register to JADE-PEARL Program to RAMP and PEP Program
    Ivy H.Y. Ng, Kitty K.T. Cheung, Tiffany T.L. Yau, Elaine Chow, Risa Ozaki, Juliana C.N. Chan
    Endocrinology and Metabolism.2018; 33(1): 17.     CrossRef
  • Ethnicity Does Not Influence Glycemic Outcomes or Diabetes Remission After Sleeve Gastrectomy or Gastric Bypass in a Multiethnic Asian Cohort
    Phong Ching Lee, Kwang Wei Tham, Sonali Ganguly, Hong Chang Tan, Alvin Kim Hock Eng, John B. Dixon
    Obesity Surgery.2018; 28(6): 1511.     CrossRef
  • Effects of GABAB receptor activation on spatial cognitive function and hippocampal neurones in rat models of type 2 diabetes mellitus
    Xiao-Jun Cai, Lei Wang, Chun-Mei Hu
    Bioscience Reports.2018;[Epub]     CrossRef
  • Metabolic surgery ameliorates cardiovascular risk in obese diabetic patients: Influence of different surgical procedures
    Jih-Hua Wei, Ruey-Hsing Chou, Po-Hsun Huang, Wei-Jei Lee, Shu-Chun Chen, Shing-Jong Lin
    Surgery for Obesity and Related Diseases.2018; 14(12): 1832.     CrossRef
  • Pulmonary function evaluation in type 2 diabetes mellitus patients submitted to metabolic surgery
    Ariana de Melo Tosta, Marisa de Carvalho Borges, Élida Mara Carneiro da Silva, Tharsus Dias Takeuti, Júverson Alves Terra Júnior, Eduardo Crema
    Fisioterapia em Movimento.2018;[Epub]     CrossRef
  • The Role of Sleeve Gastrectomy on Preventing Type 2 Diabetes Mellitus
    Serdar Olt, Sabri Özdaş, Mehmet Şirik
    Open Access Macedonian Journal of Medical Sciences.2017; 5(3): 316.     CrossRef
Original Articles
Others
Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
Ji Min Kim, Min Kyung Back, Hyon-Seung Yi, Kyong Hye Joung, Hyun Jin Kim, Bon Jeong Ku
Diabetes Metab J. 2016;40(1):70-78.   Published online February 19, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.1.70
  • 7,799 View
  • 51 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Elevated serum levels of growth differentiation factor-15 (GDF-15) are associated with type 2 diabetes. Therefore, the effects of atorvastatin on metabolic parameters and GDF-15 levels in patients with type 2 diabetes and dyslipidemia were evaluated.

Methods

In this prospective randomized trial from February 2013 to March 2014, 50 consecutive type 2 diabetic patients with a low density lipoprotein cholesterol (LDL-C) levels ≥100 mg/dL were enrolled. The patients were divided into two groups based on the amount of atorvastatin prescribed, 10 mg/day (n=23) or 40 mg/day (n=27). The effect of atorvastatin on metabolic parameters, including lipid profiles and GDF-15 levels, at baseline and after 8 weeks of treatment were compared.

Results

The baseline metabolic parameters and GDF-15 levels were not significantly different between the two groups. After 8 weeks of treatment, the total cholesterol (TC) and LDL-C levels were significantly decreased in both groups. The mean changes in TC and LDL-C levels were more significant in the 40 mg atorvastatin group. The GDF-15 level was decreased in the 10 mg atorvastatin group, from 1,460.6±874.8 to 1,451.0±770.8 pg/mL, and was increased in the 40 mg atorvastatin group, from 1,271.6±801.0 to 1,341.4±855.2 pg/mL. However, the change in the GDF-15 level was not statistically significant in the 10 or 40 mg atorvastatin group (P=0.665 and P=0.745, respectively).

Conclusion

The GDF-15 levels were not significantly changed after an 8-week treatment with atorvastatin in type 2 diabetic patients.

Citations

Citations to this article as recorded by  
  • The relationship of Growth differentiation factor-15 with renal damage and dyslipidemia in non-albuminuric and albuminuric Type-2 Diabetes Mellitus
    Hasan Esat Yücel, Bilal İlanbey
    Medical Science and Discovery.2022; 9(6): 334.     CrossRef
  • Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis
    Alexander Hodkinson, Dialechti Tsimpida, Evangelos Kontopantelis, Martin K Rutter, Mamas A Mamas, Maria Panagioti
    BMJ.2022; 376: e067731.     CrossRef
  • The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker
    Boel De Paepe
    International Journal of Molecular Sciences.2022; 23(21): 13180.     CrossRef
  • Biomarkers of subclinical atherosclerosis in patients with psoriasis
    Hannah Kaiser, Xing Wang, Amanda Kvist-Hansen, Martin Krakauer, Peter Michael Gørtz, Benjamin D. McCauley, Lone Skov, Christine Becker, Peter Riis Hansen
    Scientific Reports.2021;[Epub]     CrossRef
  • Growth differentiation factor-15 regulates oxLDL-induced lipid homeostasis and autophagy in human macrophages
    Kathrin Ackermann, Gabriel A. Bonaterra, Ralf Kinscherf, Anja Schwarz
    Atherosclerosis.2019; 281: 128.     CrossRef
Obesity and Metabolic Syndrome
Increased Risk of Progression of Coronary Artery Calcification in Male Subjects with High Baseline Waist-to-Height Ratio: The Kangbuk Samsung Health Study
Hyung-Geun Oh, Shriram Nallamshetty, Eun-Jung Rhee
Diabetes Metab J. 2016;40(1):54-61.   Published online February 19, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.1.54
  • 7,150 View
  • 34 Download
  • 11 Web of Science
  • 13 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The waist-to-height ratio (WHtR) is an easy and inexpensive adiposity index that reflects central obesity. In this study, we examined the association of baseline WHtR and progression of coronary artery calcification (CAC) over 4 years of follow-up in apparently healthy Korean men.

Methods

A total of 1,048 male participants (mean age, 40.9 years) in a health-screening program in Kangbuk Samsung Hospital, Seoul, Korea who repeated a medical check-up in 2010 and 2014 were recruited. Baseline WHtR was calculated using the value for the waist in 2010 divided by the value for height in 2010. The CAC score (CACS) of each subject was measured by multi-detector computed tomography in both 2010 and 2014. Progression of CAC was defined as a CACS change over 4 years greater than 0.

Results

During the follow-up period, progression of CAC occurred in 278 subjects (26.5%). The subjects with CAC progression had slightly higher but significant baseline WHtR compared to those who did not show CAC progression (0.51±0.04 vs. 0.50±0.04, P<0.01). The proportion of subjects with CAC progression significantly increased as the baseline WHtR increased from the 1st quartile to 4th quartile groups (18.3%, 18.7%, 28.8%, and 34.2%; P<0.01). The risk for CAC progression was elevated with an odds ratio of 1.602 in the 4th quartile group of baseline WHtR even after adjustment for confounding variables (95% confidence interval, 1.040 to 2.466).

Conclusion

Increased baseline WHtR was associated with increased risk for CAC progression. WHtR might be a useful screening tool to identify individuals at high risk for subclinical atherosclerosis.

Citations

Citations to this article as recorded by  
  • Risk of Coronary Artery Calcification Based on Degree of Obesity and Age Group in Korean Adults: Analysis of Kangbuk Samsung Health Study Data
    Da-Eun Sung, Da-Youn Lee, Eun-Jung Rhee
    The American Journal of Cardiology.2025; 246: 80.     CrossRef
  • Nicotine dependence and visceral adiposity as risk factors for the development and severity of carotid artery stenosis
    Mahmood Shaker Khazaal, Farqad Bader Hamdan, Qasim Sharhan Al-Mayah
    Journal of Medicine and Life.2023; 16(3): 463.     CrossRef
  • Differences in the number of stented coronary arteries based on the seven traditional obesity parameters among patients with coronary artery diseases undergoing cardiac catheterization
    Audai A Hayajneh, Islam M Alhusban, Mohammad Rababa, Sami Al-Rawashdeh, Shatha Al-Sabbah, Dania Bani-Hamad
    Electronic Journal of General Medicine.2022; 19(5): em391.     CrossRef
  • Predictive Model for High Coronary Artery Calcium Score in Young Patients with Non-Dialysis Chronic Kidney Disease
    Tae Ryom Oh, Su Hyun Song, Hong Sang Choi, Sang Heon Suh, Chang Seong Kim, Ji Yong Jung, Kyu Hun Choi, Kook-Hwan Oh, Seong Kwon Ma, Eun Hui Bae, Soo Wan Kim
    Journal of Personalized Medicine.2021; 11(12): 1372.     CrossRef
  • Computed tomography calcium scoring association and reclassification of clinical cardiovascular risk in asymptomatic Mexican patients
    Aldo Javier Vázquez Mézquita, Michelle Claire Williams, Rafael Choza Chenhalls, Nancy Berenice Guzmán Martínez, Ana Patricia Chischistz Condey, Maria José Acosta Falomir, Marco Antonio Téliz Meneses, María Nayeli Vázquez Sánchez
    SAGE Open Medicine.2020;[Epub]     CrossRef
  • The association of waist-to-height ratio and other anthropometric measurements with subclinical atherosclerosis: Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
    Rosana Raele, Paulo A. Lotufo, Marcio S. Bittencourt, Maria de Jesus M. Fonseca, Alessandra C. Goulart, Itamar S. Santos, Isabela M. Bensenor
    Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(11): 1989.     CrossRef
  • The Risk of Myocardial Infarction and Ischemic Stroke According to Waist Circumference in 21,749,261 Korean Adults: A Nationwide Population-Based Study
    Jung-Hwan Cho, Eun-Jung Rhee, Se-Eun Park, Hyemi Kwon, Jin-Hyung Jung, Kyung-Do Han, Yong-Gyu Park, Hye Soon Park, Yang-Hyun Kim, Soon-Jib Yoo, Won-Young Lee
    Diabetes & Metabolism Journal.2019; 43(2): 206.     CrossRef
  • Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
    Eun-Jung Rhee
    Diabetes & Metabolism Journal.2018; 42(1): 19.     CrossRef
  • The renal tubular damage marker urinary N-acetyl-β-d-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes
    So Ra Kim, Yong-ho Lee, Sang-Guk Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
    Cardiovascular Diabetology.2017;[Epub]     CrossRef
  • Influencia de la actividad física y el consumo calórico sobre la adiposidad visceral en adultos de la ciudad de Cuenca, Ecuador
    Rina Ortiz, Maritza Torres, Wilson Siguencia, Nube Sigüenza-Cobos, Juan Salazar, Roberto Añez, Joselyn Rojas, Valmore Bermúdez
    Revista Argentina de Endocrinología y Metabolismo.2017; 54(4): 160.     CrossRef
  • The association between various indices of obesity and severity of atherosclerosis in adults in the north of Iran
    Arsalan Salari, Maryam Shakiba, Marjan Mahdavi-Roshan, Mahboobeh Gholipour, Moona Naghshbandi, Ramin Rajabi
    Medicine.2016; 95(50): e5670.     CrossRef
  • Diet Quality and Mortality Risk in Metabolically Obese Normal-Weight Adults
    Yong-Moon Mark Park, Teresa T. Fung, Susan E. Steck, Jiajia Zhang, Linda J. Hazlett, Kyungdo Han, Seung-Hwan Lee, Anwar T. Merchant
    Mayo Clinic Proceedings.2016; 91(10): 1372.     CrossRef
  • Waist Circumference as a Marker of Obesity Is More Predictive of Coronary Artery Calcification than Body Mass Index in Apparently Healthy Korean Adults: The Kangbuk Samsung Health Study
    Jongsin Park, Eun Seo Lee, Da Young Lee, Jihyun Kim, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
    Endocrinology and Metabolism.2016; 31(4): 559.     CrossRef
Review
Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
Leigang Jin, Zhuofeng Lin, Aimin Xu
Diabetes Metab J. 2016;40(1):22-31.   Published online January 29, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.1.22
  • 11,185 View
  • 83 Download
  • 42 Web of Science
  • 38 Crossref
AbstractAbstract PDFPubReader   ePub   

Fibroblast growth factor 21 (FGF21) is a metabolic hormone with pleiotropic effects on energy metabolism and insulin sensitivity. Besides its antiobese and antidiabetic activity, FGF21 also possesses the protective effects against atherosclerosis. Circulating levels of FGF21 are elevated in patients with atherosclerosis, macrovascular and microvascular complications of diabetes, possibly due to a compensatory upregulation. In apolipoprotein E-deficient mice, formation of atherosclerotic plaques is exacerbated by genetic depletion of FGF21, but is attenuated upon replenishment with recombinant FGF21. However, the blood vessel is not the direct target of FGF21, and the antiatherosclerotic activity of FGF21 is attributed to its actions in adipose tissues and liver. In adipocytes, FGF21 promotes secretion of adiponectin, which in turn acts directly on blood vessels to reduce endothelial dysfunction, inhibit proliferation of smooth muscle cells and block conversion of macrophages to foam cells. Furthermore, FGF21 suppresses cholesterol biosynthesis and attenuates hypercholesterolemia by inhibiting the transcription factor sterol regulatory element-binding protein-2 in hepatocytes. The effects of FGF21 on elevation of adiponectin and reduction of hypercholesterolemia are also observed in a phase-1b clinical trial in patients with obesity and diabetes. Therefore, FGF21 exerts its protection against atherosclerosis by fine-tuning the interorgan crosstalk between liver, brain, adipose tissue, and blood vessels.

Citations

Citations to this article as recorded by  
  • The Association Between Serum FGF21 Level and Coronary Artery Calcification: Impact of the Degree of Insulin Resistance
    Cong Wang, Yingkai Li, Hongyu Peng, Jinghua Liu
    Reviews in Cardiovascular Medicine.2026;[Epub]     CrossRef
  • Exerkine-mediated organ interactions: A new interpretation of exercise on cardiovascular function improvement
    Renhan Liu, Yue Xi, Xinyan Duan, Yifei Zhao, Zhenjun Tian
    Life Sciences.2025; 371: 123628.     CrossRef
  • Association between plasma proteomic dynamic changes and metabolic outcomes in patients undergoing bariatric surgery
    Candela Diaz-Canestro, Wah Yang, Jiarui Chen, Kit Cheung, Hao Han, Cunchuan Wang, Erfei Song, Kwan Ming Lee, Jiang Xue, Aimin Xu
    International Journal of Obesity.2025; 49(9): 1745.     CrossRef
  • Research progress on the role of FGF21 in insulin resistance
    Haixin Zhang, Rongyu Zhu, Quanhao Sun, Likun Du
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Promotion of Cardiovascular Homeostasis by the Perivascular Adipose Tissue Secretome
    Olivia R. Whittaker, Matthew D. Lynes, Ilka Pinz, Lucy Liaw
    International Journal of Molecular Sciences.2025; 26(20): 10173.     CrossRef
  • Fibroblast Growth Factor–Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications
    Leigang Jin, Ranyao Yang, Leiluo Geng, Aimin Xu
    Annual Review of Pharmacology and Toxicology.2023; 63(1): 359.     CrossRef
  • Efruxifermin, an investigational treatment for fibrotic or cirrhotic nonalcoholic steatohepatitis (NASH)
    Tobias Puengel, Frank Tacke
    Expert Opinion on Investigational Drugs.2023; 32(6): 451.     CrossRef
  • The role of perivascular adipose tissue-secreted adipocytokines in cardiovascular disease
    Meichao Cai, Dongsheng Zhao, Xiao Han, Shuang Han, Wenxin Zhang, Zhennan Zang, Chenchen Gai, Rong Rong, Tian Gao
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis
    Cong Liu, Milena Schönke, Enchen Zhou, Zhuang Li, Sander Kooijman, Mariëtte R Boon, Mikael Larsson, Kristina Wallenius, Niek Dekker, Louise Barlind, Xiao-Rong Peng, Yanan Wang, Patrick C N Rensen
    Cardiovascular Research.2022; 118(2): 489.     CrossRef
  • Relationship between Serum FGF21 and vWF Expression and Carotid Atherosclerosis in Elderly Patients with Hypertension
    Jing Bian, Lairong Chen, Qin Li, Yunfeng Zhao, Delu Yin, Shanhong Sun, Bhagyaveni M.A
    Journal of Healthcare Engineering.2022; 2022: 1.     CrossRef
  • Serum FGF21 Levels Predict the MACE in Patients With Myocardial Infarction After Coronary Artery Bypass Graft Surgery
    Wei Xie, Dan Li, Yaru Shi, Ning Yu, Yu Yan, Yingchao Zhang, Qiongli Yu, Yulin Li, Jie Du, Zhuofeng Lin, Fan Wu
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Adipokines, adiposity, and atherosclerosis
    Longhua Liu, Zunhan Shi, Xiaohui Ji, Wenqian Zhang, Jinwen Luan, Tarik Zahr, Li Qiang
    Cellular and Molecular Life Sciences.2022;[Epub]     CrossRef
  • Change of Fibroblast Growth Factor 21 Level Correlates with the Severity of Diabetic Sensory Polyneuropathy after Six-Week Physical Activity
    Ágnes Molnár, Anita Szentpéteri, Hajnalka Lőrincz, Ildikó Seres, Mariann Harangi, Zoltán Balogh, Péter Kempler, György Paragh, Ferenc Sztanek
    Reviews in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Current understanding and controversies on the clinical implications of fibroblast growth factor 21
    Yasaman Badakhshi, Tianru Jin
    Critical Reviews in Clinical Laboratory Sciences.2021; 58(5): 311.     CrossRef
  • The potential role of plasma fibroblast growth factor 21 as a diagnostic biomarker for abdominal aortic aneurysm presence and development
    Ting Xie, Liangying Yin, Dan Guo, Zixin Zhang, Yuexin Chen, Bao Liu, Wei Wang, Yuehong Zheng
    Life Sciences.2021; 274: 119346.     CrossRef
  • Ultrasound-assisted C3F8-filled PLGA nanobubbles for enhanced FGF21 delivery and improved prophylactic treatment of diabetic cardiomyopathy
    Jiameng Gao, Jingjing Liu, Zheying Meng, Yanming Li, Yuping Hong, Lirui Wang, Lan He, Bing Hu, Yuanyi Zheng, Tianliang Li, Daxiang Cui, E. Shen
    Acta Biomaterialia.2021; 130: 395.     CrossRef
  • Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model
    Hyo Jin Maeng, Gha Young Lee, Jae Hyun Bae, Soo Lim
    International Journal of Molecular Sciences.2020; 21(18): 6836.     CrossRef
  • The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
    Leiluo Geng, Karen S. L. Lam, Aimin Xu
    Nature Reviews Endocrinology.2020; 16(11): 654.     CrossRef
  • Two-hundred-liter scale fermentation, purification of recombinant human fibroblast growth factor-21, and its anti-diabetic effects on ob/ob mice
    Qi Hui, Zhen Huang, Shucai Pang, Xuanxin Yang, Jinghang Li, Bingjie Yu, Lu Tang, Xiaokun Li, Xiaojie Wang
    Applied Microbiology and Biotechnology.2019; 103(2): 719.     CrossRef
  • Fibroblast growth factor 21: A role in cardiometabolic disorders and cardiovascular risk prediction?
    Niki Katsiki, Christos Mantzoros
    Metabolism.2019; 93: iii.     CrossRef
  • Heparin‐poloxamer hydrogel‐encapsulated rhFGF21 enhances wound healing in diabetic mice
    Huan Liu, Yeli Zhao, Yuchi Zou, Wenting Huang, Liyun Zhu, Fei Liu, Dongxue Wang, Kaiming Guo, Jian Hu, Jun Chen, Lixia Ye, Xiaokun Li, Li Lin
    The FASEB Journal.2019; 33(9): 9858.     CrossRef
  • Fibroblast growth factor 21 association with subclinical atherosclerosis and arterial stiffness in type 2 diabetes
    Saeed Yafei, Fathy Elsewy, Eman Youssef, Mohammed Ayman, Mohamed El-Shafei
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 882.     CrossRef
  • Myokines in metabolic homeostasis and diabetes
    Jürgen Eckel
    Diabetologia.2019; 62(9): 1523.     CrossRef
  • Inhibition of vascular neointima hyperplasia by FGF21 associated with FGFR1/Syk/NLRP3 inflammasome pathway in diabetic mice
    Wei Wei, Xiao-Xue Li, Ming Xu
    Atherosclerosis.2019; 289: 132.     CrossRef
  • LY2405319, an analog of fibroblast growth factor 21 ameliorates α-smooth muscle actin production through inhibition of the succinate—G-protein couple receptor 91 (GPR91) pathway in mice
    Cong Thuc Le, Giang Nguyen, So Young Park, Dae Hee Choi, Eun-Hee Cho, Partha Mukhopadhyay
    PLOS ONE.2018; 13(2): e0192146.     CrossRef
  • Relationship of Selected Adipokines with Markers of Vascular Damage in Patients with Type 2 Diabetes
    Jaromíra Spurná, David Karásek, Veronika Kubíčková, Dominika Goldmannová, Ondřej Krystyník, Jan Schovánek, Josef Zadražil
    Metabolic Syndrome and Related Disorders.2018; 16(5): 246.     CrossRef
  • Serum FGF21 Is Associated with Future Cardiovascular Events in Patients with Coronary Artery Disease
    Yun Shen, Xueli Zhang, Yiting Xu, Qin Xiong, Zhigang Lu, Xiaojing Ma, Yuqian Bao, Weiping Jia
    Cardiology.2018; 139(4): 212.     CrossRef
  • Relationship between Circulating FGF21 Concentrations and the Severity of Coronary Artery Damage in Subjects with Cardiovascular Disease
    Sung Don Park, Kwi-Hyun Bae, Yeon-Kyung Choi, Jae-Han Jeon, Jung Beom Seo, Namkyun Kim, Chang-Yeon Kim, Sung Woo Kim, Won Kee Lee, Jung Guk Kim, In-Kyu Lee, Jang Hoon Lee, Keun-Gyu Park
    Journal of Lipid and Atherosclerosis.2018; 7(1): 42.     CrossRef
  • Fibroblast growth factor 21 regulates foam cells formation and inflammatory response in Ox-LDL-induced THP-1 macrophages
    Nan Wang, Jun-yan Li, Shuai Li, Xiao-chen Guo, Tong Wu, Wen-fei Wang, De-shan Li
    Biomedicine & Pharmacotherapy.2018; 108: 1825.     CrossRef
  • Chip‐based high resolution tandem mass spectrometric determination of fibroblast growth factor—chondroitin sulfate disaccharides noncovalent interaction
    Adrian C. Robu, Laurentiu Popescu, Daniela G. Seidler, Alina D. Zamfir
    Journal of Mass Spectrometry.2018; 53(7): 624.     CrossRef
  • Conditioned medium from contracting skeletal muscle cells reverses insulin resistance and dysfunction of endothelial cells
    Yihe Zhao, Nana Li, Zhu Li, Da Zhang, Liming Chen, Zhi Yao, Wenyan Niu
    Metabolism.2018; 82: 36.     CrossRef
  • Dietary n-3 long-chain polyunsaturated fatty acids upregulate energy dissipating metabolic pathways conveying anti-obesogenic effects in mice
    Stefanie Worsch, Mathias Heikenwalder, Hans Hauner, Bernhard L. Bader
    Nutrition & Metabolism.2018;[Epub]     CrossRef
  • Metabolic Values of Fibroblasts Growth Factor 21 in Patients with Coronary Artery Disease and Obesity
    L. M. Pasiyeshvili, K. V. Ivanova
    Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2018; 3(4): 110.     CrossRef
  • FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process
    Antero Salminen, Anu Kauppinen, Kai Kaarniranta
    Journal of Molecular Medicine.2017; 95(2): 123.     CrossRef
  • Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses
    Antero Salminen, Kai Kaarniranta, Anu Kauppinen
    Ageing Research Reviews.2017; 37: 79.     CrossRef
  • Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death
    Yun Shen, Xueli Zhang, Xiaoping Pan, Yiting Xu, Qin Xiong, Zhigang Lu, Xiaojing Ma, Yuqian Bao, Weiping Jia
    Cardiovascular Diabetology.2017;[Epub]     CrossRef
  • Fibroblast growth factor 21 – a key player in cardiovascular disorders?
    Monika Lenart-Lipińska, Dariusz Duma, Magdalena Hałabiś, Marcin Dziedzic, Janusz Solski
    Hormone Molecular Biology and Clinical Investigation.2017;[Epub]     CrossRef
  • The role of fibroblast growth factor 21 in atherosclerosis
    John Kokkinos, Shudi Tang, Kerry-Anne Rye, Kwok Leung Ong
    Atherosclerosis.2017; 257: 259.     CrossRef
Original Article
Complications
Serum Total Bilirubin Levels Provide Additive Risk Information over the Framingham Risk Score for Identifying Asymptomatic Diabetic Patients at Higher Risk for Coronary Artery Stenosis
Jaechan Leem, Eun Hee Koh, Jung Eun Jang, Chang-Yun Woo, Jin Sun Oh, Min Jung Lee, Joon-Won Kang, Tae-Hwan Lim, Chang Hee Jung, Woo Je Lee, Joong-Yeol Park, Ki-Up Lee
Diabetes Metab J. 2015;39(5):414-423.   Published online October 22, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.5.414
  • 8,476 View
  • 49 Download
  • 11 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The diagnosis of coronary artery disease (CAD) is often delayed in patients with type 2 diabetes. Serum total bilirubin levels are inversely associated with CAD. However, no studies have examined whether this can be used as a biochemical marker for identifying asymptomatic diabetic patients at higher risk for having obstructive CAD.

Methods

We performed a cross-sectional study of 460 consecutive asymptomatic patients with type 2 diabetes. All patients underwent coronary computed tomographic angiography, and their serum total bilirubin levels were measured. Obstructive CAD was defined as ≥50% diameter stenosis in at least one coronary artery.

Results

Serum total bilirubin tertiles showed an inverse association with the prevalence of obstructive CAD. In multivariate logistic regression analysis, the odds ratio for the highest versus the lowest tertile of total bilirubin was 0.227 (95% confidence interval [CI], 0.130 to 0.398), and an increment of 1 µmol/L in serum total bilirubin level was associated with a 14.6% decrease in obstructive CAD after adjustment for confounding variables. Receiver operating characteristic curve analysis showed that the area under the curve for the Framingham Risk Score (FRS) plus serum total bilirubin level was 0.712 (95% CI, 0.668 to 0.753), which is significantly greater than that of the FRS alone (P=0.0028).

Conclusion

Serum total bilirubin level is inversely associated with obstructive CAD and provides additive risk information over the FRS. Serum total bilirubin may be helpful for identifying asymptomatic patients with type 2 diabetes who are at higher risk for obstructive CAD.

Citations

Citations to this article as recorded by  
  • Interference Assessment for High‐Performance Liquid Chromatography HbA1c Assays
    Linghao Zhao, Wei Yang, Shengjin Cui, Jingang Luo, Yaxin Cao, Nan Yan, Hongying Wang
    Biomedical Chromatography.2026;[Epub]     CrossRef
  • Association between bilirubin and biomarkers of metabolic health and oxidative stress in the MARK-AGE cohort
    Vanessa Schoissengeier, Lina Maqboul, Daniela Weber, Tilman Grune, Alexander Bürkle, Maria Moreno-Villaneuva, Claudio Franceschi, Miriam Capri, Jürgen Bernhard, Olivier Toussaint, Florence Debacq-Chainiaux, Birgit Weinberger, Efstathios S. Gonos, Ewa Siko
    iScience.2024; 27(7): 110234.     CrossRef
  • Nanoparticle-driven biosensors for diagnosis of viral hepatitis
    Chenggong Zhu, Zhen Xun, Ruijie Fu, Qunfang Huang, Qishui Ou, Yunlei Xianyu, Can Liu
    TrAC Trends in Analytical Chemistry.2024; 180: 117985.     CrossRef
  • DECREASE IN SERUM BILIRUBIN AS AN UNFAVORABLE MARKER OF CARDIOVASCULAR DISORDERS
    L. M. Strilchuk, O. O. Zimba, I. B. Zhakun
    Eastern Ukrainian Medical Journal.2020; 8(3): 268.     CrossRef
  • Contemporary diagnostic algorithm for coronary artery disease: achievements and prospects
    A. S. Akselrod, D. Yu. Shchekochikhin, E. S. Tebenkova, A. V. Zhelankin, D. A. Stonogina, E. A. Syrkina, S. K. Ternovoy
    Kardiologiya i serdechno-sosudistaya khirurgiya.2019; 12(5): 418.     CrossRef
  • Pharmacological actions and therapeutic potentials of bilirubin in islet transplantation for the treatment of diabetes
    Qing Yao, Xue Jiang, Longfa Kou, Adelaide T. Samuriwo, He-Lin Xu, Ying-Zheng Zhao
    Pharmacological Research.2019; 145: 104256.     CrossRef
  • Evaluation of genetic effect of NOS3 and G×E interaction on the variability of serum bilirubin in a Han Chinese population
    Yingshui Yao, Zhengmei Fang, Song Yang, Hailong Zhao, Yanchun Chen, Yuelong Jin, Xianghai Zhao, Lijun Zhu, Yuanrui Tian, Chong Shen
    Nitric Oxide.2017; 70: 25.     CrossRef
  • Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin—Potential for Preventing or Slowing the Progression of Diabetic Complications
    Mark McCarty
    Healthcare.2017; 5(1): 15.     CrossRef
  • Effect of bilirubin concentration on the risk of diabetic complications: A meta-analysis of epidemiologic studies
    Bo Zhu, Xiaomei Wu, Yifei Bi, Yang Yang
    Scientific Reports.2017;[Epub]     CrossRef
  • Role of Bilirubin in Diabetic Vascular Complications: Can Bilirubin Predict More than Just Liver Disease?
    Jun Sung Moon
    Diabetes & Metabolism Journal.2015; 39(5): 384.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP